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Background: Proven health interventions, when implemented with high fidelity and 
adequate coverage, could save millions of maternal and newborn lives. In many low and 
middle-income countries, however, coverage levels of these interventions are still low. 
The mCARE program, implemented from 2011 to 2015 in Gaibandha district in 
Bangladesh, was implemented with the aim of developing and testing a mobile phone-
based system to improve healthcare-seeking behaviors of pregnant women during and 
after their pregnancy through health worker-delivered automated and personally 
scheduled Short Message Service (SMS) and home visit reminders. Despite the growing 
recognition of the potential benefits of mobile health (mHealth) in improving knowledge, 
care seeking, and treatment adherence, little evidence exists on the value of mHealth for 
money or affordability in developing countries.  
 
Methods: Following established guidelines (e.g. CHEERS, ISPOR), we present analyses 
of the costs, consequences and affordability of the study drawn from a wide spectrum of 
datasets from the mCARE project including system-generated data on utilization, 
financial records from implementation and technical organizations, interviews with local 
experts and stakeholders, observations of service provision and exit interviews with 100 
pregnant women in rural Bangladesh. Secondary data were also drawn from the literature 
and published national surveys. We used an ingredients-based approach to measure 
program costs by activity, and developed an Excel-based spreadsheet model to forecast 
program, provider and user costs and consequences for various alternatives and service 
delivery scenarios. The Lives Saved Tool (LiST) was used to model the number of lives 
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saved and disability adjusted life years (DALYs) averted stemming from increases in 
coverage over time. We tested the robustness of the results though deterministic and 
probabilistic sensitivity analyses using Monte Carlo simulations. Finally, based on cost-
effectiveness findings, we assessed the affordability of implementing the mCARE 
program using a budget impact analysis and cost-effectiveness affordability curves from 
the perspective of a budget holder. 
 
Results: At a cost of $12 per newborn death averted and $0.41 per DALY averted, the 
comprehensive mCARE program, which includes pregnancy surveillance and personally 
scheduled SMS and home visit reminders, is highly cost-effective from a program 
perspective, compared to a basic mCARE program, which does not include scheduled 
SMS and home visit reminders (Chapter 5). When delivered at scale over a 10-year 
analytic time horizon (2016 to 2025) and compared against a paper-based alternative, the 
comprehensive mCARE model costs $580,185 in the first year (2016) to start up and 
incrementally increases from $1,730,599 to $6,917,807 in the subsequent years (2017 to 
2025) with incremental geographical expansion to another district each year. An 
estimated 19,682 total lives (including maternal, neonatal, and stillbirth) would be saved 
as a result, over a 10-year period. This corresponds to an incremental cost per DALY 
averted of $47 (Chapter 6). Assuming a willingness to fund $1,080 per DALY averted, 
based on the Bangladesh gross national income (GNI) per capita, the program has a 97% 
probability of being highly cost-effective. Key activities driving costs and estimates of 
cost-effectiveness, include census enumeration, pregnancy surveillance, and supervision 
and training. The annual program budget impact of implementing the comprehensive 
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mCARE program versus the existing paper-based system in Gaibandha district is an 
additional $258,508 in the first year (2015) and $102,658 in subsequent years (2016 to 
2020) – without adjusting for inflation and excluding overhead costs (Chapter 7). Above 
a budget threshold of $2.5 million, the program has a 93% probability of being cost-
effective. Nationwide implementation of the comprehensive mCARE program would cost 
an estimated $47 million over the 2015-2020 period, comprising 0.9% of total annual 
health expenditure ($5.4 billion) and 2.5% of public health expenditure ($1.9 billion). 
 
Conclusion: The results suggest that implementing the comprehensive mCARE program 
in Bangladesh may be cost-effective and affordable. Study findings are based on the 
primary data of 690 pregnant women; additional data are needed to verify forecasted 
costs and consequences of implementation at scale. Assumptions of the translation of 
changes in coverage for key maternal and newborn health services, including antenatal 
care, facility delivery and postnatal care, are dependent on supply side factors – relying 
on adequate human resources, supplies and commodities, and other inputs associated 
with quality of care, the measurement of which was beyond our scope. Even given these 
limitations, the study findings provide information that can help project the resources 
necessary to fund the program, and the consequences of potential variations of cost inputs 
at different levels of scale, which can be used to guide efforts of the government of 
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Chapter 1. Introduction 
 
1.1 Problem statement 
 
Efforts to improve access to health service delivery systems have taken many innovative 
approaches since the Alma Ata Declaration of 1978, which demonstrated a global 
consensus that “primary healthcare service improvements are necessary to achieve a 
minimum standard quality of life”.[1] Much of the global disease burden and its impacts 
– especially maternal, newborn, and child deaths – could be addressed if existing, proven 
interventions were deployed at a large scale within a country’s primary healthcare 
system. In many low- and middle-income countries (LMICs), however, the household 
coverage levels of these interventions are still low. 
 
In light of the shortage of professional health workers and inadequate health 
infrastructures in LMICs, in the past decades, the use of community health workers 
(CHWs) has become an increasingly popular strategy to deliver primary health care at the 
community level.[2, 3] Many countries have developed large-scale national CHW 
programs (e.g. Pakistani Lady Health Worker program[4], Ethiopian Health Extension 
Worker system[5], and India Accredited Social Health Activist system[6]), recognizing 
the potential of CHWs to address several key obstacles of delivering primary health 
services beyond health facilities.[2, 7] CHWs, as members of the communities they serve, 
can facilitate informational and educational campaigns through existing social networks, 
enabling outreach to vulnerable populations such as women and children, who often have 




mHealth – the facilitation of improved healthcare services, health outcomes and provision 
of information via mobile and wireless technologies[9] – has created a unique 
opportunity to transform the way in which global health challenges can be tackled. In 
recent decades, numerous organizations have recognized the potential of harnessing 
mobile platforms[10, 11] and have begun to explore ways to employ mobile applications 
for strengthening the capacity of frontline health workforces and improving service 
access and quality in low-resource settings.[12]   
 
Several pilot mHealth projects have been conducted around the world. Their evaluations 
have revealed positive results to improve access, quality, efficiency of health service 
delivery as well as intended health outcomes.[13] Yet, few of these successfully piloted 
innovations have been taken to scale, with fewer still scaled up in a sustainable way.[14] 
Growing concern with the number of mHealth programs, consisting largely of pilot 
projects or small-scale implementations, acknowledge that the failure is partly due to a 
lack of knowledge on how to deliver proven interventions at scale, how to build capacity 
in countries, and determining what resources are needed. Accordingly, policymakers and 
donors are demanding evidence on the costs and effectiveness of health innovations that 
can help investments and decision-making to obtain governments’ buy-in and scale up 
mHealth programs in national health systems.[15] 
 
Similar to many other LMICs, in Bangladesh, lack of access to quality health services 
and a shortage of skilled health professionals still remain major health system 
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challenges.[16] The Bangladeshi government is recognizing the impact of mobile 
communication as an effective means of bringing healthcare services to the people, even 
to those in some of the most remote and resource-poor environments.[17, 18] In 
particular, given the fact that 70% of Bangladeshis live in rural areas and 85% of births 
take place at home[19], mHealth can be an effective solution for poor and marginalized 
populations, by increasing access to healthcare and health-related information.[20] 
 
To achieve universal health coverage as part of the United Nations Sustainable 
Development Goals and a health reform agenda, the Bangladeshi government promotes 
innovative approaches for strengthening the health workforce.[21]  A Lancet study also 
recommended community-based approaches and partnerships in pursuing innovations in 
health service delivery, through “rapid adoption of context-specific innovative 
technologies and policies that identify country-specific systems and mechanisms.”[22] 
Since 2008, the government has promoted the Digital Bangladesh 2021 initiative, which 
places special emphasis on information communication technology (ICT) for a broad 
range of public services.[23] 
 
This study presents evidence on the costs, consequences, and affordability of alternative 
packages of the mCARE program in Bangladesh, the core package of which includes 
pregnancy surveillance using mobile tools and scheduled SMS and CHWs’ home visit 
reminders to promote utilization of essential maternal and newborn care services.[24] 
Comprehensive and systematic pregnancy surveillance is the first step for a continuum of 
care of maternal and newborn health services in the population and the integrated health 
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information system within the health system. Surveillance can help determine the required 
amount of resources in financing, help the planning of when and how to distribute services 
in communities, ensure timely service and care administration, and facilitate management 
of treatment or crises. The addition of SMS reminders may serve to bolster timely and 
appropriate care-seeking, and ultimately save lives.   
 
Our study supports the policy interest and vision of the Bangladeshi Ministry of Health by 
examining alternative strategies for harnessing the potential of mHealth to improve service 
delivery and bolster demand. The study intends to contribute to the evidence on economic 
evaluations and affordability of mHealth interventions in Bangladesh and globally, which 
is currently limited. The study also expects to contribute to the literature on implementation 
research of scaling up mHealth programs, by providing a feasible model and contextualized 
input parameters of mHealth programs in LMIC settings. Accordingly, the study findings 
can serve as evidence to develop strategies and guidelines to introduce proven, cost-










The overall aim of this study is to examine the costs, consequences and affordability of 
alternative packages of the mCARE program in Bangladesh, the core package of which 
includes pregnancy surveillance using mobile tools and scheduled SMS reminders to 
promote utilization of essential maternal and newborn care services. The findings are 





Objective 1: To determine the incremental cost-effectiveness of a comprehensive 
mCARE program of SMS and home visit reminders to promote care seeking of maternal 
and newborn health services, versus a basic mCARE program in rural Bangladesh.  
 
Sub-objectives: 
• To describe specific activities and resource requirements for program 
development, from start-up to implementation  
• To evaluate program costs associated with the intervention and control groups 
• To evaluate health impact associated with the intervention and control groups 
• To determine an incremental cost-effectiveness ratio (ICER) between 




Objective 2: To forecast the incremental cost-effectiveness of a comprehensive mCARE 
program including pregnancy surveillance and care-seeking reminders, compared to 
paper-based systems, from 2016 to 2025 in the Rangpur Division of Bangladesh. 
 
Sub-objectives: 
• To develop scenarios and required input parameters  
• To identify data sources and assumptions of input parameters associated with 
each scenario 
• To determine program costs associated with each scenario 
• To determine provider and user costs associated with each scenario 
• To evaluate health impact associated with each scenario 
• To determine ICERs among the following scenarios: comprehensive mCARE 
program, basic mCARE program, and paper-based groups 
 
Objective 3: To determine the affordability of a comprehensive mCARE program 
implementation, compared to a paper-based system, over the 2015-2020 period in 
Gaibandha district in Bangladesh. 
 
Sub-objectives:   
• To develop scenarios and required input parameters  
• To determine the affordability curve  
• To determine the cost-effectiveness affordability curve 
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• To determine the financial expenditures of implementing the program 
• To estimate the budget impact on nationwide scale-up of the program in the 
context of national health expenditures 
8 
 
1.3 Organization of the dissertation 
 
Below is an overview of consecutive chapters. 
 
Chapter 1 provides the problem statement, study goal and objectives, and organization of 
the dissertation.  
 
Chapter 2 provides background on the country of Bangladesh to understand the research 
context. It presents the demographic and epidemiologic profiles of the country and an 
overview of health system governance and financing as well as the country’s health 
information systems. 
 
Chapter 3 summarizes the literature on mHealth and economic evaluation. This section 
describes the opportunities and challenges associated with mHealth in low- and middle-
income countries (LMICs), economic evaluation in public health, eHealth and mHealth 
economic evaluation, and cost-effectiveness studies of maternal and newborn health 
(MNH) services in LMICs.  
 
Chapter 4 explains the methodologies used in the study, describing the preparation, data 
collection and analysis strategies for both costing and effectiveness, and cost-effectiveness 
analyses steps based on a standardized guideline. 
 
Chapters 5-7 present the analysis and findings of the four research objectives. Chapter 5 
examines the cost-effectiveness of the comprehensive versus basic mCARE programs; 
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Chapter 6 forecasts the cost-effectiveness of the comprehensive mCARE program 
implemented at scale across one district as compared to existing paper-based systems; 
Chapter 7 provides an evaluation of the affordability and financial impact of the 
comprehensive mCARE program. 
 
Chapter 8 summarizes the main findings, discusses the relevance of the study results and 
describes challenges of the study, policy and program implications, and recommendations 
to policymakers in Bangladesh and the Ministry of Health. This chapter also describes 




Chapter 2. Background 
 
2.1 Demographic and epidemiologic profile of Bangladesh  
 
Country overview (geographic, political, economic overview). Bangladesh is a country 
located in South Asia and is one of the world’s most densely populated countries, with a 
population of more than 160 million in a land mass of 147,570 square kilometers.[25] 
Bangladesh is a lower-middle-income country with a gross national income (GNI) per 
capita of $1,190 and an estimated gross domestic product (GDP) per capita of 
$1,572.[26] About 50% of the population live with an income of less than $1 a day and 
two-thirds live on the agricultural industry in rural areas. Income inequality is high in the 
country, with a Gini coefficient index of 33.2 – the 11th largest in the world.[26] Despite 
a number of major challenges the country faces, including poverty, corruption, political 
turmoil and frequent natural disasters, the past decade has been marked by sustained 
growth, stable macroeconomic management, a significant reduction of poverty, rapid 
social transformation, and in particular, human development. Bangladesh has made more 
notable gains in a number of health indicators especially when compared to some of its 
neighboring countries that have higher income per capita, such as India and 
Pakistan.1[28][29]  
 
                                                     
1 “During the past decades, Bangladesh has made more notable gains in a number of indicators than some of its 
neighboring countries, which have higher per capita income. For instance, GDP per capita in Bangladesh ($1,777) was 
half that of India ($3,650) in 2011, and lower than that of Pakistan ($2,567), yet average life expectancy, percentage of 
children immunized against diphtheria and measles, and the literacy rate for young women were higher in Bangladesh 
than in Pakistan and in India (Baxter, 2003). In the two decades between 1990 and 2010, under-five mortality has fallen 
by more than 60%, while infant mortality and neonatal mortality have declined by around half (Table 1.3). The under-
five mortality rate (46 deaths per 1,000) in Bangladesh is significantly lower than India (41 per 1,000) and Pakistan (86 
per 1,000).” Source: World Health Organization, Bangladesh Health System Review. 2015: p. 1-214. 
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Demographic status. Bangladesh’s population has gone through the second stage of its 
demographic transition (i.e. the population grows rapidly as the death rate begins to fall 
while birth rates remain high) and is now in the third stage of the transition (i.e. the 
population growth rate decreases as birth rates start to decline).[30] The population 
growth rate has declined to 1.7% due to continuous reductions in mortality and fertility 
rates over the past decades. Yet, the population is expected to continue growing due to a 
large population of reproductive age (Figure 1.1). While the mortality and fertility rates 
remain relatively high compared to other countries, Bangladesh has made significant 
progress in reducing maternal and child mortality rates as well as the fertility rate. 
According to UNICEF’s 2009 estimates, the crude death rate is 7 per 1,000 and crude 
birth rate is 21 per 1,000 (Table 1.1). Total fertility rate is 2.3 births, and life expectancy 
at birth is 66 years. During the 1960s and 1970s, Bangladesh's population growth rate 
was among the highest in the world at 2.5%, and the total population nearly doubled 
during the two decades from 65 to 110 million.[30] However, the population started to 
decrease since the 1980s due to a considerable reduction in fertility through successful 
family planning and birth control programs, and as a result, population growth has 
declined to about 1.5%.[30] 
 
Epidemiologic transition. With the decline in birth and death rates and an increase in the 
proportion of mortality due to noncommunicable diseases (NCDs), Bangladesh has 
entered the epidemiological transition.[31] Bangladesh now faces a double burden of 
disease with acute, infectious, and parasitic diseases as well as noncommunicable, 
degenerative and chronic diseases. There has been a substantial change in the leading 
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causes of mortality in Bangladesh over the last two decades. Mortality from 
communicable, maternal, neonatal and nutritional disorders fell dramatically from 583 
deaths per 100,000 in 1990 to 178 deaths per 100,000 in 2010. This decline was 
principally the result of decreases in childhood infectious diseases, together with declines 
in maternal mortality and nutritional deficiencies. Mortality rates from NCDs remained 
steady at around 360 deaths per 100,000 population.[32] However, death rates from 
cardiovascular and circulatory diseases, including ischemic heart disease rose. Death 
rates from cancers and other NCDs remained fairly steady. Mortality rates from injuries 
also fell significantly during this period.[34] 
 
Progress in health status. Bangladesh has made sustained and remarkable progress in 
many areas of maternal and child health in recent decades. The country is one of only 
nine Countdown countries that were on a successful track to achieve the fifth Millennium 
Development Goal (MDG) by 2015.[33] The maternal mortality rate significantly 
decreased from 322 deaths per 100,000 live births between 1998 and 2001, to 194 deaths 
per 100,000 live births from 2007 to 2010, an annual rate of decrease of 5.6%.[33] In 
terms of child (age 12-59 months) health, Bangladesh is one of the few countries that 
were on track to achieve MDG 4 (reducing the under-five mortality rate by two-thirds by 
2015). The significant progress in improving child health has reduced the country’s child 
mortality rate by more than half, from 133 deaths per 1,000 live births in 1990 to 53 
deaths per 1,000 live births in 2011.[34] The infant mortality rate has also declined 
considerably, from 87 per 1,000 live births in 1990 to 43 per 1,000 in 2011.[27] There are 
several factors that have contributed to the significant improvement in maternal and child 
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health in Bangladesh.[27] Among them are improved access to essential health programs 
such as the Expanded Program on Immunization (EPI), oral rehydration therapy (ORT), 
and antenatal care (ANC), the use of skilled birth attendants and family planning, higher 
levels of women’s education, and improved economic conditions.[21, 22] 
 
Remaining challenges. Although it is improving, the maternal health status remains poor 
for many women in Bangladesh. Around 50% of Bangladeshi women suffer from chronic 
malnutrition with a body mass index less of than 18.5.[34] Low birth weight incidence is 
estimated at 45%, and multiple micronutrient deficiencies are often found among 
pregnant women. In terms of causes of maternal deaths, 69% are due to direct obstetric 
causes, 14% are related to injury and violence, leaving 17% of maternal deaths due to 
indirect causes.[34] The most common obstetric causes of maternal deaths are postpartum 
hemorrhage (31%), eclampsia (20%), complications of unsafe abortion (1%), obstructed 
labor (7%), and postpartum sepsis (5%), and other direct and indirect causes (35%).[35] 
Currently, neonatal (a life less than one month) deaths contribute to more than two-thirds 
(70%) of infant (a life less than one year) deaths and more than half (57%) of under-five 
deaths in Bangladesh.[36][37] Neonatal mortality declined at a slower pace than infant 
and child mortality over the last 20 years. Each year 171,000 neonates die in the country, 
the majority in the first month of life, with the most common cause of death being serious 
infections (24%), followed by birth asphyxia (21%), pneumonia (13%), and pre-term 
birth (11%).[34] The majority of these deaths occur in low-resource settings where most 
births occur at home. These neonatal losses can be prevented with simple interventions or 
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behavior changes such as exclusive breastfeeding or home-visiting postnatal care after 
childbirth.[38] 
 
Essential maternal and newborn care. Increased use of antenatal care (ANC) can 
potentially help decrease the high maternal mortality ratio. However, nearly two-thirds 
(63%) of mothers do not receive quality ANC in Bangladesh. The percentage of women 
who have had at least one ANC visit is 51% (among the total pregnant population), and 
the percentage having had at least four visits is only 21%. Within the small population 
receiving ANC, the difference between rural and urban areas is high. 59% of urban 
mothers receive ANC, while in rural areas only 28% do.[39] Many studies suggest that 
delivery of a child with a skilled birth attendant is one of the most important health 
interventions in reducing maternal mortality.[40] However, in Bangladesh only 31% of 
births are delivered at health facilities, and skilled attendants assist only 41% of women 
during childbirth. Furthermore, almost 62% of births are delivered at home, often in 
unsafe and unhygienic conditions. Traditional birth attendants assist 56% of births.[41] 
Again, there are significant differences depending on area of residence – professionally 
trained health workers attend 64% of births in urban areas, compared to only 8% in the 
rural areas.[34] The status of postnatal care (PNC) is even worse than ANC among poor 
mothers who do not deliver at a health facility – only 8%  receive PNC. In 2004, only 
18% of mothers received (PNC) from a trained provider within six weeks after delivery. 
There is a great room for improvement of maternal and newborn care in Bangladesh, 




2.2 Health systems in Bangladesh  
 
The governance of the public health system in Bangladesh is complex . The system 
remains highly centralized, with planning undertaken by the Ministry of Health and 
Family Welfare (MOHFW) and little authority delegated to local levels. The 
organizational structure of health services in Bangladesh follows the general 
administrative division of the country. While the MOHFW is responsible for overseeing, 
managing and regulating health, family planning and nutrition programs countrywide, 
health services are delivered by a complex mix of public and private institutions. For 
example, different ministries are responsible for primary health care in rural and urban 
areas. The MOHFW directly oversees primary healthcare facilities in rural areas, and the 
Ministry of Local Government, Rural Development and Cooperatives (MOLGRDC) is 
responsible for the urban areas. Family planning services are managed and delivered 
separately from other health services at all levels of the public health system.[27, 42] 
 
Public health system. Bangladesh’s public health system, which was established during 
the 1970s, reflects the country’s general administrative pattern.[50] The MOHFW 
directly oversees a network of health facilities (see Figure 2.1), which stretches from the 
national level down through seven divisions, 64 districts, 485 sub-districts (known as 
Upazilas), 4,501 unions and 13,503 wards.[50] Bangladesh has a well-established 
network of public health facilities across the country from field-based domiciliary 
services and facilities at different levels like village (e.g. community clinics), union (e.g. 
union sub-centers, union health and family welfare centers, etc.), Upazila (e.g. 31-50 bed 
Upazila health complexes), district (100-250 bed district hospitals), division (250-500+ 
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bed medical college hospitals) and several specialized hospitals (mostly in Dhaka).[27] 
The number of heatlh personnel in the public system is more than 100,000, including 
doctors, nurses, paramedics and community health workers; this accounts for 26% of the 
country’s total health expenditure.[43, 44] 
 
Nongovernmental organizations. There is also a substantial private not-for-profit health 
care sector. Largely enabled by donor funding, nongovernmental organizations (NGOs) 
have played an enormous role in Bangladesh since the country’s independence in 1971, 
stepping in to deliver health care services, respond to famine and natural disasters, and 
fight poverty during a time when the country lacked strong public institutions. There are 
more than 2,000 local and international NGOs working on health in Bangladesh [45], and 
many focus on providing primary health care services to the poor, including in urban 
slums. In 2007, 9% of the country’s total health expenditure was managed by NGOs.[27] 
 
Private Sector. Alongside the public system in Bangladesh is a large and heterogeneous 
private sector. The private spending accounts for more than three-fifths of the country’s 
total expenditure on health.[27] The private for-profit sector has been growing steadily in 
line with rapid urbanization. Some 45,000 formally trained doctors and nurses are 
employed in private secondary and tertiary care facilities.[44] However, private services 
are poorly regulated. 
 
Informal sector. There is a large cadre of health care providers in the country’s informal 
sector. This comprises semi-qualified allopathic providers (e.g. community health 
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workers, medical assistants, trained midwives), unqualified allopathic providers (e.g. 
drug shop retailers, rural doctors), traditional healers (e.g. practitioners of Ayurvedic, 
Unani and homeopathic medicine) and faith healers.[43] It is estimated that there are 
more than 500,000 traditional medical and homeopathic practitioners, village doctors and 
drug vendors working, largely unregulated, countrywide.[43] They are not a part of the 
mainstream health system, and the quality of their services cannot be properly monitored. 
However, given that they comprise a major source of healthcare provision for the poor 
rural population, circumstances force the poor to compromise quality of healthcare, 
especially in remote rural and hard-to-reach areas.  
 
Health financing. Health services in Bangladesh are predominantly financed by 
households’ out-of-pocket payments, comprising 64% of total health expenditure. Of the 
remaining 36% coming from public financing, about 60% is financed by the government 
from tax revenues and development outlays, and the remaining 40% through international 
development assistance.[27] In 2012, total health expenditure accounted for 3.6% of the 
country’s GDP, lower than the average of 5% for other low-income countries, and well 
below the global average of 9.2%. Public allocations to fund the health sector comprised 
around 7.7% of total government expenditure. This was slightly lower than the average of 
8.1% for other low-income countries and well below the global average of 15%. Donor 
financing accounted for only 7% of total health sector expenditure in 2012. This was 





2.3 Health information systems in Bangladesh  
 
Digital Bangladesh. Being the world’s eighth largest country in terms of population, 
there are 134 million mobile phone users and 53 million Internet users in Bangladesh. 
The population is predominantly rural, with almost 80% living in rural areas and with 
limited access to education, health care, clean drinking water and proper hygiene. Most 
people living in the countryside are excluded from many of the facilities available in 
urban areas. The rapid spread of Information and Communication Technology (ICT) in 
Bangladesh over the past decade offers opportunities to solve some of these problems. In 
this vein, the country has declared its national vision on Digital Bangladesh 2020 since 
2007, which promotes the use of information technology (IT) for management, 
administration and governance to ensure transparency, accountability and accessibility at 
all levels of society and state.[18][47] The government’s effort to modernize Bangladesh 
through an ICT initiative was highly acclaimed by the world community. Bangladesh 
received the ICT’s Sustainable Development Award in 2015 from the International 
Telecommunication Union (ITU) and the South-South Cooperation Visionary Award in 
2014 from the United Nations for effectively using ICT in public service delivery and 
improving people’s lives, and in 2015 the nation was elevated from the World Bank’s 
low-income status to lower-middle-income status.  
 
There are a number of areas and ongoing initiatives where ICT can tap into the potentials 
not only within health but also in education, agriculture, climate change, and mobile 
banking. For instance, in the health sector, lack of access to quality health services and a 
shortage of skilled health professionals are major system challenges in Bangladesh. 
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mHeath – the facilitation of improved healthcare services via mobile and wireless 
technologies – has the potential to open access and deliver healthcare services at low 
costs in collecting surveillance data, sending SMS text messages for health promotion, 
using sensors for diagnostic support or using calls for basic consultation.   
 
In the education sector, ICT can harness the potential of Bangladesh’s large unutilized 
and unemployed youth workforce through technical and vocational education and 
training by employing appropriate education and training into a skilled, "ICT-capable" 
labor force. The use of ICT can also help poor, remote populations and women access 
education and gain skills that can increase their chances of finding better employment.  
 
A third area where ICT can provide value is the agriculture sector, which by itself 
employs 44% of the labor force and comprises around 21% of the total GDP. ICT can 
help provide important information to farmers such as weather forecasting, production 
and cultivation advice about diseases and insects, and the latest information on price. ICT 
can empower rural farmers to make informed decisions about their production and can 
facilitate market linkages by connecting them to distributors and retailers.  
 
Climate change is another area in which ICT can have a positive impact. Bangladesh is 
highly vulnerable to climate change and recurrent natural disasters such as floods, 
cyclones or riverbank erosion due to its location and topography. Besides the traditional 
ICT media such as radio or television, rapid advancement in ICT in the form of the 
Internet, Geographic Information System (GIS), remote sensing and satellite-based 
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communication can facilitate the process of preparedness, response and mitigation 
through better forecasting, early warning systems, and effectively coordinating relief 
efforts.  
 
Fifth and finally, ICT can make mobile banking more effective. About 60% of 
Bangladeshi adults do not have any formal bank account, which limits access to financial 
services. Moreover, around 6 million Bangladeshis work abroad and send about $13 
billion annually back to their families, which accounts for more than 10% of the 
country’s GDP.[48] Mobile banking can allow millions of previously unbanked people 
and migrant workers to send remittances via mobile phone to family members in the 
villages from which they came.  
 
eHealth/mHealth initiatives. A recent study showed that there are 26 eHealth and 
mHealth initiatives in Bangladesh.[49] Popular eHealth programs include “video 
conferencing, a uniquely designed monitoring cell at health management information 
system (MIS) in reducing doctors’ absenteeism from remote health facilities; 
telemedicine networks over eight hospitals; free-of-charge mobile phone health services 
available in all of 418 Upazilas and 64 district hospitals”. [44] There are also a number of 
mHealth services, such as SMS-delivered advice for safe pregnancy, and use of mobile 
phones as a data collection tool. The most common initiatives include tele-consultation, 




Bangladesh is beginning to establish country-level health information systems such as 
District Health Information Systems (DHIS2) and Open Medical Record Systems 
(OpenMRS) that enable national aggregate record-keeping and facility-level medical 
records via a robust, low-cost, open-source platform. OpenMRS is a powerful tool for 
data collection, allowing huge amounts of detailed information to be compiled about 
individual cases. DHIS2 is a tool for aggregating, compiling and analyzing data. By June 
2014, data was being captured directly in DHIS2 at more than 4,500 health facilities from 
the national level down to the union level, and at 3,500 of the country’s 13,500 
community clinics.[50] 
 
Other initiatives both within and outside the health sector such as MOVE-IT 
(Measurement of Vital Events through IT)[51], NPR (National Population Register) and 
Civil Registration (Birth and Death Registration) can help improve data availability and 
utilization. Recently, the Prime Minister’s Office started to receive sufficient resources 
for SDMX-HD (Statistical Data and Metadata Exchange-Health Domain) from WHO 
(which provides a standard set of core indicators with data definitions, standards, 
standard sources of data, mechanisms of data collection, utilization of data, and more), 
ICD-10 (International Classification of Diseases)[52], HL7 (vocabularies of health 
information communications), Open MRS and Care2x (Open source software for 
Hospital Information System)[53], iHRIS (Open source software for Integrated Human 
Resource Information System), and Open ELIS (Open source software named District 




Challenges of health information system (HIS). Bangladesh’s HIS is highly 
fragmented. Each health care provision sector has their own routine data collection 
method with various service delivery channels. For example, the public sector operates a 
routine surveillance and multiple information systems, connecting different level of 
health facilities. Large NGOs, such as BRAC, have their own information systems, often 
designed to meet the monitoring and evaluation requirements of donor agencies. Other 
private providers use their own systems for various purposes such as managing patient 
records, drug supplies and human resources.[50] Each system uses its own platforms, 
definitions of terms, standards for capturing data and procedures for collecting and 
analyzing information. The result is siloed data, which makes it challenging to understand 
population health and health system performance in a given region.[50] 
 
By collecting data on the same indicators yet using their own systems, different 
departments and programs would generate differing results. Multiple overlapping 
reporting systems result in unnecessarily heavy paperwork and poor data quality, which 
affects timeliness, completeness, and accuracy. The data may be useful to those running 
individual information systems, but this method of information collection makes it 
extremely challenging to obtain an accurate overview of service coverage distribution of 
antenatal care, delivery care, or treatment of sick children by different types of providers. 
As a result, these health data are rarely used for national-level health planning. Such 
weak routine information systems also hamper the management of health services at a 
decentralized level. Local health planners or facility managers are less likely empowered 
and seldom use data to improve outcomes in their facilities from such one-way 
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information flows – “where data is collected at the point of delivery, then compiled into 
summary reports and sent upwards through vertical hierarchies”.[50]  
 
An effective health information system brings together information from a wide range of 
population- and facility-based data sources – censuses, civil registration systems, 
population surveys, health service records and health facility surveys – to generate an up-
to-date information of the population health.[54]  Further, the performance of a country’s 
health information system depends not only on data sources, but also upon certain policy, 
administrative and organizational prerequisites, which allow the institutions that produce 
and use health information to interact effectively with one another. In Bangladesh, the 
absence of these prerequisites and fragmented health information systems have prevented 
policymakers from monitoring population health in a timely manner and targeting 




Figure 2.1  Population pyramid for Bangladesh 
 
Reference: US Census Bureau. 
(URL: http://www.census.gov/population/international/data/idb/country.php Retrieved February 5, 2017) 
 
 
Table 2.1 Demographic and economic indicators for Bangladesh 
Indicators Year Value Source 
Demographic Indicators: 
Total population 2015 160,995,642 World Bank 
Annual population growth rate (%) 2016 1.02 U.S. Census Bureau   
Sex ratio (male/female) 2015 1.026 Bangladesh Health 
Bulletin 
Population growth rate 2015 1.37% Bangladesh Health 
Bulletin 
Population density (people/sq km) 2015 1108 World Statistics Pocket 
Book Series 
Distribution of population 
(rural/urban) 




Crude death rate (per 1,000 
population) 
2014 5.40/1,000 World Bank 
Crude birth rate (per 1,000 population) 2014 19.80/1,000 World Bank 
Life expectancy at birth 2015 71.63 Human Development 
Report  
Urban population (% of total) 2014 34.28% World Bank 
Total fertility rate 2014 2.18 World Bank 
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Contraceptive prevalence, any 
methods (% of women ages 15-49) 
2015 62.4% World Bank 
Total adult literacy rate (population 
15+ years) (%) 
2014 61.49%  
Economic Indicators: 
GDP (current US$) 2015 $195.079 billion World Bank 
GNI per capita, Atlas method (current 
US$) 
2015 $1,190 UN Data 
% population with an income of less 
than $1.25 PPP per day 
2010 43.3% World Bank 
Health expenditure, public (% of total 
health expenditure) 
2014 23.1% World Bank 
Health expenditure, public (% of 
government expenditure) 
2014 15.91% World Bank 
Health expenditure, public (% of GDP) 2014 5.99% World Bank 
Out of pocket payments as proportion 
of total health expenditure 
2014 63.3% World Bank 
Voluntary health insurance as 
proportion of total health expenditure 
2015 0.1% Bangladesh National 
Health Accounts 
Proportion of households experiencing 
catastrophic health expenditure 
2013 9% Rahman MM et al [56] 
IBRD/IDA Operations Approved by 
Fiscal Year 
2016 $493.71 million  
Income or wealth inequality (Gini 
coefficient) 
2015 32.1 Human Development 
Report 
Healthcare Workforce Indicators: 
Number of doctors per 1,000 
population 
2006 0.26 World Health Report  
Number of nurses per 1,000 population 2006 0.14 World Health Report 
Estimated number of community 
health workers per 1000 population 
2013 1.37 El Arifeen et al[57] 
Relative geographical distribution 
(rural/urban) of 
doctors/nurses/community health 
workers (CHWs), respectively 





Ahmed SM et al.[58] 
 
Proportion of informal providers, and 
practitioners of traditional 
complementary and alternative 
medicine (TCAM), out of the total 

















Table 2.2 Burden of disease in Bangladesh 
 Value Reference 
World Health 
Organization region  
South-East Asia Region WHO 
Mortality stratum Sear-D WHO 
Three most populous 
countries in this stratum 
(Under-five mortality rate) 
Country 1: India (69) 
Country 2: Bangladesh (52) 
Country 3: Myanmar (98) 
UNICEF 2008 
Total DALYs lost in this 
stratum 
426,573 World Health Report 
DALYs lost to 
communicable, maternal, 




World Health Report 
Top three causes of DALY 
loss for this category 
 
Infectious and parasitic diseases (88,953 
DALYs 
Perinatal conditions (39,147 DALYs) 
Respiratory infections (33,026 DALYs) 
World Health Report 





World Health Report 
Top three causes of 
DALYs lost for this 
category 
 
Neuropsychiatric conditions (48,314 
DALYs) 
Cardiovascular diseases (42,987 
DALYs) 
Sense organ diseases (22,368 DALYs) 
World Health Report 
DALYs lost to injuries 55,547 (13%) World Health Report 
Top three causes of DALY 
loss for this category 
 
Unintentional injuries (Road traffic 
accidents) (10,016 DALYs) 
Intentional injuries (Self-inflicted) (7,191 
DALYs) 
Unintentional injuries (Fires) (6,554 
DALYs) 
World Health Report 
Maternal mortality ratio 
(per 100,000 live births) 
176 The World Bank (2015)  
Infant mortality rate 
(per 1,000 live births) 
31 The World Bank (2015)  
Under-5 mortality rate 
(per 1,000 live births) 
38 The World Bank (2015)  
Top five main causes of 
death (ICD - 10 
classification) 
 
Diseases of the circulatory system 
(33.2%) 
Perinatal conditions (15.93%) 
Diseases of the respiratory system 
(13.9%) 
External causes (injuries) (11.02%) 
Injury & poisoning (9.26%) 
Diseases of the nervous system (3.89%) 
Bangladesh Health 
Bulletin 2014.  
Note: Figures based on 
combined reports from 
all public hospitals in 
Bangladesh and 










Source: World Health Organization. Julie Evans and Md. Imtiaz Alam B. Pharm, PRIMARY CARE 




Figure 2.3 Timeline of relevant policies to primary healthcare and ‘Digital Bangladesh’ 
 
Source: Modified from World Health Organization. Julie Evans and Md. Imtiaz Alam B. Pharm, PRIMARY CARE SYSTEMS PROFILES & PERFORMANCE 
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Chapter 3. Literature review 
 
3.1 Remaining challenges in maternal and newborn health in low- and middle-
income countries 
 
Globally, about 830 women died every day in 2015 due to complications related to 
pregnancy and childbirth, resulting in more than 303,000 maternal deaths a year[59], with 
99% of these deaths occurring in developing countries.[60] Of such deaths, the largest 
proportion is avoidable complications such as obstetric hemorrhage, mostly during or just 
after delivery, followed by eclampsia, sepsis, complications of unsafe abortion or indirect 
causes such as malaria and HIV.[61] Additionally, nearly 3.5 million babies die each year 
in their first month of life from largely preventable or treatable conditions such as birth 
asphyxia, prematurity and neonatal infections.[62] As the United Nations Millennium 
Development Goals (MDGs) 4 and 5 had set country targets to reduce the maternal 
mortality ratio (MMR) by three-quarters and the under-five mortality rate (U5MR) by 
two-thirds by 2015, governments have sought to identify promising solutions to improve 
the delivery of effective life-saving interventions, although often with limited financial 
and human resources.  
 
3.2 mHealth opportunities and challenges in low-and middle-income countries 
 
Opportunities for mHealth. “mHealth enables the facilitation of improved healthcare 
services, health outcomes and provision of information via mobile and wireless 
technologies.[63], thereby creating a unique opportunity to transform the way in which 
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global health challenges can be tackled. At the end of 2013, there were more than 6.8 
billion mobile subscriptions worldwide, with 89% in developing countries.[64] Most 
people living on no more than $1 per day have access to mobile phones, which have 
leapfrogged the pace of conventional landline infrastructure development. Numerous 
organizations have recognized the potential of harnessing mobile platforms[11] and are 
exploring ways to employ mHealth innovations to improve the delivery of maternal and 
neonatal health interventions and practices. Among the persistent health system 
challenges of improving maternal and newborn indicators are the lack of timely and 
actionable disease surveillance, a shortage of professional health workers, delays 
throughout the health delivery system, poor supply chain management and use of 
counterfeit drugs.[65] Driving the many experiments with mHealth is a belief that such 
strategies can help to overcome health system challenges through improved access, 
efficiency and quality while reducing cost and time.[66] mHealth initiatives also show 
promise in reaching underserved populations, particularly those in the developing world, 
changing health behaviors and outcomes, and addressing a wide variety of healthcare 
challenges.[10] The mobile platform presents the unique capability to strengthen the role 
of community health workers (CHWs) to deliver higher quality healthcare services 
wherever people are –not just in healthcare facilities”.2[67, 68]  
 
Key functions of mHealth in developing countries can be categorized into three types: 1) 
Data collection for surveillance (e.g. risk assessment and classification, vital event 
tracking)[69][70][71]; 2) SMS reminders for health promotion or service 
                                                     
2 An excerpt from a published article by the author: Jo et al. Using the Lives Saved Tool (LiST ) to Model mHealth 
Impact on Neonatal Survival in Resource-Limited Settings, PLOS One, 2014. 
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adherence[72][73][74]; and 3) Emergency medical referral[75] and point-of-care 
support[76], often through two simple functions, voice communication[77] and 
texting[78], and sometimes with customized applications linked to more complex back-
end, or server-side, messaging and information services. One key mHealth function is 
data collection for census enumeration or disease surveillance. Some studies show 
positive benefits in terms of reduction of errors and time as well as cost savings 
compared to paper-based systems.[79] For example, Mobile Technology for Community 
Health (MOTECH)[80][81] and Cell-PREVEN[82] used mobile phones and personalized 
digital assistants (PDAs) for data collection and automated patient tracking management 
to help CHWs register, identify, and track women and newborns in their area who need 
healthcare services. In a similar fashion, mobile phone applications can be used for 
decision support in treatment compliance. For example, Electronic Integrated 
Management of Childhood Illness (eIMCI)[83] has been used to guide point-of-care 
support to reduce mortality and morbidity among children under five years of age. The 
system is designed for CHWs to adhere to standardized Integrated Management of 
Childhood Illness (IMCI) protocols, developed by the World Health Organization and 
UNICEF.[84][85] 
 
A second key function of mHealth is the use of SMS applications to promote healthy 
behaviors by helping patients adhere to timely drug intake, and reminding them of 
appointments. For example, during the maternal postpartum or neonatal postnatal period, 
Mobile Alliance for Maternal Action (MAMA)[78, 86][87] and Mobile for Reproductive 
Health (m4RH)[88] used voice communication and SMS texting to remind clients of their 
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scheduled antenatal care (ANC) or postnatal care (PNC) visits and to promote behavior 
change communication (BCC) messages in the antenatal or early pregnancy period. To 
improve child health, Interactive Research and Development (IRD)[89], mTika[90] and 
M-SIMU[91] “use text messaging systems with cash incentives to facilitate routine 
immunization programs, sending reminders to registered parents when their child is due 
for immunization and/or to provide health promotion notifications for immunization 
campaign days. These programs help improve health-seeking and preventative behaviors 
of pregnant women, new mothers and their families such as antenatal care attendance, 
immediate exclusive breastfeeding, wrapping of the newborn, clean postnatal practices, 
and danger sign recognition”. 3 
 
mHealth can also facilitate emergency medical referrals. One way is by using a hotline to 
allow patients to request a service during an emergency crisis. The success of this type of 
mHealth strategy requires a well prepared, timely, organized health system that includes 
transportation access, medical commodities and equipment and skilled health 
professionals. In Uganda, the Rural Extended Services and Care for Ultimate Emergency 
Relief (RESCUER) Project[92] demonstrated the improved referral practice between 
traditional birth attendants and health posts to a large number of pregnant women, which 
led to a reduction of about 50% in the maternal mortality rate (MMR) in three years 
(although the evaluation was not based on an exclusive attribution to the mHealth 
intervention). 
 
                                                     
3 An excerpt from a published article by the author: Jo et al. Using the Lives Saved Tool (LiST ) to Model mHealth 
Impact on Neonatal Survival in Resource-Limited Settings, PLOS One, 2014. 
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Challenges of mHealth implementation. Ideally, mHealth strategies are expected to 
tackle both supply and demand side barriers in health systems. However, in reality, there 
may be multiple barriers on the ground that are challenging to overcome. First and 
foremost, stable Internet is critical to be able to use mobile phones, as is wireless 
technology and electricity connections. While the increasing use of mobile phones is 
widespread in many developing countries, critical challenges remain in remote or rural 
areas. In addition to limited or no network connectivity, many countries lack a common 
technical architecture that would enable interoperability and scale.[93] In this respect, 
studies and practitioners emphasize the need for an agreed mHealth and eHealth technical 
architecture, including data exchange standards, to overcome barriers to integration and 
interoperability with relevant national health systems.[93] It is critical not only to enhance 
country ownership but also managing policy, business rules and incentives for 
entrepreneurship or public-private partnerships and information flow for better health 
provision.[93]  
 
Furthermore, given the multifaceted complexity and logistical challenges of scaling up 
health services, the effectiveness of mHealth is significantly affected by fundamental 
conditions of health systems. These include stable technological platforms, literacy of the 
population, availability of well-trained healthcare providers, consistent and affordable 
drug supplies and geographical access to health facilities. For instance, while SMS 
reminders or call referrals could promote skilled birth attendance or facility delivery 
(SBA/FD), if geographical accessibility or availability of skilled health professionals are 
lacking, then an mHealth strategy is likely to have limited impact. Alternatively, if health 
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systems constraints are more related to low service utilization but not availability, 
accessibility, and affordability, then the reminder strategy may be able to effectively 
increase service uptake. Therefore, health systems strengthening as a whole would be 
critical to the success of mHealth for treatment compliance, since reminders to attend 
clinics in the absence of reliable services and a steady drug supply would not lead to 
desired outcomes. “In this respect, some successful mHealth strategies may incorporate 
additional incentive mechanisms (e.g. conditional cash transfer, voucher programs)[94, 
95] or access mobilization strategies (e.g. ambulance services)[96] together to promote 
care-seeking practices or facility delivery for pregnant women living in remote areas.”4 
 
3.3 Economic evaluation in public health 
 
In public health, policymakers are increasingly faced with difficult decisions with scarce 
resources and growing demand for healthcare services under financial constraints.[97] 
Such financial constraints are much more binding in developing countries. In this respect, 
economists argue that achievement of greater efficiency from scarce resources should be 
a major criterion in priority setting. Economic evaluation attempts to identify ways in 
which scarce resources can be allocated efficiently. Efficiency is concerned with how to 
compare between resource ‘inputs’ (costs, labor, capital or equipment) and intermediate 
or final ‘outputs’ (coverage of service provision or a number of lives saved).[98] Types 
of economic efficiency can be categorized based on the three different purposes of 
choice; 1) Technical (operational) efficiency, which concentrates on maximizing the 
                                                     
4 An excerpt from a published article by the author: Jo et al. Using the Lives Saved Tool (LiST ) to Model mHealth 
Impact on Neonatal Survival in Resource-Limited Settings, PLOS One, 2014. 
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achievement of a given objective within a given budget – “doings things right”; 2) 
Productive efficiency: choosing different combinations of resources to achieve the 
maximum health benefit for a given cost; 3) Allocative efficiency: a broader concept that 
focuses on choosing the optimal mix of interventions for a given level of expenditure, in 
the sense that they maximize health gains in a societal perspective – “doing the right 
things”.[99] Ultimately, the best choice in decision-making in economic efficiency 
implies that society makes choices that maximize the health outcomes gained from the 
resources allocated to healthcare.[100]  
 
Determining the best in the context of utilitarian philosophy suggests that economic 
evaluation of healthcare programs consist of four main forms: cost analysis, cost-
effectiveness analysis, cost-utility analysis and cost-benefit analysis.[101] Each form 
deals with costs but differs in the way that the consequences of healthcare programs are 
measured and valued.[101] The first type of economic evaluation, cost analysis, 
determines three important aspects: the viewpoint of analysis (scope of cost), type of cost 
(fixed and variable cost or capital or recurrent costs), and timing of the cost (techniques 
of discounting and annualization). The second form, cost-effectiveness, compares 
associated costs to the consequences of programs that are measured in the most 
appropriate natural effects or physical units, such as ‘years of life gained’ or ‘cases 
correctly diagnosed’. Cost-effectiveness analysis (CEA) may present an array of output 
measures alongside cost and allow decision-makers to determine the relative importance. 
On the other hand, a cost-utility analysis (the third type of economic evaluation) 
considers the value of the outcomes, adjusted by health state preference scores or utility 
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weights (i.e. states of health associated with the outcomes are valued relative to one 
another). The most common measure of consequences in cost utility analysis is the 
Quality Adjusted Life Years (QALY). Lastly, cost-benefit analysis attempts to value the 
consequences of programs in money terms, so as to make them commensurate with the 
costs. This can help assess whether the benefits of a program justify the costs. In this 
study, the net benefit of a healthcare program could be determined by a threshold value of 
the decision-maker’s willingness to pay for a life-year or QALY.[101, 102]  
 
Costing tools in public health. Numerous costing tools have been developed to estimate 
the cost and impact of strategies to reach the Millennium Development Goals (MDGs). 
To harmonize the various approaches to costing and budgeting health sector plans and 
activities, several international development partners conducted a technical review of 13 
selected costing tools in 2015.[103][104] The findings show that while each tool has a 
different approach and logic (framework, formulas and parameters), costing involves two 
basic production functions: intervention and health. The intervention production function 
is based on a combination of inputs (labor, drugs, medical supplies, equipment, vehicle, 
mobile phone, training, etc.) to produce a given intervention (or output). The sum of the 
input price in conjunction with input quantity can generate total intervention quantity and 
total intervention costs. For each intervention, based on a ingredients approach, costs 
were estimated using country-specific prices and quantities of goods and services needed, 
based on WHO’s evidence-based clinical guidelines[105][106-109] and expert opinions. 
The intervention production function is used to compute total intervention quantity and 
costs. The intervention cost is then calculated by multiplying the quantity of inputs by the 
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input prices. Following best practice protocols, the calculations for each of the 
interventions are determined according to a set of required resources (e.g. human 
resources, equipment, supplies, medicines, etc.). In addition to the direct costs of the 
intervention, other planning and management activity costs are also considered, such as 
a) program planning and management; b) supervision of services and staff; c) health 
education and promotion; d) advocacy and campaign and e) monitoring and 
evaluation.[104] Further, considering the efforts of strengthening the health system while 
scaling up coverage, additional elements were considered such as; a) upgrading and 
maintenance; b) acquiring means of transport and communication and c) human resource 
development (training and upgrading skills).[104, 110]  The second function, the health 
production function, is used to compute health outcome. Health outcome is generally 
calculated by multiplying the quantities of interventions produced by their effectiveness 
(e.g. effect size). Total intervention coverage is determined by dividing the intervention 
quantity by the size of the population, a subset of demographics. Demographic trends are 
partially influenced by disease prevalence and incidence. Total utilization of the 
intervention can be proportional to the total coverage based on demand and supply side 
factors in the health system. All these variables are considered over a set period of time 
and under specific geographic contexts as well as macroeconomic conditions. The 
findings of the review noted the significant complexities of the tools, which have limited 
transparency and usability as well as a lack of standardization in the use of terminologies 




WHO-CHOICE (CHOosing Interventions that are Cost-Effective). A standard cost-
effectiveness guideline follows WHO-CHOICE (http://www.who.int/choice/en/), which 
was developed in 1998 with the objective of providing policymakers with evidence to 
help them decide which interventions and programs maximize health given available 
resources. Using a complied regional database, WHO-CHOICE uses a country 
contextualization tool including disease models and costing tools that are appropriate to 
the local setting. Based on that, a WHO publication, “Methodology and Assumptions used 
to estimate the Cost of Scaling Up selected Child Health Interventions,” presented an 
ingredient-based approach to calculating financial requirements in implementing 
maternal and newborn health (MNH) interventions on a nationwide scale.[112] In terms 
of intervention and delivery mechanisms, costs were first estimated for 16 priority 
interventions, selected based on feasibility of implementation and ability to reduce child 
mortality and morbidity, and then were regrouped into seven strategic intervention sets 
according to the associated illness or condition and their level of delivery in the health 
system. In terms of specific inputs, costs are captured and divided into ‘patient costs’ and 
‘program costs’ considering a societal perspective. Patient costs refer to costs at the point 
of delivery, such as those related to bed days, outpatient visits, drugs, or transportation. 
Program costs include costs incurred at the administrative levels of the district, provincial 
or central levels – rather than the delivery point of an intervention to beneficiaries –  and 
components include such items as infrastructure, equipment, training, supervision or 
media campaigns.[112] These inputs are defined in accordance with current standards of 
treatment and are based on the general experience of health system requirements. The 
WHO-CHOICE team has developed CostIt (Costing Interventions templates) to help 
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calculate the economic costs of interventions, as well as to estimate financial costs.[113] 
WHO-CHOICE provides a set of separate templates for the reporting and analysis of 
costs at the program, hospital, primary health facility and household levels. 
 
Costs of scaling up. Although the phrase ‘scaling up’ is now frequently used in the 
international health literature, the meaning often is ambiguous. The notion is primarily 
used to describe the objective or process of expanding coverage of health 
interventions[114][115] and increasing the financial, human or capital resources required 
to expand coverage.[116] WHO-ExpandNet has defined scale up as “efforts to increase 
the impact of innovations successfully tested in pilot or experimental projects so as to 
benefit more people and to foster policy and program development on a lasting 
basis.”[115] 
 
Yet, little empirical work has been done on the cost of scaling up interventions. A few 
studies attempt to evaluate changing cost functions at different levels of coverage.[117] 
Ideally, tracking time series cost data by activity or intervention may be the best method 
for determining the cost functions.[118] However, such a method can be time-consuming 
and expensive. Thus, many studies use cross-sectional data (point-in-time measurements) 
and annualize over the lifetime of the intervention program to generate average costs or 
incremental costs compared with a control program. It is a widely used practice for 
studies to present average costs per recipient and multiply them by projected future need 
to calculate the total costs of scaling up. [119] However, the World Development Report 
1993 acknowledges caveats of such approaches and suggests that cost-effectiveness ratios 
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would vary with population coverage, though it did not provide clear guidance or 
methodology of how to address the difference.[117] 
 
There has been continued interest in understanding scaling up health interventions in 
efforts to achieve the MDGs.[120, 121] Some studies have reviewed the literature and 
suggested key issues on the cost of scaling up. WHO-CHOICE identified a number of 
factors that affect economies or diseconomies of scale: “geography and transportation, 
fixed costs of establishing a health infrastructure, human resources, and management 
transition costs.”[117] A systematic review by Johns and Tan Torres demonstrates that 
costs of scaling up an intervention vary according to the type of intervention and its 
particular setting as well as size of the population at risk, type of illness, demographic 
and socio-economic factors, geography and infrastructure, availability of health workers, 
and other characteristics of the health system in each country.[119] Taking into account 
these factors can be a complex and challenging task as each interacts differently 
depending on the intervention. Therefore, the study recommended that cost-effectiveness 
researchers address the heterogeneity in costs, outcomes, or cost-effectiveness with 
sensitivity analyses by accounting any observed and possible variations of inputs or 
subgroup analysis of populations or regions with different baseline characteristics.[122]  
 
In addition, many studies have looked at understanding various dimensions and 
constraints – from system, supply and demand aspects – of scaling up health 
interventions. First, in considering health systems, scaling up the coverage of priority 
health interventions not only requires additional financial resources but a capable health 
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system in delivering the interventions on a large scale.[123] The ability to scale up health 
service delivery can be influenced by multiple constraints[123, 124], including a lack of 
infrastructure and equipment[125]; inadequate drugs and medical supplies; shortage and 
distribution of qualified staff; weak management[126], technical knowledge and 
inadequate supervision.[127, 128] Hanson et al. demonstrated conceptual work on the 
constraints related to expanding coverage of health interventions, and categorized five 
levels at which barriers may occur: “(1) community and household; (2) health services 
delivery; (3) health sector policy and strategic management; (4) public policies cutting 
across sectors; and (5) environmental and contextual characteristics”.[127] Still, 
understanding these major constraints in health systems may not be enough to guide 
practical actions on how to account for or manage certain components in consideration of 
many others. Further, uncertainties and unpredictable change of political interests[129] 
and program management[130] are also major sources of variation in the scaling up 
process.  
 
Secondly, in terms of supply, human resources is highlighted as a major cost driver in 
many cost-effectiveness studies and an impediment in scaling up of health 
interventions.[131] [132, 133] Insufficient number of health workers, as well as problems 
with their distribution, range of skills and motivation are common critical challenges in 
low- and middle-income countries. Challenges like these cannot be simply be solved with 
additional funding. Building capacity and improving providers’ practice require 
time.[134, 135] Patient demand for services is a third important factor to consider when 
determining the cost-effectiveness and scale-up of a service.[136-138] Access barriers on 
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the demand side, such as acceptability or affordability, affect service utilization; this is 
especially true for poor or marginalized populations in remote regions.[139] In addition, 
lack of trust or poor quality of health provision often will dampen demand for 
services.[140] Lack of demand and utilization or physical, financial, or social barriers 
may lead to higher average or marginal costs; in other words, average costs can be lower 
where service demand and utilization are high.[141] Understanding these factors could 
help provide insights to develop an analytical framework for cost-effectiveness analyses 
as well as inform practical questions of planning, implementation, monitoring, and 
evaluation for scale-up.  
 
3.4 Economic evaluation of eHealth/mHealth 
 
eHealth economic evaluation. Confronting the challenges of increasing healthcare 
spending in recent decades, some innovative approaches to medical care delivery have 
been deployed in various forms such as health information systems (HIS) and telehealth. 
These innovations require significant upfront and ongoing costs; thus there has been 
growing interest in economic evaluations of such healthcare technologies to justify 
investment decisions.[142] However, economic evaluations of HIS or telehealth remain 
rare, and little evidence exists on how to present ‘value’ and how that value needs to be 
considered in relation to investment in the system to determine whether it is worth the 
cost.5 While these healthcare technologies involve different characteristics in terms of 
                                                     
5“There is general agreement that mHealth can be a cost-saving method to collect health data and widely disseminate 
health information to increase health knowledge and promote healthy behaviors. However, very few studies we 
reviewed included a cost analysis or a financial evaluation of any kind to confirm this assumption. In fact, a 
retrospective analysis of telemedicine projects noticed this gap, and concluded that cost analysis of future mobile 
technology interventions for health must be prioritized for better decision making (Kahn, Yangn & Kahn, 2010). Later 
studies and meta-analyses have affirmed the importance of cost analysis of mhealth interventions (Aranda-Jan et al., 
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their motivations, intervention settings, or value propositions, earlier studies in this 
similar domain provide relevant lessons for mHealth economic evaluation. In general, the 
value of health information has been characterized in terms of cost savings, system 
efficiencies (e.g. increased coverage or quality of services), or improved health outcomes 
(e.g. DALYs saved or improved health equity). In terms of methodological techniques, 
most papers have used historical costs to estimate future outcomes for a specified time 
period. Many adjust for inflation, discounting, and amortization or depreciation. 
Accounting for financial costs was the most commonly used method. The values were 
demonstrated as incremental cost-effectiveness ratios (ICER), return on investment, net 
present value, net benefit, operating margin, least cost, average cost, and cost 
savings.[143][144][145] Some rigorous studies used statistical methods such as t-test, 
chi-squared (χ2) test, linear and logistic regression, scenarios, econometric or financial 
modeling methods.[146][147] 
 
Health Information Systems, utilizing computerized information systems, have been 
widely deployed in hospital-based institutional settings to support physicians in managing 
order entry systems, medical records and billing systems, or medication and disease 
management systems.[142, 146] Some studies demonstrate favorable impacts to cost 
saving by reducing service utilization associated with hospitalizations, laboratory tests or 
medications.[148] Some studies show the value as “revenue metrics,” increases in cases, 
                                                     
2014; Eysenbach, 2011; Mbuagbaw, 2011; Mechael et al., 2012; Schweitzer and Synowiec, 2012; Zolfo et al., 2010). 
Still, few studies on mHealth have incorporated an extensive cost analysis, likely because most of the studies have not 
moved beyond the pilot phase.” Source: USAID, Measure Evaluation, Mobile Technology for Monitoring and 





patient days, or outpatient volumes[149, 150], and a few studies presented “clinical 
impact,” using adverse drug events. The value proposition presented in the studies ranged 
from process measures (e.g. diagnostic accuracy and agreement in reading of transmitted 
data, medication compliance, time spent on diabetes care for both patients and 
professionals, number of days to independent pouch change after abdominal surgery and 
colostomy and length of stay) and health-related outcome measures such as blood glucose 
levels, hypoglycemic events, percentage reduction in wound size and body mass index. 
Many studies used disease-specific surrogate measures related to future health statuses 
such as QALYs or DALYs.[146] 
 
Telehealth, utilizing telecommunications technology to improve service delivery and 
health outcomes, has been deployed at homecare or local health post settings to deliver 
healthcare services to patients who are remotely located or have limited access to 
specialty care.[151] Studies show that the use of telemedicine was most common in 
chronic disease management such as diabetes care and cardiology in a homecare 
setting.[152] Most studies suggest that telemedicine-related cost savings are related to its 
impact on health care delivery, reducing health service utilization such as “physician 
office visits, emergency department visits, number of hospitalizations, hospital 
readmissions, home visits, length of hospital stay, use of ambulance services, number of 
referrals, duration of consultations, number of laboratory tests, and avoided transfers and 
evacuations.”[153] Many studies in telehealth significantly consider how much telehealth 
can reduce travel time and costs, since one of the common objectives of telehealth is to 
reach those in remote areas.[154] Some studies demonstrate the impact of medication 
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adherence on the reduction of healthcare utilization and costs[155] through early 
detection of a condition, timely treatment, and the preventing need for further tests.[156]  
 
mHealth economic evaluation. Many studies present the potential benefits of mHealth 
to overcome traditional obstacles to the delivery of health services in developing 
countries – issues related to access, quality, time, and shortage of health workers.[157] 
Tools and frameworks, such as total cost of ownership model, for assessing costs have 
been developed and applied.[158][159] Schweitzer et al. compiled a list of potential 
mHealth outcomes that can be used in economic evaluations.[157] A few empirical 
studies conducted costing or cost-effectiveness studies in mHealth. Existing evidence of 
mHealth costing or cost-effectiveness studies can be summarized by two major types of 
strategies: (1) surveillance or survey tools for data collection[160-163] and (2) SMS 
reminders or video monitoring for treatment adherence.[164-170] Most studies[171] on 
using mobile phones for self-monitoring for asthma presented positive effectiveness and 
cost-savings for mHealth compared to paper-based or other conventional approaches. The 
perspective of costing was mostly based on program managers, accounting financial costs 
with a time horizon ranging from 2-3 months to 2-3 years. Only a few studies have 
conducted a systematic evaluation of costs or outcomes linked to such investments.[164, 
170] A recently published systematic review evaluated and summarized the mHealth 
cost-effectiveness studies by following the Consolidated Health Economic Evaluation 




The first type of study, on mHealth-facilitated data collection, compares the mHealth 
approach to paper-based systems based on accounting financial costs of implementation 
from a program manager’s perspective. Studies involved a community-based household 
survey or hospital-based study settings in developing countries. Studies reported total 
cost, setup costs and operational costs and derived average unit costs (e.g. cost per case, 
patient or attendance) and compared them to paper-based systems. Common benefits 
were reported on data accuracy, reduction in processing time and completeness. Most 
studies reported that the paperless system was less costly.[160-163] 
 
The second type of mHealth strategy is the SMS reminder approach. Rigorous economic 
evaluation studies were done on this approach for treatment adherence through various 
methods. A study of a pilot in Malawi found that “giving 75 CHWs cellphones for patient 
adherence reporting, appointment reminders, and physician queries saved the hospital 
$2,750 in fuel costs and doubled the capacity of the hospital’s tuberculosis program”. 
[173] Guerriero C, et al. considered the lifetime incremental costs and benefits of adding 
text-based support to smoking cessation practices. Using Markov modeling, the cost-
effectiveness was measured as 0.3 LYs per quitter; 0.5 QALYs per quitter.[164]  Under 
various conditions, the deterministic and probabilistic sensitivity analyses confirmed the 
mHealth approach is beneficial and cost-saving. In addition, Hoddinott et al.[166] 
examined the cost-effectiveness of telephone support for breastfeeding women and 
compared proactive and reactive calls in a randomized control trial study. Results showed 
incremental cost per change in breastfeeding behavior (any or exclusive breastfeeding at 




Furthermore, Zurovac et al.[165] evaluated costs and cost-effectiveness of text-message 
reminders to improve health workers’ adherence to Malaria Guidelines in Kenya with 
three implementation scenarios based on a randomized control trial setting: (1) Text-
messaging intervention under the trial condition; (2) Text-messaging intervention under a 
routine condition; and (3) Scaling up to the national level. The latter two scenarios were 
designed to estimate actual implementation costs in routine conditions managed by 
district public health nurses and then nationwide scaled-up costs. The study demonstrated 
that if mHealth can be adopted by the Ministry of Health (data collection conducted by 
district public health nurses), the costs would be 28% lower than the trial setting and if 
the program is scaled up nationwide, the major cost driver would be sending text 
messages. Sensitivity analyses were performed with higher program costs and lower 
effect sizes. The findings demonstrated economies of scale ($0.03 per additional child 
correctly managed) for implementing this intervention at the national level. In developing 
a scaled-up scenario, the study also addressed important considerations: (1) Reasonable 
frequency and duration of a text message reminder intervention; (2) Effectiveness of the 
intervention under a trial condition; (3) Differing effectiveness for different population 
groups (age, gender, region); (4) Potential change in effectiveness over a longer-term 
period; and (5) Integrated management of the most common outpatient disease. [165] 
 
Other two studies were found for mobile phone monitoring in treatment adherence for TB 
and asthma.[170, 174] Wade et al. conducted a comprehensive cost-effectiveness study of 
home videophones to improve direct observation in TB treatment in South 
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Australia.[170] An incremental cost-effectiveness ratio, comparing the video call and 
traditional forms (in-person) of observation, showed a favorable effect of mHealth with 
AUD$1.32 (95% CI: $0.51-2.26) per extra day of successful observation. One-way 
deterministic sensitivity analyses were conducted with various parameters (e.g. number 
of patients, type of patient, driving time, cost of technology, staff salaries, and length of 
service). Major cost savings can be driven from less staff time if implemented at a large 
scale.[170] Another randomized control study (performed in a UK primary care setting) 
on mobile phone-supported self-monitoring of asthma demonstrated that there was no 
significant difference in the change in asthma control or self-efficacy (based on scores of 
knowledge, attitude, and self-efficacy from a questionnaire, KASE-AQ). [174]   
 
3.5 Cost-effectiveness of maternal and newborn health services in low and middle-
income countries 
 
Substantial evidence exists on the effectiveness of maternal, newborn and child health 
(MNCH) services that have been widely studied over the past decades in efforts to 
achieve MDGs 4 and 5. Several studies have summarized the evidence on the 
effectiveness of these strategies to improve MNCH care in low- and middle-income 
countries.[175-177] Examples include “iron supplements to prevent anemia, tetanus 
toxoid immunization, magnesium sulphate for eclampsia, uterotonics to prevent and 
manage post-partum hemorrhage, hygienic cord care, immediate thermal care, exclusive 
breastfeeding, and management of neonatal sepsis, meningitis and pneumonia”.[178] A 
recent study in the Lancet journal estimated that increased coverage and quality of pre-
conception, antenatal, intra-partum, and postnatal interventions by 2025 could avert 71% 
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of newborn deaths.[179] However, given resource constraints, it is important to know not 
only what strategies are effective at improving coverage of MNCH interventions, but also 
whether the strategies are cost-effective.  
 
In this respect, a recent systematic review identified 48 publications on the cost-
effectiveness of strategies to improve the utilization and provision of MNH care in low-
income and lower-middle-income countries.[180]The most common theme of the 
synthesized studies focuses on community-based strategies and care during pregnancy. 
However, there was considerable diversity in the strategies used to improve MNH care, 
and also intensity and scale of implementation. Overall, the synthesis presented various 
demand and supply-side strategies that are cost-effective in enhancing the utilization and 
provision of MNH care and improving health outcomes.[180] Specifically, identified 
cost-effective strategies included the use of women’s groups[181, 182]; home-based 
newborn care using community health workers, volunteers and traditional birth 
attendants[183][184]; adding services to routine antenatal care[185]; a facility-based 
quality improvement initiative to enhance compliance to care standards[186]; and the 
promotion of breastfeeding in maternity hospitals.[187]  
 
The studies presented large differences in terms of the content, approach and methods 
used to estimate costs in economic evaluation. In terms of the study design, the vast 
majority of studies compared the strategy to the situation prior to or without the strategy, 
though seven studies were conducted in the context of cluster randomized trials. The 
effect of the strategies was measured using various indicators, such as the change in 
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maternal or newborn mortality rates, the percentage of pregnant women having at least 
three antenatal visits, or the proportion of facility births. These studies referred to health-
specific cost-effectiveness measures such as cost per life-year saved and cost per DALY 
averted or strategy-specific cost-effectiveness measures such as the cost per insecticide-
treated mosquito net (ITN) delivered, cost per facility-birth, or cost per home visit.  
 
Most studies reported the incremental cost-effectiveness of a strategy (either compared to 
an alternative strategy or doing nothing) and reported on sensitivity analyses that had 
been undertaken to explore uncertainty around the cost-effectiveness ratio. In most 
studies, the mHealth strategy was found to be more effective but also more costly than its 
comparator. Therefore, the decision on whether to adopt a strategy depends on the 
decision-maker’s willingness to pay for improvements in health or health care. Using 
GDP per capita as a benchmark to consider the measures such as the cost per DALY 
averted, cost per QALY gained and cost per life-year saved, the review considered cost-
effective all the strategies that report these measures.[108] Among the selected 16 high 
quality studies, 10 focused on or included ANC interventions, which are highlighted in 
Appendix 1. 
 
3.6 Importance and evaluation of antenatal care service delivery 
 
Why ANC? Today we have better evidence and knowledge about what works and what 
does not work in reducing maternal mortality and morbidity, and the role that antenatal 
care (ANC) can play. ANC is widely known as an accessible and cost-effective method 
for improving maternal and perinatal health outcomes. It offers the opportunity to 
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connect women to the health system, improve maternal and child health outcomes 
through treatment, prevention, and health promotion during pregnancy. It can also serve 
as a vehicle for integrated care of the multiple programs through an operational 
continuum of care. 
 
For example, ANC is particularly important in the early detection and management of 
hypertension (pre-eclampsia and eclampsia), and antepartum hemorrhage, two leading 
causes of maternal death.[188, 189] There is evidence of effective interventions including 
those on tetanus immunization, detection and treatment of anemia, prevention and 
treatment of malaria, and management of sexually transmitted infections (STIs).[123] 
These interventions, together with a combination of interventions to improve women’s 
nutritional status, can significantly improve fetal outcomes and improve maternal health. 
Moreover, ANC can help start discussions on breastfeeding and contraception, two 
critical interventions that should be reinforced and implemented in the postpartum 
period.[190] 
 
In particular, ANC can increase the access to and chance of using a skilled attendant at 
birth around labor and delivery – which is when most maternal deaths occur – through a 
birth and emergency preparedness plan. The plan includes “identification of the following 
elements: the desired place of birth; the preferred birth attendant; the location of the 
closest appropriate care facility; funds for birth-related and emergency expenses; a birth 
companion; support in looking after the home and children while the woman is away; 
transport to a health facility for the birth; transport in the case of an obstetric emergency; 
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and identification of compatible blood donors in case of emergency”.[191] A study 
conducted in rural Bangladesh showed that attendance of at least one antenatal visit was 
associated with increased odds (adjusted OR: 1.7 95% CI:1.5-1.9) of skilled attendance at 
delivery compared to women who received no ANC.[125] Improving the quality of ANC 
and sustaining its implementation should be key priorities. 
 
Considerations for ANC evaluation. In 2001, WHO published the conclusions of a 
randomized controlled trial of a new model of ANC and also carried out a systematic 
review of other randomized trials that looked at the effectiveness of different models of 
ANC.[192] This work has led to a growing consensus around a general recommended 
frequency of the visits (i.e. 4+ ANC visits) and key ANC elements that are likely to 
improve maternal and perinatal health outcomes.[193-197] 
 
Despite the broad consensus on what the content and quality should be, the actual service 
delivery of ANC currently provided in many parts of the world fail to meet WHO-
recommended standards due to various challenges and limitations faced in the field. In 
addition, available data in most surveys and studies provide no information on the 
specific content or quality of the services. Current efforts to monitor progress in ANC 
coverage (e.g. DHS and MICS surveys) have generally focused on quantifiable issues 
such as the number and timing of visits, type of care provider, characteristics of ANC 
users and non-users.[198] These indicators alone present missed opportunities to deliver 
essential care to the mothers, leading to sub-optimal effectiveness of the interventions. 
For example, in Bangladesh, 78% of pregnant women have at least one ANC visit, but 
53 
 
the percentage of women who make four or more antenatal visits from skilled health 
professionals was only 26% in 2011.[199] Further, there are also equity gaps in ANC 
uptake between the rich and poor and between urban and rural areas. For example, 
according to the 2011 Bangladesh DHS, 74% of urban women receive ANC from a 
trained provider, compared with only 49% of rural women. In terms of the median 
number of visits, women residing in urban areas make on average 1.3 visits more than 
rural women.[199] 
 
Moreover, in recent years, attention has been directed to the essential elements of the 
postnatal care package, to ensure that quality is not overlooked in favor of quantity. 
WHO emphasizes renewed interest on coverage, suggesting effective coverage as an 
intermediate goal for health system performance measurement.[200] Effective coverage 
involves multidimensional concepts encompassing traditional concepts of access, 
utilization and effectiveness. In his earlier work, Tanahashi (1987) presented a conceptual 
diagram on effective coverage, illustrating the five measures of coverage including: (1) 
Availability coverage (people for whom the service is available), (2) Accessibility 
coverage (people that can use the service), (3) Acceptability coverage (people that are 
willing to use the service), (4) Contact coverage (people who use the service) and (5) 
Effectiveness (people that receive care).[201] These factors address various aspects of 
health systems bottlenecks, including the physical availability of services, distance or 
time to a facility, economic costs associated with seeking and receiving care and services, 
cultural and social factors that may hinder access and quality and therefore the 
effectiveness of services offered. Tanahashi’s approach allows for assessment of the 
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capacity of the health system – both supply (service provision) and demand (service 
utilization) – to achieve effective coverage.[202] These efforts help identify gaps in ANC 
coverage and uptake and can, therefore, guide considerations for effective strategies 
towards improving access to healthcare for pregnant mothers. 
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Chapter 4. Methodology 
 
4.1 mCARE I study preparation, data collection, and data analysis 
 
mCARE program. mCARE is a mobile phone-based maternal and newborn health 
information system designed to connect rural frontline health workers with pregnant 
women and their families through a cloud-based server. The system is designed to 
standardize the way frontline health workers engage with their clients when performing 
their key responsibilities such as population enumeration, pregnancy surveillance, 
pregnancy registration and promoting the uptake of antenatal, postnatal and essential 
newborn care. To improve coverage and utilization of antenatal and postnatal 
interventions, the mCARE system reminds community health workers (via phone alerts 
and day-to-day scheduling systems) and pregnant women (via text messages) when a 
pregnant client is due to receive antenatal care (ANC) or postnatal care (PNC). 
Additionally, the program has an additional in-person component, where the health 
workers conduct household visits on the scheduled dates to remind the women to seek 
care.  
 
mCARE study design. For the pilot phase, we selected a quasi-experimental design, 
with two comparable regions within the broader, well-characterized JiVitA study site 
(one of the largest population research sites in the Gangetic region, established by, the 
Center for Human Nutrition at Johns Hopkins University), to serve as the intervention 
and comparison arms of the study. (Figure 4.1) In each arm, 20 community health 
workers (CHWs) were assigned to either the mobile or non-mobile group. Both groups 
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conducted mobile census enumeration and pregnancy surveillance, but only the mobile 
group’s clients received personally scheduled phone reminders and in-person reminders 
to access ANC and PNC. Women in the non-mobile arm did not receive personally 
scheduled reminders. The primary feature of the intervention being measured is whether 
personally scheduled reminder text messages have an impact on increased antenatal and 
postnatal care utilization and on reducing neonatal and maternal mortality. 
 
1) Research preparation 
 
The mCARE system was developed through intensive and collaborative efforts with 
various stakeholders of national and local health systems. The research preparation, 
which took place between from October 2011 to April, involved program development 
activities like building partnerships with local public and private stakeholders; 
performing key informant interviews to document process and information flow; 
developing digital forms for data collection; designing backend scheduling systems; 
testing system functionality and stabilization; developing training manuals and 
implementation protocols; training community health workers on mCARE system 
implementation; and debugging and system stabilization.  
 
For the first step in the research preparation stage, the JHU-JiVitA team formally 
launched the mCARE project in October 2011 in the JiVitA study area. The team 
organized an event and invited major stakeholders including health practitioners and 




In May 2012 the JiVitA field management team conducted key informant interviews to 
document process flows and information use within the government health system. 
After gaining an understanding of the overall health system and CHWs’ role and 
responsibilities, the team designed a series of manual forms for systematic census 
enumeration, pregnancy surveillance and registration, information on socio-economic 
status, and forms to verify the receipt and content of antenatal and postnatal care as 
well as during emergency events.  
 
JHU-JiVitA contracted mPOWER (a social enterprise of mobile information 
technologies and data) in August 2012 to provide technical system support to the 
mCARE project. The two teams jointly designed the scheduling logic and skip patterns 
to automate the future event reminders based on reported outcomes and events. These 
automation include the server-based calculation of up to four ANC reminders for every 
enrolled pregnant woman. The timing is based on the date of her last menstrual period 
(LMP) and the expected delivery date, as well as postnatal follow-up appointments for 
pre-term infants (if a birth notification was sent a week or more prior to the due date).  
 
In November 2012 the mPOWER programming team initiated the technical coding to 
develop the system platform through several iterative processes. The team field tested 
these platforms and feedback loops to optimize performance based on prior experience 
using the system. The Johns Hopkins investigators and the JiVitA field management 
team developed field implementation plans to guide data collection and management 




In May 2013 the JiVitA team procured and distributed Android phones to 40 female 
CHWs and eight team leaders who would supervise and support the CHWs and 
conduct verification interviews during implementation. The team conducted training 
with CHWs, team leaders, field supervisors, quality control teams and research 
physicians. During this process, the team observed the field workers’ enthusiasm about 
working with touchscreen phones and their ability to quickly learn how to manipulate 
the devices.  
 
In July 2013 JHU-JiVitA began implementing the mCARE system. Their tasks 
included a baseline master list of census and registration data of married women of 
reproductive age (MWRA) from the catchment areas, mapping of households, and 
pregnancy surveillance, using mCARE. The management team held intensive 
monitoring and evaluation sessions with the CHWs to understand challenges the 
workers faced and to evaluate whether the system was performing with fidelity in 
regards to the intended technical design and study protocols.  
 
2) Data collection 
 
From July 2013 to August 2013, JiVitA conducted census enumeration and ascertaining 
pregnancy status. Initially, CHWs visited each household in their catchment area to list 
all MWRAs in the community. Pregnancy status was ascertained by asking women if 
they are pregnant and by eliciting a history of menstruation in the previous month. All 
women who self-reported their pregnancies were asked permission to be registered with 
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the mCARE system. Additionally, women were asked questions regarding mobile phone 
ownership and use as well as whether they are able to read and send an SMS. During the 
first five weeks of census enumeration, the team registered around 12,000 MWRAs 
through the mCARE system.  
 
Between August 2013 and June 2014, CHWs conducted pregnancy surveillance and 
registration. Non-pregnant women were asked to consent in participating in the routine 
pregnancy surveillance, which entailed being visited at their home every five weeks by 
JiVitA CHWs, who would ask about their menstruation in the previous month. During 
the 10 months, a total of 800 pregnant women (400 in each study arm) were identified 
and enrolled.  
 
CHWs received consent from all women identified as pregnant for enrollment in the 
mCARE study. Based on the date of last menstrual period, the mCARE system scheduled 
up to four ANC visits, depending on the gestational age at enrollment. The server also 
sent reminders to CHWs to notify them to remind pregnant women in person of 
upcoming ANC or PNC visits. Accordingly, women who had access to phones in the 
intervention arm received these reminders on their phones during week 8, 16, 24 and 32 
for ANC care seeking. Women in the control group did not receive any ANC SMS 
reminders on their phone. Neither did they receive any in-person visits from CHWs to 




Throughout August 2013 to July 2015, CHWs in both groups visited their clients to 
check on their experience of the ANC visits. Post-delivery, CHWs in both groups visited 
the new mothers as soon as possible and within 24 hours of delivery to remind them to 
access PNC and encourage essential newborn care.  
 
3) Data analysis 
 
We used Stata 14 for data analysis, first checking the data for completeness and accuracy 
and screening for missing values. We tabulated frequency distributions for categorical 
variables to explore the data. We performed chi-square tests to assess differences 
between outcome categories. We retained variables strongly associated with care seeking 
in the literature as well as potential confounders in the base model. To determine 
additional variables to include, we used a selection procedure based on Akaike 
Information Criterion (AIC) values. The model, which we selected based on AIC values, 
suggested that all independent variables significantly contributed to the model.  
 
Characteristics of study participants: After checking and screening the data and 
tabulating frequency distributions, we conducted simple t-tests to compare the study 
participants in the two groups. Most basic biological, nutritional and economic statuses 
were similar in both groups, although there were differences in literacy levels.  
 
Multinomial logistic regressions. To ascertain the association between the intervention 
and coverage increase (any ANC or PNC visit), we performed multinomial logistic 
regressions to obtain an odds ratio, which would allow us to estimate the association 
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between the intervention and mortality impact (miscarriage, stillbirth, early neonatal 
death, perinatal death). We tested the assumption of independence of irrelevant 
alternative using a generalized Hausman test, which showed that the assumption was not 
violated for the multinomial model. We conducted univariable and multivariable analyses 
and examined variables expected to mediate, confound or modify the effectiveness of 
association. These associations were hypothesized from the literature review. The 
multivariable regression model controlled for demographic factors (maternal age, parity), 
and socioeconomic status (living standards index). We used a 0.05 p-value cutoff to 
assess levels of significance.  
 
Population standardization. To ensure standardization of the sample denominator 
(number of pregnant women) between the two groups, we proportionally extrapolated the 
number of deaths for a scenario in which the population was 1 million in each group’s 
catchment area. We estimated the number of pregnant women in a given year by 
assuming the number of women of reproductive age in 2015, given the fertility rate, 
abortion rate, and fetal loss rate . These figures are based on the Bangladesh national 
statistics report; there was no available district level information. Accordingly, we 
estimated the number of CHWs, assuming a ratio of one CHW per 20 pregnant women 
for the pregnancy surveillance and program intervention over a year.  
 
LiST modeling. We used the Lives Saved Tool (LiST) to estimate mortality impact 
based on service outcome measures (e.g. coverage) for mHealth-based strategies, aimed 
at reducing maternal, newborn and child mortality. With a special focus on coverage as a 
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primary measure of mHealth impact, we used LiST to incorporate two potentially 
advantageous aspects of mHealth: accelerated coverage uptake and improved coverage 
quality. In terms of coverage uptake, we first set the baseline coverage from the 
Demographic and Health Survey (DHS) and assumed different coverage increase rates 
among various interventions based on historical evidence and feasibility. In terms of 
service quality, we chose the defined intervention criteria in LiST, which are similar to 
the current intervention protocols and subcomponents observed in Gaibandha district. 
Additionally, given that LiST default data is based on national statistics in Bangladesh, 
we adjusted the national estimation to the relevant district level based on the proportional 
ratio of population size. 
 
LiST validation. We compared the extrapolated number of lives saved in a standardized 
mCARE program – population of 1 million – and adjusted the number of deaths averted 
in a LiST subnational adjustment. The extrapolation and subnational adjustment were 
made by the proportional ratio of population size. In this modeling, we selected service 
subcomponents based on the Bangladeshi government guidelines and interviews with 
local service provision stakeholders. The specific subcomponents that were included for 
LiST modeling are listed in Appendix 3. We used these measures forecast estimations.  
 
DALY. After estimating the number of lives saved through LiST, we calculated the 
Disability-Adjusted Life Years (DALYs) – years of life lost (YLL) and years lost due to 
disability (YLD) – using the standard formula from the Global Burden of Disease study. 
[203] Since our study did not have information related to morbidities, we only accounted 
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for the YLL component of DALYs. Based on the estimates from WHO life tables, a life 
expectancy estimate of a newborn was based on the age less than 1 year; a life 
expectancy estimate of mothers would be based on the average age (29 years) of women 
in the study sites when delivering a child between 2013 and 2014. A discount rate of 3% 
was used in reference case calculations.  
 
4.2 Costing preparation, data collection, and analysis 
 
1) Program costing preparation, data collection, and analysis 
 
Preparation. Based on the WHO CostIt guideline (http://www.who.int/choice/en/), the 
mHealth characteristics and costing categories were incorporated to develop an mHealth 
costing template. We also referred to other studies and costing templates such as Integrated 
Community Case Management (ICCM) costing tools[204] or the Coreplus tool[205] to 
develop the template. The template aims to help estimate resource requirements and 
associated costs to deliver the necessary services at scale in addition to primary data 
collection. 
 
Data collection. mCARE I provider costs involve two major stakeholders, mPOWER 
and JHU-JiVitA. Referring to the WHO and SNL standardized guidelines, we chose the 
relevant program activities and resources to identify costs from each stakeholder through 
informant interviews with key program staff and financial records. First, we found that 
costs can be categorized according to the phases of program development and 
implementation and mCARE I timeframe (2011-2015), which is divided into three 
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phases: 1) Development phase – program and system development activities; 2) Startup 
phase – preparation activities, including training and community outreach and advocacy; 
and 3) Implementation phase – execution of data collection, processing and analyses. 
This categorization allowed us to determine what major activities and resources are 
required in different development stages. Within each phase, we captured costs using an 
‘ingredients’ approach per activity and divided into capital costs and recurrent costs. We 
obtained cost data from a retrospective review of program financial records and 
categorized them into relevant activities through the informant interviews. We also 
divided activity costs into major subcategories like personnel, equipment and supplies, 
transportation, and building costs, within each phase, by time period of occurrence.   
 
Analysis. Beyond the expenditure and budget line items, activity-based costing requires a 
deep level of conceptualization to define major activity components and to identify the 
scope of the cost inputs. For each stakeholder’s activity-based costing, we first carefully 
distinguished and processed relevant identifying input factors as well as the time-variant 
determinants of unit quantities (e.g. a number of staff, their level of effort, salaries etc.), 
classifying them into major activity components. We performed this analysis for each 
stakeholder and program phase. We then divided these components into capital and 
recurrent costs based on the purpose of the activities and items (instead of simply 
dividing them by expenditure cycle). For example, our capital costs included not only 
furniture and equipment costs, but also activity costs related to program and system 
development, including personnel and office maintenance costs, since these can be 
considered one-time costs for the entire program and do not recur through program 
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implementation. Capital item costs were annualized according to international or local 
estimates of each item’s life expectancy with an annual 3% discount rate (WHO 
CHOICE), presented in 2015 base year US dollars and adjusting for inflation according 
to IMF consumer price indices.[206] We considered activity costs and office maintenance 
costs during the development and start-up phases as capital costs, and therefore 
annualized them with a life expectancy of three years and 3% annual discount rate, 
considering a three-year program implementation period.  
 
Personnel costs were attributed to each activity based on the estimated level of effort 
(LOE) incurred each month. Time allocation estimates were obtained through in-depth 
interviews with personnel. Office maintenance costs were also attributed to each year 
based on the estimated level of utilization of the space, facilities, and supplies toward the 
mCARE project by each stakeholder. Three years of life expectancy were accounted for 
annualization for each program phase. Acknowledging staff or organizations involve 
multiple programs and responsibilities beyond mCARE, so we took into account the 
time-variant nature of resource utilization (e.g. a number of staff, their LOE, salaries, 
etc.) and calculated costs attributed to the mCARE project. Financial costs of each 
stakeholder were then aggregated for the main components of global capital and recurrent 
costs, for each development phase. For recurrent costs, we estimated standard unit costs 
of the intervention per relevant client (MWRAs/mothers) in the implementation phases 
for intervention and control groups. These unit costs were used to calculate an estimated 
measure per 1 million population for both groups. In this process, we carefully reviewed 
characteristics of each cost item and proportionally adjusted any variable costs based on 
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the increased number of CHWs for mobile phone procurement, training, server 
maintenance, census enumeration, pregnancy surveillance, SMS, ANC home visit 
reminders and data collection. We did not include research costs here. We considered 
program costs such as partnership development, system development and optimization, 
furniture and equipment, office maintenance, community outreach, and supervision as 
one-time fixed costs that are not likely changed by the increased number of beneficiaries. 
 
2) Provider/User costing preparation, data collection and analysis 
 
Preparation. The mCARE program measured service coverage as an intermediate 
outcome indicator given that the mCARE intervention – SMS and home visit reminders 
promote pregnant women’s care-seeking, which increases service utilization. While our 
intervention provides reminders for care seeking, pregnant women decide themselves 
where to seek care in their community. In defining the scope of the study, therefore, we 
considered comprehensive service provision channels including government, NGOs, and 
the private sector from community to primary to secondary care.  
 
Study setting. The study was conducted from July to September in 2016 in a well-
characterized population research site, JiVitA, located in northern Bangladesh, where 
18.5% of pregnant women reported receiving any ANC service, of which a majority 
(71%) received care (Figure 4.2) from a community-based NGO (i.e. BRAC) and some 
from government health workers (15%). Assessing service provision at the study site 
requires an understanding of community and facility level health services. Community 
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ANC services are mainly provided by CHWs via household visits anchored to mobile 
or temporal clinics like satellite clinics that are often set up on days in community 
members’ homes or in public spaces where people can gather. Major stakeholders in 
the formal sector of these services in Gaibandha district include the government and 
the country’s largest NGO, BRAC, and the Smiling Sun franchise satellite clinics. 
ANC service provision at the facility level involves different levels of public and 
private actors and NGOs in primary and secondary care. The public facilities include 
Community Clinics (CC), Family Welfare Centers (FWC), Union-sub centers, Upazila 
Health Complex (UHC), and Maternal and Child Welfare Center (MCWC). NGO 
facilities include the Smiling Sun franchise static clinics or emergency obstetric care 
(EMoC) clinics. Private facilities include doctors’ private chambers set up in their own 
houses and private secondary care clinics in Gaibandha district.  
 
The study was implemented at JiVitA in rural northwest Bangladesh, a project of the 
Center for Human Nutrition of Johns Hopkins School of Public Health, which has been 
conducting community trials for the last 15 years. This longtime established 
partnership and good reputation of JiVitA facilitated support from the Project 
Investigator and JiVitA Senior Management Team in identifying key stakeholders and 
initiating conversations for this study. We contacted and discussed with the local 
government’s Deputy Director of Family Planning and leaders of relevant service 
provision organizations from BRAC (Director, Health Nutrition & Population, BRAC) 
and Smiling Sun (Chief of Party, USAID-DFID NGO Health Service Delivery Project, 
NHSDP). We used convenience sampling to choose the facilities or communities, on 
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the basis of relevance of the mCARE I research site, availability of facilities’ service 
schedule, the volume of service provision, and perceived representativeness of 
organization’s routine practices. At each respective service provision site, we 
purposively recruited an organization manager for a structured interview and the most 
representative 1-2 ANC service providers for an observational study. The identification 
of pregnant women within a community or facility was purposive and made on the day 
of observation. We conducted the study with the community level group at the satellite 
clinics, which are often set up on certain days in a community member’s house. Each 
CHW’s working area is divided into 3-5 clusters and each cluster generally consists of 
75-100 households and has a satellite clinic set up twice a month. Community 
mobilizers, who visit each house for pregnancy surveillance, family planning and other 
health promotion activities in their assigned catchment areas, inform clients of specific 
ANC provision dates and locations of satellite clinics. At facilities, research staff 
approached pregnant women in the ANC waiting area and received consent for 
observational and exit interviews prior to the start of ANC clinical services. 
 
Sample size. Our primary research intent is to describe and differentiate the content of 
ANC services in the community and facility groups. This descriptive study consists of 
the observation of 50 ANC consultations conducted in health facilities and 50 in 
communities as well as exit interviews with ANC recipients. This builds upon a 
previous study [207] that collected data on 36 ANC consultations in a facility setting in 
Tanzania. We aimed to include all 50 women observed during ANC in the community 
and 50 observed in the health facility, because it is possible that some women may 
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drop out prior to the completion of the exit interview due to health, work, family or 
other responsibilities. In Bangladesh, according to proportional sampling based on 
mCARE I study finding, our sample at a community level included service provision 
by Family Welfare Visitors (20 samples) and by BRAC Shyastho Kormi (SK) (20 
samples), and by Smiling Sun Paramedic/CHW (10 samples) in satellite clinics. In 
primary health centers at the facility level, we observed and conducted exit interviews 
among FWVs in FWCs/CCs (20 samples), SACMOs in UHCs (10 samples) in public 
facilities and paramedics in the Smiling Sun static clinic (10 samples). In secondary 
health centers at the facility level, we also observed ANC provided by an 
MBBS/Gynecologist doctor in MCWC (10 samples). In case service contents and costs 
were associated with delivery and PNC, we conducted in-depth interviews with the 
seven facility managers in each care setting.  
 
Data collection. According to standardized guidelines, we devised service costing and 
coverage tools that can be used for various stakeholders at different levels of care (e.g. 
community and facility settings), throughout the continuum of maternal and newborn 
health (MNH) care services to capture the service content, practice, and commodities 
such as equipment (e.g. blood pressure meter) and supplements (e.g. micronutrient, iron-
folic acid tablet). These tools, reviewed by project investigators and local health experts, 
are largely adapted from standardized service quality assessment tools (e.g. Service 
Availability and Readiness Assessments from WHO; Service Provision Assessments 
survey conducted by USAID’s Demographic and Health Survey) and they include 
relevant indicators from the Lives Saved Tool for subnational modeling to estimate 
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mortality impact from coverage measures. Data collection was carried out by a student 
investigator and four interviewers in JiVitA. Two interviewers were in charge of 
observing providers’ service provision and two other interviewers in charge of client exit 
interviews.  
 
The study uses four different data collection methods with three modules. The first 
method is a desk review of service protocol and guideline documents, which collects 
information on service provision activities and required equipment at an accepted 
standard of quality in the local setting. The second method consists of a structured 
interview guideline, which the interviewer uses to ask organization managers and health 
service providers for information on overall organization governance, financing, staffing, 
service capacity, volume, protocols, and related issues. The student, with assistance from 
a translator, interviewed organization representatives (Deputy Director of Family 
Planning, BRAC district manager and Smiling Sun NHSDP country representative) or 
clinic managers (Maternal and Child Welfare Center, Upazila Health Clinic, Family 
Welfare Center, Community Center, and Smiling Sun). 
 
The third method consists of observing actual service provision, categorizing ANC 
service contents into five components: clinical history, general examination, counseling, 
screening and lab testing, and treatment. It also categorizes the types of providers, the 
average time of service provision and any consumed commodities in specific service 
provision activities. At the community level, CHWs observed and interviewed during 
their service provision activities at satellite clinics. Assuming 8-10 ANC service 
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provisions per day per satellite clinic, in order to observe 20 ANC service provisions, 
interviewers would spend 2-3 days observing practices. There are specifically scheduled 
dates for ANC service provision in these satellite clinics, which correspond to the data 
collection dates. At the facility setting, ANC service provider roles may take on a range 
of occupation categories from family welfare visitors, paramedics, Sub-Assistant 
Community Medical Officer (SACMO), to doctors. In primary healthcare centers, the 
interviewer identifies a provider and observes the ANC services at CC, FWC, UHC and 
Smiling Sun static clinic, respectively. In secondary healthcare centers, interviewers 
identify a provider and observe the ANC service provision events from MCWC. 
 
The fourth data collection method consists of exit interviews with clients at the end of 
each service provision observation. They are asked about direct costs and indirect costs 
such as fees for transportation, drugs and services and loss of schooling or wage due to 
care seeking. In total, 100 pregnant women (50 in community settings and 50 in facility 
settings) are asked to participate in the user cost survey. The community-level study was 
conducted at the satellite clinics. Each CHW’s working area is divided into 3-5 clusters 
and each cluster generally consists of 75-100 households. In each cluster, a satellite clinic 
is set up twice a month. Community mobilizers, who visit each house for pregnancy 
surveillance, family planning and other health promotion activities in their assigned 
catchment areas, inform clients of the specific ANC provision dates and locations of 
satellite clinics. Based on the scheduled dates, pregnant women are recruited purposively 




Data analyses. The data from the structured interviews regarding organization profiles 
were analyzed descriptively. Characteristics of samples including both providers and 
pregnant women were described overall and independently for each group. The basic 
demographic and epidemiologic profile were compared to the entire district and national 
profile.  We analyzed ANC observation data and described ANC service content, 
including counseling and clinical care provided, at the community and facility levels 
independently and overall, and juxtaposed them against recommended ANC according to 
national guidelines using basic cross-tabulations and frequencies. We used a t-test to 
compare the content of care provided within and between groups as well as across 
pregnancy stages. Data about service practice from the observations were used to 
contextualize and validate the findings from the in-depth interviews. We estimate the cost 
of ANC service provision based on unit price and quantity of commodities provided (e.g. 
micronutrient supplementation, etc.) as well as staff category, average salary, and service 
time. The study also determined the direct and indirect costs incurred by users (e.g. out-
of-pocket payments for services and drugs, transportation, as well as lost wages) due to 
seeking ANC. Costs were determined based on pregnancy stages of care seeking (first, 
second and third trimester) and level of care setting (community or facility).  
 
4.3 Cost-effectiveness analysis following the Drummond’s 10-step checklist 
 
Once the effectiveness and costs measures were determined, the study set up an analytical 
framework for cost effectiveness analysis. The standardized guidelines of Drummond’s 
10-step checklist [208]  is as follows; 1) define the objective; 2) define the perspective; 3) 
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define the counterfactual; 4) define the health program; 5) define implementation period 
and time horizon; 6) identify major cost categories; 7) collect costing data; 8) identify and 
define effectiveness measures; 9) perform analysis; and 10) interpret and disseminate 
costing results.  
  
Step 1: Define the study objective. The main objective of the thesis is to assess the 
value for money and affordability of investing in mHealth strategies for pregnancy 
surveillance and care-seeking reminders in rural Bangladesh. In this economic evaluation, 
we considered three efficiency principles depending on the research questions. We 
defined the following three alterative health program scenarios: comprehensive mCARE, 
basic mCARE and paper-based – to determine incremental cost-effectiveness ratios. 
 
1) Study Aim 1 examines productive efficiency based on the research question, 
“How much can mHealth improve a particular health outcome for a given cost, 
compared to an alternative option?” In this study, we assessed the value of 
investing in specific subcomponents of mCARE intervention strategies on SMS 
and home visit reminders, based on systematic pregnancy surveillance, by using 
the mCARE system in both intervention and control groups.  
 
2) Study Aim 2 examines allocative efficiency based on the research question, 
“How much can mHealth maximize the welfare of the society through the right 
mixture of resource allocation?” In this study, we assessed the value of investing 
in an mCARE program to scale up over 10 years, compared to a status quo 
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scenario. We considered a wide spectrum of service provision costs in a given 
heath system and user costs including opportunity costs from a societal 
perspective.  
 
3) Study Aim 3 examines technical efficiency based on the research question, 
“How much can an mHealth program maximize improvement in outcomes from a 
set of resource inputs or minimize resources required for a given set of outputs?” 
In this study, we assessed financial costs associated with the government 
implementing the mCARE program compared to the status quo scenario, with a 
six-year timeframe. We also considered specific subcomponents of activities and 
resource inputs to determine major cost drivers and factors associated with cost 
savings over time with scale.  
 
Step 2: Define the perspective. The costing perspective determines the methodology to 
be used and the scope of data to be collected. The stakeholders bearing the costs may 
differ from those experiencing the benefits, and thus it is important to be clear about the 
viewpoint is chosen for the analysis and how this affects the results. Such a clarification 
is also helpful to examine whether all the relevant costs are included. Aim 1 takes a 
program perspective in order to evaluate the value of the specific program intervention 
and determine major cost drivers. Aim 2 takes a societal perspective and includes 
program, provider and user costs to evaluate the value of the program at the expenses 
associated with overall resource requirements within the health systems. The societal 
perspective is helpful for evaluating the directions for enhancing allocative efficiency in a 
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variety of setting across various strategies. Aim 3 sees government from a payer’s 
perspective to estimate the financial impact related to national health expenditures. This 
is to help government investment decisions for health and utilize cost-saving strategies.  
 
Step 3: Define the health program. We compared the two study arms of the mCARE I 
pilot study for study aim 1 and developed scenarios for aims 2 and 3, describing all 
required activities and resources that are expected to lead to implementation of the 
mCARE intervention (defined as comprehensive mCARE), mCARE I control (defined as 
basic mCARE) and a paper-based status quo groups. For aim 1, definitions of 
intervention and control are below.  
 
1) Comprehensive mCARE program group: 35 CHWs used mobile phones for 
census enumeration and pregnancy surveillance. Pregnant women receive 
automated SMS and home visit reminders delivered by CHWs on their personally 
scheduled first to fourth ANC dates. 
 
2) Basic mCARE program group: 35 CHWs used mobile phones for census 
enumeration and pregnancy surveillance.  
 
For aims 2 and 3, we developed the scenarios and described the definitions of 
intervention, control, and status quo below. The analytic framework and input parameters 




1) Comprehensive mCARE program scenario: CHWs use mobile phones for 
population mapping and census enumeration and pregnancy surveillance. 
Pregnant women receive automated SMS and home visit reminders by CHWs on 
specific personally scheduled ANC for four appointment dates. 
 
2) Basic mCARE program scenario: CHWs use mobile phones for population 
mapping and census enumeration and pregnancy surveillance.  
 
3) Paper based status quo scenario: CHWs use the traditional paper-based census 
enumeration and pregnancy surveillance method. Pregnant women receive 
community-based ANC promotion activities. 
 
Step 4: Define the counterfactual/competing alternatives. WHO cost-effectiveness 
analysis (CEA) guidelines suggest a generalized CEA[209] where “the costs and benefits 
of a set of related interventions should be evaluated with respect to the counterfactual of 
the null set of the related interventions.” For study aim 1, the comparison group is the 
basic mCARE program. The research question is to evaluate the cost-effectiveness of the 
add-on component of SMS and home visit reminders in the comprehensive mCARE 
program, compared to basic mCARE program – not the entire comprehensive mCARE 
program itself. For study aims 2 and 3, we set the comparison group as paper-based 
system as a status quo scenario, a counterfactual of the null set, and mCARE I control. 
The research design allowed CEA of the mCARE program compared to the current 
paper-based practice. Accordingly, we evaluated whether and to what extent the mCARE 
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program would increase or offset costs compared to the existing paper-based practice 
over time, with geographical expansion, sustainability and scale in mind. The study 
findings are widely comparable to other community-based MNH strategies and programs 
(e.g. women’s group program, conditional cash transfer, etc.) in LMICs.  
 
Step 5: Define the scope of program and time horizon. For study aim 1, the scope of 
program costing included a program life cycle from development, start-up to 
implementation. This study was based on JiVitA CHWs with retrospective costing from 
2011 to 2015. For study aim 2, the scope of program costing assumed the system was 
developed and thus, included start-up and implementation from 2016 to 2025. Here, we 
assumed an incremental geographical expansion in Rangpur district. This study was 
based on government CHWs (FWAs) for pregnancy surveillance and home visit 
reminders. For study aim 3, the scope of program costing assumed the system to be 
implemented in Gaibandha district from 2015 to 2020. We used the cost as a reference 
case to project national budget impact assuming replications of the program to all 64 
districts in the country. In terms of providers, we defined the comprehensive service 
delivery channels including government and NGOs, from community to primary to 
secondary care. In terms of users, we estimated the number of pregnant women who seek 
care for ANC, delivery, and PNC based on demographic projections. For care-seeking 
practices we assumed different increase rates for each scenario.  
 
Step 6: Identify input parameters and data sources. Data sources were drawn from 
mCARE I with reference to current standard practices, large-scale studies, and historical 
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data. Data collection included a literature review, review of financial records of 
implementation agencies, observation for service costs and exit interview for user costs. 
Informant interviews were conducted for program costs. Data on program costs, 
coverage, and a number of deaths averted for aim 1 were mostly drawn from an mCARE 
I pilot. To forecast scaled-up costs and effectiveness for aims 2 and 3, we collected and 
synthesized multiple data sources to set up assumptions to estimate relevant coverage and 
costs. First, demographic assumptions of relevant population and epidemiologic 
parameters were drawn from health statistics reports from the World Bank and 
Bangladeshi Bureau of Statistics database. Baseline service coverage data were drawn 
from the 2014 Bangladeshi Demographic Health Survey (BDHS). In the second step, 
program assumptions of activity-based costing were identified from informant interviews 
with program staff. We identified FWVs’ routine activity protocols and general time 
allocation for each activity in the current paper-based practice. Based on field expert 
interviews, we set assumptions about the change in time allocation to each activity 
component (caused by productivity and efficiency change) by using the mCARE system 
in the first year and each subsequent year over time. The rate of service coverage increase 
was drawn from mCARE I data results. The rate of service coverage increase in the status 
quo scenario was drawn from the past five years of service coverage trends from BDHS 
2014. For the third step in identifying input parameters, we assumed service provision 
content and costs for ANC delivery and PNC at the community and facility level. Service 
provision content and costs were drawn from 100 samples collected through the 
structured observation study and in-depth interviews from various health service 
provision agencies in Gaibandha district. User costs were drawn from 100 samples 
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collected through exit interviews with pregnant women who sought ANC care in the 
community and facilities in the district.  
 
Step 7: Adjustments of costs and consequences for different timing.  
 
Discounting. Discounting refers to “the process of determining the present values of 
payment to be received at some point in the future.”[210] In forecasting cost estimation, 
the study used a 3% discount rate as a base to adjust future costs to its present value. Based 
on WHO recommendations, we tested our total program costs results with a discount rate 
of 0%, 3%, and 6% in sensitivity analyses. LMICs generally use higher discount rates than 
high-income countries.  
 
Annualization. We annualized capital spending to allocate the cost of fixed assets to the 
accounting time periods that are expected to benefit, and simultaneously reduced the value 
of fixed assets on an organization’s balance sheet.[211] For example, in the case of the 
equipment purchased in the year of evaluation, we used its purchase price.[212] In the case 
of old equipment, we used the cost of replacing the item today, or the original cost of the 
item inflated to the base year and a full useful life.[212] The useful life of a component is 
the amount of time that it serves its function, not its physical life. For mHealth, a life cycle 
of technology may be a few years, as a newer technology that has more functionality with 
equivalent technology may be less expensive in the future. To make them comparable to 
variable costs, we amortized the capital costs by calculating the annual value of capital 
costs. To obtain lifespans for annualizing capital costs, we referred to WHO-
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CHOICE[109], or used asset life estimated by the local team. To find corresponding 
annuity factors for different discount rates, we referred to standard textbooks and manuals 
such as Drummond et al.[208] and Saving Newborn Lives (SNL) (2004) costing 
guidelines.[213] We used the straight line method assuming that the value of assets reduces 
by the same amount over time. 
 
Inflation. For some variable cost items, for which expenditures are made over several 
years, we considered using Consumer Price Index (CPI) methods, accounting for domestic 
inflation by comparing prices of a single basket of goods to an average consumer over time.  
We chose the base year as 2015 and adjusted future costs to be presented for the same 
year.[214] CPI estimates for global regions or countries can be obtained from the 
International Monetary Fund (IMF) website in the ‘Data and Statistics’ section.[215] Using 
this method, we multiplied the costs in their original currency by the ratio of the CPI index 
of the base year, and divided by the CPI index of the year they were reported.  
 
Step 8: Incremental cost effectiveness ratios 
 
Cost effectiveness estimates are presented from a program perspective for aims 1 and 3 
and from a societal perspective for aim 2. With estimated total costs and health effects for 
each group – mCARE intervention, mCARE control and status quo paper system – 
findings were presented in league tables (Table 5.6; Table 6.6; Table 7.3) of incremental 
cost effectiveness ratios (ICERs) for mCARE intervention versus mCARE control; 
mCARE intervention versus status quo paper system; and mCARE control versus the 
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status quo paper system. ICERs represent cost difference between the intervention (C1) 
and comparison arm (C2), divided by the difference in effectiveness between arms (E2-
E1).  
 
Step 9: Uncertainty analysis   
 
Sensitivity analyses allow a certain range of variation to the parameters to test the 
robustness of the model. At large, there are two forms of uncertainty: parameter 
uncertainty and model (or structural) uncertainty.[216] The first is internal to the model 
and the latter is external to the model. Parameter uncertainty is from the estimated 
parameters (not true value) of a given model. A standard statistical method, using 
standard error measure, can be employed to represent uncertainty to the estimate. On the 
other hand, model (or structure) uncertainty is related not to the parameters, but to the 
assumptions imposed by the modeling framework. In fact, any estimated parameter 
uncertainty through the model will be contingent upon the structural assumptions of the 
model.[217] 
 
Model (structure) uncertainty. As there is little empirical evidence on scaling up the 
mHealth program, structural uncertainty may exist in the model framework, scenario and 
intervention patterns. We addressed structural uncertainty from the process of 
conceptualizing and building a model by incorporating major implementation and scale-
up concerns, based on field implementers’ experiences. For the mCARE program, 
defining the analytical framework and determining an appropriate scope of analyses 
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involve a great level of conceptualization and understanding of the operational 
mechanisms as well as their impact within a broad health system. Referring to the 
recently published conceptual framework (i.e.Tanahashi 2.0)[218], implementation 
principles (i.e. MAPS)[219], and evaluation guideline (i.e. mERA)[220] of mHealth 
programs, we incorporated the recommended key components of operational and 
evaluation principles in designing the analytic framework. Table 4.2 describes how the 
general concerns and interest in mHealth program evaluation were incorporated into the 
modeling framework. The table also defines scenarios, time horizons, and parameters in 
the mCARE cost-effectiveness analyses.  
 
Parameter uncertainty. To evaluate the robustness of the findings when key variables 
change, we used one-way deterministic sensitivity analyses (DSA) and probabilistic 
sensitivity analyses (PSA). The impact of a single parameter’s uncertainty was assessed 
with one-way DSA, “which varies one of the input variables from its baseline values 
while observing the effect on the outcome of the model.” [221]Tornado diagrams were 
presented to depict results from a number of one-way sensitivity analyses. For a 
multivariate sensitivity analysis, in “which more than one input variable is varied,” PSA 
allows the analyst to assign a range and distribution to input variables.[222] Considering 
that the final estimates are driven by joint effects of multiple parameters, we conducted 
multivariate PSA with all the variables examined in the one-way DSA.  
 
Parameter selection. The parameters included cost items for program costs, provider 
costs, and user costs. Also, parameters included population coverage of census 
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enumeration and pregnancy surveillance for each scenario (e.g. 90% and 80%), service 
coverage increase rates in each scenario (e.g. 10%, 5% and 1%) as well as the modeled a 
number of lives saved for each scenario. Considering the census enumeration and 
pregnancy surveillance as major costs drivers, we assessed one-way DSA on factors 
related to CHW productivity such as a number of household visits per day, level of effort, 
and CHW salary. We also examined one-way DSA on factors related to technological 
components such as costs of mobile phone device, server maintenance, or network 
connection, which generally pose high uncertainty and potential changes within a short 
time period based on innovation, scale, and competition in the market. The results of one-
way DSA are presented as a tornado diagram. 
 
Parameter distributions were chosen to represent statistical uncertainty in the parameter 
values of the model.[223, 224] These were assumed for the target population, program 
costs, provider and user costs as well as population and service coverage rates. In terms 
of program costs, based on our activity-based costing, the parameter ranges were 
determined by results of respective input variation of level of productivity, LOE and 
overtime, salaries, and time duration for activity components. We drew the mean and 
variance from a plausible range reported by an expert. A conservative approach was 
adopted with an appropriately broad range of possible estimates elicited from each 
expert. Based on the mean and variance measures, we drew the values of scale and shape 
for gamma distribution and values of alpha and beta for a beta distribution based on 
statistical equations. We produced probability distribution functions for each parameter 
based on standard statistical methods. In case of provider and user costs drawn patient 
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level data, we checked the fitness of the distribution from the actual dataset and defined 
the distribution shapes (Chapter 6, Table 5). In estimating the target population, we 
referred to historic data based on the past five years for population growth rate[225], 
fertility rate[199], fetal loss rate[226]  and abortion rate[227] from the World Bank 
database and other literature.   
 
Simulation. The study used Monte Carlo simulation (MCS) assuming that the data came 
from a probability distribution and made inferences about the parameters of the 
distribution such as gamma, beta or lognormal distributions. The statistical distribution 
was chosen based on the characteristics of the input parameters and standard 
recommendations in the literature. A total of 1,000 iterations were generated using a 
Visual Basic macro in Excel. This approach predicts the results that might arise from our 
trial if it were performed a large number of times. The means of each cost component 
were summed by calculating each iterated incremental cost-effectiveness ratio. By 
demonstrating how a variable affects the output of a model over a range of values, 
sensitivity analyses can help determine whether results are generally consistent (robust) 
with a plausible variation in a parameter. 
 
Step 10: Presentation and discussion of the study results  
 
We presented results from the analyses in a variety of ways – numerical outputs and 
graphical demonstrations based on the costing categories; program phases, subtotal and 
total program costs, as well as unit cost per CHW per pregnant woman over time; and 
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key cost drivers with cost categories as a percent of total costs. These findings can be 
used to inform decisions about resource allocation, budgeting or policy planning.  
 
ICER league table: In comparing costs among three scenarios, together with 
effectiveness measures, an lCER league table was constructed to guide prioritization 
among possible options and determine the most efficient strategy to achieve a goal.[214]   
 
Cost-effectiveness plane: To address uncertainty surrounding the estimates of the 
expected costs and effects, cost-effectiveness planes were constructed to show the scatter 
plot points of incremental cost-effect pairs (between the intervention and the alterative), 
coming out of each iterated input parameter from the MCS.[228] The plane is divided 
into four quadrants by the origin, each quadrant having different costs and effect 
implications in economic decision-making.  
 
Cost effectiveness acceptability curves (CEAC) is “a method for summarizing 
information on uncertainty in cost effectiveness.”[229-231] CEAC illustrates the 
proportion of the scatter plot points that fall below a range of threshold ceiling ratio 
values, which can be drawn as a diagonal line joining the origin (0) on the cost-
effectiveness plane. It is derived from the joint distribution of incremental costs and 
incremental effects.[228] Setting a series of hypothetical threshold values was considered 
for net benefit analysis and a cost-effectiveness acceptability curve. Based on the 
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standardized guideline6, Bangladesh GNI per capita was considered as the willingness to 
pay to avert deaths from government decision-makers’ perspective.[233] 
 
Generalizability of the study findings was discussed in regards to population 
characteristics and the condition of the health systems. First, we considered that 
population characteristics may include care-seeking practice, mobile phone ownership 
level, literacy, socioeconomic status and barriers to care seeking. These characteristics 
determine to what extent the intervention (SMS and home visit reminders) may 
contribute to increasing service coverage. Secondly, health systems conditions may 
include wireless network connectivity, availability of qualified health workers and 
medical supplies, and other ongoing primary health service programs such as family 
planning in the community. These characteristics determine the size of target population, 
the extent to which reminder intervention contributes to service uptake, and the extent to 
which service coverage contributes to the health outcome.  
 
4.4 Inclusion and exclusion of costs and outcome analyses   
 
1) Costs:  
Costs of the health system. Our scenarios focused on optimizing and strengthening 
existing health systems capacity under financial constraints. We included costs for 
                                                     
6 “The World Health Report 2002 proposed a different approach to setting CE threshold. “The recent report of the 
Commission on Macroeconomics and Health, which was commissioned by WHO, suggested that interventions costing 
less than three times GDP per capita for each DALY averted represented good value for money.” In the report of the 
Commission, this threshold is justified on the basis of expected direct and indirect benefits to national economies, 
though the report does not specify the types of costs that should be considered. This is remarkable for the intent to base 
allocation decisions not on the appeal of arbitrary round numbers, but on an objective national benchmark that is 
directly related to the affordability criterion.” Source:  232. Eichler, H.G., et al., Use of cost-effectiveness analysis in 
health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value 
Health, 2004. 7(5): p. 518-28. 
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building the existing workforce capacity. We assumed medical supplies and health 
providers would be available at the time of care seeking by pregnant women at facilities. 
However, we did not include costs for increasing the number of CHWs or upgrading 
health facilities, although it may be desirable in some regions.  
 
Costs of scaling up. In this study, we assumed horizontal scale up (i.e. “replication in 
different geographic sites or expansion to serve larger or different population groups”), 
not vertical scale up (i.e. “policy, political, legal, regulatory, budgetary or other health 
systems changes needed to institutionalize the innovation at the national or sub-national 
level”).[234] We did not account for potentially critical direct and indirect costs 
associated with economies and diseconomies of scale. For example, we did not include 
additional costs to deliver services to households in hard-to-reach areas. We did not 
include additional incentives to promote their care seeking to reduce access barriers for 
the poor. We considered costs based on market-based mechanisms. We did not include 
potential health systems-negotiated costs such as donation, or cost sharing through 
partnerships, as it is difficult to predict if and when it will happen. For a similar reason, 
we did not include certain new types of technology or innovation that may have changed 
the cost or process. 
 
Hidden costs. There may be substantial hidden costs during the startup and 
implementation periods that this study could not incorporate. These include costs from 
technical or system errors, complex tasks associated with assigning unique identification 
values to households and population for mapping and census enumeration, incentives for 
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health workers and managers due to increased workload during the transition time, 
partnership and advocacy activities when the program scales up, and unpredicted political 
turmoil and blockages that can suspend program activities. We excluded these costs 
because of high uncertainty and difficulty of anticipating them in advance. However, 
local experts addressed that these are feasible scenarios to consider.  
 
2) Outcome:  
 
Service delivery. We included a wide spectrum of service delivery channels including 
government and major NGOs in both community and facility settings. However, our 
study did not include private and informal sectors, although they play a major role in 
semi-urban and rural areas. The focus of our study is to see whether and to what extent 
formal health sectors’ general practices follow the national service quality guidelines, in 
order to identify gaps and provide actionable recommendations to improve their service 
and organization management. The mCARE reminders and standard recommendation of 
referrals suggest that pregnant women should seek care at the formal health sectors.  
 
Service quality. We considered that service quality may differ between community and 
facility levels. Therefore, for LiST modeling, we designed the selection of service 
subcomponents differently by community and facility level for each scenario. This 
approach generated a range (low and high) of the number of deaths averted for the 
respective scenarios. The selected list of LiST interventions is presented in Appendix 3. 
For each choice of service (such as ANC or skilled health attendance), the specific 
subcomponents of the service are automatically calculated following the model default 
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values that are based on DHS, MICS and other nationally representative household 
surveys.  
 
Other interventions that may impact the target population or service coverage and 
quality have been excluded in these estimates such as family planning programs, 
conditional cash transfer programs, or upgrading service quality of health facilities or the 
communities. These programs are financed and implemented through other sectors with 
different objectives, and there is no clear evidence base on how and to what extent they 
will happen.   
 
4.5 Ethical clearance  
 
The original mCARE I trial and the service contents and costing study received ethical 
approval from the Bangladesh Medical Research Council (Reference number: 
BMRC/NREC/2013-2016/375, dated 14/10/2015) and the Johns Hopkins Bloomberg 
School of Public Health Institutional Review Board (IRB00006999). For the data from 
the observation study and exit interviews, subjects enrolled in the study completed 
consent procedures from pregnant women. (Appendix 7)
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Figure 4.2 Conceptual framework illustrating essential maternal and newborn health care service provision agencies in 









Table 4.1 Development of model scenarios for the three groups: (i) comprehensive mCARE program; (ii) basic mCARE 
program; (iii) paper based status quo 
Study arms Comprehensive mCARE program Basic mCARE program Paper based status quo  
Study area Rangpur division in Bangladesh 
Target population Number of women in reproductive age 
Fertility 
Fetal loss rate 
Abortion rate 
Number of pregnant women 
Population coverage Census enumeration 90% Census enumeration 80% 
Population surveillance 90% Population surveillance 80% 
Number of registered pregnant women  Number of registered pregnant women 
Intervention SMS reminder N/A N/A 
Home visit reminder N/A N/A 
Service coverage Annual coverage increase rate 10% 
for ANC, facility delivery, and PNC 
Annual coverage increase rate 5% for 
ANC, facility delivery, and PNC 
Annual coverage increase rate 1% for 
ANC, facility delivery, and PNC 
Number of women who seek care of 
ANC, facility delivery, and PNC 
Number of women who seek care of 
ANC, facility delivery, and PNC 
Number of women who seek care of 
ANC, facility delivery, and PNC 
Health outcome Maternal, stillbirth, neonatal deaths 
averted 
Maternal, stillbirth, neonatal deaths 
averted 




Table 4.2 Structural uncertainty and model translation 
 
Reference Unique characteristics/challenges of 
mHealth 
Translation (Model/Assumptions) 
The MAPS Toolkit:  
(WHO,2015)[219]; 






(a) Addressing key elements of 
planning and implementation: 
ground work, partnership, 
technology, M&E 
(b) Program/research health workers 
as subject of study (not gov’t buy-in) 
• Include activity costs such as partnership, system optimization, data 
reporting and processing 
• Consider program operation in a phased approach: start-up (first year) 
and implementation (subsequent years) 
• Set government as program implementation agency for scale-









(b) Operational transition from 
paper-based data collection to 
phone-based data collection 
• Include not only FWAs training but also training of trainers for their 
supervisors who will monitor and evaluate FWAs’ data collection 
activities 
• Determine government CHWs’ overall role and responsibility and 
adjust the respective time allocation by scenarios for activity-based 
costing. 
• Assume intensive workload of census enumeration and pregnancy 
surveillance in the first year of implementation 
mERA guideline 






Modeling LiST for 
mHealth (Jo et al, 
2014)[68] 
Evaluation: 
(a) Addressing intermediate outcome 
of mHealth strategies—pregnancy 
surveillance and care seeking 
reminders 
(b) Comparing service coverage 
impact for each scenario on a same 
denominator 
(c) Lacking a null counterfactual to 
evaluate mHealth program as a 
whole  
(d) Care-seeking/service utilization 
across various service delivery 
channels within health systems 
(e) Measuring health effect from 
service coverage outcome 
• Estimate ‘population coverage’ as a measure of mCARE performance 
in pregnancy surveillance coverage (# of registered pregnant women 
women/total pregnant women in a district)  
• Define ‘service coverage’ as an outcome of the mCARE demand 
promotion strategy (# of pregnant women who seek care/# of 
registered pregnant women) 
• Set same baseline service coverage and population for the 
comparison of three scenarios 
• Set a scenario of a comparison arm of status quo paper-based system 
• Include various service provision agencies and level of care including 
government and NGOs as well as satellite clinic and 
primary/secondary level clinics in sampling 
• Consider different provider/user costs and service contents (quality) 
in community and facility 





(a) Economies of scale in mHealth 
program 
(b) Concern over factors associated 
with technological components 
• Assess cost function by increasing CHW productivity (# of 
household visits per day) over time with scale  
• Include sensitivity analyses on cost of mobile phone device, phone 
loss/break rate, SMS connection fee, etc. 
• Consider ‘horizontal scale up’—not ‘vertical scale up’ 






Table 4.3 CHEERS/ISPOR guideline for thesis aims and analyses 
Research question What is the value of investing in mCARE intervention to improve pregnancy surveillance and care 
seeking reminders in Bangladesh? 
Type of efficiency Productive efficiency Allocative efficiency Technical efficiency 
Research objectives Objective 1: To determine the 
incremental cost-effectiveness 
of a comprehensive mCARE 
program of SMS and home 
visit reminders to promote care 
seeking of maternal and 
newborn health services, 
versus a basic mCARE 
program in rural Bangladesh 
Objective 2: To forecast the 
incremental cost effectiveness of 
a comprehensive mCARE 
program including pregnancy 
surveillance and care-seeking 
reminders, compared to paper-
based systems, from 2016-2025 
in the Rangpur Division of 
Bangladesh. 
Objective 3: To determine the 
affordability of a 
comprehensive mCARE 
program implementation, 
compared to a paper-based 
system, over 2015-2020 in a 
Gaibandha district in 
Bangladesh 
Research aims Aim 1: Retrospective mCARE 
I CEA (2011-2015) 
Aim 2: Forecasting mCARE 
CEA (2016-2025) 
AIm 3: Budget Impact Analysis 
of mCARE (2015-2020) 
Guideline CHEERS ISPOR Modeling study ISPOR BIA study 
Introduction Background & 
Objectives 
To determine incremental cost 
effectiveness ratio of mCARE 
intervention compared to 
mCARE control from program 
perspective  
To forecast incremental cost 
effectiveness ratio of mCARE 
intervention compared to 
mCARE control and status quo 
from societal perspective over 
the next 10 years 
To estimate budget and 
resource requirement to 
implement mCARE in 
Gaibandha district over the next 
5 years  
  
Methods Target population mCARE I study sites (2 unions 
in Gaibandha districts) 




Rural Bangladesh Rural Bangladesh Rural Bangladesh 
Study perspective Program Societal Government 
Comparators mCARE I control mCARE control and status quo 
(paper system) 
mCARE control and status quo 
(paper system) 
Time horizon 2011-2015 2016-2025 (10 years) 2015-2020 (6 years) 
Discount rate 3% 0%,3%,6% No discounting 
Choice of health 
outcome 
Newborn deaths averted, 
DALY 
Maternal, newborn, child deaths 











Discounting (3%), no age 
weighting 






Primary field data  Extrapolation of primary field 
data  
Secondary data: DHS, LiST 






USD USD USD 
Choice of model Retrospective Prospective forecasting Prospective forecasting 
Assumptions  Discounting, including 
overhead costs 
Accounting scaling up factors, 
time variant factors (e.g. 
population / service coverage) 




Cost-effectiveness Cost-effectiveness Payer specific costing 
Results Study parameters Total cost, program costs, 
number of deaths, DALY 
Total cost, 
program/provider/user costs, 
average unit cost per 
MWRA/Pregnant woman/CHW; 
number of deaths, DALY 
Total cost, 
program/provider/user costs, 




mCARE intervention vs. 
control 
mCARE intervention vs control; 
mCARE intervention vs status 
quo; mCARE control vs status 
quo 
mCARE intervention vs 
control; mCARE intervention 
vs status quo; mCARE control 














Discussion Discussion Discussion 





Discussion with other MNCH 
or mHealth CEAs 
Discussion on mHealth CEA 
with scaling up context 
Discussion based on financing 




Chapter 5. Costs and cost-effectiveness analyses of mCARE 
strategies for promoting care seeking of maternal and 




Despite growing recognition of the potential benefits of mHealth, little economic 
evaluation research exists to guide priority setting or policy making in developing 
countries. This study presents findings from the implementation of two mCARE programs, 
implemented from 2013 to 2015 in rural Bangladesh: (1) Comprehensive mCARE program 
and (2) Basic mCARE program. Both programs included a core package of services 
provided by an established cadre of digitally enabled community health workers (CHWs). 
The package includes census enumeration and pregnancy surveillance. In the 
comprehensive package, short message service (SMS) and home visit reminders were 
additionally sent to pregnant women (n=690) from CHWs (n=70). In this study, we aim to 
compare the costs and consequences of the comprehensive and basic mCARE packages. 
Economic costs were assessed from a program perspective for an analytic time horizon of 
August 2011 to June 2015, which included development, start-up, and implementation 
phases. We drew from implementing partners’ activity specifications and financial records. 
Coverage estimates inputted into the Lives Saved Tool (LiST) were used to estimate 
incremental lives saved and Disability-Adjusted Life Years (DALYs) averted for 
newborns. For comparative purposes, we normalized our evaluation to estimate total costs 
and total deaths averted per 1 million people in a community to the intervention and control 
groups. Uncertainty was assessed using one-way and probabilistic sensitivity analyses 
(with Monte Carlo simulation). Costs associated with mobile phones and health worker 
training were key drivers of cost effectiveness. Study findings suggest that the addition of 
97 
 
SMS and home visit reminders based on an existing mobile intervention of census 
enumeration and pregnancy surveillance corresponds to an incremental cost per DALY 
averted as $0.41 ($0.31-0.72). The comprehensive mCARE program had at least 97% 
probability of being highly cost-effective as compared to the basic mCARE program based 
on the threshold of Bangladesh’s GNI per capita. Overall study findings suggest that in this 
context, the addition of SMS and reminders atop an existing digital health intervention 
represents good value for money. Future research should aim to generate evidence on the 
comparative costs and consequences of implementing alerts and reminders in the absence 
of a basic mobile health intervention. Study findings compare favorably with other low-
cost, high priority community-based interventions recommended for use in South Asia. 
Additional analyses are needed to compare the costs and consequences of mHealth 




Globally, every 90 seconds a woman dies of complications related to pregnancy and 
childbirth, resulting in more than 303,000 maternal deaths in 2015.[238] Almost one-fourth 
(24%) of these occur in South Asia.[239] Among children under five years of age, 45% of 
the estimated 298,000 annual deaths annually occurred within the first 28 days of life.[240] 
Bangladesh, home to 156 million people, is the eighth most populous country in the world 
and accounts for 5,200 maternal deaths and 76,722 newborn deaths each year.[241] Efforts 
to reduce maternal newborn and child morbidity and mortality in Bangladesh have sought 
to bolster access to and utilization of high-quality health services.[242] Community health 
workers (CHWs) have been a key strategy for promoting health services, and in some cases 
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providing preventive services and clinical care in the home with the broader aim of 
extending the reach of the health system. The widespread availability of technology, 
including mobile phones, has the potential to improve the efficiency of and access to health 
services in communities.  
 
Mobile-health (mHealth) – defined as the use of mobile and wireless technology for health 
– aims to improve health outcomes by addressing critical health systems constraints to 
service delivery, coverage, and utilization.[243] In Bangladesh, a wide array of mHealth 
initiatives have been piloted, yet few have been scaled to the national level.[49] The 
mCARE program was initiated in 2011 as a partnership between research, technical and 
implementation organizations, including Johns Hopkins University, mPOWER Social, and 
the JiVitA Project in Bangladesh.[244] The aim of mCARE is to develop and test a mobile 
phone-based system to improve communication and coordination between government 
health providers and the pregnant women they serve. 
 
In this chapter, we present findings on the incremental cost-effectiveness of two alternative 
mCARE strategies implemented until the larger mCARE-I pilot: (1) Comprehensive 
mCARE program; and (2) Basic mCARE program. Both programs included a core package 
of services provided by an established cadre of digitally enabled community health workers 
(CHWs), including census enumeration, and pregnancy surveillance. In the comprehensive 
package, short message service (SMS) and home visit reminders were additionally sent to 
pregnant women (n=690) from CHWs (n=70). By exploring the incremental costs and 
consequences of these two alternative programs, we hope to inform efforts to streamline 
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mCARE program content and optimize the use of mobile tools in providing health services 
and bolstering uptake. Study findings aim to contribute to the current paucity of data on 
the cost-effectiveness of digitally enabled CHW programs in low- and middle-income 




Setting: The mCARE I pilot program was implemented in 19 unions of Gaibandha district 
of the Rangpur Division in northern Bangladesh. Gaibandha has been part of the Johns 
Hopkins University JiVitA field site for 16 years and is home to an estimated population 
of 2.4 million, 80% residing in rural areas and 60% being women.[245] Public health 
services are mainly provided through the following primary health care facilities: Satellite 
Clinics, Community Clinics/Family Welfare Clinics, and Upazila Health Complexes. 
Private sector services include informal and formal providers, with the latter comprising of 
clinics supported by nongovernmental organizations (NGOs), including BRAC and 
Smiling Sun.  
 
Study design: In a quasi-experimental design, two comparable regions were selected 
within the JiVitA study site for an intervention arm and a comparison arm. In each study 
arm, community-based services were provided by a cadre of 35 full-time, paid community 
health research workers (CHRWs) responsible for enrolling and conducting follow-up 
visits for approximately 400 pregnant women in each study arm. In two weeks, 70 JiVitA 
CHRWs were trained in the use of the mCARE mobile application, and in five weeks they 
conducted a census of 11,836 women. 6,652 women were found to be eligible for the study 
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and consented to be visited every five weeks for pregnancy surveillance. 800 pregnant 
women were enrolled in mCARE phase I, 50% (n=400) of those being part of a quasi-
experimental intervention arm and the remaining 50% (n=400) part of a control arm. The 
final sample based on eligibility criteria was 408 pregnant women in the intervention group 
and 282 pregnant women in the control group. 
 
Program description: Table 5.2 depicts key activities for the intervention and comparison 
areas. The program activities began in August 2011 and continued through June 2015. In 
both study arms the following activities were performed, in three phases: 1) Development 
phase (August 2011 to April 2013) – partnership development, program and system 
development; 2) Startup phase (May 2013 to August 2013) – system optimization, training, 
community outreach and advocacy; and 3) Implementation phase (September 2013 to July 
2015) – the four major activities: pregnancy surveillance (including census enumeration), 
SMS reminders, and ANC reminder home visits.  
 
First, the team sought to create a complete household enumeration by registering every 
resident with a unique identifier in the catchment area, and then identifying married women 
of reproductive age (MWRAs, 15-45 years old), eligible for regular pregnancy surveillance 
in both intervention and comparison areas. Routine pregnancy surveillance was conducted 
every five weeks with the broader aim of identifying pregnancies among MWRAs based 




After identifiying the timing of ANC, based on gestational age, women were enrolled into 
two program interventions – (i) scheduled SMS reminders and (ii) ANC advocacy home 
visits – implemented to promote care-seeking for ANC, SBA/FD, and PNC in the 
intervention group. First, based on a woman’s last menstruation period, the system 
calculates gestational age and automatically schedules four ANC visits (+8-10, +12-27, 
+26-28 and +32-34 weeks) and sends SMS reminders to the pregnant woman on the 
scheduled dates. During labor or (after) birth, a pregnant woman or her family or CHWs 
can send an SMS text, by using the “6969” short code with their identification number, to 
notify the CHRWs of the labor or birth. The birth notification then triggers SMS reminders 
on day 1, 2 and 7 of the newborn’s life for postnatal visits for the woman and essential 
newborn care for the baby. Second, in addition to the scheduled SMS reminders to the 
pregnant women, CHWs (field distributors, n=20) visited pregnant women (n=436) shortly 
in advance of the scheduled ANC visit dates.  
 
In the intervention arm, SMS and home visits reminders were implemented as the two 
major components. In the comparison arm, these two interventions were not implemented. 
All other activities including partnership and system development, mobile phone 
procurement, training, community outreach, supervision, census enumeration, pregnancy 
surveillance, data processing and reporting throughout the development, startup and 
implementation phases were conducted and shared identically in both study arms. This 
study design allowed for a systematic evaluation of the program outcomes – differing 
service coverage and health outcomes based on a comparable denominator — the number 




Costing: Economic costs were measured from a program perspective for the analytic 
time horizon of August 2011 to July 2015. Program costs were drawn from the financial 
records of the two implementing partners, mPOWER and JHU-JiVitA. Using 
standardized guidelines[246] and an ingredients-based approach, costs per activity were 
captured for the three phases: Development phase (August 2011-April 2013), Start-up 
phase (May 2013-August 2013) and Implementation phase (September 2013-July 2015). 
Within each phase, costs were divided into capital costs and recurrent costs and 
categorized into relevant activities through informant interviews with key program staff. 
All capital costs were annualized according to international or local estimates of each 
item’s life expectancy using a 3% discount rate.[247] Together with recurrent costs, these 
costs give an estimate of the annual program costs of running a program or intervention. 
Costs are presented in 2015 as the base year and in US dollars, adjusting for inflation 
according to consumer price indices from the IMF.[248] All costs related to the 
development and start-up phases were also treated as capital costs, and similarly 
annualized using a 3% discount rate and an assumed life expectancy of three years.  
 
To allow for a more approximate allocation of shared costs between the arms, we adjusted 
for differences in the sample sizes between study arms and standardized costs to a 
population of 1 million per arm.[249] In this adjustment, we carefully reviewed 
characteristics of each cost item such as activity-based costs and overhead costs and 
divided the costs into capital and variable costs. Capital costs, unlikely to change based on 
the number of beneficiaries, include partnership development, system development, system 
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optimization, data processing and analyses, furniture and equipment procurement, and 
office maintenance during development and start-up phases. Variable costs include mobile 
phone procurement, training, community outreach, supervision, server maintenance, 
census enumeration, pregnancy surveillance, SMS reminders, ANC reminder home visits 
and data collection home visits. In terms of the variable costs, unit costs were calculated 
per CHW, except SMS air-time costs, which are calculated per client (pregnant woman). 
We chose the CHW and not the client as the unit because most program activity costs are 
directly drawn from their work capacity, salary and time. Given a scenario of 1 million 
people in each group’s catchment area, the number of pregnant women was estimated as 
3,400 in a given year by assuming the number of women of reproductive age (243,478) in 
2015, fertility rate (2.21), abortion rate (18.20), and fetal loss rate (37.00) based on the 
national and district health bulletin statistics reports. Based on the ratio of one CHW to 10 
pregnant women enrolled (1 year) and management (1 year), 340 CHWs were assumed to 
manage pregnancy surveillance and program intervention in a year. Accordingly, each unit 
cost was then extrapolated by the estimated number of CHWs and clients to calculate 
standardized costs per 1 million people. 
 
Effects: Effects were calculated as disability adjusted life years (DALYs) and the number 
of newborn deaths averted. Estimates of the Years of Life Lost (YLLs) to newborns were 
drawn from the primary data collected from the household survey implemented during the 
mCARE I program, from 2014 to 2015. Findings from unadjusted analyses suggest that 
there was a significant reduction (p<0.05) in the number of neonatal deaths. While declines 
in maternal deaths and stillbirths were observed, they were not statistically significant. 
104 
 
Accordingly, the primary outcome measure used was neonatal deaths averted. Once 
adjusting for a population of 1 million, we estimated that total averted number of deaths 
between the intervention and comparison groups are 80 (range 35~123). Newborn YLLs 
were determined using the mean life expectancy of males and females in Bangladesh, 
which is 72 years. Due to the lack of morbidity data, YLDs were not included in the DALY 
calculation, assuming their impact to total DALY measure is negligible based on the 
literature. Base case DALYs for newborns were discounted at a rate of 3% without age 
weighting. Incremental DALYs averted through the mCARE interventions were calculated 
by subtracting the respective estimates of DALYs for each arm.  
 
Cost-effectiveness analysis: Comparisons of costs and effects for each study arm were 
used to generate incremental cost-effectiveness ratios (ICERs). Variations in individual 
parameters were tested within this framework using one-way deterministic and multi-way 
probabilistic sensitivity analyses. ICERs were estimated in both sensitivity analyses. 
Deterministic sensitivity analyses (DSA) tested uncertainty around each cost parameter 
according to a plausible range of input values, such as mobile phone costs, CHWs 
salaries and time periods of key interventions. Collectively, we assumed +/- 20% as a 
plausible range of variation from each cost based on expert opinion, as we did not have 
survey-based data for each input value. The DSA was only applied for variable costs 
because the purpose of DSA is to identify key determinants and cost drivers in the 
implementation of the program. A tornado diagram was generated to depict results of 




For probabilistic sensitivity analyses (PSA), as the cost estimates are not based on 
sampled data, we assumed distributions following common standards based on data 
characteristics. For example, cost parameters are assumed as a gamma distribution, as the 
cost distribution is generally right-skewed. The number of deaths parameter is assumed 
as a triangular symmetric distribution as a general standard practice for the value without 
sample data and evidence of a particular distribution pattern.[250] For a gamma 
distribution, standard errors were estimated based on 20% of the point estimate. For 
triangular symmetric distribution, upper and lower values were from 95% confidence 
intervals from the outcome samples.  
 
To test the effect of simultaneous variations in multiple parameters, a Monte Carlo 
simulation was used to generate a PSA. The mean of each variable cost component (e.g. 
census numeration, pregnancy surveillance, training, SMS) was used to calculate each 
iterated incremental cost-effectiveness ratio. A total of 1,000 iterations were generated 
using a Visual Basic macro in Excel. Following the recommendation by the Commission 
for Macroeconomics and Heath, the ICERs were then compared with the per capita value 
for the GNI of Bangladesh 2015. Cost-effectiveness acceptability curves were generated 




Study participant characteristics: Table 5.1 illustrates general characteristics of the study 
population. Our study sample draws from the 690 pregnant women – 330 in the 
intervention and 280 in the control arm – who reported pregnancy outcomes between 
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September 2013 and August 2015. Most basic biological, nutritional and economic statuses 
were similar in both groups, although literacy level differed. Approximately 87-88% 
women in both groups were aged 18-35 years. 56% women reported a parity status of 1-2 
births and 22-25% were null parity and 18-22% had more than two births. In terms of 
nutritional status, 87% women in both groups reported a Mid-Upper Arm 
Circumference (MUAC) measure of greater than 21.5 cm, a typical cutoff for malnutrition. 
In terms of economic status, both groups reported a similar number (24-27% for each 
quintile in both groups based on household wealth index) of women across household 
wealth quintiles. 57% of women in the intervention arm and 71% in the control were 
literate.  
 
Program costs: Table 5.3 depicts total program costs as well as program costs, by study 
arm. The standardized program costs for a population of 1 million for the development 
phase was $83,001 and for start-up was $48,988. The substantial cost of development is in 
part due to the long time period of this phase (21 months), compared to the start-up phase 
(4 months). Office maintenance (overhead costs) makes up about 50% of the costs in each 
phase. Among the activity costing components, system development and mobile phone 
procurement were the major cost drivers, at $23,723 and $13,940, respectively, in the 
development phase. In the start-up phase, training was the major cost at $22,440. The first 
year of implementation costs were $127,012 and second year costs were $131,252 due to 
the additional activity of data processing and analyses in the second year. Besides office 
maintenance costs, supervision (program governance) and pregnancy surveillance were the 
major costs: $49,640 and $20,400, respectively, during the implementation phase. 
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Interestingly, server maintenance and connection fees were estimated at only $170 for 
ANC home visits and $306 for SMS reminders, a mere 0.4% in the implementation phase. 
This is because of a very low unit cost for each activity of $0.5 per CHW and $0.1 per 
client. Unit costs of these activities are low because SMS airtime cost is very inexpensive 
in Bangladesh and ANC reminder home visits were conducted by staff with low salary 
levels, and the visits required a small amount of time from their working hours. 
Calculations of the annual cost for implementation including development and start-up 
with one year of implementation costs turned out to be $243,662 for the intervention arm, 
and $243,186 for the control arm. In the second year, they amounted to $247,903 for the 
intervention arm and $247,427 for the control arm. The slight increase in annual costs in 
the second year is due to additional activities like data processing and reporting.  
 
Effects: Table 5.4 summarizes key outcomes of the mCARE program. In the intervention 
area, a total of seven neonatal deaths, 17 stillbirths and 30 miscarriages were observed out 
of 413 pregnant women. Over the same time period, in the comparison area, a total of 10 
neonatal deaths, one maternal death, seven stillbirths and 14 miscarriages were observed 
out of 282 pregnant women. Findings from unadjusted analyses suggest that there was a 
significant reduction (p<0.05) in the number of neonatal deaths. While a lower number of 
maternal deaths and greater numbers of miscarriages and stillbirths in the intervention arm 
were observed then the control arm, they were not statistically significant. Accordingly, 
the primary outcome measure used was neonatal deaths averted. Once adjusting for a 
population of 1 million, we estimated a difference of 63 (range 32-94) newborn deaths 




Incremental Cost Effectiveness Analyses: Our results indicate that the mCARE 
intervention (SMS and home visit reminders) was highly cost-effective compared to the 
control group, from a programmatic perspective. The incremental cost per death averted 
was $12 and per DALY averted was $0.41, suggesting high cost-effectiveness as it is well 
below Bangladesh’s per capita GNI. It is important to acknowledge that the only cost 
difference between the two arms are from the SMS and ANC home visits costs, which were 
very low. Both study arms had the same activities during the preparation phases and 
implemented pregnancy surveillance using mobile phones with supervision and technical 
assistance.  
 
Sensitivity analyses: Figure 1 depicts a tornado diagram based on one-way sensitivity 
analyses, indicating that total program costs were driven by supervision following 
pregnancy surveillance, technical assistance, server maintenance, training, and mobile 
phone procurement. As discussed, the impact of SMS and home visit reminders were 
minimal due to the small amount of costs. The cost-effectiveness plane (Figure 5.2) depicts 
individual results of 1,000 points of incremental costs and the number of neonatal deaths 
averted from the Monte Carlo simulation. The PSA with Monte Carlo simulation quantified 
that the probability that the program would be highly cost effective is 97% at a threshold 








Summary/highlights/implications of findings: Despite a relatively small difference in 
mortality impact between intervention and control groups, study findings suggest that the 
comprehensive mCARE program is highly cost-effective according to thresholds 
recommended by WHO and the Commission for Macroeconomics and Health. In the 
absence of a ‘status quo’ comparator, study findings compare the minimal added costs and 
consequences attributed to the SMS and home visit reminders components of the mCARE 
program. Key drivers of cost effectiveness included supervision and pregnancy 
surveillance, which were associated with increasing numbers of CHWs and management. 
The results suggest that once surveillance is initially conducted via mobile phone, marginal 
costs of adding personally scheduled SMS and home visit reminders to promote care-
seeking are almost negligible, and this small investment can make a life-saving impact in 
low-resource settings.  
 
To consider the broader health systems implications of adopting a mobile health strategy 
in Bangladesh, we conducted a detailed activity-based costing to identify who is involved, 
what the new resource requirements are, how and why the processes are changed, and to 
what extent these changes are occurring over the full course of program development, 
preparation and implementation. With this approach, we conceptualized and categorized 
major activities based on their purpose and characteristics and identified the costs of the 
activity item based on relevant staff salaries, working months, and their levels of effort. 
Compared to alternative approaches to costing that broadly defines a cost item as human 
resource for staff salaries, this activity-based costing helped to identify major activities and 
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the associated time of completion, and consequently, their implications on resources 
required.  
 
Comparison with other MNCH CEA studies: Several recent community-based trials of 
maternal and neonatal intervention packages in low-resource settings in South Asia have 
shown statistically significant reductions in neonatal mortality, employing a variety of 
healthcare delivery approaches. To provide preventive and curative services in low-
resource settings, strategies have taken into account “the risk factors for and causes of 
mortality, the quality and accessibility of the health care system, and community perception 
and acceptance of the interventions.”[251] In Bangladesh, there have been seven CEA 
studies on MNCH[252][181, 253, 254], according to a recent systematic review.[180] Most 
studies used service output measures as effectiveness units such as the number of ANC 
services provided, the number of clients per year, percent of deliveries; and only two 
studies demonstrated mortality outcome as an effectiveness unit based on randomized 
controlled trials.[181] Another study used conditional cash transfer as demand promotion 
strategy to improve child delivery with skilled birth attendance.[255]  
 
A study by Fottrell et al. used a women’s group to stimulate community mobilization and 
presented the prospective cost-effectiveness as $11,974 per neonatal death averted and 
$393 per year of life lost averted.[181] The study highlights that the size of a population in 
a CHW’s areas of responsibility may be an important determinant of a community health 
intervention’s effect on behavior and mortality. Thus, it concluded that mobilizing a 
women’s group community, delivered at an adequate size of target population coverage 
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per CHW, is a highly cost-effective approach to improve newborn survival and health 
behavior indicators in rural Bangladesh. In a similar fashion, a study by LeFevre et al,[253] 
evaluated CHW home visits for neonatal infection prevention and treatment and presented 
cost per neonatal death averted at $2,939, and cost per DALY averted at $103. The study 
concludes that the home care package of interventions is highly cost-effective and thus 
should be considered for replication and scale up throughout Bangladesh in similar settings 
where neonatal mortality is high, and the utilization of facility-based delivery and postnatal 
care services is low. A study by Hatt et al.[256] used vouchers for free MNH care with 
conditional cash transfers, which showed that each additional delivery with a qualified 
provider that can be attributed to the demand-side financing program costs roughly $70. 
These studies suggest that successful strategies of the cost-effective community-based 
interventions include adequate care package programs, human resource management to 
cover populations in needs, and demand promotion incentives in a Bangladeshi context.  
 
Our findings are comparable to the results of a global summary of meta-analyses of the 
costs per DALY averted in community-based programs for MNCH, recently published in 
Disease Control Priorities: Reproductive, Maternal, Newborn and Child Health (Figure 
14.1; Figure 17.1).[257] In terms of the measure for cost per deaths per DALY averted, the 
addition of SMS and home visit reminders in the mCARE program – on the basis of the 
mobile phone based pregnancy surveillance system – is similar to or less expensive than 
community-based MNH interventions such as vitamin A supplementation, zinc added to 
oral rehydration therapy or pneumococcus vaccines in low-income countries. While these 
studies involve different strategies for different purposes, overall findings indicate that 
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mHealth strategies can be complementary to or may enhance the cost-effectiveness of these 
interventions as demand promotion strategies. mHealth may introduce other benefits such 
as information sharing, increased workers’ empowerment, economies of scale and 
efficiency. A study by Lund et al., for example, added a voucher system to an mHealth 
program to improving ANC care-seeking, which resulted in statistically significant 
coverage uptake and perinatal mortality reduction in Tanzania.[258]  
 
Comparison with other mHealth CEA studies: Few rigorous economic evaluations exist 
in the mHealth domain. Most existing studies include mHeath strategies of SMS reminders 
for treatment adherence for HIV/ART treatment[259], malaria[165, 167] and TB 
treatments[260] and smoking cessation[164]. Other studies also include mHealth strategies 
for data collection[261, 262] family planning training[263] and telephone support for 
breastfeeding[166]. These studies presented feasibility, quality and efficiency 
improvement, cost-effectiveness, and cost-saving potential when scaled up. However, no 
study has yet examined value for money regarding SMS reminders on top of an existing 
digital surveillance system. Only two studies[164, 260] presented cost effectiveness as cost 
per Quality Adjusted Life Years (QALY) gained, and cost per DALY averted, but most 
other studies demonstrated the findings as costing and cost savings or cost-output measures 
with some processing time and quality improvement indicators. While there is growing 
evidence of mHealth on MNCH in LMICs, there is yet little systematic mHealth CEA 
research being done in LMICs. This analysis is thus an important contribution to the field 
because it evaluates major mHealth strategies for MNCH interventions, including 





Our study has some limitations. First, the mCARE I study was a pilot study using a quasi-
experimental design, which lacks the statistical power and adjustment of confounding 
factors in evaluating mortality impact. Thus, the findings of statistical significance on 
health impact are suggestive and not definitive. Given the fact that the mHealth 
intervention was a reminder for care seeking, not provision of care itself, the health 
impact can be influenced by access to and quality of the local health facilities and the 
pregnant women’s care-seeking habits. The enabling components of a health system, 
such as level of a mobile phone penetration and ownership in the community, stable 
electricity and network connection, and available community health workforce to manage 
operations at scale are critical aspects to consider.   
 
Based on the study design, it is important to clarify that our work demonstrates 
incremental benefits of adding SMS and home visit reminders, rather than an entire 
mHealth program. Since our comparison group, basic mCARE program, also used mobile 
phone for pregnancy surveillance, our finding does not present mCARE effectiveness 
compared to the current best practice – paper based system. Rather, as discussed above, 
this allows for a systematic comparison and evaluation of the mHealth intervention’s 
impact on service coverage improvement and mortality reduction based on similar 
population denominators between the intervention and control groups.    
 
We took a program perspective, and thus did not include household costs or service 
provision costs associated with the intervention. However, in this setting where ANC 
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services are largely free of charge in all public facilities and very inexpensive (e.g. $0.06 
per ANC) in some NGO clinics, we consider that user or provider costs would not affect 
our cost-effectiveness conclusions. Similarly, our study measured mortality and not 
morbidity; however, because estimates suggest that inclusion of morbidity would have a 
negligible effect on the DALYs averted by newborn home visits, we believe our use of 
DALY-based thresholds for assessment of cost-effectiveness remains broadly 
appropriate.  
 
Our cost adjustment for standardized estimations to a population of 1 million may not 
systematically incorporate potential changes with scaling up. The proportional 
extrapolation based on the relevant user and beneficiaries may not consider potential 
productivity or efficiency gains associated with mHealth programs at scale over time. 
However, the method of extrapolation with a unit cost to the increased number of the 
target population is a common practice in economic evaluation of health programs.[249] 
Besides the mortality impact, mHealth is expected to provide great benefits in operational 
practices with improved accuracy, quality, and efficiency, shown in many qualitative 
studies. The currently limited evidence makes it difficult for systematic quantification of 
these features for cost-effectiveness analyses. Considering these direct benefits as well as 
positive externalities, our measure of cost per death averted may be considered a 






5.7 Conclusions   
 
The study contributes to the currently available economic evaluation data on mHealth 
interventions in Bangladesh and globally. Study findings suggest that in this context, the 
addition of SMS and home visit reminders based on a mobile phone-facilitated pregnancy 
surveillance system was highly cost effective at a cost per DALY averted of $0.41 
according to thresholds recommended by WHO and the Commission for 
Macroeconomics and Health. Future research should aim to generate evidence on the 
comparative costs and consequences of implementing alerts and reminders in the absence 
of a basic mobile health intervention. Based on our findings on a broader evidence 
landscape of community-based MNCH practices, we suggest that incorporating simple 
mHealth strategies such as SMS reminders to clients and workflow optimization to 
proven community-based delivery strategies may improve service utilization and 





















Characteristics of pregnant 
women 
Comprehensive mCARE  
(n=330) 
Basic mCARE (n=280) 
% % 
Women’s age  <18 years 7.3% 8.9% 
18-35 years 89.1% 86.8% 
>35 years 3.6% 4.3% 
Missing 0.0% 0.0% 
Parity Nulliparity 21.2% 25.4% 
1-2 births 56.7% 56.1% 
>2 births 22.1% 18.2% 




<21.5 cm 12.7% 13.2% 
>= 21.5 cm 87.3% 86.8% 
Missing 0.0% 0.0% 
Women’s 
Literacy 
Illiterate 41.2% 25.7% 
Literate 57.3% 71.1% 
Missing 1.5% 3.2% 
Household 
wealth index 
Lowest quartile 24.8% 24.3% 
2nd quartile   24.2% 23.9% 
3rd quartile 24.5% 24.6% 
Highest quartile   26.4% 27.1% 
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Table 5.2 Activity based program costs definitions over mCARE I program development (August 2011-April, 2013), start up (May-
August, 2013), and implementation (September 2013-August, 2015) 
Program 
activities 
Activity descriptions  





Development (August 2011-April 2013): 21 months       
Partnership 
development 
JHU/JiVitA / mPOWER held leadership meetings and an official launch on mCARE 
project among central, regional, and district health management teams. JHU contracted 
mPOWER as technical  system developer. 
√ √ 
Capital costs  





mPOWER prepared systems requirement specifications; developed scheduling logic, skip 
patterns, question type feedback; development of detailed technical specifications (end user 












JiVitA/mPOWER office rent, office supplies, utilities (electricity, gas, water etc.) 
√ √ 
Start up (May-August 2013): 4 months       
System 
optimization 
mPOWER developed system prototype and testing : outsourced SMS service component  
√ √ 
Capital costs 
(3 yrs of useful 
time; 
annualized) Training 
JiVitA / mPOWER prepare training manuals; conduct 3 weeks trainings with mobile 
phones to 70 CHWs; evaluate CHWs performance and acceptability; print out survey 





JHU/JiVitA established MOU with government DGFP; held an official launching meeting 
by inviting local leaders and partners in Gaibandha; distributed mCARE brochure to 
community √ √ 
Office 
maintenance 
JiVitA/mPOWER office rent, office supplies, utilities (electricity, gas, water etc.) 
√ √ 
Implementation (September 2013-August 2014): 12 months       
Supervision 
JiVitA senior management team and field supervisor monitor field implementation 
activities and progress through weekly meetings, field visiting, data monitoring, quality 




Field distributers visit all households for census enumeration, MWRA registration through 
mobile phones for 5 weeks.  √ √ 
Pregnancy 
surveillance 
Field distributors visit eligible couple's households for pregnancy registration, receive 
consent for the study through mobile phones for 10 months.  √ √ 
SMS 
SMS automatically sent from server to pregnant women's phones at their expected ANC 1-
4 dates. √   
Reminder 
home visit 
Field distributers visit pregnant women' houses four days before their scheduled ANC  1-4 
dates to remind/encourage ANC care-seeking. √   
Server 
maintenance 
Server to automatically send scheduled SMS to pregnant women and update workflow 
(e.g. list of households to be visited in the week) to CHWs √ √ 
Office 
maintenance 
JiVitA/mPOWER office rent, office supplies, utilities (electricity, gas, water etc.) 
√ √ 
Implementation (September 2014-August 2015): 12 months       
Supervision 
JiVitA senior management team and field supervisor monitor field implementation 
activities and progress through weekly meetings, field visiting, data monitoring, quality 
control activities etc.  √ √ 
Recurrent costs Pregnancy 
surveillance 
Field distributors visit all households for pregnancy registration, consent for the study 
through mobile phones for 10 months.  √ √ 
SMS SMS automatically sent from server to pregnant women's phones at their expected ANC 1-





Field distributers visit pregnant women's houses four days before their ANC  1-4 dues to 
remind/encourage ANC care-seeking. √   
Server 
maintenance 
Server to automatically send scheduled SMS to pregnant women and update workflow 









































mCARE I program 
unit cost/unit 
(USD$) 
1 million standardized estimations 
Comprehensive Basic Comprehensive Basic 
Number of population ~40000 ~20,000 ~20,000 1 million  1 million  
Number of pregnant women (1 year) 700 350 350 3400 3400 
Number of CHWs 70 35 35 340 340 
Development costs (21 months) 
Partnership development $14,811 11% $7,406  $7,406  n/a $7,406 $7,406 
System development $47,446 34% $23,723  $23,723  n/a $23,723 $23,723 
Mobile phone procurement $2,852 2% $1,426  $1,426  $41/CHW $13,940 $13,940 
Office maintenance $66,419 47% $33,209  $33,209  n/a $33,209 $33,209 
Furniture and equipment $9,446 7% $4,723  $4,723  n/a $4,723 $4,723 
Total development costs (A) $140,974   $70,487  $70,487    $83,001 $83,001 
Start-up costs (4 months)  
System optimization $11,988 23% $5,994  $5,994  n/a $5,994 $5,994 
Community outreach $2,060 4% $1,030  $1,030  $13/CHW $4,420 $4,420 
Training $6,832 13% $3,416  $3,416  $66/CHW $22,440 $22,440 
Office maintenance $32,269 61% $16,134  $16,134  n/a $16,134 $16,134 
Total start-up costs (B) $53,149   $26,574  $26,574    $48,988 $48,988 
Implementation cost--Year 1 
Supervision $61,900 37% $30,950 $30,950 $146/CHW $49,640 $49,640 
Pregnancy surveillance  $29,732 18% $14,866 $14,866 $60/CHW $20,400 $20,400 
ANC reminder home visit $643 0% $643 0 $18/CHW  $6,120 $0 
Technical assistance $6,256 4% $3,128 $3,128 $40/CHW $13,600 $13,600 
Data processing & analyses $0 0% $0 $0 n/a $0 $0 
SMS $17 0% $17 0 $0.09/Client $306 $0 
Server maintenance $8,116 5% $4,058 $4,058 $35/CHW $11,900 $11,900 
Office maintenance $61,991 37% $30,996 $30,996 n/a $30,996 $30,996 
Total implementation Yr1 costs (C) $168,654   $84,657 $83,997   $127,012 $126,536 
Total program year 1 costs (A+B+C) 362,776   $181,718 $181,058   $259,001 $258,525 
Implementation costs-- Year 2  
Supervision $61,900 35% $30,950 $30,950 $146/CHW $49,640 $49,640 
Pregnancy surveillance  $29,732 17% $14,866 $14,866 $60/CHW $20,400 $20,400 
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ANC reminder home visit $643 0% $643 $0 $0.5/CHW  $170 $0 
Technical assistance $6,256 4% $3,128 $3,128 $40/CHW $13,600 $13,600 
Data processing & analyses (2nd year) $8,481 5% $4,240 $4,240 n/a $4,240 $4,240 
SMS $17 0% $17 $0 $0.09/Client $306 $0 
Server maintenance $8,116 5% $4,058 $4,058 $35/CHW $11,900 $11,900 
Office maintenance $61,991 35% $30,996 $30,996 n/a $30,996 $30,996 
Total Implementation Yr2 costs (D) $177,135   $88,897 $88,237   $131,252 $130,776 




Table 5.4 Health outcome: unadjusted multinomial logistic regressions and 1 M population standardization  
Birth Outcomes n (%) = # 
of pregnant women  





Comprehensive (n=3,400) Basic (n=3,400) 
Miscarriage** 5 (1.5%) 14 (5.2%) 52 170 
Stillbirth 13 (3.9%) 7 (2.6%) 134 85 
Neonatal death* 4 (1.3%) 10 (4.1%) 41 121 
Perinatal mortality 17 (5.2%) 17 (6.3%) 175 206 
*p<0.05; **p<0.01; ***p<0.001, based of  Χ2 test for categorical variables 
 
(Note:  Annual number of pregnant women (3,400) was calculated based on estimated women of reproductive age (243,000), fertility rate (2.21), abortion rate (18.20), 
fetal loss rate (37.00) based on a formula published by CDC)  
 
Table 5.5 Standardized costs per 1 million population by study groups for sensitivty analyses 
Standardized cost per 1 million population Comprehensive mCARE  Basic mCARE  Probabilistic 
Sensitivity Analysis 
Distribution  
One time capital costs Deterministic sensitivity analysis 
Development 
Partnership development $7,406 $7,406 
n/a 
Systems development $23,723 $23,723 
Furniture and equipment $4,723 $4,723 
Office maintenance $33,209 $33,209 
Start-up 
System optimization $5,994 $5,994 
Office maintenance $16,134 $16,134 
Implementation Data processing/analyses $4,240 $4,240 
Total fixed costs $95,429 $95,429 
Variable costs  Base 














Development Mobile phone procurement $13,940 $11,152 $16,728 $13,940 $11,152 $16,728 25 558 
Start-up 
Community outreach $4,420 $3,536 $5,304 $4,420 $3,536 $5,304 25 177 
Training $22,440 $17,952 $26,928 $22,440 $17,952 $26,928 25 898 
Implementation 
Supervision $99,280 $79,424 $119,136 $99,280 $79,424 $119,136 25 3,971 
Pregnancy surveillance $40,800 $32,640 $48,960 $40,800 $32,640 $48,960 25 1,632 
Server maintenance $23,800 $19,040 $28,560 $23,800 $19,040 $28,560 25 952 
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SMS reminder $612 $490 $734 
n/a 
25 24 
ANC reminder home visit $340 $272 $408 25 14 
Technical assistance $27,200 $21,760 $32,640 $27,200 $21,760 $32,640 25 1,088 
Office maintenance $61,991 $49,593 $74,389 $61,991 $49,593 $74,389 25 2,480 
Total variable costs $294,823 $235,859 $353,788 $293,871 $235,097 $352,645     
Total program costs $390,252 $235,859 $353,788 $389,300 $235,097 $352,645     
Incremental costs $952 $762 $1,142 n/a     












Newborn deaths 41 11 71 121 47 194 Triangular symmetric 
Total neonatal deaths averted n/a 80 $36 $123   
(Note: the one way sensitivity analyses were only applied to the variable costs to see the major cost drivers during implemetnation. The one time fixed 
costs are shared equallty between the two groups as they both groups invovled the major developemtn and start up activities together and used mobile 
phone for pregnanty surveillance and data processing.)  
 
Table 5.6 Summary of incremental cost effectiveness ratios between comprehensive mCARE vs. basic mCARE programs 
(2011~2015) based on 1 million population standardized estimations 
Summary Incremental cost effectiveness ratios 
Comprehensive 





Total incremental costs $952 $762 $1,142 
Incremental neonatal death averted 80 36 123 
Incremental DALY averted 2,347 1,054 3,640 
Incremental cost per neonatal death averted $11.96 $9.26 $21.32 
Incremental cost per DALY averted $0.41 $0.31 $0.72 
Probabilistic calculation 
Total incremental costs $953 $910 $996 
Incremental neonatal death averted 65 62 67 
Incremental DALY averted 1,905 1,841 1,968 
Incremental cost per neonatal death averted $14.76 $14.58 $14.92 









































































Neonatal deaths averted Average Threshold
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Figure 5.3 Cost effectiveness acceptability curve showing 97% probability of being cost effective at a threshold value defined 





























































Theoretical thresholds (willingness to pay) to save 1 neonatal death (US$ 2015)
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Chapter 6. Forecasting of the cost effectiveness of the mCARE 
program on pregnancy surveillance and care-seeking 




Despite growing recognition of the potential benefits of mHealth in improving 
knowledge, care seeking, and treatment adherence, little economic evaluation research 
exists to guide priority setting or policymaking in developing countries. Following 
established guidelines, we conducted a costing and cost-effectiveness analyses of a 
comprehensive package of the mCARE program including pregnancy surveillance and 
scheduled SMS and home visit reminders provided by community health workers 
(CHWs) and compared these to existing paper-based practices in order to promote 
utilization of essential maternal and newborn care services in rural Bangladesh. The study 
used datasets from the mCARE project, financial records from implementation and 
technical organizations, interviews with local experts and stakeholders, observation 
studies and exit interviews, and a literature review related to mHealth and Bangladeshi 
health systems. We used an ingredients approach to measures costs by activity and 
developed an Excel spreadsheet model to forecast program, provider and user costs for 
implementation at scale across one district in Bangladesh. We also used the Lives Saved 
Tool (LiST) to model service coverage increase and to project the number of lives saved 
from each scenario of service delivery. We tested the robustness of the results though 
deterministic and probabilistic sensitivity analyses with Monte Carlo simulation. Study 
findings suggest that with a cost per DALY averted of $47 the comprehensive mCARE 
program had at least 98% probability of being highly cost effective when compared to 
paper systems based on the threshold of Bangladesh GNI per capita. Program costs were 
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driven by two major activities of census enumeration and pregnancy surveillance. This 
study suggests that incorporating mCARE strategies to proven community-based 
interventions may enhance cost effectiveness of the program and health outcomes in low-




Improving maternal, newborn, and child health (MNCH) remains an essential health 
priority for Bangladesh despite progress over the past decades. Home to 156 million 
people, Bangladesh is the eighth most populous country in the world and accounts for 
5,200 maternal deaths and 76,722 newborn deaths each year.[264] Many maternal and 
neonatal deaths can be averted using evidence-based interventions such as utilization of 
antenatal care, early initiation of breastfeeding, and timely access to healthcare. In many 
low and middle-income countries, however, coverage levels of these interventions are 
still low. The first 1,000 days between pregnancy to a child’s second birthday is a critical 
window for maternal and child survival and wellbeing.[265] Under these circumstances, 
use of mobile and digital health solutions to improve access and quality of service 
delivery of critical MNCH services is increasing.[266] Emerging evidence suggests that 
mHealth solutions may be effective in improving knowledge, care seeking and treatment 
adherence, and can contribute to reductions in mortality. [258][267] However, less is 
known, about the value for money of mobile and other digital health solutions. The 
absence of this evidence limits efforts to compare solutions against alternative resource 
uses and ultimately, advocating for their scale up.[268-270]  
 
A number of pilot studies of health innovations have been conducted around the world. 
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Evaluations have revealed positive results on intended health outcomes. Yet, few of these 
successfully piloted innovations have been taken to scale, with even fewer scaled up 
sustainably. There are growing concerns with the number of mHealth programs – that are 
they are mostly pilot projects or implemented on a small scale. Studies acknowledge that 
the gap is partly due to a lack of knowledge on how to deliver proven interventions at 
scale using health innovations, how to build capacity in countries, and what resources are 
needed.[271][219] Accordingly, efforts to determine the value for money of mHealth 
programs have largely been constrained to small-scale pilot programs or model-based 
analyses that forecast costs and consequences over time.[272] While the latter may 
provide important insights into the probable value for money, often these analyses fail to 
consider alternative program design scenarios wherein stakeholders that are likely to 
assume responsibility for the program at scale (e.g. governments) carry out the 
implementation.  
 
In Bangladesh, a wide array of digital health solutions have been piloted throughout the 
last decade, including eHealth (e.g. health information system, telemedicine), and 
mHealth (e.g. short message service (SMS) advice for safe pregnancy, use of the mobile 
phone as a data collection tool).[49] However, no program to date has been scaled at a 
national level. The mCARE program was implemented from 2011 to 2015 as a digital 
health platform that supports CHWs’ pregnancy surveillance activities and promotes 
care-seeking behaviors to pregnant women in the Gaibandha district of Rangpur division 
(study area). Emerging findings suggest that the mCARE intervention was associated 
with a 2.6 times increase in utilization of antenatal care, 1.6 times increase in postnatal 
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care, (as reported in the prior Chapter 5), and highly cost effective as compared to the 
mCARE control with an estimate of $15 per death averted.  
 
Less is known about the costs and consequences of a larger scale deployment of mCARE, 
which would be implemented by the Ministry of Health.  As part of efforts to improve the 
scalability of mCARE, a second phase (mCARE-II) is presently underway, which will 
shift implementation away from non-government organization (NGO) staff toward 
government CHWs such as Family Welfare Assistants (FWAs) and Family Welfare 
Visitors (FWVs). In this analysis, we model the incremental cost effectiveness of 
mCARE II over a 10-year analytic time horizon (2016-2025), with implementation 
occurring at scale across the Rangpur division (15.8 million population, 8 districts, 6,249 
square). We consider three scenarios: (1) mCARE program inclusive of pregnancy 
surveillance, CHW home visits, and automated scheduled SMS reminder for pregnant 
women; (2) mCARE program inclusive of pregnancy surveillance only; and (3) status 
quo – existing services with no added program. Study findings suggest recommendations 
to introduce proven, cost-effective innovations into a health system, or to promote their 




Study setting. The Rangpur division is home to approximately 15.8 million people 
disbursed across eight districts. An estimated 52% are married women and 44% are 
literate. Agriculture remains the primary source of employment. As of 2011, coverage for 
maternal and newborn health (MNH) services for four or more antenatal care visits is 
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31%, 38% for facility delivery, and 36% for postnatal care, which compares favorably 
with national estimates reported in the 2014 Demographic Health Survey (DHS). Health 
services are provided through a mix of private and public health facilities. The public 
facilities include Community Clinics (CC), Family Welfare Centers (FWC), Union-sub 
centers, and Upazila Health Complex (UHC) as primary healthcare centers and Maternal 
and Child Welfare Center (MCWC) as a secondary health care center. NGO facilities 
include Smiling Sun franchise static clinics or emergency obstetric care clinics. Private 
facilities mainly cover complex obstetric care services such as caesarian section in the 
community. Frontline health workers in rural Bangladesh take on many important 
responsibilities including identifying and registering married women of reproductive age 
for routine pregnancy surveillance, distributing services in their communities (e.g. family 
planning), administering essential MNH services, promoting public health campaigns or 
programs (e.g. immunization), managing treatment or referrals in emergency situations, 
and keeping records and reporting to health workers.  The FWAs (the lowest level of 
government health workers) and Shastoshebika of BRAC are the two major types of 
frontline heath workers in this region.  
 
Target population. Model-based analyses explored the costs and consequences of the 
mCARE program from one district in Rangpur (Gaibandha district, approximately 2.4 
million population) up to total eight districts (15.8 million population) in the entire 
Rangpur region over the 10-year time horizon 2016-2025. The number of CHWs and 
married women of reproductive age (MWRAs) in the division wascalculated by 
multiplying the total number of districts in the division based on the numbers of CHWs 
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and MWRAs in one district (Gaibandha district). The number of pregnant women was 
calculated in each district based on the respective number of married women of 
reproductive age (15-49 years) in each district, fertility rate[273], abortion rate, and fetal 
loss rate, based on the World Bank database and a formula published elsewhere.[274]  
 
Program description. We developed an Excel spreadsheet-based model[275] to project 
cost and resource requirements and potential mortality impact resulting from averting 
maternal, neonatal, stillbirths and child deaths in Bangladesh by 2025, in the three 
scenarios. In this analysis, we consider three comparators and their implementation over 
the 10-year time horizon recommended by WHO CHOICE[276] and the Bangladesh 
investment plan for health data collaboration by 2025.[277] The programmatic activities 
for each scenario are briefly described below and their specific cost components defined 
in Table 6.1. The scenarios are purely illustrative and not prescriptive for any particular 
project or country. 
 
• Comprehensive mCARE program scenario: Population mapping and census 
enumeration, pregnancy surveillance by using mobile phone based system 
through government CHWs (family welfare assistants); automated SMS and 
CHWs’ home visit reminders to pregnant women at specific personally scheduled 




• Basic mCARE program scenario: Population mapping and census enumeration, 
pregnancy surveillance by using mobile phone based system through government 
CHWs (family welfare assistants) 
 
• Paper based status quo scenario: Paper-based census enumeration and 
pregnancy surveillance and community-based ANC promotion activities to 
pregnant women by government CHWs (family welfare assistants)  
 
The focus of the model is to see how much the mCARE program would improve service 
utilization and heath impact based on the change of existing operational processes, 
workforce productivity and pregnant women’s care-seeking levels. Therefore, we set the 
three scenarios starting from the same target population (number of pregnant women) and 
same baseline service coverage in 2016 for a systematic comparison of the costs and 
consequences. Also, as the model focuses on the value of the mCARE program in 
improving existing workforce productivity and operational efficiency, we did not 
consider additional investment to increase the number of CHWs or health facilities.  
 
In terms of operational change, the model determined relevant pregnancy surveillance, 
population coverage and service coverage for each scenario, listed in Table 6.2. In terms 
of workforce productivity, the model assumed incremental increase of the number of 
household visits per day by a CHW within a feasible range of capacity, for mCARE 
groups, while the model assumed a constant number of household visits per day by a 
CHW for the paper-based system. The model assumed the existing number of CHWs and 
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health facilities to be constant over time, given the current health system conditions and 
health budget constraints. In terms of pregnant women’s care seeking level, the model 
assumed differing incremental increases of service utilization levels for each scenario. 
Given the mCARE intervention – SMS and home visit reminders – as demand promotion 
strategies, the model considers the increased level of service utilization as an intermediate 




Target population. The model set the target population and its change overtime to be 
equal across the three scenarios to compare the cost and consequences associated with 
each scenario. Based on a feasible number of daily household visits per CHW in the 
current paper-based system, different census enumeration and pregnancy surveillance 
coverage rates were assumed for the mCARE system as 90% and 80% for the paper 
group. This determines ‘population coverage’ for each scenario, which represents the 
number of pregnant women who are registered in the program through census 
enumeration and pregnancy surveillance, over the actual number of pregnant women in 
each district. We used data from multiple sources including government health reports, 
national and regional statistics, published literature, primary data collection, and 
interviews with relevant local stakeholders. Demographic data are drawn from the 
Bangladesh Demographic and Health Survey (BDHS) [34] and World Bank database. 
Regional service coverage information was drawn from the BDHS and mCARE I study. 
When no regional data was available, we used the national average for fertility rate, 
abortion rate, and fetal loss rate from the DHS, Bangladesh Bureau of Statistics (BSS) or 
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World Bank database. Service quality and cost data are mainly drawn from observation 
of the field sites and interviews with relevant local stakeholders. 
 
Service coverage. Based upon the estimated number of registered pregnant women, the 
model forecasts incremental changes in the utilization of health services, ‘service 
coverage’, as a function of each scenario over the 10-year program time horizon. ‘Service 
coverage’ was calculated as the number of pregnant women who sought care, over the 
number of registered pregnant women in the system. Different coverage increase rates 
were assumed for the mCARE intervention (10%), mCARE control (5%), and the paper 
system (1%) from 2016 to 2025, using the same baseline from 2016 across the three 
scenarios. The coverage increase rate for the mCARE intervention was based on early 
findings from the pilot phase implementation of mCARE in Gaibandha district. The 
coverage increase rates for the mCARE control group (which does not have a demand 
promotion component) and the paper system were based on the past trend of the relevant 
service coverage from the BDHS – an increase from 58% in 2004 to 88% in 2014 with a 
3-5% annual coverage increase rate. Estimates of the incremental changes in coverage 
assumed a linear increase for each of the 10 years of implementation. This resulted in a 
2.4 times increase for the mCARE intervention group, 1.6 for the mCARE control group, 
and 1.1 times increase in coverage for the status quo group, from the baseline in 2016 to 
2025. 
 
The Lives Saved Tool (LiST) was used to generate estimates of incremental lives saved 
based on respective incremental service coverage increase for ANC, home delivery, 
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facility delivery and PNC for each scenario. Assumptions of co-coverage of interventions 
embedded into LiST were used for each intervention (ANC, delivery and PNC). This 
resulted in the number of lives saved for mothers, stillbirths, newborns, and children 
based on national default values. Considering the geographical expansion over time, for 
each year, we adjusted the number of lives saved based on a proportional ratio between 
increasing number of districts over the total number of districts, which is 64, in the 
country. Specific input assumptions and model outputs are described in Appendix 3. 
 
The number of lives saved was used to generate an estimate of DALYs using the standard 
formula from the Global Burden of Disease study.[278] Given the lack of data on 
disabilities, we only accounted for years of lives lost (YLL) for the DALY calculation 
based on the number of lives saved. Life expectancy was estimated as 72 years based on 
World Health Organization life tables. A life expectancy estimate of mothers would be 
based on average age of women in the study sites when they delivered a child between 
2013-2014. Without adjusting age weighting, a discount rate of 3% was used in reference 




Economic costs were measured from a societal perspective and included incremental 
costs to the program, health system, and user. In terms of program costs, we interviewed 
and consulted with relevant local experts and program developers for operational practice 
and technical requirements. Standard service provision protocols and supplementation as 
well as their approximate costs were identified based on observation and consultation 
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with the government health workers and local program officers. When historical data 
– such as the cost of system optimization and customization – were lacking, we consulted 
relevant stakeholders like technology firms and local experts, to estimate the activities 
and resources required. Provider and user costs were identified based on observations and 
exit interviews at various levels of service provision in Gaibandha district. We used 
market-based approaches to account for costs of items and to estimate the value of 
activities or services, although some costs involved no expenditure due to procurement 
from higher government authorities. The specific methods we used in the model are 
described below.   
 
Program costs. The program costing consists of two stages: one year of start-up 
preparation and subsequent years of implementation. For each scenario, we identified 
relevant activities and resource requirements in each phase as described above. Following 
the activity-based costing, we defined and categorized the cost items based on the activity 
or purpose of the expenditure rather than simply following financial line items such as 
staff salaries. This approach helps measure specific costs associated with the mHealth 
project in an organization where multiple projects are running simultaneously and staff 
has multiple responsibilities. For each activity component, we calculated costs based on 
relevant input costs, quantities and time period consumed. As we assumed that the 
program rolls out from one to eight districts in each year, the program costs gradually 
increase over time. Based on the population size and cost estimation in one district 
(Gaibandha district), program activity costs – except system optimization and 
customization, which are one-time fixed costs as described above – in other districts were 
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proportionally adjusted based on their respective population sizes. Based on such an 
incremental geographical expansion, total program implementation costs are increased 
stepwise annually. We did not include the costs for expanding or upgrading infrastructure 
related to these interventions, nor potentially increasing program costs for conducting 
pregnancy surveillance in hard-to-reach areas, given the lack of information to make 
these estimates.[279] We also did not account for a potential change of unit input costs 
based on economies or diseconomies of scale. We accounted for an annual inflation rate 
of 6% [280] and capital costs annualized with five years of life expectancy. Costs were 
calculated using the year 2015 in US dollars. Details regarding costing assumptions and 
data used in calculations are summarized in Table 6.1. 
 
Provider costs. Provider costs were calculated based on service coverage, which is the 
number of pregnant women who seek care multiplexed with relevant service unit costs. 
As the total number of pregnant women who seek care gradually increases over time due 
to geographical program expansion, so does service coverage. Accordingly, provider 
costs are gradually increasing over time. We estimated a unit cost of service provision in 
rural Bangladesh for an ANC, a facility delivery, a home delivery, and a PNC based on 
the survey data, which is described in Chapter 4: Methodology. We estimated only the 
costs to providers of delivering these interventions and not costs from other activities. A 
unit cost of service provision mainly consists of service cost and supplementation cost. 
Service costs are calculated based on the provider’s salary and time consumed for 
providing a service. Supplementation costs are calculated based on quantity and unit 
costs of any supplementation such as micronutrients or vitamin A, distributed or 
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consumed during the service provision. To calculate the market based economic costs 
from the provider’s aspect, considering that the supplementation is procured from a 
higher government agency without charge or is distributed to clients for free, we 
accounted an approximate market price for the item and included in the supplementation 
cost calculation. We did not take into account local variations in supply or costs. 
Information regarding staff salary, service time, quantity or unit cost of supplementation 
were obtained based on consultation with government health workers and were reviewed 
by local health experts and program officers. Unit costs for service provision and 
supplementation were obtained from observation study conducted in Gaibandha, which is 
described in Chapter 4: Methodology section.  
 
User costs: Similar to provider costs, user costs were calculated based on the number of 
pregnant women who seek care, multiplexed with relevant user costs. We estimated a 
service user cost in rural Bangladesh for an ANC, a facility delivery, a home delivery, 
and a PNC based on the survey data, which is described in Chapter 4: Methodology. A 
user cost mainly consists of direct and indirect costs. Direct user cost is any cost spent to 
seek care, including round trip costs (e.g. transportation), or fees for service, medical tests 
or drugs. Indirect user cost is an opportunity cost that is foregone due to the care seeking, 
which we mainly considered as wage loss and total time spent for care seeking including 
round trip transportation, waiting, consultation, and treatment. The input measures for 
direct and indirect user costs as well as average wage level were obtained from exit 
interviews conducted with 100 pregnant women in Gaibandha district. The information 
required for calculation of direct and indirect costs were obtained based on interviews 
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with pregnant women in the village. Along with an increasing number of pregnant 
women who seek care as mentioned above, user costs are gradually increasing over time.  
 
Sensitivity analyses  
 
To evaluate the robustness of the findings when key variables change, we used one-way 
deterministic sensitivity analyses (DSA) and probabilistic sensitivity analyses (PSA). The 
impact of a single parameter’s uncertainty to the total program cost was assessed with 
one-way DSA. We conducted one-way sensitivity analyses to examine the impact of 
parameters related to total program costs. Tornado diagrams were presented to depict the 
major cost drivers of total program costs. Considering that the final estimates are driven 
by joint effects of multiple parameters, we conducted multivariate PSA with all the 
variables examined in the one-way DSA. 
 
Parameter selection. The parameters included cost items for program costs, provider 
costs, and user costs. Also, parameters included population coverage of census 
enumeration and pregnancy surveillance for each scenario (e.g. 90% and 80% coverage 
rates, respectively), service coverage increase rates in each scenario (e.g. 10%, 5% and 
1%, respectively), as well as the modeled number of lives saved for each scenario. 
 
Parameter distribution. For PSA, we attached statistical distributions of the cost items, 
coverage, and a number of deaths averted and fitted to relevant data (Table 6.4 and 
Figure 6.1). In terms of program costs, based on our activity-based costing, the parameter 
ranges were determined by results of respective input variation of the level of 
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productivity, a level of effort, overtime, salaries, and time duration for activity 
components. We drew the mean and variance from the plausible range reported by an 
expert. A conservative approach was adopted with an appropriately broad range of 
possible estimates elicited from each expert. In the case of provider and user costs, we 
drew mean and variance from the survey data, and fitted to the relevant data. For 
population and service coverage, which has no historic reference to set a plausible range, 
we set +/- 20% of the point estimate as low and high values and estimated the mean and 
variance. For a number of deaths averted, we modeled different service quality scenarios 
for each service over time and determined a potential range of health impact for each 
scenario by 2025. We attached the LiST model input assumptions and results to the 
Appendix of this chapter. The statistical distribution was chosen based on the shape and 
characteristics of the data. We produced the probability distribution functions for each 
parameter based on the standard statistical equation, published elsewhere.[281] 
 
Simulation. We used the Monte Carlo simulation for multivariate PSA. In total, 1,000 
iterations were generated using a Visual Basic macro in Excel. The means of each cost 
component were summed by calculating each iterated incremental cost-effectiveness 
ratio. Cost-effectiveness planes show the distributions of costs and effects from each 
iterated input parameters (Figure 6.4).  Cost-effectiveness acceptability curves show the 
probability of cost effectiveness from comparisons among the scenarios. Setting a series 
of hypothetical threshold values was considered as the willingness to pay. Finally, in 
comparing the comprehensive mCARE group and the paper based group, we populated 
an ellipse of confidence to the cost effectiveness plane as a graphical presentation of 95% 
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confidence intervals of probability of cost effectiveness between the two groups (Figure 
6.4). Accordingly, we also calculated net benefit values by multiplying the threshold 
ratios to the incremental death averted and then subtracting incremental costs between the 
two groups. The result was presented as a cost effectiveness acceptability curve as a 
function of the incremental threshold values. (Figure 6.5) We set Bangladesh GNI per 
capita as a threshold from government decision makers’ perspective based on the 
standardized guideline.  
 
 
6.4 Results  
 
Program costs: Table 6.3 demonstrates the total program costs and major cost drivers in 
each group. Total program costs are $37 million for the intervention group, $31 million 
for the status quo group, and $24 million for the control group. With a geographical 
expansion of the program of an additional district per year, the annual program cost 
would increase from $468,294 to $5,613,986 in the intervention group, $468,294 to 
$4,780,953 in the control group, and $220,124 to $3,728,556 in the paper group between 
2016 and 2025. Figure 6.3 depicts the major cost driver per study arm. In the intervention 
group, the major cost drivers are training (26%), supervision (21%), pregnancy 
surveillance (18%) and reminder home visits (16%). Phone procurements, SMS 
reminders or SMS server hosting have a fairly marginal impact on the total program 
costs. In the control arm, the major cost drivers are training (31%), supervision (26%), 
and pregnancy surveillance (22%). In the paper group, the major cost drivers are 




Provider costs over the period of 2016-2025 are $9.5 million in the intervention group, 
$8.9 million in the control group, and $6.7 million in the paper group. The major costs 
drivers are facility and home delivery, as their unit costs are much higher than ANC or 
PNC. Similarly, user costs over the period of 2016-2025 are $11.6 million in the 
intervention group, $1.3 million in the control group, and $7.7 million in the paper group. 
Major costs are from child delivery. Given the high out-of-pocket payment in 
Bangladesh, the results also show higher user costs than provider costs. Consequently, 
total societal costs throughout 2015-2025 including program, provider and user costs are 
estimated as $58 million in the intervention group, $41 million in the control group, and 
$39 million in the paper group. 
 
Effects. Table 6.5 summarizes key outcomes for the mCARE program based on LiST 
modeling. In the intervention area, a total of 761 estimated deaths was averted including 
one maternal death, 594 neonatal deaths, 56 stillbirths and 110 child deaths. Over the same 
time period, in the comparison area, an estimated total of 397 deaths were averted including 
one maternal death, 311 neonatal deaths, 29 stillbirths, and 56 child deaths. In the status 
quo group, a total of 94 deaths were estimated to be averted, including 76 neonatal deaths, 
5 stillbirths, and 12 child deaths.  
 
Incremental cost-effectiveness analyses. The summary of Incremental Cost 
Effectiveness Ratio (Table 6.6) indicates that the mCARE intervention (SMS and home 
visit reminders) is highly cost effective compared to the mCARE control and status quo 
groups respectively, from a societal perspective. The incremental cost per death averted is 
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$973 and cost per DALY averted is $33, which is well below Bangladesh’ per capita GNI 
($1,080), suggesting high cost effectiveness. Similarly, the mCARE intervention (SMS 
and home visit reminders) was highly cost effective compared to the status quo group, 
from a societal perspective. The incremental cost per death averted $1,385 and per 
DALY averted as $47. Comparing the control and status quo groups, the incremental cost 
per death averted $1,873 and per DALY averted as $63, suggesting cost effectiveness. 
The cost effectiveness planes and cost effectiveness acceptability curves of comparison 
of the three groups are presented in Figures 6.3 and 6.4.  
 
Sensitivity analyses. Figure 6.3 indicates that total program costs were mostly driven by 
census enumeration and pregnancy surveillance, followed by supervision, reminder home 
visits, training, and data processing – for the intervention group. In the control group, it 
was similar except the reminder home visit was not the main cost driver. In the status quo 
group, the major cost drivers were pregnancy surveillance, supervision, data processing 
and survey printing. Comparing the mCARE control and status quo groups, the cost-
effectiveness acceptability curve with a threshold (Figure 6.6) quantified that the 
probability of the program to be highly cost-effective is at least 70% at $1,080 of the 
threshold value.  
 
Net benefit analyses. Figure 6.5 presents an ellipsis of confidence based on alpha 5% and 
estimated correlation (-0.05) between the iterated incremental costs and incremental 
numbers of deaths averted between mCARE intervention and paper based group. The 
Figure 6.7 shows that the net benefit between the two group had about 27.5% probability 
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of cost effectiveness at a (‘highly cost effectiveness’) threshold value of Bangladesh GNI 
per capita ($1,080) and 99% probability of cost effectiveness at a (cost effectiveness) 




Cost-effectiveness analyses of mHealth programs on pregnancy surveillance and care 
seeking reminders are complex due to technical and organizational arrangements and the 
nature of the services being provided by different types of providers. A recent study[283] 
acknowledged the complexities in the aspects of broader program delivery characteristics 
by the addition of SMS technology. Referring to a recently published conceptual 
framework (Tanahashi)[218], implementation principles (MAPS)[219], and evaluation 
guidelines (mERA)[220] of mHealth programs, we designed model scenarios and an 
analytic framework based on the recommended key components of operational and 
evaluation principles. Based on the Tanahashi Framework 2.0[218], which describes how 
mHealth programs could promote coverage in a given population, we first considered that 
mCARE programs could promote ‘population coverage’ by improving workforce 
productivity and task efficiency in pregnancy surveillance activities. We also considered 
that mCARE programs could promote ‘service coverage’ by encouraging pregnant 
women to seek essential maternal and newborn care services. In terms of care-seeking 
patterns, we assumed that mCARE strategies could cause women to seek care more 
frequently (e.g. ANC visit 4) and toward higher quality services (e.g. from home delivery 
to facility delivery). These aspects were incorporated in designing scenarios and 
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assumptions for the analyses. Based on MAPS, in planning the scale-up process, we 
incorporated key activity and strategic components related to planning as well as 
monitoring and evaluation, in a phased program approach such as partnership building, 
system optimization, and data reporting and processing. Throughout this process, we 
clarified the specific mHealth intervention and incorporated local data related to its 
technical features and the contextual grounds for evaluation.[220] 
 
In recent years, there have been some interesting quantitative analyses and evidence in 
the context of how scaling up of mHealth programs improves task efficiency and 
accuracy in a given standardized process or protocol (such as data collection or data 
reporting) or how mHealth improves user behavior to achieve uptake of certain practice 
such as adherence to drug intake, vaccinations, etc.[282-284] For example, Kukla et 
al[.284] (D-tree) presented that the mobile tool costs an additional $10.43 per annum in 
Malawi for a CHW, compared with the existing paper-based system, to improve his/her 
diagnostic and treatment accuracy by 1%. The study also demonstrated that the tool’s 
cost effectiveness improves as more CHWs enter the program – from $5.24 for 50 CHWs 
to $1.07 for 5,000 CHWs. Zurovac et al.[165] evaluated the cost effectiveness of text 
message reminders for CHW adherence to malaria case management guidelines. The 
study showed that the cost per additional child correctly managed was $0.50 under study 
conditions in Kenya, $0.36 if implemented by the MoH in the same area, and estimated at 
only $0.03 if implemented nationally. Additionally, Larsen-Cooper et al.[285] showed a 
cost outcome of an mHealth program (texting and communication among workers) in 
Malawi as $29.33 per user. The sensitivity analyses showed that cost per user could be 
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reduced by 48% if the service were to operate at full capacity.  Most of these studies 
demonstrate the value of mHealth interventions from the supply side, such as CHW 
adherence and accuracy in task performance. These studies demonstrate economies of 
scale based on the shared fixed and overhead costs with a larger number of users and 
beneficiaries.  
 
From an overall program evaluation point of view, much is unknown regarding how and 
to what extent mCARE changes the operational process, workforce productivity, and how 
and to what extent all these changes might affect overall societal costs and service 
coverage as well as health impact. mHealth is not just about improving efficiency or 
accuracy, but changing how the health system works. Acknowledging the comprehensive 
aspects of operational practice, our study determined program activities for each scenario, 
examined major factors that can be influenced by mCARE practices and tested the key 
input parameters by using uncertainty analyses. In terms of service provision, our study 
incorporated relevant survey data drawn from direct observations and exit interviews at 
major service provision agencies including government and NGOs and various levels 
from community satellite clinics to primary and secondary level clinics. Based on the 
contextualized understanding around service costs and content in the given settings, we 
calculated provider and user costs. Throughout the analyses, we synthesized a large 
volume of local demographic and service coverage data from various sources into a 
unified method for projecting the mHealth program costs and health outcomes in 
Bangladesh. These scenarios were further refined by verifying the feasibility of 
148 
 
assumptions in consultation with relevant stakeholders consisting of policymakers, local 
experts, program developers, public health experts, health economists, and donors. 
 
For the analytic framework of scaling up a program, we considered horizontal scaling up 
as ‘geographical expansion’ by replicating the program in a new district each year, thus 
assuming a linear increase of costs and effectiveness based on the size of population. The 
scaling-up pathway may also involve vertical scale up, which is associated with 
integrating different levels of health information systems, health institutions and service 
delivery platforms. A well-established community-based pregnancy surveillance system 
using an mHealth platform linked to primary health service delivery can serve as a 
powerful tool to create new incentives, value-added services and even business models 
throughout continuum of care among various health systems stakeholders. As mHealth is 
often referred as a “disruptive innovation” in the health sector, rapid technological 
innovation and the scale-up process may occur in an exponential manner.  
 
In this regard, future studies may consider incorporating a modeling approach in mHealth 
for scaling up monitoring and evaluation. In an effort to achieve the United Nations 
Millennium Development Goals, modeling approaches in scaling up health program 
evaluation have been widely developed and used in various demographic and 
epidemiological studies over the past decades. These include mathematical dynamic 
models to project population growth (PopMod)[286] and discrete event simulation of 
infectious disease transmission and progression (e.g. EPIFIL; AEM, EMOD-HIV, SIR, 
etc.)[287, 288] or state transition models of noncommunicable diseases (e.g. obesity, 
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cancer). With a growing interest in implementation science and health systems research 
in recent years, some innovative studies have conceptualized scaling-up pathways[289] 
and incorporated systems dynamic modeling approaches in program evaluation such as 
agent-based modeling, causal loop diagrams, or stock and flow diagrams.[290] These 
modeling approaches may be used to evaluate mHealth strategies on particular disease 
domains or intervention approaches to understanding the role of technology in service 
delivery processes and scaling-up pathways. For example, the feedback loop model[291] 
may help understand the learning effect within providers’ network (e.g. telemedicine or 
hotline call center), neighborhood effects through information sharing among individuals 
in a community[292] (e.g. text messages for health promotion and behavior change), or 
effective referral strategies through a positive reinforcement process between provider 
(supply) and client (demand) sides in service delivery.  In addition, scale-free 
networks[289]  can be used in modeling the diffusion of knowledge and behaviors by 
mHealth strategies on a geospatial platform (e.g. GIS system) or a social network 
platform (e.g. Facebook); understanding what the focal points or hubs of the systems are 
and how to manage them in a given local context could offer useful insights in planning 




Parameter/scenario uncertainties: While cost effectiveness often requires substantial 
data inputs, only a few scaled-up ( more than 500 CHWs) programs exist and little 
empirical data has been collected in the mHealth domain.[293] Evaluation of mHealth 
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scaling up thus involves many structural and parameter uncertainties. First, given the 
early stage of mHealth programs, there is limited data for many of the parameters, and 
much of the parameter uncertainty cannot be meaningfully quantified. Moreover, scaling 
up of programs involves many structural uncertainties that cannot be easily 
parameterized. For example, we assumed a constant coverage increase rate of 10% for all 
districts in the intervention group, but the coverage increase rates can vary depending on 
local health system conditions such as mobile phone penetration, availability of sufficient 
CHWs, access to health services, health facility condition and district characteristics. 
Through conceptualization and systematic and conservative assumptions based on the 
best existing knowledge, we attempted to incorporate these multiple factors in the 
evaluation mechanisms through a cost effectiveness analysis framework. Given that our 
analytic focus is on the different implications from cost, performance, and effectiveness 
among the three scenarios, we simplified our assumptions of baseline service coverage, 
scaling up patterns and geographical heterogeneity to be consistent among the districts in 
the scenarios. Accordingly, we undertook linear proportional adjustments of costs and 
effectiveness measures based on a proportional population size. This is also in part due to 
the lack of regional data – such as fertility rate, abortion rate, fetal loss rate, or specific 
coverage in district level, in currently published resources.  
 
Generalizability of the findings: Given that scaling up of programs is influenced by 
health systems conditions, we will consider level of mobile phone uptake, wireless 
network, current status of availability and training of CHWs, and quality or capacity of 
major MNCH service provision agencies to meet the needs and demand of the target 
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population in the given setting.[294] Together, the effectiveness of mHealth programs is 
influenced by a series of factors, including literacy and education, geographical and 
financial access to health facilities, social and cultural norms, and women's access to 
information technology.[295] These factors determine the way a technological innovation 
is spread as well as the distribution of benefits from the technology and the diversity of 
ways the technology can be applied. It is also important to acknowledge that the process 
of expanding into new target areas involves significant planning around a set of inter-
related activities, which include identifying target facilities, districts, and mobilizing 
resources. In forecasting costs over the 10-year time horizon with incremental expansion 
of service coverage, additional investment to strengthening health systems (e.g. 
additional recruitment or training of CHWs, upgrading health facilities or health 
information systems) should be considered in developing scaling-up assumptions. In 
many developing countries, services are generally underutilized and facilities are 
generally under-resourced, especially in terms of staffing. In most cases, significant 
investment would be required to provide sufficient resources for the expected numbers of 
services provided, and much more to expand services to cover the whole population. 
Plans for scaling up primary health services should take into account that current levels of 
services may be under-funded and that it may be more important to improve quality 
before expanding packages of services or utilization.[296] Throughout the course of the 
program, and as a result of increased experience and learning, the decision to invest in 
adopting mHealth practices should be informed by broad assessments considering 
demographic condition, technical feasibility, social and cultural characteristics, and 
capacity of and impacts on health systems. 
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6.7 Conclusions  
 
The main program cost drivers are census enumeration and pregnancy surveillance. We 
suggest that the program implementers consider strategies to improve workforce 
productivity and cost sharing on the activity. On the policy level, we suggest cooperation 
with other public agencies that can share activities and information such as Civil 
Registration and Vital Statistics (CRVS) initiatives or the census bureau, to share costs. 
While system optimization is a one-time cost, system algorithm would be the key to 
determining the efficiency and impact of the program by optimizing personalized and 
scheduled reminders, workflow management, and automated data reporting and 
management. The algorithm can be used for risk-screening based on proven and well-
known maternal risk factors such as age, multiple pregnancy and mal-presentation, and 
symptoms or signs related to previous or current pregnancy complications. Finally, to 
improve health impact, it is important to promote not only care-seeking behaviors but 
also service access and quality in the given health system. In this regard, additional 
incentives such as conditional cash transfers or a voucher system for facility delivery can 
help reduce financial constraints for users and thus improve health impact further. 
Information collected through pregnancy surveillance in the mCARE system can be 
better utilized to identify the poor or vulnerable and to strategically target such incentives 
or provide more attention at a timing of delivery. Overall, by leveraging the intelligence 
of the IT system and individual health information, mHealth could further improve not 
only health outcomes but also equity of access to care through better prevention and 
targeted strategies for the most vulnerable populations. 
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Table 6.1 Key activities and resource requirements for model scenarios 
Item Definition Resources Scenarios* Cost type 
C B P 





• Assume that community based pregnancy surveillance 
OpenSRP system architecture is developed. 
• Customize the system and database based on language, 
indicators, and geographic unit etc.  
• Conduct field testing for user feedback, operations, data 
verification etc.  
• To provide direct support to fix the bugs within the application 
to ensure functionalities of the developed system.  
• To manage and develop improvements within the application  
• To maintain the overall system to ensure the integrity of the 
collected data and maintain the data center for the system.  
• To customize reporting based on the collected data to enhance 
decision making by stakeholders.  
Numbers/level of staff, 
Staff salaries, number of 
working months, level of 
effort (%), travel expenses 
for field testing  
√ √  Capital costs 
(one-time costs 





• Central government office to print out registries for FWA:  
1. Couple Roster (ELCO Register), 2. Child Roster (0-1 year), 
3. Child Care Log (0-5 years), 4. Adolescent Health Service 
Delivery Log, 5.Pregnant Woman Roster (ANC Register), 6. 
Birth Roster,7. Death Register, 8. Daily Activities Log, 
9.Register of Injectable Contraceptive Users, 11. Monthly 
Supply and Distribution Roster, 12. Village Population Roster, 
13. Register family planning receiver eligible couple by # of 
children & age  
Total number of registries 
for pregnancy 
surveillance by FWAs, 
Average unit price for 
printing out one registries 
approximate market price 
in 2015) 
  √ Capital costs 






• Hold meetings at regional/province/state level to build 
partnership and consensus to implement and sustain the 
program 
• Educate and advocate community leaders about the project 
• Involve activities for community outreach campaign with 
brochures and leaflets 
Per diem, travel expenses, 
facility rent, printing 
√ √  Capital costs 





• Purchase phones and embed the system 
• Mobile phone with 5 years of useful time 
 
Unit price of phone and 
total quantities, Staff 
salaries, number of 
working months, level of 
effort (%) 
√ √  Capital costs 








• FWAs to visit every household in the district to register the 
household with demographic information through phones  
• Assign household ID and identify households with married 
women of reproductive age for pregnancy surveillance 
• Automate data processing and reporting 
Staff salaries, number of 
working months, level of 
effort (%) 
√ √  Capital costs 






• FWAs to visit every household in the district to register the 
household with demographic information through papers  
• Assign household ID and identify households with married 
women of reproductive age for pregnancy surveillance 
• Data entry staff to manually enter data to computers  
Staff salaries, number of 
working months, level of 
effort (%) 
  √ Capital costs 





• Develop capacity of trainers and health workers 
• Train FWAs to implement phone based pregnancy surveillance 
• Train FPIs (FWA’s supervisors) to monitor and evaluate 
FWAs’ data collection activities 
• Train local experts to handle complicated technology related 
issues that are encountered by users 
• Enhance local capacity to maintain software and hardware 
which may include programming, application development, 
and data management needs.  
Staff salaries, number of 
working months, level of 
effort (%) 




• Develop capacity of trainers and health workers 
• Train FWA to implement paper based pregnancy surveillance 
Staff salaries, number of 
working months, level of 
effort (%) 





• Regular visit to the sites by district health managers, 
coordinators, data managers etc. 
• Track and evaluate surveillance performance  
• Hold regular review meetings at district levels 
• Build database, enter and validate data 
• Manage teams for effective and proper use of phone/tablet 
• Monitor data processing and reporting between the different 
levels of reporting system (i.e. community level to primary 
health clinics level) 
Staff salaries, level of 
effort (%), number of 
months 




• Regular visits to the sites by district health managers, 
coordinators, data managers, etc. 
• Track and evaluate surveillance performance  
• Hold regular review meetings at district levels 
• Build database, enter and validate data 
Staff salaries, level of 
effort (%), number of 
months 
  √ Recurrent costs 
(every year) 
Program phase II: Implementation 
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C: Comprehensive mHealth program group 
B: Basic mCARE program group 






• Regular visits to households with married women of 
reproductive age for pregnancy identification and registration 
• Assign unique identification number(ID) to each woman and 
conduct survey about economic status, pregnancy 
history/complications, health condition etc.  
• Automated data processing and reporting 
Number of CHWs, 
CHWS’s salaries, level of 
effort (%), number of 
months 





• Regular visits to households with married women of 
reproductive age for pregnancy identification and registration 
• Assign women ID and conduct survey about economic status, 
pregnancy history/complications, health condition etc.  
• Data entry staff to manually enter data to computers 
Number of CHWs, 
CHWs’ salaries, level of 
effort (%), number of 
months 
  √ Recurrent costs 
(every year) 
SMS  • mCARE server system automatically sends SMS to registered 
pregnant women at scheduled ANC dates during their 
pregnancy period 
SMS unit cost to client, 
number of clients, 
frequency of SMS texting   





• Connection fee 
• Server maintenance  
Monthly mobile phone 
connection fee per CHW, 
number of CHWs, server 
maintenance monthly fee, 
number of months 




• FWAs to visit to pregnant women’s house to remind her of 
ANC schedule and promote care-seeking 
• Monitoring and evaluation of her previous care-seeking 
characteristics 
Number of CHWs, 
CHWs’ salaries, level of 
effort (%), number of 
months 






• Data collected by CHWs on the phone are stored on the 
mCARE server and can be automatically viewed and analyzed 
in real time through a dashboard. 
• These data also can be reported in real time to higher authority 
for monitoring and evaluation in decision making.  
Number of CHWs, 
CHWs’ salaries, level of 
effort (%), number of 
months 






• FWA/FWV record data to registries 
• FWV/FWV to count, aggregate, and synthesize data manually 
to report to FPI 
• FPI collect forms from FWA/FWV from six unions and 
aggregate data into summary forms to report to Upazila FPO 
Number of CHWs, 
CHWs’ salaries, level of 
effort (%), number of 
months 




Table 6.2 Model estimations for pregnancy, population coverage, and service coverage for three scenarios: (i) comprehensive 
mCARE program; (ii) basic mCARE program; (iii) paper based status quo, over 2016-2025 
    Comprehensive mCARE  Basic mCARE  Paper based status-quo 
Pregnancy 
surveillance 
Target population 2016 2025 2016 2025 2016 2025 
Population assumption 2.4 million 16 million 2.4 million 16 million 2.4 million 16 million 
ELCO  560,000 3,738,787 560,000 3,738,787 560,000 3,738,787 
Woman of reproductive age (WRA) 560,000 3,738,787 560,000 3,738,787 560,000 3,738,787 
Fertility rate (B) 2.17 1.98 2.17 1.98 2.17 1.98 
Abortion rate (A) 18.20 17.55 18.20 17.55 18.20 17.55 
Fetal loss rate (D) 37.00 35.68 37.00 35.68 37.00 35.68 
Pregnant women (in 2015) 7,793 49,872 7,793 49,872 7,793 49,872 
Population 
coverage 
Coverage assumptions 2016 2025 2016 2025 2016 2025 
Census enumeration 0% 90% 0% 90% 0% 80% 
Pregnancy surveillance 0% 90% 0% 90% 0% 80% 
Number of eligible clients 6,313 40,396 6,313 40,396 6,313 31,918 
Service 
coverage 
Coverage assumptions 2016 2025 2016 2025 2016 2025 
ANC  31% 73% 31% 48% 31% 34% 
No ANC 69% 27% 69% 52% 69% 66% 
Facility delivery 38% 90% 38% 59% 38% 42% 
Home delivery 62% 10% 62% 41% 62% 58% 
PNC  36% 100% 36% 56% 36% 39% 
No PNC 64% 0% 64% 44% 64% 61% 
• The number of pregnant women was calculated in each district based on the respective number of married women of reproductive 
ages (ages 15-49) in each district, fertility rate, abortion rate, and fetal loss rate, based on the World Bank database 
(http://data.worldbank.org/) and a formula published elsewhere.[274]  
• Population coverage represents the number of pregnant women who are registered in the program through census enumeration and 
pregnancy surveillance, over the actual number of pregnant women in each district. 







Table 6.3 Model estimations for program costs, provider costs, and user costs of the three scenarios: (i) comprehensive 
mCARE program; (ii) basic mCARE program; (iii) paper based status quo, over 2016-2025 






Actual costs  
Total costs 
Actual costs  
Total costs 

























                        
System 
optimization  
30,274 … 30,274 302,744 30,274 … 30,274 302,744 n/a … n/a n/a 
Partnership 
building 
6,672 … 44,145 313400 6,672 … 44,145 313,400 n/a … n/a n/a 
Phone 
procurement 
60,280 … 398,846 2,831,554 60,280 … 398,846 2,831,554 n/a … n/a n/a 
Recurrent 
costs 
                        
Survey 
printing  
1,648 … 10,902 77,394 1,648 … 10,902 77,394 34,270 … 226,752 1,618,463 
Training  165,232 … 1,093,278 7,761,577 165,232 … 1,093,278 7,761,577 10,874 … 71,950 513,551 
Supervision  184,173 … 1,218,600 8,651,278 184,173 … 1,218,600 8,651,278 184,173 … 1,218,600 8,697,871 
Census 
enumeration  
131,907 … 872,776 6,196,153 131,907 … 872,776 6,196,153 19,477 … 128,874 919854 
Pregnancy 
surveillance  
n/a … 1,167,619 7,121,728 n/a … 1,167,619 7,121,728 n/a … 1,310,816 8,045,259 
Data 
processing  
n/a … 649,166 3,959,498 n/a … 649,166 3,959,498 n/a … 1,148,524 7,049,179 
SMS  n/a … 2,855 17,417 n/a … n/a n/a n/a … n/a n/a 
SMS server 
hosting 
n/a … 229,115 1,397,453 n/a … n/a n/a n/a … n/a n/a 
Reminder 
home visit  































95,114 … 1,114,817 6,294,676 95,114 … 825,578 5,266,841 75,151 … 511,308 3,624,111 
Home 
delivery 
76,321 … 239,453 2,642,650 76,321 … 381,701 3,148,143 60,303 … 370,936 2,751,689 


























ANC  4,870 … 57,077 322,279 4,870 … 42,268 58,863 3,848 … 26,178 185,549 
Facility 
delivery 
124,739 … 1,462,054 8,255,313 124,739 … 1,082,726 442,751 98,559 … 670,568 4,752,933 
Home 
delivery 
71,233 … 223,490 2,466,474 71,233 … 356,255 758,345 56,283 … 346,207 2,568,243 
PNC  7,681 … 101,386 546,758 4,727 … 41,030 20,020 3,735 … 25,411 180,111 
Total user 
costs 
208,523   1,844,007 11,590,823 205,568   1,522,278 1,279,979 162,424   1,068,364 7,686,836 
Total costs 968,276   10,015,365 65,806,653 965,321   8,285,766 47,360,700 507,955   5,801,148 39,084,726 
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Table 6.4 Summary of model parameters and distributions for probabilistic sensitivity 
analysis 












Partnership and consensus building 13,068 3,404 15 886 
System optimization 59,300 10,950 29 2,022 
Phone/tablet procurement 118,073 16,039 54 2,179 
Training (w/ phone) 122,500 6,250 384 319 
Survey/registries printing 1,250 125 100 13 
Supervision 139,728 18,696 56 2,502 
Census enumeration (first year) 30,047 7,142 18 1,698 
Census enumeration (following 
year) 7,881 1,970 16 493 
Pregnancy surveillance (first year) 409,500 29,250 196 2,089 
Pregnancy surveillance (following 
year) 105,300 5,850 324 325 
SMS reminder 338 13 676 1 
Server hosting 5,120 640 64 80 
Home visits reminder 118,217 11,822 100 1,182 
Data reporting and processing 76,841 8,866 75 1,023 
Paper 
system 
Survey/registries printing 26,000 5,000 27 962 
Training (w/ paper) 8,250 875 89 93 
Supervision 139,728 18,696 56 2,502 
Census enumeration (paper) 14,777 2,955 25 591 
Pregnancy surveillance (paper) 155,160 11,083 196 792 
Data reporting and processing 135,949 20,688 43 3,148 
Provider & User costs 
ANC 
provider unit cost 2.47 0.26 90.25 0.03 
user costs  1.50 0.36 17.49 0.09 
Home 
delivery 
provider unit cost 46.00 17.00 7.32 6.28 
user costs  19.00 8.00 5.64 3.37 
Facility 
delivery 
provider unit cost 5.50 0.75 53.78 0.10 
user costs  79.00 34.00 5.40 14.63 
PNC 
Provider unit cost  1.23 0.30 16.52 0.07 
user costs  7.05 3.39 4.31 1.63 








mCARE system  0.90 0.80 1.60 0.18 
Paper system 
0.80 0.70 4.20 1.05 
Service 
coverage 
Coverage increase rate 
(intervention) 0.10 0.08 22.40 201.60 
Coverage increase rate (control) 0.05 0.04 23.70 450.30 
Coverage increase rate (status quo) 0.01 0.01 24.74 2449.26 













Intervention 761 609-913 6.64 0.10 
Control 397 317-476 5.98 0.10 
Status quo 94 75-113 4.54 0.10 
 
 

















































































































































































































































































































































































6.4.2. Gamma distributions for provider and user unit costs. 
 
 
6.4.3. Beta distributions for coverage increase rates for each scenario 
 
 


























































































































































































































Figure 6.1 Total program costs of the three scenarios: (i) comprehensive mCARE program; (ii) basic mCARE program; (iii) 
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Table 6.5 Number of deaths averted based on LiST modeling of the three scenarios: (i) comprehensive mCARE program; (ii) 
basic mCARE program; (iii) paper based status quo, over 2016-2025 
Comprehensive mCARE program 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total 
Maternal lives saved (community) 0 0 1 2 2 3 4 6 7 7 32 
Maternal lives saved (facility) 3 10 22 38 58 81 107 135 148 159 759 
Neonatal lives saved (community) 27 106 234 408 625 881 1174 1500 1650 1792 8397 
Neonatal lives saved (facility) 67 259 560 956 1432 1976 2577 3223 3471 3690 18211 
Still birth lives saved (community) 11 45 100 176 273 389 524 677 753 826 3773 
Still birth lives saved (facility) 33 131 293 516 797 1135 1528 1971 2190 2401 10994 
Total death averted (low scenario) 38 151 335 586 900 1273 1702 2183 2409 2625 12203 
Total death averted (high scenario) 103 400 875 1509 2286 3192 4211 5330 5808 6249 29964 
Total DALY averted (low scenario) 795 3126 6919 12059 18463 26039 34697 44338 48773 52956 248165 
Total DALY averted (high scenario) 2025 7787 16839 28722 43039 59414 77501 96976 104460 111079 547842 
Basic mCARE program 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total 
Maternal lives saved(community) 0 0 0 1 1 1 2 2 3 3 13 
Maternal lives saved(facility) 1 6 12 21 33 46 61 78 86 94 439 
Neonatal lives saved (community) 12 48 106 186 286 407 545 701 775 847 3912 
Neonatal lives saved (facility) 31 119 263 457 697 980 1301 1657 1817 1966 9288 
Still birth lives saved (community) 5 18 40 71 110 158 213 275 305 335 1529 
Still birth lives saved (facility) 17 67 150 265 410 584 787 1015 1128 1238 5661 
Total death averted (low scenario) 17 66 147 258 397 566 759 978 1083 1185 5454 
Total death averted (high scenario) 49 192 425 743 1139 1610 2149 2751 3032 3298 15388 
Total DALY averted (low scenario) 356 1408 3127 5487 8451 12016 16104 20702 22907 25019 115576 
Total DALY averted (high scenario) 919 3601 7925 13769 21011 29555 39247 49986 54803 59311 280128 
Paper based status quo 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total 
Maternal lives saved(community) 0 0 0 0 0 0 0 0 0 1 2 
Maternal lives saved(facility) 0 0 1 1 2 3 4 5 5 6 26 
Neonatal lives saved (community) 2 8 18 31 48 68 92 119 132 145 661 
Neonatal lives saved (facility) 4 17 39 68 105 149 201 259 287 314 1443 
Still birth lives saved (community) 1 3 7 12 18 26 35 45 50 55 250 
Still birth lives saved (facility) 1 5 11 20 30 43 58 76 84 92 421 
Total death averted (low scenario) 3 11 24 43 66 94 127 164 182 200 913 
Total death averted (high scenario) 6 23 51 89 137 195 263 339 376 412 1890 
Total DALY averted (low scenario) 59 233 519 914 1415 2013 2712 3501 3892 4270 19527 
Total DALY averted (high scenario) 130 516 1151 2024 3124 4444 5968 7696 8536 9347 42935 
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Figure 6.2  Annual total number of deaths averted based on LiST modeling of the three scenarios: (i) comprehensive mCARE 







Table 6.6 Summary of incremental cost effectiveness ratios of the three scenarios: (i) comprehensive mCARE program; (ii) 
basic mCARE program; (iii) paper based status quo, over 2016-2025 
Summary incremental cost effective ratios 
Comprehensive mCARE 
vs. Basic mCARE 
Comprehensive mCARE 
vs. Paper based status quo 
Basic mCARE vs. 
Paper based status quo 
Deterministic 
calculation 
Total incremental costs 10,370,249 27,260,042 16,889,793 
Incremental all death averted 10,662 19,682 9,019 
Incremental DALY averted 314,539 580,608 266,069 
Incremental cost per any death averted 973 1,385 1,873 
Incremental cost per DALY averted 33 47 63 
Probabilistic 
calculation 
Total incremental costs 12,744,836 27,320,544 14,575,708 
Incremental all death averted 11,014 20,257 9,243 
Incremental DALY averted 318,470 596,118 277,648 
Incremental cost per any death averted 1,157 1,349 1,577 















Figure 6.3 One-way deterministic sensitivity analysis for annualized total program costs (2016~2025) of the comprehensive 








Figure 6.4 Cost effectiveness plane of comparisons of respective two scenarios among: (i) comprehensive mCARE program; 














Figure 6.6 Cost effectiveness acceptability curves of comparisons of respective two scenarios among: (i) comprehensive 














































Theoretical thresholds (willingness to pay) to a DALY averted (US$, 2015)
Comprehensive mCARE vs Basic mCARE
Comprehensive mCARE vs. Paper based status quo
Basic mCARE vs Paper based status quo
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Chapter 7. Cost effectiveness and budget impact analyses of 
mCARE program provided through the public sector 




Economic evaluation is a comparative analysis that may assist in the prioritization of 
interventions. However, it is not sufficient in predicting whether an intervention is 
affordable in light of finite resource constraints. mCARE has been implemented since 
2013 with the goal of transforming community health workers’ (CHWs) routine 
surveillance activities and promoting pregnant women’s care-seeking behaviors through 
short message service (SMS) and home visit reminders. Based on the favorable cost-
effectiveness profile from previous studies, we assessed the affordability of implementing 
the comprehensive mCARE program over a six-year time horizon (2015~2020) across 
the entire Gaibandha district (with a population of approximately 2.4 million) by using a 
cost-effectiveness affordability curve and financial budget impact estimation from the 
government as a budget holder perspective. The cost-effectiveness affordability curve 
shows that the comprehensive mCARE program can have at least a 92% probability of 
cost effectiveness at a threshold ($3,150, three times that of the country’s GNI per 
capita), under the budget constraints of $2.5 million. For the budget impact analysis, we 
adjusted our activity-based costing into financial costing for a budget expenditure 
perspective. Following the standardized guideline (ISPOR), the results show that the 
annual program budget impact is an additional $258,508 in the first year (2015) and 
$102,658 in subsequent years (2016~2020) without adjusting for inflation in the 
comprehensive mCARE program compared to the paper system in Gaibandha district. 
The financial impact estimated over 2015-2020 ($47 million) for the mCARE 
172 
 
intervention in the entire country makes up 0.9% of total annual health expenditure ($5.4 
billion) and 2.5% of public health expenditure ($1.9 billion), which is favorable to the 
current financial arrangement in the country. As the goal of a successful mHealth 
program is to be integrated into the public health system for scalability and sustainability, 
our study provides useful information to help project the amount of resources necessary 
to fund the program, and the consequences of potential variations of cost inputs and 





The central health reform agenda in Bangladesh includes building the capacity of human 
resources and strengthening health information systems.[297][298] Comprehensive and 
systematic pregnancy surveillance is the first step for the continuum of care of maternal 
and newborn health services in the population and for the integration of health 
information systems within the health system. Pregnancy surveillance can help determine 
the required amount of resources for financing, inform the planning of when and how to 
distribute the services in communities, administer service and care in a timely fashion, 
and improve management of treatments or crises. Systematic and comprehensive 
pregnancy surveillance also allows early pregnancy identification and risk management 
for antenatal care (ANC) and beyond. 
 
ANC is widely known as an accessible and cost-effective method for improving maternal 
and perinatal health outcomes.[196, 197] ANC can increase access to and chances of 
using a skilled attendant at birth around labor and delivery – which is when most deaths 
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occur – through a birth and emergency preparedness plan. Studies show that attending 
four quality ANC sessions have led to over 60% of facility-based delivery with skilled 
birth attendants. Due to a lack of access to health providers and facilities, however, nearly 
two-thirds (73%) of mothers do not attend four or more antenatal visits from skilled 
health professionals in Bangladesh. Further, while 74% of urban women receive ANC 
from a trained provider, only 49% of rural women do.[299] 
 
Moreover, the current traditional paper-based system has failed to generate a systematic 
and comprehensive understanding of the population’s health and health system 
performance. Without mechanisms to systematically verify these data, there is a greater 
risk of error involved in capturing information. Multiple overlapping reporting systems 
result in unnecessarily heavy paperwork and poor data quality, which affects timeliness, 
completeness and accuracy. As a result, these health data are rarely used for national 
health planning. Weak routine information systems also hamper the health services 
management at a decentralized level.[50] 
 
In the seventh five-year plan (FY 2016~2020) [300], the government promotes proper 
management of the large network of public sector health care delivery systems with 
appropriate referral systems and quality assurance. In this vein, mCARE has been 
implemented since 2013 with the goal to transform community health workers’ (CHWs) 
routine surveillance activities and to promote pregnant women’s care-seeking behaviors 
through short message service (SMS) and home visit reminders. From 2011 to 2015, a 
pilot study project, mCARE I, has been developed and implemented with community 
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health research workers to assess the feasibility of the mHealth strategies. Based on the 
positive impact on service coverage, a larger scale project, mCARE II, has been 
implemented since 2014 with an open source platform with government CHWs to assess 
the impact of the program on saving lives of mothers and newborns at scale. 
 
While economic evaluations may assist the prioritization of interventions, they are not 
sufficient to predict whether an intervention is affordable in light of finite resource 
constraints. This study examined cost effectiveness, affordability and budget impact of 
implementing the mCARE program through the public sector to improve pregnancy 
surveillance and care-seeking of ANC in Gaibandha district over the next six years. We 
assess scenarios for implementing the comprehensive mCARE program (surveillance and 
reminders), the basic mCARE program (surveillance) and a status quo comparator as a 




Perspective and population. The study was conducted using a program perspective, 
considering the government as a program implementer that is investing in an mHealth 
program to improve pregnancy surveillance and pregnant women’s care-seeking for ANC 
in Gaibandha district. The number of pregnant women was calculated in each district 
based on the number of married women of reproductive age (MWRA) (15-49 years) in 
Gaibandha district in 2015, fertility rate, abortion rate, and fetal loss rate, based on the 
World Bank database[301] and a formula published elsewhere.[274] These numbers were 
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projected based on trends of the past five years in the database.[302] The number of 
CHWs (FWAs) is considered to be constant (421) over the five years.   
 
Time horizon. Model-based analyses explored the costs and consequences of the 
mCARE program in Gaibandha district (approximately 2.4 million population) over the 
six-year time horizon 2015-2020. The six years consist of one baseline year (2015) for 
start-up activities and five years (2016~2020) of implementation activities. The time 
horizon was determined based on the Bangladeshi seventh five-year plan (FY 2016-
2020).[300] 
 
Scenarios to be compared. We developed an Excel spreadsheet-based model[303] to 
project cost and resource requirements in Bangladesh by 2020, in the three groups. The 
programmatic activities for each scenario are summarized below, and their specific cost 
components are defined in Chapter 6: Table 1. The scenarios are purely illustrative and 
not prescriptive for any particular project or country.  
 
• Comprehensive mCARE program scenario: Population mapping and census 
enumeration, pregnancy surveillance via the mobile phone-based system through 
government CHWs (family welfare assistants); automated SMS and CHWs’ home 
visit reminders to pregnant women on the dates of their four personally scheduled 




• Basic mCARE program scenario: Population mapping and census enumeration, 
pregnancy surveillance via using mobile phone-based system through government 
CHWs (family welfare assistants). 
 
• Paper based status quo scenario: Paper-based census enumeration and 
pregnancy surveillance and community-based ANC promotion activities to 
pregnant women by government CHWs(family welfare assistants)  
 
The focus of the model is to see how much the mCARE program would increase or 
decrease program financial costs over time and improve service utilization based on the 
change of existing operational processes, workforce productivity and pregnant women’s 
care-seeking levels. Therefore, we set the three scenarios starting from the same target 
population (the number of pregnant women) and same 2016 baseline service coverage to 
allow for a systematic comparison of the costs and consequences. Also, as the model 
focuses on the value of the mCARE program in improving existing workforce 
productivity and operational efficiency, we did not consider additional investments to 
increase the number of CHWs or health facilities. In terms of operational changes, the 
model determined relevant program activity components for each scenario, listed in 
Chapter 6, Table 1. The specific model assumptions for the number of pregnant women, 
population coverage, and service overage over 2016-2020 was based on similar methods 




Population coverage: The model set the target population (number of married women of 
reproductive age) to be equal across the three scenarios to allow for comparison of costs 
and consequences associated with each scenario. We used a feasible number of daily 
household visits per CHW based on the current paper-based system, to assume different 
census enumeration and pregnancy surveillance coverage values – 90% for the mCARE 
system and 80% for the paper system. This determines ‘population coverage’ for each 
scenario, which is the number of pregnant women who are registered in the program 
through census enumeration and pregnancy surveillance, divided by the actual number of 
pregnant women in each district.  
 
Service coverage: Based on the estimated number of registered pregnant women, the 
model forecasts incremental changes in the utilization of health services, ‘service 
coverage’, as a function of each scenario over the five-year program implementation time 
horizon. ‘Service coverage’ was calculated as the number of pregnant women who sought 
care, over the number of registered pregnant women in the system. Different coverage 
increase rates were assumed for the mCARE intervention (10%), mCARE control (5%), 
and the paper system (1%) from 2015 to 2020, using the same baseline from 2015 across 
the three scenarios. Estimates of the incremental changes in coverage assumed a linear 
increase for each year of implementation. The baseline coverage in 2015 was set as 31% 
for ANC (more than four visits), facility delivery at 38%, and 36% for PNC, based on the 
Bangladesh Demographic and Health Survey data.[304] Coverage of home delivery was 
calculated by deducting facility delivery coverage from 100%. As a result, in the 
intervention group, the ANC coverage reached 50%, which reflects the target set by the 
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government; facility delivery reached 61% and PNC coverage reached 58% by 2020. 
Consequently, this resulted in a 1.6 times increase for the mCARE intervention group, 
1.3 for the mCARE control group, and 1.05 times increase in coverage for the status quo 
group, from the baseline in 2015 to 2020.  
 
The program costing consists of two stages: one year of start-up preparation (2015) and 
subsequent years of implementation (2016~2020). Preparation activities include 
partnership building, system optimization, phone procurement, survey printing, and 
training. Implementation includes training, supervision, census enumeration, pregnancy 
surveillance, SMS, server connections, reminder home visits, and data processing. The 
activity-based costing followed a similar method as described in Chapter 6. To estimate 
costs of census enumeration and pregnancy surveillance, we considered that the 
operational transition from using a paper-based system to phone-based data collection 
would require intensive efforts in the first year of implementation. Therefore, we 
assumed a greater level of effort and a longer time period to complete the data collection 
for these activities in the first year of implementation. We then assumed a lower level of 
effort and shorter time period in the subsequent years of implementation. As a 
consequence of the operational transition, we also expected that the mCARE system 
would reduce the volume of activities and time required for FWAs to complete data 
entry, processing, and reporting. As a result, FWAs could spend more time on pregnancy 
surveillance or service provision activities, as we assumed increased population coverage 
and service coverage in the model when using the mobile system, compared to the 
traditional paper-based practice.[305] We applied a 6% annual inflation rate for the 
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program costs. We did not include overhead costs such as the cost of office maintenance 
or furniture or equipment.  
 
Sensitivity analyses. We conducted sensitivity analyses to examine the impact of 
parameters related to total program costs. The parameters included activity-based cost 
items and selected cost inputs perceived as key cost determinants and high uncertainty 
with no historic reference, based on researchers and local experts’ recommendations. 
Given the census enumeration and pregnancy surveillance as major costs drivers, we 
assessed one-way deterministic sensitivity analysis (DSA) with particular interest on 
factors related to CHW productivity such as a number of household visits per day, the 
level of effort, and CHW salary. We also examined one-way DSA on factors related to 
technological components such as costs of mobile phone device, server maintenance, or 
network connection, which can be damaged, lost, or stolen, need upgrading or can change 
their prices within a short time period due to innovation, scale, and competition in the 
market. The key determinants from the one-way DSA were used for scenario analyses in 
the budget impact analyses are presented in Table 7.4. For probabilistic sensitivity 
analysis (PSA), we followed similar methods as described in Chapter 6. We used Lives 
Saved Tool to estimate the number of lives saved during 2015-2020 in a similar way as 
described in Chapter 6. Based on total program costs and estimated number of deaths 





Affordability analysis. We assessed affordability based on the method described by 
Sendi and Brigg (2001)[306] and Kim et al. (2007)[307] First, we evaluated the 
program’s cost-effectiveness and derived cost-effectiveness acceptability curves from 
a program perspective. A cost-effectiveness acceptability curve presents the 
probability that a program will be cost-effective in relation to a range of incremental 
thresholds, as a hypothetical value of willingness to pay or fund. Next, we assessed the 
affordability of the incremental program cost between mCARE I and paper groups 
compared with a specified budget constraint. We derived probability–within a 
multivariate PSA – under which the program might be assigned a single fixed budget, 
for which we set a wide range between $0.1 million to $6.5 million. An affordability 
curve was then used to present the probability that a program (based on incremental 
program costs) will be affordable under various program budgets.  
 
We evaluated program affordability based on the incremental costs of the mCARE 1 
group compared to the paper group from a program perspective. On the cost 
effectiveness plane with a cost effectiveness threshold, budget constraints distinguish 
the simulated outcomes, where the joint distributions of costs and effects that share the 
same correlations between these two dimensions but differ in scale.[306, 308] 
Graphically, as we plot the simulated outcomes on a cost-effectiveness plane, cost 
effectiveness acceptability curve captures the proportion of points in this plane that 
fall below the diagonal line representing a particular cost effectiveness threshold 
(here, Bangladesh GNI per capita). An affordability curve captures the proportion of 
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points in this planes that fall below the horizontal line, representing a particular budget 
line. (Figure 7.4)[306] 
 
Collectively, a cost-effectiveness affordability curve combines the results from a cost-
effectiveness acceptability curve and an affordability curve to represent the proportion 
of the points under the threshold and budget lines on the plane. (Figure 7.5) These 
curves depict the probabilities that a program will be both cost-effective and 
affordable under a set of budget constraints such as $2 million and $2.5 million and at 
a range of threshold values of cost-effectiveness. The sizes of budget constraints were 
set by increasing the current budget spending (here, estimated program cost in the 
paper based group) by 1.5-2 times the ceiling ratios.  
 
Budget impact analysis (BIA). We formed BIA to assess the financial consequences of 
implementing and scaling up mCARE comparing mCARE I and paper groups in 
Bangladesh, following the ISPOR guideline[309] and Dee at al.[310, 311] While the 
government is both a program implementer and a service provider, our analysis only 
included program costs and excluded provider costs associated with service provision. 
This is mainly because while our intervention sends care seeking reminders to pregnant 
women, the women could receive care from various channels including government, 
nongovernmental organizations (NGOs) and the private sector. It is also because within 
government, our analysis focused on the frontline health workers – here, FWAs – who 
will use the mobile phone-based mCARE system in pregnancy surveillance activities. 
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Service provision, however, is done by different level workers, such as FWVs, SACMO, 
or nurses at various care settings that this study did not take into account. 
 
For the BIA, we adjusted our activity-based costing into financial costing for a budget 
expenditure perspective. We simplified assumptions to demonstrate our rationales and 
analytic framework in the most transparent manner possible. In this process, we 
comprised different activity costs (e.g. census enumeration, pregnancy surveillance, 
home visit reminders) into an FWA’s same fixed annual salary in both groups because 
these activities would be conducted within FWAs’ routine workflow based on the given 
salary expenditures. In that sense, the supervision costs were also same between the two 
groups. However, we accounted for different financial expenditures for survey printing, 
data processing and training between the two groups based on respective cost 
implications.  We considered that mCARE would lower survey printing and data 
processing costs but increase training costs from the paper group. We also included 
additional new expenditures for partnership building, system optimization, phone 
procurement, SMS and server maintenance costs in mCARE I group. We did not account 
for annual inflation or discounting in this calculation.  
 
We conducted sensitivity analyses to project budget impact based on the variation of 
parameters used in the analysis. The parameters included the cost of training, phones lost 
or broken, server maintenance, and SMS unit costs. This was done as a series of one-way 
sensitivity analyses, i.e., only one parameter was varied at a time, maintaining all others 
in the reference case. We also estimated budget impact, assuming an incremental 
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geographical expansion over the next five years. Finally, we estimated national scaled-up 
costs by 2020 by multiplexing the total number of districts (64) in Bangladesh for each 
scenario. The simple extrapolation of program costs intended to estimate incremental 
financial consequences across scenarios based on total national health expenditures. We 
did not take into account local variations in cost inputs. 
 
7.4 Results  
 
Total program costs: Table 7.2 illustrates the total program costs and the major cost 
drivers in each group. Total program costs are $5.0 million for the intervention group, 
$4.2 million for the status quo group, and $2.8 million for the control group. There were 
significant upfront capital costs in the start-up phase in the mCARE system at $350,616, 
more than 10 times the paper-based system at $34,250. Figure 7.1 depicts the major cost-
drivers per study arm. In the intervention group, the major cost-drivers are training 
(22%), pregnancy surveillance (19%), supervision (16%) and census enumeration (17%). 
Phone procurement (2%), SMS reminder (0.04%) or server hosting (3%) have a fairly 
marginal impact compared to total program costs. In the control arm, the major cost 
drivers are training (27%), pregnancy surveillance (17%), and supervision (19%). In the 
status quo group, the major cost drivers are pregnancy surveillance (32%), supervision 
(29%), and data processing (28%).  
 
Annual program costs: Figure 7.2 shows the annual program costs throughout 2015-
2020. There were significant upfront costs in the first two years, 2015 and 2016, 
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including start-up and implementation costs mainly due to the operational transition from 
paper to phone-based data collection in census enumeration and pregnancy surveillance 
in the comprehensive mCARE program (estimated $1.6 million) and basic program 
(estimated $1.5 million). In the subsequent year (from 2016), the annual program cost is 
$768,730 in the comprehensive program and $614,324 in the basic program, gradually 
increasing over time with a 6% inflation rate. On the other hand, in the paper group, there 
was a minimal cost of $34,250 in the first year of the start-up phase (2015), and annual 
program costs of $481,919 in the subsequent year (from 2016), gradually increasing over 
time with 6% inflation.  
 
Tornado diagram on program costs. The one-way DSA on program cost items (Figure 
7.3) showed that census enumeration and pregnancy surveillance are the most influential, 
followed by supervision, training, reminder home visits, data processing, server 
connection, and telephone procurement among the other costs. SMS reminders showed 
the least cost implications as the proportion of these costs were only marginal to the total 
program costs. This suggests that on the basis of systematic population surveillance, the 
add-on personalized SMS and home visit reminders could substantially improve cost-
effectiveness with a small amount of cost implications. 
 
Affordability curve. The affordability curve (Figure 7.4) shows that the probability that 
the mCARE intervention is affordable is 0% up to a budget of $1 million but increases as 
the budget increases, reaching 93% when the budget increases to $3 million and beyond. 
The cost-effectiveness affordability curve (Figure 7.5) shows that the mCARE 
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intervention can have at least 93% probability of cost effectiveness at the standard cost-
effectiveness threshold ($3,150, 3 times the Bangladesh GNI per capita), with budget 
constraints of $2.5 million.  
 
Budget impact analysis. Table 7.4 shows the budget impact reference case between the 
mCARE I and paper groups over 2015-2020 in Gaibandha district. The annual program 
budget impact is an additional $258,508 in the first year and $102,658 in the subsequent 
years without adjusting for inflation in the mCARE I group compared to the paper group. 
If we included costs associated with resource utilization by service provision in 
government from increased pregnant women’s care-seeking, the annual budgetary impact 
would be greater than $102,568, under the current public/private service provision mix. 
In terms of sub-cost items, costs of survey printing and data processing are decreased, 
while training, partnership building, system optimization, phone procurement, SMS and 
server maintenance are increased in the mCARE group when compared to the paper 
group. Assuming staff salaries are constant, the result of sensitivity analyses show that 
budget impact is most sensitive to the training costs as it is the major cost-driver, while 
other costs associated with technological components are marginal in the total costs. The 
results also show that if mCARE is incrementally scaled up to another district each year, 
about a $4 million budget would be required throughout 2015-2020. Given the budget 
impact in one district, if mCARE is implemented in all 64 districts, a total budget of $47 
million and $16.5 million in the first year (in 2015) and $6.1 million in subsequent years 
would be required throughout 2016-2020. In the budget impact reference case, the 
estimated unit cost per registered pregnant woman who seeks an ANC service is $630 in 
186 
 
the mCARE I group, which is $14 less than $644 in the paper group. This is because the 
mCARE intervention, compared to the paper group, contributed to a greater number of 
pregnant women who seek care at a given expenditure. This suggests that the mCARE 
intervention is likely to achieve cost savings at scale when making pregnant women seek 
care, compared to the paper-based system.  
 
In the context of health financing,7 Table 7.5 shows that the national estimated costs of 
the mCARE intervention scenario ($47 million) makes up 0.9% of total annual health 
expenditure (THE) ($5.4 billion), 2.5% of public health expenditure ($1.9 billion), 12% 
of international development assistance ($387 million) in 2015. In regards to annualized 
national estimated costs, the mCARE implementation ($6.1 million) makes up 0.08% of 
total health expenditure, 0.2% of public health expenditure, and 1% of international 
development assistance.[27] In terms of dollar per capita expenditure, the country 
currently spends $26.6 per capita, and only $4.2 per person per year is spent on health 
from the government budget. In the budget impact implementation reference case 
(excluding the startup cost in the first year), the estimated unit cost per MWRA is $3 and 
unit cost per pregnant woman is $215 in the comprehensive mCARE program scenario, 
which requires only an additional $0.18 and $14 from the status quo scenario. This 
                                                     
7 In 2015, total health expenditure accounted for 3.6% of the country’s Gross Domestic Product (GDP), an amount that 
was lower than the average of 4.5% for other low-income countries, and well below the global average of 9.9%. Of 
this, 64% comes from individual pocket which is one of the highest and has a serious impoverishing effect on 
household economy. Of the remaining 36% comes from public financing, about 60% is financed by the Government 
out of tax revenues, development outlays, and the remaining 40% through interventional development assistant. Public 
allocations to fund the health sector were around 7.7% of total government expenditure. This was slightly lower than 
the average of 8.1% for other low-income countries and well below the 15% the global average. Donor financing 
accounted for only 7% of total health sector expenditure in 2012. This was considerably lower than the low-income 
country average of 28%. To tackle financing issues, a Health Financing Strategy (2012-32) has also been developed for 
addressing this issue of reducing out of pocket expenditure. (Source: World Health Organization. Bangladesh Health 
System Review. 2015) 
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indicates that a district with 1 million pregnant women would require an additional $14 
million budget to implement the mCARE intervention (assuming a similar ratio between 
CHWs and pregnant women). While per capita THE grew at a higher pace (11%) than 
per capita GDP (8%) in recent years [312][313], THE in Bangladesh as a share of GDP 
has remained one of the lowest in the WHO South-East Asian Region, and is still lower 
than that of even lower middle-income countries (4.5%), as classified by the World 
Bank.[314] Under the current funding arrangement, the results from the affordability 
curve based on cost-effectiveness analysis and the incremental budgetary measure from 
BIA suggest that mCARE may be an affordable option in a limited budget expenditure 




Since the concept was first introduced by Trueman in 2001 [315], budget impact analysis 
(BIA) has been increasingly used in various settings – national, district, hospital, or 
community program levels – to predict the potential financial impact of the adoption and 
diffusion of a new technology into a healthcare system with finite resources.[309, 316, 
317] Notable studies have used BIA in actual budget planning processes and investment 
decision making. For example, Meyer-Rath conducted BI modeling in changing the 
policy of antiretroviral therapy in South Africa. The budget impact model, named the 
National ART Cost Model, has been used for the government’s Conditional Grant for 
HIV/AIDS. In the field of pharmaceutical budget planning and decision making, other 
studies also used BIA to assess drug acquisition costs from the reimbursement payer’s 




In the field of health information systems, some earlier studies on telehealth and 
electronic health record (EHR) system in hospital-based institutional settings used budget 
impact analysis and total cost ownership model (TCO) for decision making in business 
and for IT infrastructure acquisition. In the field of mHealth, tools and frameworks for 
assessing costs have been developed, and applied in real-world settings. [321, 322] Some 
programs have used the TCO method to assess costs over the project life cycle for 
designing, piloting, and scaling up such technologies to help program managers in their 
budget planning and advocacy efforts.[284] 
 
The study assessed the affordability of implementation of the mCARE intervention in 
Gaibandha district over 2015-2020 through a cost-effectiveness affordability curve 
and budget impact estimations from a program perspective. The results show that 
incremental cost to implement the comprehensive mCARE program from the current 
paper based system is a cost effective and affordable health intervention in 
Bangladesh.  The incremental total program costs (2015-2020) between the 
comprehensive mCARE program and paper based system is $2.3 million (i.e. annual 
average program cost estimation: $374,855) according to activity based costing in 
CEA and $736,130 (i.e. annual average program cost estimation: $138,513) based on 
financial costing in BIA. The estimated annual average program budget $138,513 is 
only 1.28% out of the sectoral budget allocation to health (FY16), estimated as $10.8 
million to one district.8 
                                                     
8 The Seventh Plan Annual Development Plan Sectoral Allocations to Health Sector is $692 million (5.5%) out of the 




The budget impact estimate is much lower than the estimates based on activity based 
costing. This is because latter accounts for different respective cost implications from 
activities such as census enumeration, pregnancy surveillance, home visit reminders 
into the analysis, while BIA accounted for them in a fixed amount of CHW salary 
between the two groups. For a program such as mCARE, which involves multiple 
stakeholders and substantially complex operational transition, these results show that 
ingredient-based activity costing and a particular payer’s financial expenditure can be 
substantially different.  
 
Based on the favorable cost-effectiveness profile, in BIA, we focused on the 
government (as a budget holder) planning and budget cycle for its analytic scope and 
time frame – rather than a project life cycle – under the budget constraints. As a 
recommended strategy of the successful mHealth program is to be integrated into the 
government health systems for scalability and sustainability, the result of BIA 
provides useful information to project the magnitude of resources needed to fund the 
program, and the consequences of potential variations of cost inputs and scale-up 
scenarios, which can guide real-world decisions. 
 
Cost saving strategies.  From a program manager’s perspective, the study findings 
suggest several cost-saving strategies. First, findings from sensitivity analyses on CHW 
                                                     
estimated the budget allocation to health sector to one district as $10.8 million (FY16). (Source: Seventh Five Year 




productivity suggests that the system may consider setting a target of a number of routine 
household visits or designing the user interface to encourage CHWs to conduct 
comprehensive census registration and pregnancy identification. Costs can be 
substantially saved by reducing the number of required months with increased daily 
household visits by a CHW to complete the registration of estimated target population in 
a given district. Also, given the major cost-drivers of phones breaking or being lost, the 
program could consider these particular aspects in the choice of tablet devices and in the 
process of maintenance and training for how to use the tablet or phone to minimize 
phones lost or broken. Program managers could also consider SMS unit costs and the 
frequency of texting to clients in designing the intervention strategies and negotiating 
with telecommunications companies, as the target population increases with scaling up. 
In addition, as the system algorithm can be continuously upgraded over time or server 
system may need to be upgraded with increasing size of clients, program managers 
should also consider the maintenance costs associated with software or system upgrades 
and troubleshooting in addition to the existing monthly server connection fee. 
 
Implications of scale up.  The results also indicate greater benefits of cost-saving and 
health impact by sustaining and scaling up these programs over time in the entire country. 
First, the results of CEA show that the major cost drivers are census enumeration, 
pregnancy surveillance, training and supervision which involve substantial operational 
changes from the paper system, especially in the beginning of the program 
implementation. The marginal costs of these activities, however, can be reduced over 
time, because an established master list of households and population in the system can 
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reduce time and costs associated with registering new clients and survey form printing, 
data collection and reporting process, and can also improve data quality and accuracy, 
compared to the paper system. In addition, the relatively small proportion of costs for 
reminder interventions indicates that greater benefits can be achieved by scaling up these 
programs in the entire country. While the costs for pregnancy surveillance would increase 
with population size, the add-on reminder intervention costs are relatively small despite 
substantial impact. Given the nature of census enumeration and pregnancy surveillance, 
we suggest cooperation with other public agencies that can share activities or costs, such 
as Civil Registration and Vital Statistics (CRVS) initiatives or the census bureau. In this 
way, the Ministry of Health may then save budget costs to invest in other life-saving 
public health priorities. 
 
In terms of financial implications to health systems, increasing service coverage with the 
currently high level of out-of-pocket payment (OOP) in Bangladesh may result in 
regressive impact and financial burden to poor households. We suggest that mHealth 
programs consider including some demand-side financing schemes, especially for the 
poor, in order to reduce the risk of catastrophic health expenditures that may result from 
receiving care. These types of support can reduce financial and access barriers to seek 
care and can reduce inequity for service utilization. Regarding service provision, 
effective mHealth programs demand quality health services so that care-seeking can be 
attributed to health efficacy. In this study, while we considered the government a main 
formal stakeholder in the health system as the program implementer and service provider, 
in reality, service provision consists of many other stakeholders such as NGOs, the 
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private sector, as well as informal sectors, including unqualified providers such as village 
doctors and drug vendors. They play a major role in the private healthcare market in 
Bangladesh, especially in semi-urban and rural areas.[323] Even in urban areas where 
there is relatively good access to public providers, the majority of the poor tend to see 
unqualified practitioners as they are comparatively less expensive, easier to access, and 
their services are more familiar to patients.[43] Strategies for scaling up mHealth 
programs may need to consider this aspect based on the care-seeking characteristics and 
available service provisions in the given health system.  
 
NGOs provide some health services, especially at the grassroots level. They provide 
mainly primary and preventive care services, which complement public health services in 
Bangladesh. NGOs, especially BRAC, conduct their own pregnancy identification 
activities apart from government programs. This is partly due to the insufficient human 
workforce capacity in the government to cover the population’s needs. However, with the 
implementation of mHealth programs overtime, the government may focus on this 
pregnancy surveillance systematically, and best practices can be shared with other 
providers. In Bangladesh, NGOs have taken the lead in health care innovation, often in 
partnership with government. In collaborating with NGOs, the government could better 
allocate resources in quality service provision and promote innovative approaches with 
mHealth strategies.  
 
Why invest in mHealth? Bangladesh set its vision to achieve universal health coverage 
by 2035.[21] Global recommendations[324][21] and government policy 
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plans[325][326][327] discuss a health reform agenda and suggest a roadmap toward 
universal health coverage. Priorities of the agenda include improving the responsiveness, 
equity and quality of healthcare services, human resource policy, national insurance 
system, use of information communication technology (ICT), and governance capacity. 
Among these many competing priorities, investment decision-making may not be an easy 
task for policymakers. Further, amidst a shrinking health budget and financial constraints, 
the solution would require more than just increasing financial resources for health but in 
addition, improving ways of “organizing resource mobilization, allocation and 
expenditure in order to obtain the maximum value for money to ensure equitable and 
sustainable financing and financial protection against health expenditures for the entire 
population.” [328] 
 
In this regard, the study argues that investing in mHealth can help improve address a 
better way to coordination through a sector-wide approach to strengthen health financing 
and the health system at large. First, an mHealth approach for census enumeration and 
pregnancy surveillance can serve as a platform for not only health services, but also for 
broader social welfare benefits through its ability to facilitate public service delivery such 
as education, financial services, and even ensuring the right to vote. Achieving these 
policy and development outcomes may invite creative opportunities with a multi-sectoral 
and collaborative approach with other government ministries in financing and pooling 
resources. Second, individual health and socioeconomic information collected through 
health information systems can be better used in identifying and targeting the poor to 
improve equity in health financing and service delivery. For instance, using a voucher 
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scheme can support the poor to reduce their out-of-pocket expenditures and allow them to 
access necessary and quality health services. Third, the quality data collected from health 
information systems can generate better evidence for decision-making on resource 
allocation that can be based on performance or outcome measures, rather than on the 
basis of historical or political patterns. Clearly, mHealth is not just about increasing 
coverage, but it requires promoting workforce capacity, improving ways of managing 
workflow and organizing resource allocation in order to achieve effective coverage. 
Finally, these processes can promote dynamic and proactive stewardship in policy 





The results presented in this study should be interpreted while considering the limitations 
of the approach and data used. To estimate program activities and costs, we relied on our 
observations and experience from the mCARE I project, which might only approximately 
represent the actual costs in project scale-up. We did not include potential leaning effects 
as the relevant detailed information is proprietary and unavailable. We did not consider 
health systems negotiated costs such as donations or cost reduction through negotiation or 
new partnerships (e.g. mobile network operators to reduce airtime costs) to reflect 
market-based values of implementing the program, as it is difficult to predict or plan in 
advance. If it did happen, program costs may decrease. We also did not consider 
alternative business or financing models (e.g. ‘Freemium’ models where users pay for 
some features) as potential revenue generation or cost-sharing strategies.[219] However, 
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such potential approaches are encouraged to promote, as there can be many creative 
innovations and strategic partnerships that can add value in this field with scale-up. 
 
There are other factors that could affect resource utilization but were not included in the 
analysis. We did not consider illness effects in increasing service coverage. Besides the 
program effect of promoting care-seeking in the intervention group, people in the status 
quo or control group might be sicker due to less care-seeking in the earlier state of 
pregnancy and thus seek more care in the later stages of pregnancy. If that were to 
happen, service coverage may increase based on the severity of illness in the control and 
status quo groups. We did not consider the people who were not enrolled in the system 
but might seek care for the service coverage. In our approach, the denominator of service 
coverage is bound to the population coverage. This might result in a different measure of 
service coverage than the actual measure of service utilization, but we hold this approach 
as we evaluated the mCARE impact to be based on its capacity to capture population 
coverage. We did not consider the potential impact of new interventions or advanced 
tools because it is difficult to predict when they would be developed and operationalized. 
If new effective and affordable tools (such as risk prioritization or workflow algorithms 
on openSRP) are operationalized, the strategies of surveillance and care-seeking 
reminders could change, thereby influence costs. We did not consider any unexpected 
political unrest that could interrupt interventions. Overall, given the early stage of 
mHealth programs being implemented, there are limited data for many of the parameters, 
and much of the parameter uncertainty cannot be meaningfully quantified. Moreover, 
much of the uncertainty is structural and not easily parameterized. 
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Our budget impact analysis may not reflect some other important policy priorities or 
constraints. The budget thresholds were based on standard guidelines such as GNI per 
capita and a relative increase (e.g. 1.5-2 times) based on the cost estimates of the status 
quo scenario, as we did not have enough information to set specific values of willingness 
to pay. In the scenarios, we did not consider costs associated with vertical scale up, while 
it may be an important policy priority and substantial initial cost drivers for data and 
system integration across the different levels of health facilities, as stated in the recent 
report.[50] Future studies may conduct a survey with policymakers and relevant 





In limited resource settings, efficient allocation of available personnel and resources are 
difficult decisions, which are common challenges in many developing countries. A key 
aspect of the national eHealth policy is “the development of an integrated health 
information system, which includes a health management information system and an 
integrated human resource information system.”[329][330] This study is the first of its 
kind in Bangladesh to estimate the comparative costs and consequences of a digital health 
solution at scale compared to existing services and measure its affordability from a 
budget holder perspective. We believe our study is a meaningful contribution to the field 
and will help to guide decision-making in Bangladesh and globally related to investing in 
healthcare innovations based on evidence – cost effectiveness and affordability – rather 
than historic or political patterns.  
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Table 7.1 Model assumptions for pregnancy, population coverage, and service coverage for the three scenarios: (i) 
comprehensive mCARE program; (ii) basic mCARE program; (iii) paper based status quo, over 2015-2020 
 Model components 
Comprehensive mCARE program Basic mCARE program Paper based status quo  

























Number of eligible 
couple 560,000 560,560 … 562,806 560,000 560,560 … 562,806 560,000 560,560 … 562,806 
Married woman of 
reproductive age  560,000 560,560 … 562,806 560,000 560,560 … 562,806 560,000 560,560 … 562,806 
Fertility rate (B) 2.17 2.15 … 2.06 2.17 2.15 … 2.06 2.17 2.15 … 2.06 
Abortion rate (A) 18.2 18.16 … 18.02 18.2 18.16 … 18.02 18.2 18.16 … 18.02 
Fetal loss rate (D) 37.00 36.93 … 36.63 37.00 36.93 … 36.63 37.00 36.93 … 36.63 
Pregnant women  7,793 7,778 … 7,719 7,793 7,778 … 7,719 7,793 7,778 … 7,719 
Population 
coverage 
CHW performance 2015 2016 … 2020 2015 2016 … 2020 2015 2016 … 2020 
Census enumeration 0% 90% … 90% 0% 90% … 90% 0% 80% … 80% 
Pregnancy 
surveillance 0% 90% … 90% 0% 90% … 90% 0% 80% … 80% 
Number of eligible 




seeking  2015 2016 … 2020 2015 2016 … 2020 2015 2016 … 2020 
ANC (more than 4) 31% 34% … 50% 31% 33% … 40% 31% 31% … 33% 
ANC (less than 4) 69% 66% … 50% 69% 67% … 60% 69% 69% … 67% 
Facility delivery 38% 42% … 61% 38% 40% … 48% 38% 38% … 40% 
Home delivery 62% 58% … 39% 62% 60% … 52% 62% 62% … 60% 
PNC  36% 40% … 58% 36% 38% … 46% 36% 36% … 38% 
No PNC 64% 60% … 42% 64% 62% … 54% 64% 64% … 62% 
• The number of pregnant women was calculated in each district based on the respective number of married women of reproductive 
ages (ages 15-49) in each district, fertility rate, abortion rate, and fetal loss rate, based on the world bank database 
(http://data.worldbank.org/) a formula published elsewhere.[274]  
• Population coverage represents the number of pregnant women who are registered in the program through census enumeration and 
pregnancy surveillance, over the actual number of pregnant women in each district. 




Table 7.2 Model estimations for pregnancy, population coverage, and service coverage the three scenarios: (i) comprehensive 
mCARE program; (ii) basic mCARE program; (iii) paper based status quo, over 2015-2020 











Partnership building 13,068 0% 13,068 0% n/a   
System optimization  59,300 1% 59,300 1% n/a   
Tablet/phone procurement 118,073 2% 118,073 3% n/a   
Survey printing  7328 0% 7328 0% 181,358 7% 
Training  1,117,272 22% 1,117,272 27% 57,546 2% 
Supervision  787,660 16% 787,660 19% 787,660 29% 
Census enumeration  689,880 14% 689,880 17% 83,300 3% 
Pregnancy surveillance  953,081 19% 953,081 23% 874,649 32% 
Data processing  433,159 9% 433,159 10% 766,359 28% 
SMS  1,905 0% n/a   n/a   
Server hosting 152,878 3% n/a   n/a   
Reminder home visit  666,399 13% n/a   n/a   









Figure 7.1 Total program costs for the three scenarios: (i) comprehensive mCARE program; (ii) basic mCARE program; (iii) 










Figure 7.2 Annual program costs and service coverage for the three scenarios: (i) comprehensive mCARE program; (ii) basic 













Table 7.3 Summary of incremental cost effectiveness ratios of the three scenarios: (i) comprehensive mCARE program; (ii) 
basic mCARE program; (iii) paper based status quo, over 2016-2025 
 
Summary of incremental cost effectiveness ratios 
Comprehensive 
mCARE vs. Basic 
mCARE 
Comprehensive 
mCARE vs. Paper based 
status quo 
Basic mCARE  




Total incremental costs 821,182 2,257,850 1,436,668 
Incremental all death averted 845 1,254 409 
Incremental DALY averted 10,261 17,966 7,705 
Incremental cost per any death averted 972 1,801 3,513 
Incremental cost per DALY averted 80 126 186 
Probabilistic 
calculation 
Total incremental costs 669,754 2,260,853 1,591,099 
Incremental all death averted 853 1,278 425 
Incremental DALY averted 10,409 18,226 7,817 
Incremental cost per any death averted 785 1,769 3,741 



















Figure 7.4 An affordability curve showing the probability that the incremental cost of comprehensive mCARE program 
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Figure 7.5  Cost effectiveness affordability curve showing the probability that the comprehensive mCARE program is 










Table 7.4 Budget impact reference case of program financial costs of comprehensive mCARE program and paper based 
groups over 2015-2020 
Paper based system Comprehensive mCARE program 
Phase Status quo Phase Start-up Implementation 
Year 2015 2016 2017 2018 2019 2020 Year 2015 2016 2017 2018 2019 2020 
Survey 
printing 
26,000 26,000 26,000 26,000 26,000 26,000 
Survey 
printing 
1,250 1,250 1,250 1,250 1,250 1,250 
Supervision 139,728 139,728 139,728 139,728 139,728 139,728 Supervision 139,728 139,728 139,728 139,728 139,728 139,728 
CHW 
salary  
1,263,000 1,263,000 1,263,000 1,263,000 1,263,000 1,263,000 CHW salary  1,263,000 1,263,000 1,263,000 1,263,000 1,263,000 1,263,000 
Training 8,250 8,250 8,250 8,250 8,250 8,250 Training 160,175 160,175 160,175 160,175 160,175 160,175 
Data 
processing 
135949 135,949 135,949 135,949 135,949 135,949 
Data 
processing 
76,841 76,841 76,841 76,841 76,841 76,841 
          
Partnership 
building 
13,068 0 0 0 0 0 
n/a n/a n/a n/a n/a n/a n/a 
System 
optimization 
59,300 0 0 0 0 0 
       
Phone 
procurement 
118,073 0 0 0 0 0 
       SMS 0 338 338 338 338 338 
       
Server 
maintenance 
0 34253 34253 34253 34253 34253 
Total costs 1,572,927 1,572,927 1,572,927 1,572,927 1,572,927 1,572,927 Total costs 1,831,435 1,675,585 1,675,585 1,675,585 1,675,585 1,675,585 
















Table 7.5 Results of effect on key cost determinants brought about by variation of parameters used in the analysis  
  2015 2016 2017 2018 2019 2020 Total 
Budget impact (reference case, Gaibandha district) 258,508 102,658 102,658 102,658 102,658 102,658 771,798 
If cost of training increases by 20% 290,543 127,560 127,560 127,560 127,560 127,560 928,340 
If cost of training decreases by 20% 226,473 63,490 63,490 63,490 63,490 63,490 543,920 
If phone break rate increases by 15% 265,435 102,658 102,658 102,658 102,658 102,658 778,723 
If phone break rate decreases by 15% 240,435 102,658 102,658 102,658 102,658 102,658 753,723 
If server maintenance cost increases by 10% 258,508 114,515 114,515 114,515 114,515 114,515 831,080 
If server maintenance cost decreases by 10% 258,508 94,753 94,753 94,753 94,753 94,753 732,270 
If SMS unit cost increases by 20% 258,508 102,752 102,752 102,752 102,752 102,752 772,265 
If SMS unit cost decreases by 20% 258,508 102,560 102,560 102,560 102,560 102,560 771,305 
If mCARE is incrementally scaling up to another 
district each year 
258,508 293,099 569,883 828,885 964,520 1,027,075 3,941,969 
If mCARE is implementing in the entire country (64 
district) 
16,544,480 6,113,574 6,113,574 6,113,574 6,113,574 6,113,574 47,112,352 
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Chapter 8. Policy implications 
 
 
8.1 Summary of findings 
 
This dissertation conducted an economic evaluation of the mCARE program to 
demonstrate its cost effectiveness, to forecast the program’s resource requirements and 
health outcomes under various scaled-up scenarios, and to assess financial impact and the 
program’s major cost drivers. This chapter summarizes the main findings, the policy and 
programmatic implications of this research, as well as strengths and limitations and 
directions for further research.  
 
Paper 1: Results of this study indicate that adding SMS and home visit reminders is 
highly cost-effective, based on the established mCARE pregnancy surveillance system, 
given the program perspective in rural Bangladesh. The incremental cost-effectiveness 
ratio estimates $12 per newborn death averted and $0.41 per DALY averted. The 
program was conducted in three phases: program development (22 months), start-up (4 
months) and implementation (21 months) from 2011 to 2015. Calculations of the annual 
cost for implementation including development and start-up turned out to be $243,662–
$247,903 for the comprehensive mCARE arm and $243,186–$247,427 for basic mCARE 
arm. One-way sensitivity analysis revealed that the major program cost drivers are 
supervision and pregnancy surveillance. SMS and home visits reminders have a marginal 
impact on the total program costs. Since mCARE strategies are reminders to seek care 
and not provision of care, the health impact can be influenced by access to and quality of 
the local health facilities and the pregnant women’s care-seeking habits. This study 
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suggests that incorporating mCARE strategies to proven community-based interventions 
may enhance cost-effectiveness of the program and health outcomes in low-resource 
settings.  
 
Paper 2: The results of the study, which takes a societal perspective, confirm that the 
mCARE program (pregnancy surveillance and care-seeking reminders) is cost-effective 
compared to paper-based systems. The $47 per DALY averted fell well below 
Bangladesh’s per capita gross national income ($1,080). If the mCARE program were 
incrementally scaled up from one district up to the total eight districts in the Rangpur 
division by government community health workers (CHWs) from 2016-2025, the total 
program costs would be an estimated $37 million; provider costs would be $9.4 million; 
and user costs are estimated at $12 million – more cost effective than scaling up a paper-
based system: $24 million, $6.7 million, user costs, $7.7 million, respectively. The 
projected total number of lives saved (including maternal, newborn, and stillbirths) from 
2016 to 2025 would be 12,203–29,964 lives in the mCARE intervention group, and 913–
1,890 in the paper group. One-way sensitivity analysis revealed that census enumeration 
and pregnancy surveillance are the major cost drivers of scaling up. These costs are high 
in the first year due to the operational transition from the paper system to the mCARE 
system.  
 
Paper 3: Based on the favorable cost effectiveness profile from the previous studies, the 
study assessed affordability of implementing the mCARE program over the 6-year time 
horizon (2015-2020) in the entire Gaibandha district (approximately 2.4 million 
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population) by using a cost effectiveness affordability curve and financial budget impact 
estimation from perspective of the government as a budget holder. The cost effectiveness 
affordability curve shows that the mCARE intervention would have at least 93% 
probability of cost effectiveness at a threshold ($3,140, three times the Bangladesh GNI 
per capita), under the budget constraints of $2.5 million. For the budget impact analysis, 
we adjusted our activity-based costing into financial costing from a budget expenditure 
perspective. Following the standardized guideline (ISPOR), the annual program budget 
impact is an additional $258,508 in the first year (2015) and $102,658 in subsequent 
years (2016-2020) without adjusting for inflation in the mCARE 1 group compared to the 
paper group in Gaibandha district. The financial impact estimated over 2015-2020 ($47 
million) of the comprehensive mCARE program scenario makes up 0.9% of total annual 
health expenditure ($5.4 billion) and 2.5% of the public health expenditure ($1.9 billion), 
which is favorable to the current financial arrangement in the country. 
 
8.2 Implications for policy and programs 
 
This study comes at an important point in time when global health agencies and national 
governments are beginning to establish country-level health information systems such as 
District Health Information Systems (DHIS2) and Open Medical Record Systems 
(OpenMRS). These types of systems enable robust recordkeeping of national-level 





This section presents the implications for policy and programs through the following 
questions: How can mCARE change public health service delivery processes in 
Bangladesh? What are potential unintended consequences of the transition from a paper 
to the mobile phone based system? What are ethical and equity considerations? How can 
mHealth be a platform for strengthening health systems in low-resource settings?  
 
How can mCARE change health service delivery processes? 
 
One way that mCARE can change health service delivery is through systematic 
pregnancy surveillance, which can help identify the appropriate denominators that will 
enable the calculation of population-based morbidity and mortality rates using routinely 
available information. Pregnancy surveillance can also reduce gaps and instances of 
‘double counting’ since each pregnant woman and infant would be individually identified 
and entered into a shared electronic register. The traditional paper-based system takes 
manual summations and compiling of daily records to derive monthly data from paper 
registers at different administrative levels and various health service provision points. 
Without mechanisms to systematically verify these data, there is a greater risk of error 
involved in capturing information. The paper-based system records patient information 
and service items being provided, but it is almost impossible to track previous patient 
records. The data are rarely used for performance monitoring and resource allocation. On 
the other hand, if individual records are linked to the health information system (e.g. 
DHIS2) at community clinics across the country, it is possible to track an individual’s 
health status over time or know when a patient is overdue for a check-up. If an mCARE 
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system is established at scale, the amount of costs and time spent on reporting data may 
decrease significantly, allowing providers to better serve patients. In terms of health 
planning and policy, the mCARE program can facilitate automatic generation of many 
disaggregated reports and actionable public health measures to help mitigate risk and 
protect the poor. Moreover, a mobile system would allow for real-time monitoring and 
evaluation, which can strengthen decentralized decision-making processes and enable 
resource allocation based on performance and needs.  
 
What are possible unintended consequences of the change?  
 
A change from the current paper system to the mCARE system would require a 
substantial period of time to fully transition. Unintended consequences may occur. For 
example, during the transition process, family welfare assistants may be faced with a 
double burden of data collection activities handling both paper documents and a mobile 
phone. The change will also require time and intensive training and supervision until 
system operation and staff performances are stabilized. Considering that family welfare 
assistants will undertake census enumeration and pregnancy surveillance (who conduct 
routine household visits), the transition may reduce their dedication to other important 
responsibilities such as their roles in family planning, health promotion or referrals of 
emergency cases in the community. Given the intensive workload it demands, (although 
the initiative may be positively received by the data collectors and possibly even result in 
increased motivation and respect in the community), the program may be expected to 
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increase workers’ salaries or provide additional incentives to retain staff as well as 
supervisors.  
 
In addition, it would be important to ensure the access, availability, and quality within the 
health system in advance of promoting care-seeking to the pregnant women. In the case 
that the mCARE SMS and home visit reminders promote care-seeking but there is no 
available staff or medical supplies in the facilities, negative consequences may result, 
such as waste of user time and costs, complaints or reduced trust toward the health 
system. Moreover, increased demand to seek care at public facilities – where there are 
often shortages of supplies and are often congested with people – may result in longer 
waiting times for patients who need urgent care. Consequently, poor women or families 
may be more likely to end up receiving care from informal or unqualified health 
providers. In regards to service provision and referrals, it would be important to 
collaborate with nongovernmental organizations (NGOs) or private facilities in the 
community to ensure adequately responsive services.  
 
What are the ethical and equity considerations?  
 
In designing and implementing the mobile program in Bangladesh, it is important to 
consider equity during the transition process in regards to the social and cultural 
implications of program consequences. Increasing service demand along with the 
currently high level of out-of-pocket spending in the country may result in a regressive 
financial impact on poor households. As a result of care seeking promotion, rich women 
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may increasingly utilize private service, while among the poor, use of informal providers 
may increase. Without adequate investment in public health service provision, this may 
increase stock-outs of medical supplies and exacerbate the equity gap of service quality 
in the community.  
 
A second consideration is that during pregnancy surveillance, certain households (e.g. 
those in hard-to-reach areas or households with members who internally migrate into 
cities to earn money) may be missed and therefore excluded from receiving system-
related benefits and become even more marginalized from the formal health system. 
Third, in the process of monitoring the performance of CHWs using a mobile phone, the 
program may likely incentivize workers who are younger, of a higher socioeconomic 
status and more adept at using new technologies. Judicious management and staff 
recruitment practices may minimize unnecessary competition or discomfort among 
younger and older staff, the latter group who likely receive the respect of their 
community based on their longstanding experiences and knowledge gained from 
participation in the existing paper-based program. Once fully established, mHealth may 
promote equitable access to marginalized populations due to the powerful connectivity 
introduced by information and communication technologies; but in the process of 
deployment, this may exacerbate a preexisting gap, thereby preventing the poor and 
marginalized population from gaining the full benefits of an accessible healthcare system. 
Given this potential concern, one notable component designed into the mCARE program 
is the personally scheduled home visit reminders delivered by CHWs, which addresses 
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the issue of equity and inclusion of poor households without mobile phones or with low 
literacy.  
 
In addition to equity, ethical aspects of the program transition should be considered.[331] 
A first consideration to note is the privacy, security, and safety of individual records. 
Personal and identifiable information is recorded by portable devices like mobile phones, 
which are not centrally controlled. While paper-based information can be stored in a 
secured location that is physically inaccessible and discarded years later, data recorded on 
a mobile device are not as protected from confidentiality risks. In terms of ethics, 
ownership issues related to the collected personal health data among various stakeholders 
(e.g. software and data storage companies, hospital and healthcare providers, patients) 
can compromise patient autonomy if their health data are shared or linked without their 
consent. There is also the risk that the information may be used for commercial purposes 
without permission. Lack of confidence in the system’s ability to securely manage private 
health data may negatively affect program participation or cause patients to conceal 
sensitive personal information.[332] 
 
A second ethical issue to consider is proper verification and security protection 
mechanisms to avoid potential misuse of the program and system. For example, the 
program needs to consider how to provide special financial support or priority of care for 
poor and at-risk populations given the possibility that women in the community who are 
not poor or at-risk may purposely report false health conditions or economic status to 
receive benefits or priority care. Moreover, as CHWs become increasingly familiar with 
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the system, including the algorithms that optimize workflow and reward CHWs based on 
their performance monitoring score, CHWs may be tempted to manipulate their score or 
passively follow the system instructions instead of responding to the real needs of the 
community. To prevent these issues from occurring, verification mechanisms would be 
required in the operational plan and management. Another challenge related to ethics is 
ensuring validity and trust toward the system algorithm (e.g. criteria for risk stratification 
and prioritization). Overall, it would be important to design the system and program to 
best use the local knowledge and optimize human interaction for better timing, access, 
and quality, instead of replacing these factors with technology. Without proper 
verification and security protection mechanisms in place, technical or system errors that 
arise may be exposed to malicious attack by hackers and can jeopardize community 
health through incorrect prescriptions and referrals or misuse of critical individual health 
data.  
 
How can mHealth be a platform for strengthening health systems in low-resource 
settings?  
 
mHealth can serve as a platform for people-centered health systems strengthening in 
various ways. First, health information systems (HIS) can improve the accuracy of data 
and efficiency of data processing and reporting that can promote transparency and 
accountability of governance and encourage evidence-based planning, budgeting, 
supervision and monitoring of health-related policy and programs. Using mobile 
technology can also improve district health managers’ capacity and promote 
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decentralized decision-making based on the needs and demands of the district. Second, 
HIS research can increase capacity in the collection, analysis and use of data with 
innovative technologies and tools available at a global level. mHealth can offer new 
insights to understand human behavior, disease transmission patterns, and effective health 
service delivery strategies. Third, through improved information and governance, HIS 
can strengthen national and sub-national procurement and supply and distribution 
systems of medicine and technology. In terms of human resources, HIS can boost 
workforce productivity and capacity by promoting e-learning, tele-health, tools for 
guideline adherence, and communication among workers. In regards to financing, HIS 
can help establish social health insurance as a social protection mechanism and plan for 
financing universal health coverage.[50] This is an important benefit of HIS because 
every element of a health insurance system – from documentation of services, to claims 
processing, to the identification of beneficiaries and their entitlements – depends on 
accurate information. Finally, mHealth can strengthen the community’s service delivery 
platform for demand generation, social accountability, social inclusion and reduction of 
financial barriers.[50] A well connected and functioning mHealth network from 
community to primary and secondary level clinics can build resilient health systems, 
particularly in emergency prevention, preparedness and response. Moreover, through 
multi-sectoral partnerships, mHealth can add even more value through services offered 





8.3 Recommendations for policy and programs 
 
Promote cost containment strategies. Under the financial constraints in LMICs, cost 
containment is important to ensure that resources are available to spend on the necessary 
workforce, medical supplies, equipment and invest in innovation and infrastructure. First 
of all, given that the major cost drivers are staff activities such as training, census 
enumeration, pregnancy surveillance, and supervision, we suggest developing 
coordinated plans and strategies to improve workforce productivity and efficiency on 
these particular activities, especially during the initial years of implementation. Once the 
system foundation and operational transition are stabilized, we suggest considering the 
technical components such as reducing phone breakage and loss rate or SMS unit costs 
and optimizing server capacity or data processing and reporting system to reduce 
maintenance costs. 
 
Promote mHealth as a platform of community health service delivery. The main cost 
drivers of the mCARE program are supervision and pregnancy surveillance. We suggest 
that program implementers consider strategies to improve work efficiency and cost 
sharing. Given the common operational characteristics and high-level coordination that 
census enumeration and pregnancy surveillance require, we suggest cooperating with 
other public agencies like CRVS initiatives or the Census Bureau, to obtain support for 
sharing activity costs. This may allow the Ministry of Health to save budgets and invest 
more on other lifesaving public health priorities. Moreover, using mHealth for census 
enumeration and routine household visits can serve as a platform for not only health 
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service delivery (e.g. medicine selling, risk identification and referral, community health 
promotion or campaigns), but also for broader social welfare by facilitating public service 
delivery such as education, financial services, and even ensuring the right to vote. 
 
Develop an mHealth early risk identification and prioritization system, which can be 
beneficial for large-scale implementation in a limited-resource setting. While system 
optimization is a one-time cost, developing a system algorithm would be the key to 
determining overall operational efficiency and workflow process of personalized and 
scheduled reminders, routine household visits, and automated data reporting and 
management. Based on personal health data, the system algorithm can also be used for 
screening risks based on proven and well-known maternal risk factors for mothers under 
the age of 16 years; multiple pregnancies and malpresentation; and previous or current 
pregnancy complications. A risk scoring system based on computerized risk screening or 
a stratification algorithm could triage pregnant women to appropriate risk groups. 
Enhanced prevention and protection interventions can be introduced with such a risk 
identification and prioritization system and with coordinated CHWs’ referral practices.   
 
Provide demand-side financing for the poor. We suggest that the mHealth program 
includes a demand-side financing scheme, especially for the poor, to reduce potentially 
catastrophic health expenditures that can result from receiving care. Incentives (e.g. 
conditional cash transfers, voucher system) for facility delivery can help reduce potential 
financial constraints for users and allow for greater health impact.[258] With careful 
identification and verification measures, information collected through mCARE 
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pregnancy surveillance can be better utilized to identify poor or vulnerable households 
and to strategically target such incentives or provide more attention to these vulnerable 
groups by the timing of delivery. By leveraging the IT system and individual health 
information, mHealth could further improve not only health outcomes for the poor but 
also access to care through better prevention and strategies targeted toward reaching the 
most vulnerable populations. 
 
Strengthen health systems preparedness. Our study finding suggests that in order to 
achieve improved health outcomes, mCARE may create opportunities to focus on health 
systems readiness; however, this does not happen automatically. Perhaps most important 
to consider is that scaling up the mCARE program must be accompanied (or even 
preceded by) a scale-up of in-country capacities and systems so that health facilities are 
prepared to respond to sustained demand for health services that are available, accessible 
and of good quality. In this study, while we considered the government a main formal 
stakeholder in the health system with the roles of program implementer and service 
provider, in reality, services are offered through many other stakeholders like 
nongovernmental organizations (NGOs), the private sector companies, as well as 
informal sector providers. Strategies for scaling up an mHealth program may need to 
consider this multi-actor involvement based on care-seeking characteristics and available 
service provisions in the given health system. Building the capacities of varied service 
providers, in consonance with efforts to strengthen health systems and workforce 
capacity will ensure that countries are ready to take proven interventions to full scale 




Collaborate with NGOs and private sector. NGOs provide some health services, 
especially at the grassroots level. They provide mainly primary and preventive care 
services and limited hospital services. To some extent, these services complement public 
health services. NGOs (especially BRAC) conduct their own pregnancy identification 
activities separately from a government program. This is partially due to the insufficient 
human workforce capacity in government to cover the population needs. However, with 
the implementation of mHealth over time, the government may prioritize a focus on the 
pregnancy surveillance systematically, and implementation activities can be shared with 
other providers. In Bangladesh, NGOs have taken the lead in health care innovation, 
often in partnership with the government. Collaboration with NGOs could help the 
government better allocate resources to ensure quality service provision and promote 
innovative approaches using mHealth strategies. Complicated obstetrics care is usually 
performed by private sector providers, so in order to establish effective referral services, 
there is a need for the government to cooperate with the private sector. 
 
Link the scale up practice and M&E practice. mHealth CHW programs grow and 
evolve in phases of continuous learning, improvement, and expansion of coverage. 
Monitoring and evaluation (M&E) strategies should take these evolutions into account. 
First, a scaling up strategy should include considerations for how to advocate for the 
innovation and plan for how to implement the innovation at multiple levels (policy, 
program, and service delivery), the organizational processes related to implementation 
and the costs and resources needed.[333] The linking of the scale-up and M&E process 
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includes both the expansion of services (horizontal scale-up) as well as the integration of 
the innovation into the country’s monitoring systems to achieve sustainability (vertical 
scale-up). Accordingly, developing and implementing a robust, comprehensive M&E 
plan will help practitioners operationalize their scale-up strategy. An M&E plan will 
allow for well-defined benchmarks and tracking of progress towards established 
goals.[333] 
 
8.4 Strengths and limitations 
 
Strengths of this study. This research shows that the mCARE program and strategies 
will be economically advantageous compared to the paper-based system in terms of both 
cost-effectiveness and long-term cost saving. The result of study aim 1 demonstrated the 
cost effectiveness of a particular mHealth strategy on care seeking reminders based on an 
empirical pilot project implemented from 2011-2015 by the JiVitA research team in rural 
Bangladesh. The study conducted detailed activity-based costing, demonstrating time and 
resource requirements of the entire program life cycle including partnership building, 
planning, and development of the mHealth operational system, testing of the mHealth 
platform, training staff, start-up preparations and implementation. Although the product 
of the open source platform can be a global public good, the analytic process and findings 
can be valuable lessons for other countries who are planning to develop or customize an 




The result of aim 2 demonstrated the cost effectiveness of mCARE program including 
pregnancy surveillance and care seeking reminders, compared to the current paper-based 
system at scaled-up scenarios by government CHWs. We used Excel spreadsheet-based 
modeling to forecast costs and the used the Lives Saved Tool (LiST) modeling to 
estimate the number of deaths averted based on incremental service coverage change over 
2016-2025. For the model-based analyses, we synthesized evidence from a wide variety 
of sources and published literature related to mHealth and Bangladesh health systems. To 
estimate societal costs, including provider and user costs, we also conducted a field study 
to collect service costs and content data through in-depth interviews, observations, and 
exit interviews with local stakeholders, service providers and 100 pregnant women at 
various service provision agencies in Gaibandha district.   
 
The study aim 3 calculated total program costs of implementing the mCARE program in 
Gaibandha district and nationwide from 2015-2020. We conducted one-way deterministic 
sensitivity analyses on factors associated with high uncertainty such as CHW 
productivity and technological components. Based on the cost function of increasing 
CHW productivity (i.e. number of household visits per day by CHW), and incremental 
geographical expansion over time (i.e. program expansion to one additional district per 
year), we also demonstrated the quantitative measure of cost saving and economies of 
scale through the decreasing unit cost of registering MWRAs from 2015-2020. Finally, 
we discussed program affordability with respect to national health expenditure and 




Many economic evaluation studies are conducted based on assumptions regarding target 
populations, unit cost from published literature and politically expedient coverage targets. 
The aim of this thesis was to improve on this situation, by using the following 
approaches: the study conducted detailed ingredient-based costing throughout the entire 
program development and implementation spectrum. The study projected the number of 
pregnant women based on local demographic and epidemiologic information for the time 
period to be examined. The study also used the Lives Saved Tool to project the number 
of deaths averted based on the empirical evidence of service coverage uptake and service 
contents and practice in the given setting. The thesis describes the methods used in 
generating the inputs for the model, including activity-based program costs, provider and 
user costs from various service provision settings in Gaibandha district, population 
coverage, and service coverage increase rates, the number of deaths averted for each 
scenario, as well as key determinants of program cost drivers and uncertainty that were 
used in the model.  
 
While economic evaluation may assist the prioritization of interventions, it is not 
sufficient to predict whether an intervention is affordable with given resources. Based on 
the favorable cost effectiveness profiles reported in the mCARE pilot (aim 1) and a 
scaled-up model of the mCARE program (aim 2), we extended our analyses to assess 
affordability and budget impact, considering budget constraints to guide real-world 
decisions. First, the study showed how cost-effectiveness affordability curves could 
enhance the information provided by traditional analyses of cost-effectiveness. Cost-
effectiveness affordability curves distinguish the joint distributions of costs and effects 
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that share the same correlations between these two dimensions but differ in scale.[306, 
308] This is especially useful for a case that has a high incremental health impact at a low 
net cost. For example, our study showed that the addition of SMS reminder is low cost 
yet can substantially improve pregnant women’s care seeking practices. In this case, the 
consideration of budget constraints in addition to cost-effectiveness thresholds can 
provide new information to guide better investment decision-making.  
 
Second, our results from BIA provides guidance relevant to actual budget planning and 
policy making. For the program, such as mCARE, which involves multiple stakeholders 
and a complex operational transition, the ingredient-based activity costing estimates and 
estimates based on a particular payer’s financial expenditures can be substantially 
different. As the strategy of the successful mCARE program is to be integrated with the 
government health systems for scalability and sustainability, the result of BIA provides 
useful information to project the amount of funding required for the program and for the 
consequences of potential variation of cost inputs and scale-up scenarios. Based on the 
BIA results, we calculated true annual program costs at scale and ‘unit costs’ per 
beneficiaries, which are compared to the annual total health expenditure and government 
health expenditure per capita to discuss the affordability in the country.  
 
Our evaluation followed the established guideline (MAPS, CHEERS, and ISPOR) in 
designing the analytical framework and reporting the findings. We believe our results are 
a unique and significant contribution to the field, as we addressed the unique 
characteristics and challenges of evaluating the mHealth program in a systematic and 
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transparent way to the established cost-effectiveness evaluation methods and practices. 
We hope our models can facilitate policy development [32] as well as implementation, by 
providing the architecture for organizing evidence for a specific policy initiative, and 
helping generate policy questions.[33] With these results and recommendations, mHealth 
could be better utilized as a strategy to deliver proven interventions in a cost-effective 
manner. 
 
Limitations of the study. The results presented in this study should be interpreted 
considering the limitations of the approach and data used. First, the mCARE I program is 
a small scale pilot study with 70 CHWs involved. Given the early stage of mHealth in 
this field, lack of data and experience made it challenging to determine model parameters 
and assumptions, which resulted in considerable structural and parameter uncertainties. 
The study is not a randomized controlled trial so there may be confounding factors that 
have an influence when assessing coverage impact between the two groups. Also, given 
the nature of the mHealth program, which may be influenced by variables like mobile 
ownership, literacy, or care-seeking characteristics, heterogeneity would be another 
important factor to consider when evaluating coverage and health impact.  
 
In regards to the field data collection for service content and costs, our sampling of the 
facilities and pregnant women were purposive based on their availability on any date that 
the facility managers agreed to welcome visits from September to December 2016. As 
our observations and exit interviews were conducted at the point of ANC service 
provision, the ANC service content and cost data presented a high level of completeness 
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and accuracy, while delivery and PNC service content and cost data had many missing 
values and recall biases. Since our data collection was conducted in Gaibandha district, 
the results might not necessarily reflect service practice and costs in other districts or 
urban settings. Measuring accurate marginal costs of service provision in a rural 
community was a challenging task due to the unpredictable availability of drugs and staff. 
Considering supply shortage, our provider and user costs might be overestimated. 
Measuring wage loss for user indirect costs was also a challenge given the high level of 
informal workers with a high variation of and unsystematic information about their 
income. Measuring service time for delivery and PNC was also challenging especially 
when mothers were hospitalized for child delivery. Identifying specific service costs from 
a pregnant woman during her delivery was also difficult because in most cases, her 
husband or another senior member of the household made the payment. As the bills were 
often issued based on all services used, it was also difficult to expect mothers to know 
and remember the specific service costs. To avoid bias from extreme values in our survey 
data, we used an interquartile range of 25% and 75% of the dataset excluding missing 
values.  
 
There are also some limitations to our modeling analysis. First, given the early stage of 
mHealth programs with no historic reference or records, there are limited data for many 
of the parameters, and much of the parameter uncertainty cannot be meaningfully 
quantified. Moreover, much of the uncertainty is structural and not easily parameterized. 
The parameter uncertainty is drawn from various complex factors that can influence 
population and service coverage rates, CHW productivity in pregnancy surveillance 
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practice, cost inputs of technological components, and factors associated with care 
seeking practices. These factors include staff motivation, capacity, population 
socioeconomic status, literacy level, mobile phone ownership, network and electricity 
connectivity, other new interventions in the community such as family planning, 
conditional cash transfer, or health facility upgrades, as well as the country’s 
macroeconomic stability.  
 
The structural uncertainty includes activities and resources required for operational 
transitioning and scaling up. Our model did not consider activities or resources required 
for system or data integration across different health facilities (vertical scale-up), 
although it would be a key cost driver. Our model also did not consider any potential 
partnership, business models or other financing mechanisms that can lead to cost saving 
or cost sharing, although these are typically desirable features during scale-up.  
 
Second, while the LiST model allowed systematic comparisons of health outcomes based 
on service coverage impact across the scenario, we assumed a linear service coverage 
uptake and efficacy of sub-components of service contents embedded in the tool. Given 
the characteristics of the mCARE intervention as care seeking reminders, health impact 
can be highly dependent upon the given health systems condition (access to and quality 
of services) and mothers’ care seeking characteristics (e.g. the rich versus the poor).  
 
Third, in calculating provider and user costs based on the projective number of pregnant 
women seeking care in our model, we assumed that there are sufficient resources at the 
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point of care seeking at the health facilities so that women’s care seeking decisions can 
be directly related to receiving appropriate care. However, in reality, it is commonly seen 
in rural Bangladesh that drugs are stocked out, and there is a shortage or absence of 
health providers at facilities. Also there are many informal health providers in rural 
villages, from whom the poor women often receive care. If these factors were to be 
considered, provider and user costs as well as health impact may be lower than our 
estimates.  
 
Fourth, our scenarios to assess cost effectiveness and affordability assessments only 
considered the comprehensive mCARE program, basic mCARE program and status quo 
scenarios. We cannot draw conclusions from outside these scenarios, as we did not 
consider other competing interventions in the analyses for the real-world decision 
making. The usefulness of a theoretical method such as cost-effectiveness affordability 
curves is more useful when a resource allocation problem needs to be addressed generally 
at a single new program’s fixed budget.[307] If there is to be a separate budget to support 
mCARE, the result may be useful and further considerations can be added to determine 
the best technology mix portfolio (frequency of SMS or home visit reminders, eligible 
target population for pregnancy surveillance, etc.) to enhance the decision-making under 
the given budget constraints, as discussed by Sendi and Gafni[334] through a ‘decision 
making plane’. If this is not the case, a more comprehensive approach including other 
competing program would be required to assess the cost effectiveness and affordability 
under a shared budget. Future research could consider all relevant programs under a 
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shared budget and incorporate complicated constraints to enhance resource allocation 
problems in the given setting.  
 
Nevertheless, given that such research would require an enormous amount of effort in 
a practical setting, and that our model took a reasonably conservative approach and 
assumptions necessary for the existing budget constraints. Based on the favorable 
cost-effectiveness profiles, our approach including affordability and budget impact 
analyses can provide valuable information to decision-makers in low-income countries 
in the context of increasing potential and use of digital healthcare solutions within 
severe budget constraints.  
 
8.5 Future research directions 
 
Our study suggests a further need for operational research and considerations of equity 
that can help policymakers and program managers to scale up delivery of effective 
interventions through mHealth strategies. A recent STEPS Centre publication described 
that the introduction and process in the spread of technological innovation could be 
characterized as “the direction of development and the way organizations incorporate the 
new technology into their operations; the distribution of benefits from the technology and 
the diversity of ways the technology is applied.”[335]  Although the mCARE program is 
a promising strategy for expanding access for women to service coverage, important 
questions remain about how these programs can be successfully implemented and scaled 
up as well as how the benefits can be distributed equally in society. Continued research 
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on mHealth can provide new research insights though enhanced capacity in data 
collection, access and management for not only biomedical research but also health 
systems research through capturing data on service processes, human behavior, and 
location of health service provision – which were previously unobtainable in a systemic 
way. 
 
First, as presented in our modeling approach in the study, the subject deserve further 
research attention, particularly addressing what factors contributed to the operational 
change and CHW productivity and efficiency gains and the scaling-up process. Given 
that the key cost determinant was CHW productivity during household visits, more in-
depth studies such as time and motion studies can be helpful to assess the impact of the 
mCARE program on CHW workload and to inform future decisions about assigning new 
responsibilities to CHWs. The impact of mHealth to the determinants of service delivery 
and referral practice can be also an important research question. Studies that are 
undertaken prospectively during the initial program rollout and are able to document 
operational processes would be useful. The model could continuously improve its 
assumptions and accuracy through iterative processes with applicable lessons.  
 
Second, although our study demonstrated the cost-effectiveness of the mCARE program 
compared to the control and status quo scenarios, further research is needed to evaluate 
the cost-effectiveness of the diverse strategies within mHealth (e.g. SMS texting versus a 
call-center, SMS texting with different frequency, timing, and contents)[237] and of 
mHealth compared with other community-based demand promotion programs (e.g. 
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conditional cash transfer). Additional comparative research that tests the cost-
effectiveness of different promotional strategies can offer insights about the role of 
technology and dynamics of specific factors that affect the process of developing delivery 
strategies. Another important research consideration is understanding the process 
mechanisms between reminders for care-seeking and what happens between care-seeking 
and change in coverage. 
 
Lastly, while the benefits of mHealth are widely acknowledged (e.g. improving access 
and quality in resource-limited settings), it would be important to assess whether and to 
what extent mHealth ultimately contributes to poverty reduction and economic inequality 
in society. As discussed in the policy and program implications section, mHealth 
programs and research have a paradoxical dilemma—especially during the transitional 
and transformative process. While mHealth is expected to help overcome health systems 
constraints through improved access and quality, the capacity to realize the potential 
requires significant pre-existing competences in the health systems such as electricity and 
wireless broadband network connections, available human resource capacity with training 
and supervision to data management. Bangladesh still faces significant constraints in 
terms of infrastructure and human resource development, which are necessary for 
successful and sustainable mHealth program implementation. Scaling up and M&E 
practices should consider this aspect carefully to avoid exacerbating the existing 
disparities in access to information technology between urban and rural residents and the 






Throughout the past decades, Bangladesh has shown impressive development related to 
not just what they have achieved – significant improvement on several human 
development indicators – but also how they have achieved through grassroots 
community-based efforts.[21]  Moving forward from the United Nations Millennium 
Development Goals (MDGs) to the Sustainable Development Goals (SDGs), Bangladesh 
has shown unequivocal lessons in achieving the MDGs and promoting a new vision: 
Digital Bangladesh 2020 – for the world. Despite many challenges such as political 
instability, financial constraints, and power shortages, many innovative and ambitious 
projects are ongoing to achieve a digital Bangladesh. 
 
Developing integrated and well-functioning health information systems on an open 
source platform (e.g. DHIS, OpenMRS, and OpenSRP) can be a ‘global public good’ and 
would potentially benefit many countries and save resources. Furthermore, the scaling up 
pathways of mHealth programs involves dynamic and transformative processes with 
integration, replication, and expansion within health systems. Valuable lessons can be 
learned through experience if financing is available to scale up mHealth systems and 
when impacts of large-scale programs and the implementation process are rigorously and 
systematically documented and analyzed. 
 
We know much in terms of which interventions to scale up, yet we know less about how 
to deliver these interventions at scale, how to build capacity in countries, and how to 
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minimize costs during the implementation and scaling-up process. Our study presented 
the cost-effectiveness and budget impact of developing, implementing, and scaling up 
mCARE for CHWs in support of pregnancy surveillance and SMS messages and home 
visit reminders in rural Bangladesh, a positive step for improving access to health 
services for a population in need. The value for money would continuously evolve as 
mHealth becomes a global platform sustained through local knowledge. As such, this 
study contributes to filling critical needs for economic evaluation and implementation 
research by providing actionable evidence for improving community-based Open SRP 
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Appendix 1. Literature review 




Strategies Type of 
MNH Care 














NMR per 1000 
LB Adj RR = 
0.62 (95% CI: 
0.43-0.89) 
The cost-effectiveness was US $220 to 














NMR per 1000 
LB: 31.2 (S), 43.1 
(C) 
The incremental programme costs of 
implementing the home-care package were $2939 
per neonatal death averted and US$ 103.49 per 
disability-adjusted life year (DALY) averted. The 
corresponding total societal costs were US$ 2971 
and US$ 104.62, respectively.  
Hutchinson 
(2006) 













number of new 
ANC users 
With respect to local promotion activities, the cost 
per attributable behavior change was considerably 
higher—nearly $8 per new ANC user, $37 per new 
DPT3 vaccination, and $32 per new measles 
vaccination. 
Routh (2000) Alternative delivery 
strategies FP & 
MCH 






Number of ANC 
services provided 
Cost per birth averted and cost per QALY gained : 
$13 and $17 delivering services from static (fixed-





Outreach clinics for 








Number of ANC 
services provided 
The provision of a wider range of services is 
improving overall cost effectiveness.  
Howlader 
(2011) 









number of clients 
per year 
In order to implement the intervention in all upazilas 
of the country, the required amount of expenditure 
in the first year of implementation will be TK. 
252.31 crore. The amount in the second year will be 
TK. 117.37 crore. The amount will remain TK. 
117.37 crore in each of the subsequent year. 
Hatt (2010) Vouchers for free 
MNH 
care, cash and in-
kind 
transfers 




 % of deliveries 
with qualified 
provider: 58-70% 
(S), 27% (C) 
The average cost per voucher distributed (based 
upon the direct costs of the DSF program) is 
estimated to be US$ 41. 
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Appendix 2. Costing analyses 








A 2.2 Cost Inputs from JiVitA 
 
1. Human resources (staff salaries)
Monthly salary (BDT)/person M LOEAnnual salary/personMonth y sala y (BDT)/person M LOEAnnual salary/personMonthly sala y (BDT)/person M LOEAnnual salary/personMonthly sala y (BDT)/person M LOEAnnual salary/person
Field Administrator 1 75,290 12 15% 135,522 60,000 12 20% 144,000 60,000 12 30% 216,000 66,000 7 10% 46,200
Finance Officer 1 0 12 15% 0 37,000 12 20% 88,800 40,000 12 30% 144,000 44,000 7 10% 30,800
Adm Officer-Accounts 1 21,800 12 15% 39,240 25,000 12 20% 60,000 27,000 12 30% 97,200 29,700 7 10% 20,790
Admin Officer-Procurement 1 31,800 12 15% 57,240 33,210 12 20% 79,704 35,867 12 30% 129,121 39,460 7 10% 27,622
Asst. Admin Officer 1 0 12 15% 0 30,000 12 20% 72,000 30,000 12 30% 108,000 0 7 10% 0
Office Assistant 1 12,870 12 15% 23,166 10,000 12 20% 24,000 10,800 12 30% 38,880 9,510 7 10% 6,657
Admin Officer-Logistics and Maintenance1 26,160 12 15% 47,088 27,000 12 20% 64,800 29,160 12 30% 104,976 32,080 7 10% 22,456
HQ admin total costs
Research Translator 1 14,080 12 15% 25,344 16,500 12 20% 39,600 17,820 12 30% 64,152 19,610 7 10% 13,727
Asst. IT Officer 1 15,000 12 15% 27,000 15,580 12 20% 37,392 24,840 12 30% 89,424 27,330 7 10% 19,131
Data Enrty Operator 3 11,630 12 15% 62,802 10,500 12 20% 75,600 11,340 12 30% 122,472 12,480 7 10% 26,208
Field Query Associate 1 14,830 12 15% 26,694 19,000 12 20% 45,600 22,680 12 30% 81,648 24,950 7 10% 17,465
Associate Archivist 1 11,620 12 15% 20,916 10,000 12 20% 24,000 10,800 12 30% 38,880 11,880 7 10% 8,316
Filling Asst. 1 9,000 12 15% 16,200 9,000 12 20% 21,600 9,720 12 30% 34,992 10,700 7 10% 7,490
HQ tech staff total costs
Motor Mecanics 1 14,830 12 15% 26,694 14,930 12 20% 35,832 16,120 12 30% 58,032 17,740 7 10% 12,418
Computer Operator 1 10,510 12 15% 18,918 10,580 12 20% 25,392 11,430 12 30% 41,148 10,060 7 10% 7,042
Asst. Motor Mecanis 1 7,030 12 15% 12,654 7,300 12 20% 17,520 7,880 12 30% 28,368 8,680 7 10% 6,076
Electrician 1 10,000 12 15% 18,000 10,070 12 20% 24,168 10,880 12 30% 39,168 11,970 7 10% 8,379
Admin Asst.-Store 2 14,720 12 15% 52,992 12,000 12 20% 57,600 12,960 12 30% 93,312 11,410 7 10% 15,974
Driver 3 14,640 12 15% 79,056 15,000 12 20% 108,000 16,200 12 30% 174,960 10,700 7 10% 22,470
Office helper 1 6,600 12 15% 11,880 6,860 12 20% 16,464 7,410 12 30% 26,676 8,150 7 10% 5,705
Support staff 2 7,260 12 15% 26,136 7,550 12 20% 36,240 8,150 12 30% 58,680 8,965 7 10% 12,551
Admin Asst. 1 14,640 12 15% 26,352 12,420 12 20% 29,808 13,410 12 30% 48,276 14,760 7 10% 10,332
Cook 1 11,990 12 15% 21,582 12,080 12 20% 28,992 13,050 12 30% 46,980 14,350 7 10% 10,045
Cleaner 1 4,620 12 15% 8,316 4,800 12 20% 11,520 5,180 12 30% 18,648 5,710 7 10% 3,997
HQ supporting total costs
Total admin & supporting staff 783,792 1,168,632 1,903,993 361,851
Project Manager 1 307,692 12 100% 3,692,304 316,923 12 100% 3,803,073 326,430 12 100% 3,917,165 336,223 7 100% 4,034,680
JiVitA Research Fellow 1 230,769 12 20% 553,846 237,692 12 10% 570,461 244,823 12 10% 587,575 252,168 7 10% 605,202
Senior Research Physician 1 95,030 12 40% 456,144 102,443 12 60% 102,443 110,638 12 30% 110,638 121,710 7 30% 110,638
Senior Finance and Admin Manager1 95,030 12 10% 114,036 102,443 12 20% 102,443 110,638 12 30% 110,638 121,710 7 30% 110,638
Data Centre Manager 1 64,000 12 10% 76,800 68,992 12 20% 68,992 68,992 12 40% 68,992 81,970 7 40% 68,992
Field Staff 1 Sr.FS 1 29,040 12 0% 0 33,170 12 40% 33,170 35,824 12 30% 35,824 39,410 7 10% 35,824
Field Staff 2 AC/Field Officer 4 18,060 12 0% 0 17,000 12 15% 122,400 18,360 12 15% 132,192 16,120 7 10% 45,136
Field Staff 3 MTL 6 14,170 12 0% 0 11,000 12 100% 792,000 11,880 12 100% 855,360 10,460 7 30% 131,796
Field Staff 4  FI 18 10,750 12 0% 0 11,000 12 20% 475,200 11,880 12 20% 513,216 10,460 7 0% 0
 FD (Kanchibari) 20  2,680 12 0% 0 2,250 12 30% 162,000 2,470 12 30% 177,840 1,360 7 10% 19,040
FD (Kupdola) 20  2,680 12 0% 0 2,250 12 20% 108,000 2,470 12 20% 118,560 1,360 7 0% 0






























1 Project Scientist 6500 3500 50000 8559 2015
2 Project Manager 6500 3500 50000 8559 2015
3 Project Manager 6500 3500 50000 8559 2015
4 JiVitA Research Fellow 6500 3500 50000 12000 8559 2015
5 Senior Research Physician 6500 3500 50000 12000 8559 2015
6 Research physician 6500 3500 50000 12000 2015
7 Senior Finance and Admin Manager6500 3500 50000 25000 8559 2015
8 Asst. Admin Officer 6500 3500 45000 12000 8559 2015
9 Finance Officer 6500 3500 45000 12000 8559 2015
10 Adminitration Officer-Accounts 6500 3500 45000 13000 8559 2015
11 Admin Officer-Procurement 6500 3500 45000 12000 8559 2015
12 Research Translator 6500 3500 45000 12000 2015
13 Office Assistant 8559 2015
14 Admin Officer-Logistics and Maintenance6500 3500 45000 12000 142000 8559 2015
15 Motor Mecanics 2015
16 Computer Operator 6500 3500 2015
17 Asst. Motor Mecanis 2015
18 Electrician 2015
19 Admin Asst.-Store 6500 3500 8559 2015




24 Office helper 2015
25 Support staff 2015
26 Support staff 2015
27 Admin Asst. 6500 3500 45000 13000 8559 2015
28 Cook 2015
29 Cleaner 2015
30 Data Centre Manager 6500 3500 50000 12000 8559 2015
31 Asst. IT Officer 6500 3500 50000 12000 8559 2015
32 Field Query Associate 6500 3500 45000 12000 8559 2015
33 Associate Archivist 6500 3500 2015
34 Fill ing Asst. 2015
35 Data Enrty Operator 6500 3500 45000 2015
36 Data Enrty Operator 6500 3500 45000 2015
37 Data Enrty Operator 6500 3500 45000 2015
38 Field Administrator 6500 3500 45000 13000 8559 2015

























39 FS 6500 3500 12000 142000 8559 2015
40 Sr.FS 6500 3500 45000 13000 142000 8559 3000 2015
41 AC/Field Officer 6500 3500 13000 142000 8559 3000 2015
42 AC/Field Officer 6500 3500 13000 142000 8559 3000 2015
43 AC/Field Officer 6500 3500 13000 142000 8559 3000 2015
44 AC/Field Officer 6500 3500 13000 142000 8559 3000 2015
45 MTL 8000 1500 6000 8559 3000 2015
46 MTL 1500 6000 8559 2015
47 MTL 8000 1500 6000 8559 3000 2015
48 MTL 1500 6000 8559 2015
49 MTL 8000 1500 6000 8559 3000 2015
50 MTL 1500 6000 8559 2015
51 MTL 8000 1500 6000 8559 3000 2015
52 FI 1500 6000 8559 2015
53 FI 8000 1500 6000 8559 3000 2015
54 FI 1500 6000 8559 2015
55 FI 8000 1500 6000 8559 3000 2015
56 FI 1500 6000 8559 2015
57 FI 8000 1500 6000 8559 3000 2015
58 FI 1500 6000 8559 2015
59 FI 8000 1500 6000 8559 3000 2015
60 FI 1500 6000 8559 2015
61 FI 8000 1500 6000 8559 3000 2015
62 FI 1500 6000 8559 2015
63 FI 8000 1500 6000 8559 3000 2015
64 FI 1500 6000 8559 2015
65 FI 8000 1500 6000 8559 3000 2015
66 FI 1500 6000 8559 2015
67 FI 8000 1500 6000 8559 3000 2015
68 FI 1500 6000 8559 2015
69 FI 1500 6000 8559 2015
70 FD 20,000     171180 2015
71 FD 20,000     171180 2015
Field Total 128,500  95,000     45,000     65,000     860,000    599,130  51,000     
Field Staff 3. Office maintenance
2012 2013 2014 2015 Average
1 Utilities (electricity bills & gas)39712 39011 65365 56291 50,095
2 wages, 53674 66509 39569 25000 46,188
3 fuel, 132964 149987 145862 84100 128,228
4 trevel and per diem, 116414 161585 101842 95932 118,943
5 repair and services, 36713 33843 70688 38648 44,973
6 bank charges, 3210 3210 4778 5037 4,059
7 supplies and other services, 173182 194741 227122 346925 235,493
8 stationaries 56247 57442 48170 53632 53,873
9 Office rent 307877 310855 245143 208687 268,141




























Chairman 1 164,165      5    30% 167,224    12  8% 200,669      12  10% 274,725       12  4% 274,725       7    10%
Chief of Reseach & Innovation 157,668      12  10% 219,780       12  4% 219,780       7    10%
Managing Director 1 154,784      5    30% 180,602    12  17%
Director 1 46,904         5    40% 47,778      12  25%
Manager, Operations 1 37,523         5    20% 119,446    12  25% 137,602      12  40% 163,836       12  8% 188,811       7    10%
R & D Coordinator 1 30,019         5    50% 76,445      12  4%
Strategic Initiative 1 34,709         5    60% 42,045      12  42%
Research Associate 1 25,328         5    60% 30,578      12  42% 53,034        12  20% 69,930         12  8% 83,417         7    25%
System Analyst 1 46,904         5    20% 57,334      12  25%
Manager, Communications 1 76,445      12  4%
Project Manager 3 43,000      12  8% 43,000        12  60% 59,940         12  50% 70,929         7    25%
Research Coordinator 1 49,689      12  17%
Asst. Project Manager 1 28,667      12  17%
Software Developer 1 81,223      12  42%
Android Developer 1 23,889      12  33% 47,778        12  40% 59,940         12  13%
Jr. Quality Control Engineer 1 15,289      12  25% 21,022        12  20%
Deployment Assistant 1 19,111      12  8% 28,667        12  30%
Field Coordinator 1 21,022      12  8%
QA Manager 2 66,890        12  40%
Jr. QC Engineer 3 43,000        12  40% 56,444         12  8%
Jr. QA Engineer 1 76,445        12  20% 119,880       12  8%
Network Administrator 2 23,889        12  20%
Senior Research Analyst 1 52,556        12  20% 57,443         12  8%
Project Manager 1 33,445        12  33%
129,870       12  8%
59,940         12  25%
29,970         12  21%
43,956         12  8%




























Designatiom Table Chair Laptop
Chairman 7000 6000 55000
Chief of Reseach & Innovation 7000 6000 55000
Managing Director 7000 6000 55000
Director 7000 6000 55000
Manager, Operations 7000 6000 55000
R & D Coordinator 7000 6000 55000
Strategic Initiative Coordinator 7000 6000 55000
Research Associate 7000 6000 55000
System Analyst 7000 6000 55000
Manager, Communications 7000 6000 55000
Project Manager 7000 6000 55000
Research Coordinator 7000 6000 55000
Asst. Project Manager 7000 6000 55000
Software Developer 7000 6000 55000
Android Developer 7000 6000 55000
Jr. Quality Control Engineer 7000 6000 55000
Deployment Assistant 7000 6000 55000
Field Coordinator 7000 6000 55000
QA Manager 7000 6000 55000
Jr. QC Engineer 7000 6000 55000
Jr. QA Engineer 7000 6000 55000
Network Administrator 7000 6000 55000
Senior Research Analyst 7000 6000 55000
Project Manager 7000 6000 55000
Staff 1 7000 6000 55000
Staff 2 7000 6000 55000
Staff 3 7000 6000 55000
Staff 4 7000 6000 55000
Staff 5 7000 6000 55000









1 House Rent 300000 3,900 Monthly Office Rent 
2 Maintenance Charges 46500 605 Monthly building maintenance charges which also 
3 Server Equipment & 
Maintenance 
25000 325 On average cost of maintaining a server elsewhere
4 Intern t Bandwidth 26000 338 Monthly charge for internet bandwidth used in the 
office5 Photocopies/Office 
Supplies/Stationery/Printer 
10000 130 On average monthly expenditure 
6 Utilities (Water, Electricity, 
Gas bill etc.)
61350 798 Average monthly expenditure for water, electricity 
and gas bill7 Telecommunication 1500 20 Average monthly telephone bill 
8 Support Staff 40000 520 Monthly cummulative salary of support staff 
9 Postage & Courier, Bank 2500 33 On average monthly expenditure 
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Chairman 164,165 5 30% 246,248
Managing Director 154,784 5 30% 232,176
Director 46,904 5 40% 93,809
Manager, Operations 37,523 5 20% 37,523
R & D Coordinator 30,019 5 50% 75,047
Strategic Initiative Coordinator 34,709 5 60% 104,128
Research Associate 25,328 5 60% 75,985
System Analyst 46,904 5 20% 46,904
911,820 11,854
Program manager 307,692 5 100% 1,538,460
JiVitA Research Fellow 230,769 5 20% 230,769
Senior Research Physician 95,030 5 40% 190,060
Senior Finance and Admin Manager 95,030 5 10% 47,515
Data Centre Manager 64,000 5 10% 32,000
2,038,804 26,504
A .Total costs 2,950,624 38,358
Chairman 167,224 12    8% 200,669 4      13% 267,559
Managing Director 180,602 12    17% 361,204
Director 47,778 12    25% 143,335
Manager, Operations 119,446 12    25% 137,602 4      25% 495,939
Manager, Communications 76,445 12    4% 38,223
Strategic Initiative Coordinator 42,045 12    42% 210,225
Project Manager 43,000 12    8% 43,000 4      75% 172,002
Research Associate 30,578 12    42% 53,034 4      25% 205,925
Research Coordinator 49,689 12    17% 99,379
Asst. Project Manager 28,667 12    17% 57,334
Software Developer 81,223 12    42% 406,116
System Analyst 57,334 12    25% 172,002
Android Developer 23,889 12    33% 47,778 4      63% 215,002
Jr. Quality Control Engineer 15,289 12    25% 21,022 4      63% 98,423
Deployment Assistant 19,111 12    8% 28,667 4      25% 47,778
Field Coordinator 21,022 12    8% 21,022
Chief of Reseach & Innovation 157,668 4      13% 78,834
QA Manager 76,445 4      25% 76,445
3,166,746 41,168
Project Manager 307,692 12 100% 316,923 4 100% 4,959,995
JiVitA Research Fellow 230,769 12 10% 237,692 4 10% 372,000
Senior Research Physician 95,030 12 40% 102,443 4 40% 620,053
Senior Finance and Admin Manager 95,030 12 10% 102,443 4 10% 155,013
Data Centre Manager 64,000 12 10% 68,992 4 10% 104,397
6,211,457 80,749
B. Total cost 9,378,204 121,917
Data Centre Manager 68,992 1 10% 6,899
IT offcer 15,580 1 50% 7,790
C. Total cost 14,689 191











Contract agreementwith mPOWER as technical system 
developer,  leadership meetings among central program 
leadership, regional, and district health management teams. 
Official launch of mCARE project with partners
Total costs (BDT)Role/designation
Aug 2011-Dec 2011 Jan 2012-Dec 2012 Jan 2013-Dec 2013 Jan 2014-Dec 2014 Jan 2015-July 2015
mPOWER
JHU-JiVitA
mPOWER prepared systems requirement specifications; develop 
scheduling logic, skip pattern, question type feedback; 
Development of detailed technical specifications (Developing 












Chief Executive Officer 200,669 7      17% 234,114
Chief of Reseach & Innovation 157,668 7      33% 367,893
Head of Operations 137,602 7      33% 321,070
Project Manager 43,000 7      50% 150,502
Senior Research Analyst 53,034 7      67% 247,492
Android Developer 47,778 7      40% 133,779
QA Manager 66,890 4      40% 107,023
Jr. QC Engineer 43,000 4      40% 68,801
Deployment Assistant 76,445 7      20% 107,023
21,022 7      20% 29,431
23,889 4      20% 19,111
52,556 7      33% 121,405
28,667 7      33% 66,221
Android Developer 33,445 3      33% 33,445
D. Total cost 2,007,310
Project Manager 316,923 1 100% 316,923
JiVitA Research Fellow 237,692 1 10% 23,769
Senior Research Physician 102,443 1 40% 40,977
Senior Finance and Admin Manager 102,443 1 20% 20,489
Data Centre Manager 68,992 1 10% 6,899
Senior field staff 33,170 1 60% 19,902
AC/Field Officer 17,000 1 50% 8,500
MTL 11,000 1 100% 11,000
E. Total cost 448,459
Project Manager 316,923 3 100% 950,768
JiVitA Research Fellow 237,692 3 10% 71,308
Senior Research Physician 102,443 3 60% 184,397
Senior Finance and Admin Manager 102,443 3 20% 61,466
Data Centre Manager 68,992 3 20% 41,395
Senior field staff 33,170 3 100% 99,510
AC/Field Officer 17,000 3 50% 25,500
MTL 11,000 3 100% 33,000
FI 11,000 3 50% 16,500
FD 2,250 3 50% 3,375
F. Total cost 1,487,219
3,942,988
Implementation (Sep 2013-Jun 2015): 22 months
Chief Executive Officer 274,725 12    4% 274,725 2     10% 192,308
Chief of Reseach & Innovation 219,780 12    4% 219,780 2     10% 153,846
Head of Operations 163,836 12    8% 188,811 2     10% 201,598
Project Manager 59,940 12    50% 70,929 2     25% 395,105
Senior Research Analyst 69,930 12    8% 83,417 2     25% 111,638
Android Developer 129,870 12    8% 129,870
59,940 12    13% 89,910
56,444 12    8% 56,444
119,880 12    8% 119,880
57,443 12    8% 57,443
59,940 12    25% 179,820
29,970 12    21% 74,925
43,956 12    8% 43,956
31,469 12    8% 31,469
1,838,212
Project Manager 316,923 4 100% 326,430 12 100% 336,223 6 100% 7,202,196
JiVitA Research Fellow 237,692 4 10% 244,823 12 10% 252,168 6 10% 540,165
Senior Research Physician 102,443 4 30% 110,638 12 30% 121,710 6 30% 740,306
Senior Finance and Admin Manager 102,443 4 30% 110,638 12 30% 121,710 6 30% 740,306
Data Centre Manager 68,992 4 40% 68,992 12 40% 81,970 6 40% 638,277
Senior field staff 33,170 4 60% 35,824 12 60% 39,410 6 60% 479,417
AC/Field Officer 17,000 4 50% 18,360 12 50% 16,120 6 50% 192,520
MTL 11,000 4 100% 11,880 12 100% 10,460 6 100% 249,320
FI 11,000 4 30% 11,880 12 30% 10,460 6 30% 74,796
FD 4,500 4 50% 4,940 12 30% 2,720 6 30% 31,680
10,888,984
G. Total costs 12,727,195
Project Manager 30,769 4 100% 123,077
Program analyst 30,769 4 50% 61,538
H. Total costs 184,615
Total implementation costs 12,911,811
Total program activity costs 29,198,316
mPOWER
Community outreach 
and advocacy (May, 
2013)
Establish MOU with govern't DGFP ;mCARE brochure; print 
community briefs; visit community Field site demarcation 
Prototype development and test;Training manual development ; 
SMS service integration/outsourcing: Dashboard design & 
development  (Oct-Dec 2013) 
JHU-JiVitA
Prepare training manuals; Print forms & methodology ; Training: 3-
weeks (2-3 days a week)  Evaluate FD/TLI/FWA 
performance/satisfaction Printing forms (census enumeration, 
JiVitA ANC pamphlets; PSR consent; MWRA registration form etc) 





JHU-JiVitA Data cleaning, data analysis, Presentation; report writing 
Supervision; Census enumeration (Sep 2013-Jun, 2014);  
Pregnancy surveillance; Intervention (SMS & advocacy home 










Technical assistance: to fix the bugs within the application in 
order to ensure functionalities of the developed system; to 
manage and develope improvements within the application 
which came as Change Request; to maintaine the overall system 
to ensure the integrity of the collected data and maintain the 
data center for the system. Finally, mPower completed 
customized reporting based on the collected data to enhance 
decision making by the stakeholders. (Jan-Dec, 2014)
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Desks 6,500 26 169,000 2,197 2,856 10 8.53 258
Chairs 3,500 26 91,000 1,183 1,538 10 8.53 139
Cabinets 12,000 17 204,000 2,652 3,448 10 8.53 311
Computer 45,000 12 540,000 7,020 9,127 5 4.58 1,533
Laptop 50,000 5 250,000 3,250 4,225 5 4.58 710
Motorbike 142,000 2 284,000 3,692 4,800 10 8.53 433
Table 1 6,500 5 32,500 423 549 10 8.53 50
Table 2 8,000 12 96,000 1,248 1,623 10 8.53 146
Chair 1 3,500 5 17,500 228 296 10 8.53 27
Chair 2 1,500 25 37,500 488 634 10 8.53 57
Bench 20,000 10 200,000 2,600 3,380 10 8.53 305
Cabinets 13,000 5 65,000 845 1,099 10 8.53 99
Computer 45,000 1 45,000 585 761 5 4.58 128
Motobike 142,000 7 994,000 12,922 16,800 10 8.53 1,515
Bicycle 6,000 25 150,000 1,950 2,535 10 8.53 229
Rack 3,000 17 51,000 663 862 10 8.53 78
Total Furniture and Equipments (HQ + Field) 3,226,500 41,945 54,533 6,015
Mobile phone 8,559 70 599,130 7,789 10,126 3 2.83 2,752
Mobile phone procurement 14,689 14,689 191 248 3 1.91 100
Mobile phone procurement 613,819 7,980 10,374 2,852
Partnership & consensus building 2,038,804 N/A 2,038,804 26,504 34,459 3 2.83 9,366
Program/System development 6,211,457 N/A 6,211,457 80,749 104,983 3 2.83 28,533
Community campaign & awareness 448,459 N/A 448,459 5,830 7,580 3 2.83 2,060
Trainning 1,487,219 N/A 1,487,219 19,334 25,136 3 2.83 6,832
Imlementation Data processing /analyses 24000 24000 3 2.83 8,481









Annualized Cost allocated 
to Component of Project 
(2015, USD)
















































office rent, 307,877 12 15% 554,179 310,855 12 20% 746,052 245,143 12 30% 882,515 268,141 7 10% 187,698 2,370,444 30,816
electricity bills, gas, purchases, printi 39,712 12 15% 71,482 39011 12 20% 93,626 65365 12 30% 235,314 56291 7 10% 39,404 439,826 5,718
wage 53,674 12 15% 96,613 66,509 12 20% 159,622 39,569 12 30% 142,448 25,000 7 10% 17,500 416,183 5,410
fuel, 132,964 12 15% 239,335 149,987 12 20% 359,969 145,862 12 30% 525,103 84,100 7 10% 58,870 1,183,277 15,383
trevel and per diem, 116,414 12 15% 209,545 161,585 12 20% 387,804 101,842 12 30% 366,631 95,932 7 10% 67,152 1,031,133 13,405
repair and services, 36,713 12 15% 66,083 33,843 12 20% 81,223 70,688 12 30% 254,477 38,648 7 10% 27,054 428,837 5,575
bank charges, 3,210 12 15% 5,778 3,210 12 20% 7,704 4,778 12 30% 17,201 5,037 7 10% 3,526 34,209 445
supplies and other services, 173,182 12 15% 311,728 194,741 12 20% 467,378 227,122 12 30% 817,639 346,925 7 10% 242,848 1,839,593 23,915
stationaries. 56,247 12 15% 101,245 57,442 12 20% 137,861 48,170 12 30% 173,412 53,632 7 10% 37,542 450,060 5,851
HQ Admin staff+Technical staff+ 783,792 1,168,632 1,903,993 361,851 4,218,268 4,218,268
Total office maintenance costs 2,439,779 3,609,871 5,318,734 1,043,445 12,411,829 4,324,784
Development (Aug 2011- April 2013) 2,439,779 1,203,290 3,643,070 47,360 61,573 1.91 32,237
Start up (May 2013-Sept 2013) 1,504,113 1,504,113 19,553 19,553 1.00 19,553
Implementation (Oct 2013-July 2015) 1,203,290 5,318,734 1,043,445 7,565,469 98,351 98,351 1.91 51,493
Project Manager 307,692 3 100% 923,076 307,692 12 100% 3,692,304 307,692 7 100% 2,153,844 6,769,224 88,000
JiVitA Research Fellow 230,769 3 10% 69,231 230,769 12 10% 276,923 230,769 7 10% 161,538 507,692 6,600
Senior Research Physician 95,030 3 30% 85,527 95,030 12 30% 342,108 95,030 7 30% 199,563 627,198 8,154
Senior Finance and Admin Manager 95,030 3 30% 85,527 95,030 12 30% 342,108 95,030 7 30% 199,563 627,198 8,154
Data Centre Manager 64,000 3 40% 76,800 64,000 12 40% 307,200 64,000 7 40% 179,200 563,200 7,322
9,094,512 118,229 118,229 1.91 61,900
Senior field staff 33,170 2 60% 39,804 33,170 12 60% 238,824 33,170 7 60% 139,314 417,942 5,433
AC/Field Officer 68,000 2 50% 68,000 68,000 12 50% 408,000 68,000 7 50% 238,000 714,000 9,282







7 100% 462,000 1,386,000 18,018
FI : Study consent, JiVitA brochers 198,000 2 30% 118,800 198,000 12 30% 712,800 198,000 7 30% 415,800 1,247,400 16,216
FD (40) : pregnancy registration 90,000 2 50% 90,000 90,000 12 30% 324,000 90,000 7 30% 189,000 603,000 7,839
448,604 2,475,624 1,444,114 4,368,342 56,788 56,788 1.91 29,732
Reminder home visits FD (20) 45000 4 10% 18,000 45000 12 10% 54,000 45000 5 10% 22,500 94,500 1,229 1,229 1.91 643
Bulk SMS are sent from the server to our clients ($0.06 per client for 4 ANC/Delivery/3PNC reminders, 350 clients in intervention group) 1,615 21 21 1.91 11
Birth and Labor notification SMS from client ($0.031 per client, 350 clients intervention group) 835 11 11 1.91 6
2,450 32 32 1.91 17
Total activity costs 14,945,804 194,295









Office maintenance costs 
(*They exclude salaries 
and allowance, 
training/seminars 




























Chair 6,000 15 90,000 1,170 1,521 10 8.53 178
Desk 7,000 15 105,000 1,365 1,775 10 8.53 208
Computer/labtop 55,000 15 825,000 10,725 13,944 5 4.58 3,044
1,020,000 13,260 17,239 3,431
Partnership & consensus building 911,820 911,820 11,854 15,411 3 2.83 5,446
Program & system development 3,166,746 3,166,746 41,168 53,523 3 2.83 18,913
Start-up phase Prototype testing and optimization 2,007,310 2,007,310 26,095 33,926 3 2.83 11,988
Total activity costs 6,085,876 79,116 85,336 36,346
92,376 102,575 39,777
CategoriesCapital costs
Costs for mCARE I Adjustment Annualized Cost 
allocated to 






























House Rent 300,000 5 30% 450,000 300,000 12 40% 1,440,000 300,000 12 40% 1440000 300,000 12 10% 360000 300,000 7 5% 105000 3,795,000 49,335
Maintenance Charges 46,500 5 30% 69,750 46,500 12 40% 223,200 46,500 12 40% 223200 46,500 12 10% 55800 46,500 7 5% 16275 588,225 7,647
Internet Bandwidth 26,000 5 30% 39,000 26,000 12 40% 124,800 26,000 12 40% 124800 26,000 12 10% 31200 26,000 7 5% 9100 328,900 4,276
Photocopies;office supplies; 
stationery/printer toner etc. 




48000 10,000 12 10% 12000 10,000 7
5%
3500 126,500 1,645
Utilities (Water, Electricity, Gas bill 
etc.)
61,350 5 30% 92,025 61,350 12 40% 294,480 61,350 12 40% 294480 61,350 12 10% 73620 61,350 7 5% 21472.5 776,078 10,089
Telecommunication (Telephone Bill) 1,500 5 30% 2,250 1,500 12 40% 7,200 1,500 12 40% 7200 1,500 12 10% 1800 1,500 7 5% 525 18,975 247
Support Staff 40,000 5 30% 60,000 40,000 12 40% 192,000 40,000 12 40% 192000 40,000 12 10% 48000 40,000 7 5% 14000 506,000 6,578
Postage & Courier, Bank Charges 2,500 5 30% 3,750 2,500 12 40% 12,000 2,500 12 40% 12000 2,500 12 10% 3000 2,500 7 5% 875 31,625 411
Employ benefit: 1) Health Insurance; 2) Festival Bonus (twice every year); 3) Daily Complimentary lunch; 4) Tax paid by Company; 5) Annual Office Tour1897 4973 5722 3379 445 9,546 124.098
733,672 2,346,653 2,347,402 588,799 171,193 6,180,849 80,351 80,351 1.91 42,069
Development (Aug 2011- April 2013) 733,672 2,346,653 782,467 3,862,792 50,216 65,287 1.91 34,182
Start up (May 2013-Sept 2013) 978,084 978,084 12,715 12,715 1 12,715
Implementation (Oct 2013-July 2015) 782,467 588,799 171,193 1,542,459 20,052 20,052 1.91 10,498
Phone connection charge for 70 CHWs 325 3 34,125 325 12 273,000 325 7 159,250 466,375 6,063
Server hosting 8000 3 24000 8000 12 96000 8000 7 56000 176,000 2,288
Server equipment and maintenance 25,000 3 75000 25,000 12 300000 25,000 7 175000 550,000 7,150
Total server maintenance costs 1,192,375 15,501 15,501 1.91 8,116
Chief Executive Officer 274,725 12             4% 137,363 274,725 2               10% 54,945 192,308 2,500
Chief of Reseach & Innovation 219,780 12             4% 109,890 219,780 2               10% 43,956 153,846 2,000
Head of Operations 163,836 12             8% 163,836 188,811 2               10% 37,762 201,598 2,621
Project Manager 59,940 12             50% 359,640 70,929 2               25% 35,465 395,105 5,136
Senior Research Analyst 69,930 12             8% 69,930 83,417 2               25% 41,708 111,638 1,451
Android Developer 129,870 12             8% 129,870 129,870 1,688
59,940 12             13% 89,910 89,910 1,169
56,444 12             8% 56,444 56,444 734
119,880 12             8% 119,880 119,880 1,558
57,443 12             8% 57,443 57,443 747
59,940 12             25% 179,820 179,820 2,338
29,970 12             21% 74,925 74,925 974
43,956 12             8% 43,956 43,956 571
31,469 12             8% 31,469 31,469 409
Total activity costs 1,838,212 23,897 23,897 1.91 12,511













Total Office maintenance costs
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Appendix 3. Lives Saved Tool Modeling 
A 3.1 Model inputs 
 
LiST Interventions (selected) 
Baseline 
(2015) 
Projected coverage increase in Bangladesh (2025) 
Comprehensive mCARE  Basic mCARE  Paper based status quo 
x 2.36 times x 1.55 times x 1.09 times 
Community  Facility  Community  Facility Community  Facility  
Pregnancy Antenatal care 31.2 73.6 73.6 48.4 48.4 34.0 34.0 
Childbirth 
Skilled birth attendance* 42.1 99.4 99.4 65.3 65.3 45.9 45.9 
Facility delivery* (Clinic and 
Hospital) 
37.4 n/a 88.3 n/a 58.0 n/a 40.8 
Breastfeeding   Promotion of breastfeeding 
(<1 month) 
61.0 100.0 100.0 94.6 94.6 66.5 66.5 
Preventive  
Postnatal care (Clean 
postnatal practice)  
31.5 74.3 74.3 48.8 48.8 34.3 34.3 
Complementary feeding 
(education only) 
20.9 49.3 49.3 32.4 32.4 22.8 22.8 
Curative 
Case management of 
premature babies (Thermal 
care) 
37.4 88.3 88.3 58.0 58.0 40.8 40.8 
Case management of 
neonatal sepsis/pneumonia 
37.4 n/a 88.3 n/a 58.0 n/a 40.8 
Notes: Baseline coverage data were compiled from Demographic and Health Surveys (DHS: Bangladesh, 2014); Multiple Indicator Cluster Survey (MICS 
Round 3: Bangladesh, 2006).  
*Coverage measure of SBA includes coverage measure of FD. Thus we modeled coverage increase for SBA and FD simultaneously as 10%, 30%, and 
50%. Data course of SBA and FD is from DHS/MICS and percentages of home deliveries and facility deliveries are based on LiST imbedded algorithms. 
**Estimations of home deliveries (unassisted deliveries, and assisted deliveries), facility deliveries (Essential care, BEmOC, CEmOC), exclusive 
breastfeeding, predominant breastfeeding, and partial breastfeeding are derived from the LiST imbedded algorithms. 
Antenatal care (ANC4+): Percent of pregnant women with at least 4 antenatal care visits during their pregnancy. The intervention includes Routine 
(TT, IPTp, Syphilis detection and treatment), Nutritional (Calcium supplementation), Case management (Diabetes, Management of pre-eclampsia), 
Other (Fetal growth restriction detection and management) This analysis does not include iron-folic acid. Data source of ANC is from DHS/MICS. 
Skilled Birth Attendance (SBA): Percent of children born who are attended by a skilled attendance, including doctors, nurses, midwives- in a facility or 
home. An SBA in the home is defined as a skilled birth attendant who deliveries the infant at home without benefit of referral to a facility in case of 
emergency. An SBA in a facility is defined as a medically skilled attendant who has the ability and facilities needed to monitor labor progress with a 
partograph and detect complications.  Episiotomy is available, if needed. Infection control is covered under clean birth practices; Facility delivery (FD): 
Percent of children born in an institution.  
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A 3.2 Model outputs (Comprehensive mCARE program) 
 
 Intervention Percentage Multiplying factor 
Annual coverage increase rate 10% 1.10 
Coverage increase rate (2016-2025)   2.36 
 
Service coverage  
Year 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Source 
ANC 4 or more 31% 34% 38% 41% 45% 50% 55% 60% 66% 73% Baseline coverage (DHS 2014; p142) 
ANC less than 4 69% 66% 62% 59% 55% 50% 45% 40% 34% 27% Baseline coverage (DHS 2014; p142) 
Facility delivery 38% 42% 46% 51% 56% 61% 67% 74% 81% 90% Baseline coverage (DHS 2014; p145) 
Home delivery 62% 58% 54% 49% 44% 39% 33% 26% 19% 10% Baseline coverage (DHS 2014) 
PNC 36% 40% 44% 48% 53% 58% 64% 70% 77% 85% Baseline coverage (DHS 2014; p153) 
No PNC 64% 60% 56% 52% 47% 42% 36% 30% 23% 15% Baseline coverage (DHS 2014; p153) 
 
Total Effectiveness (National) 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total  
Maternal lives saved (community) 6 12 18 24 30 36 41 46 52 57 
57~1271 
Maternal lives saved (facility) 163 319 466 605 737 860 975 1,082 1,180 1,271 
Neonatal lives saved (community) 1,722 3,385 4,995 6,529 7,997 9,398 10,734 12,002 13,202 14,334 
14,334~29,520 
Neonatal lives saved (facility) 4,315 8,296 11,956 15,291 18,325 21,075 23,557 25,785 27,768 29,520 
Still birth lives saved 
(community) 719 1,430 2,136 2,822 3,493 4,149 4,790 5,414 6,020 6,607 6,607~19,204 
Still birth lives saved (facility) 2,115 4,199 6,250 8,251 10,204 12,110 13,966 15,769 17,516 19,204 
Population adjustment factor 1.56% 3.13% 4.69% 6.25% 7.81% 9.38% 10.94% 12.50% 12.50% 12.50% n/a 
Total Effectiveness (District) 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total  
Maternal lives saved (community) 0 0 1 2 2 3 4 6 7 7 
7~159 
Maternal lives saved (facility) 3 10 22 38 58 81 107 135 148 159 
Neonatal lives saved (community) 27 106 234 408 625 881 1,174 1,500 1,650 1,792 
1792~3690 
Neonatal lives saved (facility) 67 259 560 956 1,432 1,976 2,577 3,223 3,471 3,690 
Still birth lives saved 
(community) 11 45 100 176 273 389 524 677 753 826 826~2401 
Still birth lives saved (facility) 33 131 293 516 797 1,135 1,528 1,971 2,190 2,401 
          Min 2,625 






A 3.3 Model outputs (Basic mCARE program) 
 
Control Percentage Multiplying factor 
Annual coverage increase rate 5% 1.05 
Coverage increase rate (2016-2025)   1.55 
 
Service coverage  
Year 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Source 
ANC 4 or more 31% 33% 34% 36% 38% 40% 42% 44% 46% 48% Baseline coverage (DHS 2014; p142) 
ANC less than 4 69% 67% 66% 64% 62% 60% 58% 56% 54% 52% Baseline coverage (DHS 2014; p142) 
Facility delivery 38% 40% 42% 44% 46% 48% 51% 53% 56% 59% Baseline coverage (DHS 2014; p145) 
Home delivery 62% 60% 58% 56% 54% 52% 49% 47% 44% 41% Baseline coverage (DHS 2014) 
PNC 36% 38% 40% 42% 44% 46% 48% 51% 53% 56% Baseline coverage (DHS 2014; p153) 
No PNC 64% 62% 60% 58% 56% 54% 52% 49% 47% 44% Baseline coverage (DHS 2014; p153) 
 
Total Effectiveness (National) 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total  
Maternal lives saved (community) 3 5 7 10 12 14 17 19 21 23 
23~751 
Maternal lives saved (facility) 89 176 259 339 416 490 560 627 691 751 
Neonatal lives saved (community) 771 1,525 2,258 2,971 3,661 4,338 4,983 5,605 6,202 6,774 
6774~15728 
Neonatal lives saved (facility) 1,952 3,823 5,608 7,307 8,919 10,454 11,898 13,258 14,534 15,728 
Still birth lives saved (community) 291 579 862 1,139 1,411 1,683 1,943 2,196 2,441 2,679 
2679~9902 
Still birth lives saved (facility) 1,086 2,156 3,207 4,236 5,243 6,233 7,191 8,123 9,027 9,902 
Population adjustment factor 1.56% 3.13% 4.69% 6.25% 7.81% 9.38% 10.94% 12.50% 12.50% 12.50% n/a 
Total Effectiveness (District) 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total  
Maternal lives saved (community) 0 0 0 1 1 1 2 2 3 3 
3~94 
Maternal lives saved (facility) 1 6 12 21 33 46 61 78 86 94 
Neonatal lives saved (community) 12 48 106 186 286 407 545 701 775 847 
847~1966 
Neonatal lives saved (facility) 31 119 263 457 697 980 1,301 1,657 1,817 1,966 
Still birth lives saved (community) 5 18 40 71 110 158 213 275 305 335 
335~1238 
Still birth lives saved (facility) 17 67 150 265 410 584 787 1,015 1,128 1,238 
          Min 1,185 









A 3.4 Model outputs (Paper based status quo) 
 
Status quo Percentage Multiplying factor 
Annual coverage increase rate 1% 1.01 
Coverage increase rate (2016-2025)   1.09 
 
Service coverage  
Year 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Source 
ANC 4 or more 31% 31% 32% 32% 32% 33% 33% 33% 34% 34% Baseline coverage (DHS 2014; p142) 
ANC less than 4 69% 69% 68% 68% 68% 67% 67% 67% 66% 66% Baseline coverage (DHS 2014; p142) 
Facility delivery 38% 38% 39% 39% 40% 40% 40% 41% 41% 42% Baseline coverage (DHS 2014; p145) 
Home delivery 62% 62% 61% 61% 60% 60% 60% 59% 59% 58% Baseline coverage (DHS 2014) 
PNC 36% 36% 37% 37% 37% 38% 38% 39% 39% 39% Baseline coverage (DHS 2014; p153) 
No PNC 64% 64% 63% 63% 63% 62% 62% 61% 61% 61% Baseline coverage (DHS 2014; p153) 
 
Total Effectiveness (National) 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total  
Maternal lives saved (community) 0 1 1 2 2 2 3 3 3 4 
4~46 
Maternal lives saved (facility) 5 10 15 20 24 29 33 38 42 46 
Neonatal lives saved (community) 127 252 375 495 613 727 839 948 1,054 1,156 
1156~2513 
Neonatal lives saved (facility) 280 555 825 1,088 1,344 1,593 1,834 2,069 2,295 2,513 
Still birth lives saved (community) 48 95 141 187 231 275 317 358 399 438 
438~737 
Still birth lives saved (facility) 80 160 238 314 389 463 534 604 672 737 
Population adjustment factor 1.56% 3.13% 4.69% 6.25% 7.81% 9.38% 10.94% 12.50% 12.50% 12.50% n/a 
Total Effectiveness (District) 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total  
Maternal lives saved (community) 0 0 0 0 0 0 0 0 0 1 
1~6 
Maternal lives saved (facility) 0 0 1 1 2 3 4 5 5 6 
Neonatal lives saved (community) 2 8 18 31 48 68 92 119 132 145 
145~314 
Neonatal lives saved (facility) 4 17 39 68 105 149 201 259 287 314 
Still birth lives saved (community) 1 3 7 12 18 26 35 45 50 55 
55~92 
Still birth lives saved (facility) 1 5 11 20 30 43 58 76 84 92 
          Min 200 








A 3.5 Causes of Deaths  
Percent of neonatal 
deaths by proximate 
causes 
Diarrhea 0.38 Percent of child deaths by proximate cause 
• Definition: The proportion of under-five deaths due to one of eight neonatal causes 
(diarrhea, sepsis, pneumonia, asphyxia, prematurity, tetanus, congenital anomalies, and 
other) and nine post-neonatal causes (diarrhea, pneumonia, meningitis, measles, malaria, 
pertussis, AIDS, injury, and other). 
• Default data source: WHO estimates for years 2000-2015. 
http://www.who.int/healthinfo/global_burden_disease/estimates_child_cod_2015/en/.  
• Notes: All causes of death can be modified in this table except the HIV deaths, which 
are brought in from the AIDS Impact Module (AIM). To modify these, you will need to 






Congeital anomalies 16.22 
Other 7.14 
Total 100 
Percent of postnatal 












Percent of stillbirths by 
proximate causes 
Antepartum 74.8 Percent of stillbirths by proximate cause  
·Definition: Stillbirths are not categorized by cause due to a lack of data. Rather, they are 
categorized by time period, either antepartum (prior to delivery) and intrapartum (during 
delivery).  
·Default data source: Lawn JE, Blencowe H, Waiswa P, et al. Stillbirths: rates, risk 
factors, and acceleration towards 2030. Lancet 2016; 387: 587-603. 
http://www.ncbi.nlm.nih.gov/pubmed/26794078. (Supplementary appendix.) 
·Notes: Values are by region. 
Intrapartum 25.2 
Total 100 
Percent of maternal 
deaths by proximate 
causes 
Antepartum hemorrhage 5.11 Percent of maternal deaths by proximate cause 
• Definition: The proportion of maternal deaths due to one of nine causes (antepartum 
hemorrhage, intrapartum hemorrhage, postpartum hemorrhage, hypertensive disorders, 
sepsis, abortion, embolism, other direct causes, and indirect causes). 
• Default data source: Say L, Chou D, Gemmill A, et al. Global causes of maternal death: 
A WHO systematic analysis. Lancet Global Health 2014; 2(6): e323-33. 
http://www.ncbi.nlm.nih.gov/pubmed/25103301. Data are from unpublished tables 
associated with this article. 
Intrapartum hemorrhage 2.05 
Postpartum hemorrhage 28.68 




Other direct causes 11.77 




A 3.6 Effectiveness Assumptions 
 
 Maternal   Effectiveness  Affected fraction 
Antepartum hemorrhage n/a n/a n/a 
Intrapartum hemorrhage n/a n/a n/a 
Postpartum hemorrhage n/a n/a n/a 
Hypertensive disorders 
Calcium supplementation 0.2 1 
Hypertensive disorder cause management 0.5 1 
MgSO4 management of pre-eclampsia 0.59 1 
Sepsis Maternal sepsis case management 0.8 1 
Abortion 
Safe abortion services 0.95 0.90526 
Post abortion case management 0.8 0.90526 
Ectopic pregnancy case management 0.9 0.09474 
Other direct causes n/a n/a n/a 
Indirect causes 
TT - Tetanus toxoid vaccination 0.98 0.0049 
Malaria case management 0.8 0.021 
 














Antepartum hemorrhage Labor and delivery management 0 0 0 0.2 0.8 1 
Intrapartum hemorrhage Labor and delivery management 0 0 0 0.2 0.8 1 
Postpartum hemorrhage 
Labor and delivery management 0 0 0 0.35 0.65 1 
AMTSL- Active management of 
the third stage of  labor 
0 0.7 0.7 0.7 0.7 1 
Hypertensive disorders 
Labor and delivery management 0 0 0 0 0.68 1 
MgSO4 management of eclampsia 0 0.6 0.6 0.6 0.6 1 
Sepsis 
Clean birth practices 0 0.6 0.6 0.6 0.6 1 
Antibiotics for pPRoM 0 0.8 0.8 0.8 0.8 0.33 
Abortion n/a n/a n/a n/a n/a n/a n/a 
Other direct causes Labor and delivery management 0 0 0 0.38 0.93 0.07816 






Stillbirth   Effectiveness  Affected fraction 
Antepartum  
Syphillis detection and treatment 0.82 0.0024 
Multiiple micronutrient supplemenetation in pregnancy 0.09 1 
Balanced energy supplementation 0.4 0.4365 
Diabetes case management 0.1 0.10634 
MgSO4 management of pre-eclampsia 0.2 0.08088 
Intrapartum 
Multiiple micronutrient supplemenetation in pregnancy 0.09 1 
Balanced energy supplementation 0.4 0.4365 
Diabetes case management 0.1 0.10634 
MgSO4 management of pre-eclampsia 0.2 0.08088 
 







at home (SBA) 
Essential 
care 
BEmOC CEmOC All deliveries 
Antepartum 
hemorrhage 
Induction of labor for pregnancies 
lasting 41+ weeks 
0 0 0 0 0.69 0.036 
Intrapartum 
hemorrhage 
Labor and delivery management 0 0.23 0.23 0.45 0.75 1 
Induction of labor for pregnancies 
lasting 41+ weeks 
0 0 0 0 0.69 0.036 
 
Neonatal deaths   Effectiveness  Affected fraction 
NN - Diarrhea 
ORS - Oral rehydration solution 0.93 0.90 
Antibiotics for treatment of dysentery 0.82 0.10 
Zinc for treatment of diarrhea 0.23 1.00 
NN - Sepsis 
Syphillis detection and treatment 0.97 0.01 
Clean postnatal practices 0.40 1.00 
Oral antibiotics for neonatal sepsis/pneumonia 0.28 1.00 
Injectable antibiotics for neonatal sepsis/pneumonia 0.65 1.00 
Full supportive care for neonatal sepsis/pneumonia 0.80 1.00 
NN - Pneumonia 
Oral antibiotics for neonatal sepsis/pneumonia 0.42 1.00 
Injectable antibiotics for neonatal sepsis/pneumonia 0.75 1.00 
Full supportive care for neonatal sepsis/pneumonia 0.90 1.00 
NN - Asphyxia n/a n/a n/a 
NN - Prematurity 
Thermal care 0.20 1.00 
KMC - Kangaroo mother care 0.51 0.58 
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Full supportive care for prematurity 0.80 1.00 
NN - Tetanus 
TT - Tetanus toxoid vaccination 0.94 1.00 
Clean postnatal practices 0.40 1.00 
NN - Congenital Anomalies Folic acid supplementation/fortification 0.46 0.70 
NN - Other n/a n/a n/a 
 






Assited delivery  
at home (SBA) 
Essential care BEmOC CEmOC All deliveries 
NN - Diarrhea n/a n/a n/a n/a n/a n/a n/a 
NN - Sepsis 
Clean birth practices 0.15 0.23 0.27 0.27 0.27 1 
Antibiotics for pPRoM 0 0 0.39 0.39 0.39 0.198 
NN - Pneumonia n/a n/a n/a n/a n/a n/a n/a 
NN - Asphyxia 
Immediate assessment and 
stimulation 0.1 0.1 0.1 0.1 0.1 1 
Labor and delivery management 0 0.25 0.25 0.4 0.85 1 
Neonatal resuscitation 0 0.2 0.3 0.3 0.3 1 
NN - Prematurity 
Immediate assessment and 
stimulation 0.1 0.1 0.1 0.1 0.1 1 
Labor and delivery management 0 0.1 0.1 0.1 0.1 1 
Neonatal resuscitation 0 0.05 0.1 0.1 0.1 1 
Antibiotics for pPRoM 0 0 0.12 0.12 0.12 0.33 
NN - Tetanus Clean birth practices 0.3 0.35 0.38 0.38 0.38 1 
NN - Congenital 
Anomalies n/a n/a n/a n/a n/a n/a n/a 
NN - Other n/a n/a n/a n/a n/a n/a n/a 
 
Impact of promotion of age-appropriate breastfeeding Odds ratio (<1 month) 
Health system promotion 2.03 
Home/community promotion 2.17 
Health system + home/community promotion 2.33 
KMC - Kangaroo mother care 1.5 
Impact of promotion on early initiation of breastfeeding Odds ratio (<1 month) 
Health system promotion 1.82 
Home/community promotion 3.38 
Health system + home/community promotion 4.96 
278 
 



















in a month) 
Registration of 
households and 
eligible couple  
Every three years, Family Welfare Assistants (FWAs) register all households 
(HH) and eligible couples (ELCO) in new register, which take about three 
months. 




If FWAs find new ELCOs who came to the village during field visits, FWAs 





FWAs identify and register pregnant women during field visits through 






ANC: FWAs assist the pregnant women for coming to satellite or family welfare 
centers from their home; FWAs provide tt vaccine to pregnant women, measure 
their weights, check edema then refer them to family welfare centers.  
48% 31% 64% 
Child delivery: When pregnant women expect due dates of child delivery, FWAs 
inform FWV over phone or verbally.  
PNC: After child delivery, FWA enter child information to the register, advise 
mothers for postnatal and newborn care and birth control within 45 days 
Family Planning: Among the total seven methods of family planning, here FWAs 
provide condom, long term injection (except first dose), and oral pills. FWAs 
also refer pregnant women to FWVs who want to take permanent method such as 
IUD. 
EPI (immunization): FWAs inform villagers for vaccination and assist Health 
Assistant (HA) for injection of vaccines (bcg, tt etc)  
Non MNCH service 
provision 
TB or other general disease: FWAs only refer pregnant women to community 
clinic or family welfare centers 
      
Meeting 
FWAs attends by weekly meetings (two times in month) at union level and a one 





 FWAs prepare reports for the meetings mentioned above. 10% 
5% 5% 
Personal (idle) time  n/a       





FWVs visit pregnant women four times for ANC, the 1st visit within 4 month, 
2nd within 6 month, 3rd visit within 8 months and 4th visit within 9 month; FWVs 







period (LMP) and estimate date of delivery (EDD) pregnancy; FWVs provide 
iron folic acid, position of a baby etc.   
DELIVERY 
FWVs do normal deliveries at the pregnant women’s home; FWVs provide some 
medicine for any complications or refer them to medical officers. 
19% 
PNC 
FWVs provide postnatal and newborn care service for one month after women’s 
child delivery; FWVs measure child weight, mother’s physical condition etc 
17% 
Family planning 
 FWVs provide permanent method of family planning such as IUD to referred 
pregnant women 
10% 
Referral  As mentioned above 5% 
Meeting 
FWVs attends by weekly meetings (two times in month) at union level and a one 




  10% 
Personal (idle) time   10% 














FPIs visit field and review FWVs’ registers frequently 10% 
EPI monitoring  
In every union, 8 EPI programs are held in a month, FPIs present at the EPI 
programs and assist and inspect data entry to the registers for HA  
10% 
Meeting with UFPO 
FPIs attend by weekly meeting as a chairperson, review/report the activities of 









villagers on family 
planning 
FPIs meet 1-3 times in a month with community residents for education and 
counseling of family planning at various places in the village that is called house 
indoor meeting, here. 
5% 
Meeting with local 
government on 
family planning  
FPIs hold a meeting to report and discuss on family planning in union council 




Generally, FWAs prepare report and FPI review and modify them and then 
submit them to UFPO  
10% 
Personal (idle) time   10% 





Appendix 5. Model Parameters  
A 5.1 Parameters of Program Costs 
 
Start-up   Input Unit Source 







Number of regional officials attending workshop 30~40 persons mPOWE 





Number of days per district workshop 1 days 
Number of district workshop over a year 4 times 
Printing documents per session 2.6 USD 
Refreshers (snacks or teas) per session 26 USD 
Long distance traveling (5 staff for 3 days stay from 
Dhaka to Gaibandha) 1550 USD 
Number of long distance traveling in a year 2 times 
Number of Program officer/coodinator (manager in each 
district) 8 person 
Average salary (based on UFPO salary) 650 UDS 
Number of months (1 week 4 times of workshops in a 
year) 1 months 
Level of effort (LOE) 100% percentage 
Total costs of partnership & consensus building $5,314 USD  
System 
optimization  
Type of software platform OpenSRP name mPOWE 





Number of engineers working on this 6 persons 
Salary: Chief of operation 6000 USD 
Salary: Senior software lead 5000 USD 
Salary: Senior engieneer 4000 USD 
Salary: Tech software 2000 USD 
Salary: Project manager 2500 USD 
Salary: mHealth specialist (research and management) 2500 USD 
Number of months required for system optimization 
(assuming they are working with 100% LOE) 2 months 
Field testing with travels (3 tech staff 1 week staying in 
Gaibandha for requirement gathering and user tests)--
including a round trip by bus, accomodation, local 
tranportation etc. $80 per diem with $70 travel costs per 
person 1410 USD 
Number of traveling in a year 1 times 




Type and model of phone/tablet Samsung name mPOWE 





Cost per phone/tablet 200 USD 
Number of phones/tablets 546 phones 
Phone breakage rate 
5% rate 




Total number of chief trainers (JiVitA and mPOWER) 10 person mPOWE 





Total number of Government trainers (FPI/UFPO) 50 person 
Number of trainers per training session 10 person 
Average number of CHW per session 25 person 
Total required number of training sessions (to train 50 
trainnees) 2 sessions 
Number of days per a training session 5 days 
Total working days (including traveling) per a trainign 
session 1 Week 
Total required number of weeks for training  2 weeks 
Average "weekly" salary of a trainer 750 USD 
Training cost per session (10 traners, 25 trainees, 1 week) 7500 USD 
Traveling of trainners  (5 staff from Dhaka to Gaibandha 




Refreshers to participants  ($20/person/day)--meals and 
snacks 10000 USD 
Daily allowance to trainers ($80/person/day for 
accomodation,transportation, meals etc) 8000 USD 
Total annual training costs (10 trainers, 50 trainees, 2 




Total number of trainners  50 person mPOWE 





Total number of CHWs (FWA nad FWV in Gaibandha) 500 person 
Number of trainers per training session 5 person 
Average number of CHW per session 25 person 
Number of days per a training session 5 days 
Total working days (including traveling) per a training 
session 1 Week 
Average "weekly" salary of a trainer 130 USD 
Training cost per session (5 trainers, 25 CHWs, 1 week) 650 USD 
Training cost 1 batch (5 trainers, 50 CHWs, 2 weeks) 1300 USD 
Training cost 10 batch  (50 trainers, 500 CHWs, 2 weeks) 13000 USD 
Traveling (if any, please specify)  0 USD 
Refreshers ($20 per person) 110000 USD 
Daily allowance (if any, please specify)  n/a USD 
Total annual training costs (50 trainers, 500 CHWs, 2  
week) $123,000 USD 
 
Status quo (Paper system) 
Survey printing 
Number of registries  20 items mPOWE 





Total number of registries for all CHWs 10000 items 
Average unit price for printing one registries 
2.6 USD 
Total costs of printing registries $26,000 USD  
Training (paper) 
Total number of trainers  50 person mPOWE 





Total number of CHWs (FWA and FWV in Gaibandha) 500 person 
Number of trainers per training session 5 person 
Average number of CHW per session 25 person 
Number of days per a training session 2 sessions 
Total working days (including traveling) per a training 
session 1 days 
Average "weekly" salary of a trainer 65 Week 
Training cost per session (5 trainers, 25 CHWs, 1 week) 325 weeks 
Training cost 1 batch (5 trainers, 50 CHWs, 2 weeks) 650 USD 
Training cost 10 batch  (50 trainers, 500 CHWs, 2 weeks) $6,500 USD  
Implementation   Input Unit  
mCARE Intervention 
Supervision 
Number of senior staff (UFPO)  7 person mPOWE 





Number of  staff (FPI) 82 person 
Salary: UFPO 650 USD 
Salary: FPI 260 USD 
Number of months 12 months 
LOE 50% percentage 




Number of CHWs 421 persons mPOWE 





Average salary of CHWs 234 USD 
Number of months for census enumeration 2 months 
LOE (First year) 10% percentage 
LOE (Following year) 3% percentage 
Total cost (First year) 19,703 USD 




Number of CHWs 500 person mPOWE 
Field staff & 
JiVita 
Average salary of CHWs 234 USD 




LOE (First year) 34% percentage Senior 
Management 
Team 
LOE (Following year) 9% percentage 
Total cost (First year) 397,800 USD 
Total annual cost (Following year) $105,300 USD  
SMS 














Frequency of SMS to a client 8 times 
Total number of clients (pregnant women) in a year 6,300 times 




Monthly connection fee 3.9 USD mPOWE 





Number of CHWs 500 persons 
Server maintenance monthly fee (8000 Taka) 234 months 
Number of months 
12 dollar 
Total costs  $4,758 USD  
Reminder home 
visits 
Number of CHWs 421 persons mPOWE 





Salay of CHW 234 USD 
Number of months 12 months 
LOE of CHW 10% percentage 
Total costs  $118,217 USD  
Data reporting & 
processing 
(w/Phone) 
Number of CHWs 421 persons mPOWE 





Salay of CHW 234 USD 
Number of months 12 months 
LOE of CHW 
5% percentage 
Total costs  $59,108 USD  




Number of CHWs 421 persons mPOWE 





Average salary of CHWs 234 USD 
Number of months for census enumeration 3 months 
LOE  
5% percentage 




Number of CHWs 421 persons mPOWE 





Average salary of CHWs 234 USD 
Number of months for pregnancy surveillance 9 months 
LOE  
17% percentage 
Total costs  $150,726 USD  
Reminder home 
visits (w/Paper) 
Number of CHWs 421 persons mPOWE 





Salay of CHW 234 USD 
Number of months 12 months 
LOE of CHW 10% 
percentage 
Total costs  $118,217 USD  
Data reporting & 
processing 
(w/Paper) 
Number of CHWs 421 persons mPOWE 





Salay of CHW 234 months 
Number of months 12 months 
LOE of CHW 
10% percentage 




A 5.2 Parameters on Provider and User Costs  
 
Demographic assumption Unit Source 
Year Baseline year 2015 year   
Geographic area 
Area 16,184.99  km2    
Rangpur division 15,787,758 person Bangladesh 2011 Census 
Population size 
Gaibandha district 2,379,255 person Bangladesh 2011 Census 
Rangpur 2,881,086 person Bangladesh 2011 Census 
Kurigram 2,069,273 person Bangladesh 2011 Census 
Dinajpur 2,990,128 person Bangladesh 2011 Census 
Nilfamari 1,834,231 person Bangladesh 2011 Census 
Larmonirhat 1,256,099 person Bangladesh 2011 Census 
Panchagarh 987,644 person Bangladesh 2011 Census 
Thakurgaon 1,390,042 person Bangladesh 2011 Census 
Pregnant women  
(in 2015) 
Population size (Gaibandha district) 2.4 million person Bangladesh 2011 Census 
Woman of reproductive age (WRA) 
(15~49) (WRA) 604,436 person LiST (2015) 
Fertility rate (B) 2.13 rate LiST (2015) 
Abortion rate (A) 18.20 rate LiST (2015) 
Fetal loss rate (D) 25.36 rate LiST (2015) 
Pregnant women 6,635 person CDC 
Service assumption Unit Source 
Baesline 
coverage (2015) 
ANC 4 or more 31% percentage DHS 2014 
ANC 0 69% percentage DHS 2014 
Facility delivery 38% percentage DHS 2014 
Home delivery 62% percentage DHS 2014 
Any PNC 36% percentage DHS 2014 
No PNC 64% percentage DHS 2014 
Coverage 
increase rate  
mCARE intervention (ANC/Facility 
delivery/PNC) 10% rate mCARE I result 
mCARE control (ANC/Facility 
delivery/PNC) 5% rate 
Estimation from mCARE I 
result 
Status quo--paper(ANC/Facility 
delivery/PNC) 1% rate DHS 2014 
Provider costs Unit Source 
Community level (Satellite clinics: Govt, BRAC, SS) 
ANC 
Service costs $0.22 USD Field data collection  
Supplementation costs $1.30 USD Field data collection  
Average unit cost per ANC $1.95 USD Field data collection  
Delivery 
Service costs $3.55 USD Field data collection  
Supplementation costs n/a USD Field data collection  
Average unit cost per delivery $3.55 USD Field data collection  
PNC 
Service costs $0.12 USD Field data collection  
Supplementation costs $0.52 USD Field data collection  
Average unit cost per PNC $0.62 USD Field data collection  
Facility level (CC, FWC, UHC, SS) 
ANC 
Service costs $0.39 USD Field data collection  
Supplementation costs $2.60 USD Field data collection  
Average unit cost per ANC $2.99 USD Field data collection  
Delivery 
Service costs $19.50 USD Field data collection  
Supplementation costs n/a USD Field data collection  
Average unit cost per delivery $19.50 USD Field data collection  
PNC 
Service costs $0.49 USD Field data collection  
Supplementation costs $5.21 USD Field data collection  
Average unit cost per PNC $1.83 USD Field data collection  
User costs Unit Source 
Community level (Satellite clinics: Govt, BRAC, SS) 
ANC 
Direct costs $0.65 USD Field data collection  




Average unit cost per ANC $0.78 USD Field data collection  
Delivery 
Direct costs $6.50 USD Field data collection  
Indirect costs $4.13 USD Field data collection  
Average unit cost per delivery $10.63 USD Field data collection  
PNC 
Indirect costs $0.26 USD Field data collection  
Average unit cost per PNC $0.26 USD Field data collection  
Facility level (CC, FWC, UHC, SS) 
ANC 
Direct costs $1.17 USD Field data collection  
Indirect costs $1.04 USD Field data collection  
Average unit cost per ANC $2.21 USD Field data collection  
Delivery 
Direct costs $39.00 USD Field data collection  
Indirect costs $7.10 USD Field data collection  
Average unit cost per delivery $46.10 USD Field data collection  
PNC 
Direct costs $13.00 USD Field data collection  
Indirect costs $0.83 USD Field data collection  




Appendix 6. Survey tools 
A 6.1 Module 1 (Community Level) 
 




Objective: The data collection instrument aims to identify organizational governance, 
staffing structure, service capacity and commodities as well as prices paid for inputs of 
major service provider agencies in Gaibandha district. 
 
Instruction: The information can be collected through available registers, records, or 
informant interviews with appropriate authorities or mangers in the organization. For each 
section, please specify the source of information or respondent details who are interviewed. 
Provider consent may not be required for this module.  
 
INTERVIEW VISITS  
100 
 
Date of organization visited  
a. Day     |___|___|     
b. Month |___|___|   
 
101 Information of organization 
 
 
a. District name: 
b. Upazila name: 
c. Union name: 




102 Type of community health workers a. Government/public (FWA/FWV) 
b. BRAC (SK/SS) 
c. Private (Smiling Sun CHW) 
 
103 Managing authority a. Government/public 
b. NGO/Not for profit 
c. Private-for profit 
 
104  Interviewer name:  
 
 








Through available registers, records or informant interviews, please identify staffing structure, 
staff productivity, operational practice, and service capacity. Some questions can be answered as 
open-ended responses.  




01 What are the general categorization/types of community health workers (CHWs) and their 
respective roles and responsibilities in this organization?  
 
Type of works Type of 
workers 
Level of effort* 
of worker type 
A: (specify type) 
Level of effort of 
worker type B: 
(specify type) 
Level of effort of 
worker type C: 
(specify type) 
Level of effort of 






     
Pregnancy 
surveillance 





     
ANC      
Delivery      
PNC      
ENC      
Immuniz
ation 
     
Others      
Non MNCH service 
(TB or other heatlh 
services) 
     
Referral      
Training      
Meeting      
Data 
keepting/reporting 
     
Personal (idle) 
time 
     
Others 
 
     
(Level of effort: % of time allocation out of their total working hours in a month) 
 
• Worker types can be FWA, FWV, SACMO, and FPI in governemnt group 
• Worker types can be Shasto sheitak, Shasto Kormi etc in BRAC 
• Worker types can be Volunteers, Paramedies etc in Smiling Sun 
 
02 How many number of CHWs of this organization 
work for maternal and newborn heatlh serivces in 











What are approximate dimension of catchment 
area (i.e. how many households in a catchment 
area) for a CHW to conduct routine surveillance 
activities? 
 
04 What are the average number of household (or 
eligible couples) visits does each CHW make in 
their routine surveillance activities per day (based 
on the past three days records)? [Define specific 
purposes of activities for routine surveillance. 




05 What are the average number of household (or 
eligible couples) visits does each CHW make for 
routine surveillance per month (based on the past 
three months records)? [Define specific purposes 
of activities for routine surveillance. Specify the 
source of information.] 
 
 
06 What are the average number of pregnancy 
identification per month (based on the latest three 




What are the average number of  ANC service 
provisions (based on the latest three months 
records) by a CHW per month? 
 
08 What are the average number of home delivery 
with a skilled birth attendance (based on the latest 
three months records) per month? 
 
09 What are the average number of PNC/ENC servic 
provision (based on the latest three months 
records) by a CHW per month? 
 
10 What other major activities that CHWs do, besides 
the household surveillance? 
 
 
SERVICE PROVISION & USER FEES 
• Through available registers, records or informant interviews, please identify scope and 
contents of standard service practice as well as any prices paid for inputs for each relevant 
essential maternal and newborn health services.  
• Some specific service items were checked * as relevant indicators for Lives Saved Tool 
modeling.  
• User fee indicates any price for service or commodities to be paid by clients to receive the 
relevant service. This information will be used to estimate user costs from service uptake.  
• The question may be answered based on standard protocols from existing documents, rather 
than prompted questions to providers. 






02 Does this facilty charge a fixed fee that covers all services that a 
client receive, or are there separate fees for different components of 











03 Does this facility have a fee for the following items? 
(Read out each response category and circle appropriately. If there is 
any user fee on specific service item, please specify the amount.) 
Yes No 
ANC Service  





04 Clinical history  Personal information 1 2  
05 Medical /surgical history 1 2  
06 Prior pregnancy information 1 2  
07 Current pregnancy information 1 2  
08 Pregnancy risk assessment 1 2  
09 Examination 
 
General examination: (including at least one of the 
followings such as temperature, pulse, weight, 
height) 
1 2  
10 BP 1 2  
11 Check for edema 1 2  
12 Anemia 1 2  
13 Jaundice 1 2  
14 Breast examination 1 2  
15 Abdominal examination (height of uterus/fundal 
height, fetal movement (applicable after 20 weeks), 
fetal heart sound (count 1 full minute, applicable 
after 24 weeks), presentation of fetus (applicable 
after 28 weeks), check for scars, previous c-
sections) 
1 2  
16 Counseling  Individual birth plan (place/person, money, 
transport, blood donor & identification of EMOC 
center) 
1 2  
17 Maternal nutrition 1 2  
18 Avoiding harmful practice 1 2  
19 Hygiene 1 2  
20 Rest and activity 1 2  
21 Danger signs during pregnancy (bleeding, 
headache, eye problems, swelling of face and 
hands)  
1 2  
22 Danger signs during delivery for the mother 1 2  
23 Danger signs for the newborn 1 2  
24 Essential newborn care 1 2  
25 Infant feeding 1 2  
26 Family planning 1 2  




28 Advising her next ANC visit 1 2  
29 Screening and 
laboratory 
tests 
Haemoglobin 1 2  
30 Proteinuria 1 2  
31 Urine for RE (including presence of albumin & 
sugar, Bacteriuria) 
1 2  
32 Blood/Rh group 1 2  
33 Ultrasonogram (ultra clinics) or referral to clinic 
offering this service) 
1 2  
34 Syphilis* (VDRL: venereal disease research 
laboratory) 







Treat syphilis if indicated*  1 2  
36 Treat bacteriuria if indicated 1 2  
37 Tetanus toxoid (TT immunization: 5 dose schedule) 1 2  
38 Iron and folate+ 1 2  
38 Calcium supplementation 1 2  
39 Balanced energy supplementation (maternal) 1 2  
40 Multiple micronutrient supplementation (maternal) 1 2  
41 MgSO4 management of pre-eclampsia** 1 2  
42 Hypertensive disease case management 1 2  
43 Diabetes screening and management 1 2  
44 Case management of malaria 1 2  
What is the general ANC consultation time per session by a provider? (Minutes) 
 
 
Please specify the source of information of above informations: 
 
 
Child Delivery Service*  





45 Labor and 
delivery 
management 
Clean practices and immediate essential newborn 
care (home): Essential care for all women and 
immediate essential newborn care 
1 2  
46 Basic emergency obstetric care (clinic): shock 
management, pain relief, ABC, parenteral 
antibiotics, IV fluids, instrumental delivery and 
manual removal of the placenta and retained 
products  
1 2  
47 Magnesium sulfate for eclampsia during delivery:  
 
1 2  
48 Chlorhexidine cord cleansing for newborn  
 
1 2  
49 Neonatal 
resuscitation 
Home: (Newborns with access to neonatal 
resuscitation (a bag and mask) if needed. This can 
be delivered by skilled birth attendants in the home 
or by trained) 




50 Facility: (Newborns with access to detection of 
breathing problems and resuscitation (with a 
mucus extractor), if needed)  
1 2  











Clinical history  
Personal information 1 2  
52 Postpartum danger signs for the mother 1 2  







General examination: temperature, BP, pulse, 
edema, anemia, jaundice 
1 2  
55 Examination of breasts: condition of nipples, 
engorgement 
1 2  
56 Per abdominal and per vaginal examination: height 
of uterus, P/V bleeding, any perineal tears, foul 
smelling discharge 






General examination: weight, temperature, 
respiratory rate, jaundice, and skin rash 
1 2  
58 Umbilicus 1 2  
59 Conjunctiva 1 2  
60 Congental anomaly 1 2  
61 
Counseling  
Danger signs after delivery for the mother 1 2  
62 Danger signs after delivery for the newborn 1 2  
63 Care for premature and/or low birth weight 
newborns 
1 2  
64 Counseling on infant feeding (exclusive breast 
feeding; position and attachment) 
1 2  
65 Counseling on maternal hygiene/recovery 1 2  
66 Counseling on maternal nutrition 1 2  
67 Advising PNC visits according to new GOB schedule 
and vaccination of newborn 
1 2  
68 Family planning (postpartum contraception) 1 2  
70 Schedule and importance of EPI 1 2  
71 Breastfeeding promotion 1 2  
72 Thermal care (with wrapping and photo therapy) 1 2  
73 Kangaroo mother care (skin to skin)  1 2  
74 Clean postnatal practices  1 2  
75 Improved water source 1 2  
76 Water connection in the home 1 2  
77 Improved sanitation 1 2  
78 Hand washing with soap 1 2  
79 Hygienic disposal of children's stools 1 2  
80 Insecticide treated materials or indoor residual 
spraying 









Maternal sepsis case management 1 2  
85 Multiple micronutrients supplementation 1 2  
86 Vitamin A supplementation to newborn (after 
birth) 
1 2  
87 Zinc supplementation to newborn 1 2  
88 Case management 
of severe neonatal 
infection 
Oral antibiotics 1 2  
89 Injectable antibiotics 1 2  
90 Full supportive care 1 2  
91 ORS 1 2  
92 Antibiotics for dysentery 1 2  
93 Zinc for diarrhea treatment to newborn  1 2  
94 Case management of pneumonia (oral antibiotics) 1 2  
95 Therapeutic feeding for low weight newborn 1 2  
96 Cotrimoxazole for ARI (acute respiratory illness) 1 2  
97 
Vaccines* 
BCG vaccine (at birth) 1 2  
98 DPT/Hib/HEB (pentavalent) vaccination (at 6-14 
weeks) 
1 2  
99 PCV (Pneumococcal vaccine) (at 6-14 weeks) 1 2  
10
0 
OPV/IPV (Polio vaccine) (at 6-14 weeks) 
1 2  




Please specify the source of information of above infomrations: 
 
STAFFING 
Community level : Please identify specific occupation categories and how many staff in each of 
the categories are currently assigned to, employed by, or seconded to this organization, whether 
full time or part-time as well as their average annual salary (including standard bonus). As salary 
may be vary depends on staff seniority, demand of workload, or other staff availability in the 
organization, if possible, please record a range of measures including average, lowest, and highest 
values.  




 Occupation categories ANC/PNC/ENC 
Provider  






Specify number of 
working days/time 
















SACMO       




03 FWA       
04 FWV (ANC)       
05 CHCP       
06 Others       
 BRAC 
CHWs 
SK (ANC)       
07 SS (Family 
Planning/referal) 
      
08 Others       
09 Smiling Sun 
CHWs 
Doctor (Satellite)       
10 Paramedies       
11 Counselors       
12 Others       








DRUGS AND SUPPLIES   
• Please identify inventory registers, or price records as source of information, and specify 
staff designation who are in charge of selling drugs or supplies.  
• Unit cost indicates any procurement costs to purchase the drugs or equip the supplies in the 
organization/facility. This information will be used to estimate provider costs from service 
provision.  
• The question may be answered based on standard protocols from existing documents, rather 
than prompted questions to providers.. 




Are any of the following drugs and supplies available with the CHWs today? 





Family Planning commodities 
01 Male condoms 1 2   
02 Combined oral contraceptive pills  1 2   
03 Progestine-only contraceptive pills 1 2   
04 Emergent contraceptive pills 1 2   
05 IUDs 1 2   
06 Implants 1 2   
07 Injectables 1 2   
08 Sterilization (surgery) 1 2   
Drugs and supplies for maternal care 




10 Folic acid tablets 1 2   
11 Iron and folic acid combined tablets 1 2   
12 Tetanus toxoid vaccine 1 2   
13 Sodiumchloride injectable solution 1 2   
14 Calcium gluconate injection 1 2   
15 Magnesium sulphate injection 1 2   
16 Ampicillin powder for injection (Inj 250 mg, 500 mg) 1 2   
17 Gentamicin injection 1 2   
18 Hydralazine injection 1 2   
19 Metronidazole injection 1 2   
20 Misoprostol 200ug tablets 1 2   
21 Azithromycin cap/tab or oral liquid 1 2   
22 Ceflxime cap/tab 1 2   
23 Benzathine benzylpenicillin power for injection (Inj 5 lac unit, 10 
lac unit) 
1 2   
24 Betamethasone injection 1 2   
25 Dexamethasone injection 1 2   
26 Nifedipine cap/tab (10 mg) 1 2   
27 Methyldopa tablet 1 2   
28 Oxytocin injection 1 2   
29 Paracetamol (Tab 500 mg/Susp 120 mg/5 ml) 1 2   
30 Oral Rehydration Salts (ORS) sachets 1 2   
Drugs and supplies for newborn care 
31 Procaine benzylpenicillin injection 1 2   
32 Oral Rehydration Salts (ORS) sachets 1 2   
33 Zinc sulphate syrup or dispersible tablets (Tab 10 mg, 20 mg) 1 2   
34 Vitamin A (retinol) capsules (Cap 50,000 IU) 1 2   
35 Antibiotic eye ointment for newborn 1 2   
36 Co-trimoxazole syrup/suspension (Tab 480 mg/Susp 240 mg/5 
ml) 
1 2   
37 Amoxicillin 250mg or 500 mg dispersible tablet or 
syrup/suspension (Susp 125 mg/5 ml, Paediatric drop 100m g/1 
ml)  
1 2   
38 Routine Vaccines for EPI: BCG, Pentavalent, OPV, Measles 1 2   
39 Additional Vaccines (Typhoid, MR, Rabies, Hepatitis A, Influenza, 
Cholera, Chicken Pox)  
1 2   
Emergency medicine commodities for delivery (adapted from Smiling Sun Emergency Medicine 
Kit) 
40 Injection Promethazine (HCL) 25 mg (2 ampoules) 1 2   
41 Injection Hydrocortisone 100 mg (with distilled water) 2 vials  1 2   
42 IV fluid 5% DNS & Hartman’s solution (500 cc) 2 bags or bottle 
with IV set (2 sets)  
1 2   
43 Injection Atropine Sulphate 0.6 mg (2 ampoules) 1 2   
44 Injection Adrenaline (1:1000) (2 ampoules) 1 2   
45 Injection (Naloxone 0.4 mg (2 ampoules) (for clinics providing 
tubectomy services)  




46 Syringes 1 2   
47 Gloves  1 2   
Relevant service delivery guidelines, standards, and job aids 
48 IMCI Chart Booklet and Sick Child Form 1 2   
49 IMCI Recording (Sick Child) Form 1 2   
50 EPI Manual 1 2   
51 Family Planning Manual 1 2   
52 Technical Standard and Service Delivery Protocol for 
Management of RTI/STD  
1 2   
53 Partograph 1 2   
54 Others, Specify any      
Laboratory Services/Tests 
55 Blood grouping and Rh typing 1 2   
56 Cross matching of blood  1 2   
57 Blood for CBC, TC, DC, ESR  1 2   
58 Blood for Hb % 1 2   
59 Random Blood Sugar 1 2   
60 Serum Bilirubin 1 2   
61 Urine R/E 1 2   




A 6.2 Module 1 (Facility Level) 
 
Module 1: Organization, Staffing and Commodities  
Facility Level 
 
Objective: The data collection instrument aims to identify organizational governance, 
staffing structure, service capacity and commodities as well as prices paid for inputs of 
major service provider agencies in Gaibandha district. 
 
Instruction: The information can be collected through available registers, records, or 
informant interviews with appropriate authorities or mangers in the organization. For each 
section, please specify the source of information or respondent details who are interviewed. 
Provider consent may not be required for this module.  
 
INTERVIEW VISITS  
100 
 
Date of facility visited  
a. Day     |___|___|     
b. Month |___|___|   
 




a. District name: 
b. Upazila name: 
c. Union name: 
d. Facility name/address:  
 
102 Type of health facility setting: a. Medical College Hospital (Public) 
b. District Hospital 
c. Maternal & Child Welfare Center 
(MCWC) 
d. Upazilla Health Complex (Health wing) 
e. Upazilla Health Complex (FP wing) 
f. Upgraded Union Heath Centre & 
Family Welfare Centre 
g. Non upgraded Union Heath Centre & 
Family Welfare Centre 
h. Union Sub-Center (RD) 
i. Community Clinic (CC) 
j. Static clinic 
k. Satelight clinic 
l. Medical College/Hospital (Private) 
m. Private Hospital/Clinic (Private) 






103 Managing authority a. Government/public 
b. NGO/Not for profit 
c. Private-for profit 
 










SERVICE CAPACITY  
Through available registers, records or informant interviews, please identify staffing structure, 
staff productivity, operational practice, and service capacity of the facility. Some questions can 
be answered as open-ended responses.  




01 How many numbers of the health facilities 




02 How many numbers of beds (and rooms) 





03 What are the average number of total 
inpatient (based on the latest three months 




04 What are the average number of total 
outpatient (based on the latest three months 




05 What are the average number of  ANC service 
provisions (based on the latest three months 
records) in this facility?  
Overall ANC: 
ANC 1st/GA (8-12 weeks): 
ANC 2nd/GA (24-26 weeks): 
ANC 3rd/GA (32 weeks): 
ANC 4th/GA (36-38 weeks): 
07 What is the “total” amount of time a provider 






Note: If possible, kindly indicate ANC 
provision time window of the day (ex. 9am-
2pm) and frequency of ANC provision dates in 
a week/month (e.g. every Wed, Thursday in a 
week: total 8 days in a month) 
08 What are the average number of normal 
delivery (based on the latest three months 




09 What are the average number of c-section 





10 What are the average number of PNC/ENC 
consultation (based on the latest three 




11 What is the amount of time (in minutes) 




SERVICE PROVISION & USER FEES 
• Through available registers, records or informant interviews, please identify scope and 
contents of standard service practice as well as any prices paid for inputs for each relevant 
essential maternal and newborn health services.  
• Some specific service items were checked * as relevant indicators for Lives Saved Tool 
modeling.  
• User fee indicates any price for service or commodities to be paid by clients to receive the 
relevant service. This information will be used to estimate user costs from service uptake.  
• The question may be answered based on standard protocols from existing documents, 
rather than prompted questions to providers. 
01 Does this facility have any routine user-fees or charges for 
client services?  
Yes No 
02 Does this facilty charge a fixed fee that covers all services that 
a client receive, or are there separate fees for different 









03 Does this facility have a fee for the following items? 
(Read out each response category and circle appropriately. If 
there is any user fee on specific service item, please specify 
the amount.) 
Yes No 
ANC Service  
Does this facility offer any of the following client services?  






Personal information 1 2  
05 Medical /surgical history 1 2  
06 Prior pregnancy information 1 2  
07 Current pregnancy information 1 2  
08 Pregnancy risk assessment 1 2  
09 Examination 
 
General examination: (including at least one of 
the followings such as temperature, pulse, 
weight, height) 
1 2  
10 BP 1 2  
11 Check for edema 1 2  
12 Anemia 1 2  
13 Jaundice 1 2  
14 Breast examination 1 2  
15 Abdominal examination (height of 
uterus/fundal height, fetal movement 
(applicable after 20 weeks), fetal heart sound 
(count 1 full minute, applicable after 24 
weeks), presentation of fetus (applicable after 
28 weeks), check for scars, previous c-
sections) 
1 2  
16 Counseling  Individual birth plan (place/person, money, 
transport, blood donor & identification of 
EMOC center) 
1 2  
17 Maternal nutrition 1 2  
18 Avoiding harmful practice 1 2  
19 Hygiene 1 2  
20 Rest and activity 1 2  
21 Danger signs during pregnancy (bleeding, 
headache, eye problems, swelling of face and 
hands)  
1 2  
22 Danger signs during delivery for the mother 1 2  
23 Danger signs for the newborn 1 2  
24 Essential newborn care 1 2  
25 Infant feeding 1 2  
26 Family planning 1 2  
27 Immunization 1 2  





Haemoglobin 1 2  
30 Proteinuria 1 2  
31 Urine for RE (including presence of albumin & 
sugar, Bacteriuria) 
1 2  
32 Blood/Rh group 1 2  
33 Ultrasonogram (ultra clinics) or referral to 
clinic offering this service) 
1 2  
34 Syphilis* (VDRL: venereal disease research 
laboratory) 









Treat syphilis if indicated*  1 2  
36 Treat bacteriuria if indicated 1 2  
37 Tetanus toxoid (TT immunization: 5 dose 
schedule) 
1 2  
38 Iron and folate+ 1 2  
38 Calcium supplementation 1 2  
39 Balanced energy supplementation (maternal) 1 2  
40 Multiple micronutrient supplementation 
(maternal) 
1 2  
41 MgSO4 management of pre-eclampsia** 1 2  
42 Hypertensive disease case management 1 2  
43 Diabetes screening and management 1 2  
44 Case management of malaria 1 2  




Note: If possible, please specify as a range of different duration of time (in minutes) between the 
first ANC and the subsequent ANCs. Here, I assume that the first ANC may take longer time than 
the subsequent ANCs in order to register pregnancy history and provide general introduction etc.  
 
 
If possible, among the selected service package that they provide, kindly indicate how much time 
would be taken for each sub section in one ANC service session of a person. For example, (i) 
clinical history—2 minutes; (ii) examination -3 minutes; (iii) counselling—5 minutes; (iv) 
screening and lab test —2-7 days from exam to result notice or 0 as no service provided; (v) sup 
and treatment—1 minutes.  
 
 
Please specify the source of information of above informations: 
 
 
Child Delivery Service*  
Does this facility offer any of the following client services? 
Yes No User fee 
45 Antenatal corticosteroids for preterm labor  
(women with suspected premature labor receiving an 
intramuscular injection of betamethasone sodium phosphate 
(6 mg, every 12 hours for 2 days)) 
1 2  
46 Antibiotics for premature rupture of membranes (PRoM)  
(women with premature rupture of membranes (PRoM) who 
are not in labor and are given oral erythromycin (250mg, 4 
times daily for 7 days) who are not in labor to prevent 
infection) 
1 2  
47 Labor and 
delivery 
management 
Clean practices and immediate essential 
newborn care (home): Essential care for all 
women and immediate essential newborn 
care 




48 Basic emergency obstetric care (clinic): shock 
management, pain relief, ABC, parenteral 
antibiotics, IV fluids, instrumental delivery and 
manual removal of the placenta and retained 
products  
1 2  
49 Comprehensive emergency obstetric care 
(clinic): ultrasound, culdocentesis, induction, 
laparotomy, salpingectomy, blood transfusion, 
caesarian section, hysterectomy, 
symphisiotomy, balloon tamponade, uterine 
ligature, MRVOP, surgical infection control and 
episiotomy.  
1 2  
50 Induction of labour to prevent births at or 
beyond 41 completed weeks. (by using clinical 
treatment) 
1 2  
51 Active management of the 3rd stage of labour 
(AMTSL): controlled cord traction, uterine 
massage and appropriate oxytocics 
1 2  
52 Magnesium sulfate for eclampsia during 
delivery:  
 
1 2  
53 Chlorhexidine cord cleansing for newborn  
 
1 2  
54 Neonatal 
resuscitation 
Home: (Newborns with access to neonatal 
resuscitation (a bag and mask) if needed. This 
can be delivered by skilled birth attendants in 
the home or by trained) 
1 2  
55 Facility: (Newborns with access to detection of 
breathing problems and resuscitation (with a 
mucus extractor), if needed)  
1 2  





Does this facility offer any of the following client services? 




Personal information 1 2  
56 Postpartum danger signs for the mother 1 2  





General examination: temperature, BP, pulse, 
edema, anemia, jaundice 
1 2  
59 Examination of breasts: condition of nipples, 
engorgement 
1 2  
60 Per abdominal and per vaginal examination: 
height of uterus, P/V bleeding, any perineal 
tears, foul smelling discharge 







General examination: weight, temperature, 
respiratory rate, jaundice, and skin rash 
1 2  
62 Umbilicus 1 2  
63 Conjunctiva 1 2  
64 Congental anomaly 1 2  
65 
Counseling  
Danger signs after delivery for the mother 1 2  
66 Danger signs after delivery for the newborn 1 2  
67 Care for premature and/or low birth weight 
newborns 
1 2  
68 Counseling on infant feeding (exclusive breast 
feeding; position and attachment) 
1 2  
70 Counseling on maternal hygiene/recovery 1 2  
71 Counseling on maternal nutrition 1 2  
72 Advising PNC visits according to new GOB 
schedule and vaccination of newborn 
1 2  
73 Family planning (postpartum contraception) 1 2  
74 Schedule and importance of EPI 1 2  
75 Breastfeeding promotion 1 2  
76 Thermal care (with wrapping and photo 
therapy) 
1 2  
77 Kangaroo mother care (skin to skin)  1 2  
78 Clean postnatal practices  1 2  
79 Improved water source 1 2  
80 Water connection in the home 1 2  
83 Improved sanitation 1 2  
84 Hand washing with soap 1 2  
85 Hygienic disposal of children's stools 1 2  
86 Insecticide treated materials or indoor residual 
spraying 
1 2  





Maternal sepsis case management 1 2  
89 Multiple micronutrients supplementation 1 2  
90 Vitamin A supplementation to newborn (after 
birth) 
1 2  
91 Zinc supplementation to newborn 1 2  
92 Case management 
of severe neonatal 
infection 
Oral antibiotics 1 2  
93 Injectable antibiotics 1 2  
94 Full supportive care 1 2  
95 ORS 1 2  
96 Antibiotics for dysentery 1 2  
97 Zinc for diarrhea treatment to newborn  1 2  
98 Case management of pneumonia (oral 
antibiotics) 
1 2  
99 Therapeutic feeding for low weight newborn 1 2  
10
0 
Cotrimoxazole for ARI (acute respiratory 
illness) 







BCG vaccine (at birth) 
1 2  
10
2 
DPT/Hib/HEB (pentavalent) vaccination (at 6-
14 weeks) 
1 2  
10
3 
PCV (Pneumococcal vaccine) (at 6-14 weeks) 
1 2  
10
4 
OPV/IPV (Polio vaccine) (at 6-14 weeks) 
1 2  
What is the general PNC consultation time per session by a provider? (Minutes) 
 
 
Please specify the source of information of above infomrations: 
 
STAFFING 
Facility level : Please identify specific occupation categories and how many staff in each of the 
categories are currently assigned to, employed by, or seconded to this facility, whether full time 
or part-time as well as their average annual salary (including standard bonus). As salary may be 
vary depends on staff seniority, demand of workload, or other staff availability in the 
organization, if possible, please record a range of measures including average, lowest, and 
highest values. Out of full occupation categories, please identify staff who are reponsible or 
qualified to provide antenatal, postnatal or essential newborn care. 
 Occupation categories ANC/PNC/ENC 
Provider  

























01 General [Non-Specialist] Medical 
Doctors 
      
02 Specialsts Medical Doctors 
[Including Anesthesiologists & 
Pathologists] 
      
03 Non-Physician 
Clinicians/Paramedical 
Professionals (Including Clinical 
Officers, Medical Assistants, etc) 
      
04 Anesthestist       
05 Nursing Professionals (Excluding 
Associate Degree Nurses) 
      
06 Degree Nurses (e.g. BSc Nurse)       
07 Paramedies (e.g. SACMO)       
08 Counselor       
09 Pharmacist       




11 Laboratory Scientist       
12 Laboratory Technician/Assistant       
13 MIS manager/Statistician/Record 
keeper 
      
14 Community Health Volunteer       
15 Messsenger       
16 Driver (including Ambulance 
driver) 
      
17 Cleaner       
18 Guard       
19 Others       
Please specify if there is any typical staff ratio among workers (e.g. a ratio between a doctor and 
nurse or a ratio between lab scientist and lab technician or a ratio between pharmacist vs. 
pharmacist assistant etc.): 
 
 
Please speficy general staff productivity (working days/hours):  
 
 
DRUGS AND SUPPLIES   
• Please identify inventory registers, or price records as source of information, and specify 
staff designation who are in charge of selling drugs or supplies.  
• Unit cost indicates any procurement costs to purchase the drugs or equip the supplies in the 
organization/facility. This information will be used to estimate provider costs from service 
provision.  
• The question may be answered based on standard protocols from existing documents, 
rather than prompted questions to providers.. 
Please specify the source of information or respondent details if these are interviewed.   
 
 
Are any of the following drugs and supplies available with the CHWs today? 
 
 





Family Planning commodities 
01 Male condoms 1 2   
02 Combined oral contraceptive pills  1 2   
03 Progestine-only contraceptive pills 1 2   
04 Emergent contraceptive pills 1 2   
05 IUDs 1 2   
06 Implants 1 2   
07 Injectables 1 2   
08 Sterilization (surgery) 1 2   
Drugs and supplies for maternal care 




10 Folic acid tablets 1 2   
11 Iron and folic acid combined tablets 1 2   
12 Tetanus toxoid vaccine 1 2   
13 Sodiumchloride injectable solution 1 2   
14 Calcium gluconate injection 1 2   
15 Magnesium sulphate injection 1 2   
16 Ampicillin powder for injection (Inj 250 mg, 500 mg) 1 2   
17 Gentamicin injection 1 2   
18 Hydralazine injection 1 2   
19 Metronidazole injection 1 2   
20 Misoprostol 200ug tablets 1 2   
21 Azithromycin cap/tab or oral liquid 1 2   
22 Ceflxime cap/tab 1 2   
23 Benzathine benzylpenicillin power for injection (Inj 5 lac unit, 
10 lac unit) 
1 2   
24 Betamethasone injection 1 2   
25 Dexamethasone injection 1 2   
26 Nifedipine cap/tab (10 mg) 1 2   
27 Methyldopa tablet 1 2   
28 Oxytocin injection 1 2   
29 Paracetamol (Tab 500 mg/Susp 120 mg/5 ml) 1 2   
30 Oral Rehydration Salts (ORS) sachets 1 2   
Drugs and supplies for newborn care 
31 Procaine benzylpenicillin injection 1 2   
32 Oral Rehydration Salts (ORS) sachets 1 2   
33 Zinc sulphate syrup or dispersible tablets (Tab 10 mg, 20 mg) 1 2   
34 Vitamin A (retinol) capsules (Cap 50,000 IU) 1 2   
35 Antibiotic eye ointment for newborn 1 2   
36 Co-trimoxazole syrup/suspension (Tab 480 mg/Susp 240 mg/5 
ml) 
1 2   
37 Amoxicillin 250mg or 500 mg dispersible tablet or 
syrup/suspension (Susp 125 mg/5 ml, Paediatric drop 100m 
g/1 ml)  
1 2   
38 Routine Vaccines for EPI: BCG, Pentavalent, OPV, Measles 1 2   
39 Additional Vaccines (Typhoid, MR, Rabies, Hepatitis A, 
Influenza, Cholera, Chicken Pox)  
1 2   
Emergency medicine commodities for delivery (adapted from Smiling Sun Emergency Medicine 
Kit) 
40 Injection Promethazine (HCL) 25 mg (2 ampoules) 1 2   
41 Injection Hydrocortisone 100 mg (with distilled water) 2 vials  1 2   
42 IV fluid 5% DNS & Hartman’s solution (500 cc) 2 bags or bottle 
with IV set (2 sets)  
1 2   
43 Injection Atropine Sulphate 0.6 mg (2 ampoules) 1 2   
44 Injection Adrenaline (1:1000) (2 ampoules) 1 2   
45 Injection (Naloxone 0.4 mg (2 ampoules) (for clinics providing 
tubectomy services)  




46 Syringes 1 2   
47 Gloves  1 2   
Relevant service delivery guidelines, standards, and job aids 
48 IMCI Chart Booklet and Sick Child Form 1 2   
49 IMCI Recording (Sick Child) Form 1 2   
50 EPI Manual 1 2   
51 Family Planning Manual 1 2   
52 Technical Standard and Service Delivery Protocol for 
Management of RTI/STD  
1 2   
53 Partograph 1 2   
54 Others, Specify any      
Laboratory Services/Tests 
55 Blood grouping and Rh typing 1 2   
56 Cross matching of blood  1 2   
57 Blood for CBC, TC, DC, ESR  1 2   
58 Blood for Hb % 1 2   
59 Random Blood Sugar 1 2   
60 Serum Bilirubin 1 2   
61 Urine R/E 1 2   
62 Ultrasonogram test 1 2   
SOURCE OF REVENUE 
Please identify the source of revenue or funding for this organization. Please identify if the 
organization received any revenue or funding from any of the listed resources during 2015 
financial year. If possible, please identify specific amount or approximate percentage of each 
source of revenue/funding out of total annual revenue/funding.  
 




 Soure of revenue Available 
(Y/N) 
Amount Percentage 
01 Government revenue (Ministry of health or 
other public ministries) 
   
02 Donor agencies    
03 NGOs    
04 Service fee    
05 Medicine sales/Lab test fee    
06 Maternal Health Voucher Scheme (Demand 
side Voucher Financing)* 
   
07 Insurance schemes/Social Security Fund     
08 Faith-based community programs    
09 Private donation/contribution    




REFERRAL PRACTICE  
This questions may be asked to different service providers in the organization who are in charge of 
respective services. Please specify the source of information and respondent details who were 
interviewed.   
 
Referral during pregnancy 
01 Provider category: Referral is made 
from 
Doctors (specialist) 01 
Doctors 02 
Nurses/Midwifes 03 
Family Welfare Assistant 04 
Family Welfare Volunteers 05 
Traditional Birth Attendant 06 
Community Healthcare Provider 07 
Heath Assistant 08 
Village doctor 09 
Spiritual Healer 10 
Homeopathic 11 
Kobiral/Hakim 12 
NGO workers (SS/SK) 13 
Other (specify) 14 




Medical College Hospital (Public) 01 
District Hospital 02 
Maternal & Child Welfare Center (MCWC) 03 
Upazilla Health Complex (Health wing) 04 
Upazilla Health Complex (FP wing) 05 
Upgraded UH&FWC 06 
Union Sub-Center (RD) 07 
Union Sub-Center (RD) + upgraded UH&FWC 08 
Union Sub-Center (RD) + non-upgraded UH&FWC 09 
Community Clinic (CC) 10 
Medical College/Hospital (Private) 11 
Private Hospital/Clinic (Private) 12 
Smiling Sun Franchise Clinic (Private/NGO) 13 
Other (specify) 14 
Provider 
category 
Doctors (specialist) 01 
Doctors 02 
Nurses/Midwifes 03 
Family Welfare Assistant 04 
Family Welfare Volunteers 05 
Traditional Birth Attendant 06 
Community Healthcare Provider 07 
Heath Assistant 08 
Village doctor 09 
Spiritual Healer 10 
Homeopathic 11 
Kobiral/Hakim 12 
NGO workers (SS/SK) 13 




03 How many referrals did you make 




04 Which timing of pregnancy do you 
make most referrals?  
  
ANC 1st/GA (8-12 weeks) 01 
ANC 2nd/GA (24-26 weeks) 02 
ANC 3rd/GA (32 weeks) 03 
ANC 4th/GA (36-38 weeks) 04 
Labor/Delivery 05 
Postnatal care 06 
05 What were the 
major reasons 





Pregnancy Vaginal bleeding 01 
Fever 02 
Headache or blurred vision 03 
Swollen face or hands 04 
Tiredness or breathlessness 05 
Fetal movement (loss of, excessive, normal) 06 
Cough or difficulty breathing for 3 weeks or  
longer 
07 
Convulsions (pre-eclampsia/eclampsia)  08 
Lower abdominal pain  09 
Any other symptoms or problems the client  
thinks might be related to this pregnancy 
10 
Other (specify) 11 
06 Labor/Delivery Excessive vaginal bleeding 01 
Foul smeling discharge 02 
High fever 03 
Baby’s hand or feet come first 04 
Baby bad position/malpresentation 05 
Prolong labor (>12 hours) 06 
Retained placenta 07 
Torn uterus 08 
Prolapsed cord 09 
Cord around neck 10 
Convulsions 11 
Perineal Tear 12 
Other (specify) 13 
07 After delivery 
(mother) 
Excessive vaginal bleeding 01 
Foul smeling discharge 02 
High fever 03 
Baby’s hand or feet come first 04 
Baby bad position/malpresentation 05 
Prolong labor (>12 hours) 06 
Retained placenta 07 
Torn uterus 08 
Prolapsed cord 09 





Perineal Tear 12 
Other (specify) 13 
08 After delivery 
(newborn) 
Breastfeeding difficulties/failure to 
breastfeed 
01 
Difficulty breathing 02 
Lethargy/limpness/always sleeping 03 
Convulsions/fits 04 
Blueness of  lips, hands or skin 05 





Low birth weight, including prematurity 09 
Jaundice/yellow color of the skin and eyes 10 
Red eyes with discharge 11 
Skin lesions/blisters 12 
Other (specify) 13 
09 What are the general 
protocol/process of the referrals?  
 
(Record whether the provider did 
any of the following.) 
Recommend that client be hospitalized 
urgenly (i.e. Admitted to the hospital or 
referred to another hospital) 
01 
Referred client to another provider within 
facility for other care 
02 
Referred client for laboratory test within or 
outside facility 
03 
Explained the reason for (any) referral 04 
Gave referral slip to caretaker 05 
Explained where (or to whom) to go 06 
Provider explained when to go for referral 07 
Referrer accompanied the client to the 
facility 
08 
Other (specify) 09 
10 
 
What are the general outcome of 
the referral?  
 
 
11 Did you use mobile phone in any of 
this process? If yes, could you 













A 6.3 Module 2 
 
Module 2: Health Service Provision Observation  
of Antenatal Care Service  
 
Objective: The data collection instrument aims to identify essential mother and newborn 
care service practice, contents and commodities to estimate marginal costs of antenatal 
care service provision of major service providers in Gaibandha district.  
 
Instruction: While an interviewer will use the Module 2 questionnaires to record 
relevant items during service observation, the consultation may not be conducted in a 
sequential or consecutive manner as structured in the module. In this case, 
interviewer/interpreter should write down all conversations or activities on a blank 
sheet as they observe during the service provision process. The information will then be 
deconstructed and compiled according to the following categorizations later.  
 
INTERVIEW VISITS 
100 Date of household/health facility visited a. Day     |___|___|     
b. Month |___|___|   
101 Information of household/health facility 
 
 
a. District name: 
b. Upazila name: 
c. Union name: 
d. Facility name/address:  
102 Level of care a. Health facility level      
b. Community level 
Go 01 
Skip to 02 
01 If facility level, type of health facility: a. Medical College Hospital (Public) 
b. District Hospital 
c. Maternal & Child Welfare Center (MCWC) 
d. Upazilla Health Complex (Health wing) 
e. Upazilla Health Complex (FP wing) 
f. Upgraded Union Heath Centre & Family 
Welfare Centre 
g. Non upgraded Union Heath Centre & 
Family Welfare Centre 
h. Union Sub-Center (RD) 
i. Community Clinic (CC) 
j. Static clinic 
k. Satelight clinic 
l. Medical College/Hospital (Private) 
m. Private Hospital/Clinic (Private) 






02 If community level, type of community 
health workers 
a. Government/public (FWA/FWV) 
b. BRAC (SK/SS) 
c. Private (Smiling Sun CHW) 
 
103 Managing authority a. Government/public 
b. NGO/Not for profit 
c. Private-for profit 
 
104 Observer/interviewer name:  
 
105 Provider name: 
 





 Record client ID number: 
 
107 Record whether permission was received 











CHARACTERISTICS OF SERVICE PROVIDER 
 Questions to client Check all that apply Comments 
1 
 
What is the provider category? 01=Qualified doctor  
02=Nurse  
03=Paramedic/Midwife  
04=Family Welfare Assistant  
05=Family Welfare Volunteers  
06=MA/SACMO  
07=Health Assistant  
08=Traditional Birth Attendant  
09=Community Healthcare Provider  
10=BRAC Community Health Workers  
(Shastto Shebika, Shasto Kormi) 
 
11=Others (Specify)  




                       years 
 
3 What was the highest class the 
provider completed in school? 
00=No schooling    
01-09=From class 1 to class 9   
10=SSC/dakhil passed    
11=11 years completed    
12=HSC/Alim passed    
13=13 years completed   
14=Degree/Fazil or higher    




4 How many years did the provider 
work on this service? 
1= Less than 1 year  
2=1-3 year  
3=3-5 year  
4=5-10 year  
5=More than 10 year  
5 Where did the provider receive 
training on professional ANC 
service provision? 
1=Government program  
2= NGO program  
3= Private program  
4=Others (Specify)  
6 When was the latest professional 
ANC service training did the 
provider receive? 
1=Less than 1 year ago  
2=1-3 year ago  
3=3-5 year ago  
4=5-10 year ago  
5=More than 10 year ago  




How long was the training 
program that the provider 
received? 
1=Less than 15 days   
2=16-30 days  
3=1-6 months  
4=6-12 months  
5=More than 1 year  
9=Don’t know  
OBSERVATION OF ANC CONSULTATION  
201 How many weeks pregnancy is the client? 
[If not asked or identified, please skip to the next question 
no. 202] 





Has the client had a previous pregnancy, regardless of the 
duration or outcome of that pregnancy, or is this the 
client's first pregnancy? 
First Pregnancy 1 
Not First Pregnancy 2 
Don’t know 3 
203 What number of ANC visit is this? 1st 1 
2nd Skip to 206 2 
3rd Skip to 206 3 
4th Skip to 206 4 
Other (Specify)  5 
If not asked/identified 6 
Questions on Service Contents Yes No Commodities 
Code: For each of the groups that follow, circle any action taken by the provider or the client. If 
no action in the group is observed, circle “Y” for each group at the end of the observation.  
Commodities: Record any commodities which are consumed during the service provision 
(Specify the item and quantity, if any) 
204 Client History 
 Record whether the provider asked about or the client mentioned any of the following 
facts.  
01 Client’s age 1 2  
02 Medications the client is taking 1 2 
03 Date client’s last menstrual period began 1 2 




205 Aspects of Prior Pregnancies 
 Record whether the provider or the client discussed any of the following aspects of the 
client’s prior pregnancies (0 = No, 1=Yes) 
01 Prior stillbirth(s) 1 2  
02 Infant(s) who died in the first month of life 1 2 
03 Heavy bleeding, during or after delivery 1 2 
04 Previous assisted delivery (caesarean section, ventouse, or 
forceps) 
1 2 
05 Previous spontaneous abortions 1 2 
06 Previous menstrual regulation and induced abortion 1 2 
07 Previous multiple pregnancies 1 2 
08 Previous prolonged labor 1 2 
09 Previous pregnancy-induced hypertension 1 2 
10 Previous pregnancy-related convulsions 1 2 
11 High fever or infection during prior pregnancy/pregnancies 1 2 
206 Danger Signs of Current Pregnancy 
 Record whether the provider asked/counselled about or the client mentioned any of the 
following for current pregnancy.  
01 Vaginal bleeding 1 2  
02 Fever 1 2 
03 Headache or blurred vision 1 2 
04 Swollen face, hands or legs 1 2 
05 Tiredness or breathlessness 1 2 
06 Fetal movement (loss of, excessive, normal) 1 2 
07 Cough or difficulty breathing for 3 weeks or longer 1 2 
08 Convulsions (pre-eclampsia/eclampsia)  1 2 
09 Lower abdominal pain  1 2 
 Vomiting with pregnancy 1 2 
10 Any other symptoms or problems the client thinks might 
be related to this pregnancy 
1 2 
207 Physical Examination 
 Record whether the provider performed the following procedures. 
01 Take the client’s blood pressure 1 2  
02 Examine conjunctiva/palms for anemia 1 2 
03 Examine legs/feet/hands for edema 1 2 
04 Examine for swollen glands 1 2 
05 Palpate the client’s abdomen for fetal presentation 1 2 
06 Palpate the client’s abdomen for uterine height 1 2 
07 Listen to the client’s abdomen for fetal heartbeat (after 28 
weeks) 
1 2 
08 Conduct an ultrasound/refer client for ultrasound/look at 
recent ultrasound report 
1 2 
09 Examine the client’s breasts 1 2 
10 Conduct vaginal examination/exam of perineal area  1 2 
11 Others (specify; e.g. Examine height or weight) 1 2  




 In case of different providers involved for the sub 
elements of ANC service provision, please specify each 
type of service provider for relevant services. Record 
whether the provider, (1) asked about; (2) performed; (3) 






01 Anemia test  1 2 3 0 
02 Blood grouping  1 2 3 0 
03 Any urine test  1 2 3 0 
04 VDRL (Syphillis etc.) test  1 2 3 0 
209 Maintaining a Healthy Pregnancy 
 Record whether the provider gave the client any of the following advice or counsel about 
preparations  
01 Discussed nutrition (i.e., quantity or quality of food to eat) 
during the pregnancy 
1 2  
02 Informed the client about the progress of the pregnancy 
(e.g. based on abdominal girth, fundal height, weight, fetal 
heart sound) 
1 2 
03 Discussed the importance of at least 4 ANC visits 1 2 
04 Informed or gave a card on next ANC scheduled visits 1 2 
210 Iron Prophylaxis 
 Record whether the provider gave the client any of the following treatment or 
counseling. 
01 Prescribed or gave iron pills or folic acid (IFA) or both 1 2  
02 Explained the purpose of iron or folic acid 1 2 
03 Explained how to take iron or folic-acid pills 1 2 
04 Explained side effects of iron pills 1 2 
211 Tetanus Toxoid Injection 
 Record whether the provider gave the client any of the following treatments.  
01 Prescribed or gave a tetanus toxoid (TT) injection 1 2  
02 Explained the purpose of the TT injection 1 2 
212 Deworming 
 Record whether the provider gave the client any of the following treatments.  
01 Prescribed or gave Mebendazole/ Albendazole 1 2  
02 Explained the purpose of Mebendazole/ Albendazole 1 2 
213 Malaria 
 Record whether the provider gave the client any of the following treatment or 
counseling.  
01 Gave malaria prophylaxis medicine (SP) to client during the 
consultation 
1 2  
02 Prescribed malaria prophylaxis medicine (SP) to client to 
obtain elsewhere 
1 2 
03 Explained the purpose of the preventive treatment with 
anti-malaria medicine 
1 2 
04 Explained how to take the anti-malaria medicine 1 2 
05 Provided ITN to client as part of consultation or instructed 





06 Explicitly explained importance of using ITN to client 1 2 
214 Preparation for Delivery 
 Record whether the provider advised or counselled about delivery in any of the following 
ways. 
01 Asked the client where she will deliver 1 2  
02 Advised the client to prepare for delivery (e.g. set aside 
money, arrange for emergency transportation) 
1 2 
03 Advised the client to use a skilled health worker for 
delivery 
1 2 
04 Discussed with client what items to have on hand at home 
for emergencies (e.g. Birth kit) 
1 2 
215 Newborn and Postpartum Recommendations 
 Record whether the provider advised or counselled about newborn or postpartum care in 
any of the following ways.  
01 Discussed care for the newborn (i.e. warmth, hygiene and 
cord care) 
1 2  
02 Discussed early initiation (e.g. 30 minutes/as soon as after 
birth) and prolonged (e.g. 2 years along with 
complementary feeding)  breastfeeding 
1 2 
03 Discussed exclusive breastfeeding (e.g. 6 months) 1 2 
04 Discussed importance of vaccination for the newborn 1 2 
05 Discussed family planning options for after delivery 1 2 
216 Overall Observations of interaction 
01 Record whether the provider asked if the client had any 
questions and encouraged questions. 
Yes 1 
No 2 
02 Record whether the provider used any visual aids for 
health education or counseling during the consultation 
Yes 1 
No 2 
03 Record whether the provider looked at the client’s health 
card (either before beginning the exam, while collecting 
information or examining the client) 
Yes 1 
No 2 




No Health Card Used 3 
05 Record the outcome of the consultation  
 
[Record the outcome at the end of the observation 
conclueded] 
Client goes home 1 
Client referred (To lab 
or other provider) at 
same facility 
2 
Client admitted to 
same facility 
3 
Client referred to other 
facility 
4 









A 6.4 Module 3 
 
Module 3: Client Exit Interview on User Costs  
 
Objective: The data collection instrument aims to determine user costs, including direct 
costs such as transportation costs, admission/service user fees, and drug costs, as well 
as any indirect costs such as loss of schooling or wage due to antenatal, postnatal or 
newborn care-seeking.   
 
Instruction: At the end of the ANC service consultation/observation (Module 2), the 
interview will be conducted based on discussions with pregnant women who is receiving 




100 Date of household/health 
facility visited 
 
a. Day     |___|___|     
b. Month |___|___|   
 
101 Information of 




a. District name: 
b. Upazila name: 
c. Union name: 
d. Facility name/address:  
 
102 Level of care a. Health facility level      
b. Community level 
Go 01 
Skip to 02 
01 If facility level, type of health 
facility: 
a. Medical College Hospital (Public) 
b. District Hospital 
c. Maternal & Child Welfare Center (MCWC) 
d. Upazilla Health Complex (Health wing) 
e. Upazilla Health Complex (FP wing) 
f. Upgraded Union Heath Centre & Family Welfare 
Centre 
g. Non upgraded Union Heath Centre & Family 
Welfare Centre 
h. Union Sub-Center (RD) 
i. Community Clinic (CC) 
j. Static clinic 
k. Satelight clinic 
l. Medical College/Hospital (Private) 
m. Private Hospital/Clinic (Private) 





02 If community level, type of 
community health workers 
a. Government/public (FWA/FWV) 
b. BRAC (SK/SS) 
c. Private (Smiling Sun CHW) 
 
103 Managing authority a. Government/public 
b. NGO/Not for profit 
c. Private-for profit 
 












Record client ID number:  
107 Record whether permission was 
received from the client. 
0 = No  
[Specify the reasons: severe health 
condition, time constraints, no permission 
by family member etc.] 
End 
1 = Yes  
CHARACTERISTICS OF PREGNANT WOMEN  
 Questions to client Check all that apply Comments 




                    years 
 
2 Including this visit, how many 
times of ANC did you receive? 
 
 
            times   
 
[The range of number should be 1-4] 
 
3 What is your gestational age? 
/How many weeks have been 
passed since your last 
menstrual period? 
 
1=1-12 weeks  
2=13-26 weeks  
3=27-32 weeks  
4=33-38 weeks  
9=Don’t know  
4 Have you had a previous 
pregnancy? 
0= No/First pregnancy (Conduct the 
survey until the section of User Cost for 
ANC) 
 
1=Yes/Not first pregnancy (Continue the 
survey until the end)  
 
9=Don’t know  
5 Can you read or write a letter 
in Bangla? 
0=No   
1=Yes   




6 What was the highest class 
you completed in school? 
 
00=No schooling    
01-09=From class 1 to class 9   
10=SSC/dakhil passed    
11=11 years completed    
12=HSC/Alim passed    
13=13 years completed   
14=Degree/Fazil or higher    
99=Don't know  
7 Aside from your own 
housework, do you do any 
work for which you are paid 
in cash or in kind?  
0=No (Go to 8)  
1=Yes (Go to 7a, do 7b)  
9=Don’t know (Go to 8)  
7a. What kind of work do you 
spend most of your time 
doing? 
1=Work on own farm / as share cropper   
2=Day, unskilled laborer (agricultural & 
migrant etc)  
 
3=Maid servant / Fisherman   
4=Contracted laborer (long term domestic, 
agricultural)  
 
5=Own business  
6=Private service (salaried, skilled factory 
and office workers etc. salesperson, skilled 
laborer) 
 






9=Don't know  
7b. What is the average cash 
income you bring into the 











8 Do your husband do any work 
for which he is paid in cash or 
in kind? 
0=No (Go to User Cost for ANC section)  
1=Yes (Go to 8a, do 8b)  
9=Don’t know (Go to User Cost for ANC 
section) 
 
8a. What kind of work does he 
spend most of his time 
doing? 
1=Work on own farm / as share cropper   
2=Day, unskilled laborer (agricultural & 
migrant etc)  
 
3=Maid servant / Fisherman   
4=Contracted laborer (long term domestic, 
agricultural)  
 





6=Private service (salaried, skilled factory 
and office workers etc. salesperson, skilled 
laborer) 
 






9=Don't know  
8b. What is the average cash 
income he bring into the 











USER COSTS FOR ANC 




Did you have to spend any 
money during your ANC 
checkup? 
0 = No  
1 = Yes  
9 = Don’t Know  
2 
What did you spend your 
money on? 
[Specify amount of 
expenditure to the relevant 





1 = Admission fee  
2 = Provider/ consultation fees  
3 = Medicines   
4 = Medical tests   
5 = Ultrasonography  
6 = Supplements  
7 = Immunization  
8 = Transportation   
9 = Food (in hospital/on way to facility)   
10 = Hospitalization  
11 = Other, specify   
12 = Don’t know   
3 
How much of your own 
money did you spend in total 
on your ANC visit? 
Specify the amount: 
  
4 
How did you arrange to pay 
for the expenses? 
1 = Personal savings   
2 = Loans from 
friends/neighbors/relatives 
 
3 = Sold assets   
4 = Microcredit  
5 = Conditional cash transfer  
6 = Vouchers   
7 = Other, specify  
9 = Don’t know  





Did you or your husband take 
time off from work to receive 
ANC? 
1 = Yes  
9 = Don’t Know  
6 
How many days did your 
husband take off from work 
for your ANC? /How much 
money did you or your 
husband lose because of this 
absence from work?   
Specify the number of days: 
 




Did you have to pay someone 
to take care of any other 
children while you went to 
receive ANC? 
0 = No  
1 = Yes  
3= Not applicable (Do not have children)  
7a 





Which mode of transport did 
you use to reach the ANC 
facility? 
0 = Not Applicable for ANC received at 
home 
 
1= Walking  
2= Paddled rickshaw/Van gari  
3 = Electric rickshaw/van gari   
4 = Nosimon/votvoti (converted shallow 
water pump into vehicle) 
 
5 = CNG/Mahindra/ Tempo  
6 = Private vehicle (Car/Micro)  
7 = Ambulance (Government, private, 
NGO’s) 
 
8 = Bus/Train  
9 = Other, specify (e.g. Wainwright, 
bullock carts, tractor, trolley van) 
 
10 = Don’t know  
9 
What is the amount of time 
(in minutes) you usually 
spend on _________ during 
your ANC visits? 
Travel time (Round trip: From the time 
you depart from your home/health facility 
until the time to arrive at the health 










Consultation time (Including physical 
examination, different test such as Hb, 





Pharmacy time (obtaining medicines at 







USER COSTS FOR CHILD DELIVERY  
Note: These questions will be completed based on discussions with pregnant women who have 
previous experience of child birth from their previous pregnancy. It is expected to take about 10 
minutes. The questions and answers may be based on the latest previous delivery experience.  
Does she have previous child 
delivery experience? 
0 = No End 
1 = Yes  
Record whether permission was 
received from the client. 
0 = No End 
1 = Yes  




Did you have to spend any 
money during your delivery? 
0 = No  
1 = Yes  
9 = Don’t Know  
2 
How much of your own 
money did you spend during 
your delivery in total? 




Which of the following things 
did you spend your money on 
during your delivery? 
 
[Specify amount of 
expenditure to the relevant 
item, if any] 
 
1 = Admission fee  
2 = Provider/ consultation fees  
3 = Medicines   
4 = Medical tests   
5 = Ultrasonography  
6 = Supplements  
7 = Immunization  
8 = Transportation   
9 = Food (in hospital/on way to facility)   
10 = Hospitalization  
11 = Other, specify   
12 = Don’t know   
4 
How did you arrange to pay 
for the expenses of your 
delivery? 
1 = Personal savings   
2 = Loans from friends/neighbors/relatives  
3 = Sold assets   
4 = Microcredit  
5 = Conditional cash transfer  
6 = Vouchers   
7 = Other, specify  
9 = Don’t know  
5 
Did your husband take time 
off from work during your 
delivery? 
0 = No  
1 = Yes  
9 = Don’t Know  
6 
How many days did your 
husband take off from work 
for your delivery?  
/How much money did you or 
your husband lose because of 
Specify the number of days: 
 






this absence from work 
during your delivery?   
7 
Did you have to pay someone 
to take care of any other 
children while you sought 
care for the child delivery? 
0 = No  
1 = Yes  
3= Not applicable (Do not have children)  
7a 





Which mode of transport did 
you use to reach the place of 
delivery? 
0 = Not Applicable for home delivery  
1= Pedaled rickshaw/Van gari  
2 = Electric rickshaw/electric van gari/Auto  
3 = Nosimon/votvoti (converted shallow water 
pump into vehicle) 
 
4 = CNG/Mahindra/Tempo  
5 = Private vehicle (Car/Micro)  
6= Ambulance (Government, private, NGO’s)  
7=Train/Bus  
8= Other  
9 = Don’t know  
USER COSTS FOR PNC/ENC 
Note: These questions will be completed based on discussions with pregnant women who have 
previous experience of postnatal care from their previous pregnancy. It is expected to take about 
10 minutes. . The questions and answers may be based on the latest previous PNC/ENC 
experience. 




Did you have to spend any 
money on postnatal/essential 
newborn care since your 
delivery? 
0 = No  
1 = Yes  
9 = Don’t Know  
2 
 
Which of the following things 
did you spend your money on 
for postnatal/essential 
newborn care since your 
delivery? 
 
[Specify amount of 
expenditure to the relevant 
item, if any] 
 
1 = Admission fee  
2 = Provider/ consultation fees  
3 = Medicines   
4 = Medical tests   
5 = Ultrasonography  
6 = Supplements  
7 = Immunization  
8 = Transportation   
9 = Food (in hospital/on way to facility)   
10 = Hospitalization  
11 = Other, specify   
12 = Don’t know   
3 
How many days did your 
husband take off from work 
for your PNC/ENC? 







/How much of your or your 
husband’s money did you 
spend in total on 
postnatal/essential newborn 
care since your delivery? 
Specify the amount:  
 
4 
How did you arrange to pay 
for your postnatal/essential 
newborn care expenses? 
1 = Personal savings   
2 = Loans from friends/neighbors/relatives  
3 = Sold assets   
4 = Microcredit  
5 = Conditional cash transfer  
6 = Vouchers   
7 = Other, specify  
9 = Don’t know  
5 
Did you or your husband take 
time off from work for you to 
receive postnatal/essential 
newborn care since your 
delivery? 
0 = No  
1 = Yes  
9 = Don’t Know  
6 
How much money did you or 
your husband lose because of 
this absence from work for 
your postnatal/essential 
newborn care since your 
delivery?   




Did you have to pay someone 
to take care of any other 
children while you took your 
youngest child for 
postnatal/essential newborn 
care since your delivery? 
0 = No  
1 = Yes  
3= Not applicable (Do not have children)  
8 
How much in total did you 
pay them to take care of your 
other children while you took 
your youngest child for 
postnatal/essential newborn 
care? 




Which mode of transport did 
you use most to reach the 
postnatal/essential newborn 
care facility? 
0 = Not Applicable for PNC received at home  
1= Walking  
2= Paddled rickshaw/Van gari  
3 = Electric rickshaw/van gari   
4 = Nosimon/votvoti (converted shallow water 
pump into vehicle) 
 
5 = CNG/Mahindra/ Tempo  
6 = Private vehicle (Car/Micro)  
7 = Ambulance (Government, private, NGO’s)  
8 =Train/Bus  




carts, tractor, trolley van) 
10 = Don’t know  
11 
What is the average amount 
of time (in minutes) you 
spent on __________ during 
your postnatal/essential 
newborn care visits, from the 
time you departed to the 
health facility until the time 
you returned? 























A 5.5 Consent forms 
 
Understanding service contents and costs of maternal and newborn health services 
for mCARE program evaluation in rural Bangladesh 
(A project of JiVitA – Johns Hopkins University Bangladesh) 
and 
Johns Hopkins Bloomberg School of Public Health, Baltimore, USA 
CONSENT FOR CLIENT 
 
 
Research Study Title: Understanding service contents and costs of maternal and 
newborn health services for mCARE program evaluation in rural Bangladesh 
Principal Investigator: Dr. Alain B. Labrique 
Student Investigator: Youngji Jo 
IRB No.: 00006999 
PI Version/Date: v3.0, June, 2016 
Salaam alaikum. I am ______. We are from the JiVitA Project of Johns Hopkins 
University-Bangladesh. The reason we are here today is to observe antenatal care 
services provision in this facility/community.  
 
Purpose: We would like to understand what services are given and what supplies and 
equipment are typically used in maternal and newborn service provision in rural 
Bangladesh. We are doing this to identify the gaps and scope of the service and to 
understand cost in community and facility care settings. 
 
Procedures: You are being asked as a client who is receiving antenatal care service in 
this community/facility.  If you give consent to participate in this study, we will be 
present while you are receiving services today and ask some questions at the end of the 
consultation. The questions will take about 10-20 minutes.  
 
Confidentiality: The information received about you will be kept confidential by JiVitA 
staff.  Your identity will not be revealed when the information is used.  
 
Risk or Discomfort/Benefit: The risks are minimal, but you may feel uncomfortable or 
embarrassed to have someone present during your medical examination. I will stay out 
of the way and will be observing the medical care and the supplies being used. If at any 
point you feel uncomfortable you can ask me to leave or ask to stop the interview. At the 
end of the interview, we will provide a snack or drink in appreciation of your time and 





Voluntariness: Please know that you can decide whether you allow me to observe the 
care that is provided and to interview you. You do not have to agree. Whether you agree 
or not, it will not affect services you receive today or during any future visit.  You may 
refuse to answer any question, and you may stop the interview at any time.   
 
Persons to Contact: If you have any questions about JiVitA or the study, I can answer them 
now or, you may contact our Field Officer (mention name) in the local field office.  For 
questions about your rights as human subjects in this project you may contact Dr. Hasmot 
Ali or Dr. Saijuddin Sheikh, senior project officers through the Gaibandha JiVitA office (tel: 
0541-52661). 
 
Would you like to provide consent for participation in the study?  
Your signature on this form means:  
• You have been informed about this study’s purpose, procedures, possible 
benefits and risks.  
• You have been given the chance to ask questions before you sign.  
• You have voluntarily agreed to be in this study.  
 
If you agree can you please sign or make your mark below on two copies of this form? 
You will receive one copy of this form and we will keep the other one.   
Thank you for your kind cooperation. 
 
 
Name                           Signature or thumbprint of woman                                       Date 
 
 
Name                           Signature or thumbprint of witness                                       Date  
 
 







Understanding service contents and costs of maternal and newborn health services 
for mCARE program evaluation in rural Bangladesh 
(A project of JiVitA – Johns Hopkins University Bangladesh) 
and 
Johns Hopkins Bloomberg School of Public Health, Baltimore, USA 
CONSENT FOR SERVICE PROVIDER 
 
Research Study Title: Understanding service contents and costs of maternal and 
newborn health services for mCARE program evaluation in rural Bangladesh 
Principal Investigator: Dr. Alain B. Labrique 
Student Investigator: Youngji Jo 
IRB No.: 00006999 
PI Version/Date: v3.0, June, 2016 
Salaam alaikum. I am ______. We are from the JiVitA Project of Johns Hopkins 
University-Bangladesh. The reason we are here today is to observe essential maternal 
and newborn services provision in this facility/community.  
 
Purpose: We would like to understand what services are given and what supplies and 
equipment are typically used in maternal and newborn service provision in rural 
Bangladesh. We are doing this to identify the gaps and scope of the service and to 
understand cost in community and facility care settings. 
 
Procedures: You are being asked as a maternal and newborn service provider in this 
community/facility.  We are not evaluating the service provision. Without any 
interruption, we will take notes about what types of care and items that you provide to 
your clients in what kind of methods or procedures. 
 
Confidentiality: The information received about you will be kept confidential by JiVitA 
staff.  Your identity will not be revealed when the information is used and no information 
about you or your clinical services will be shared with your supervisors.  
 
Risk or Discomfort/Benefit/Voluntariness: There is no known risk or direct benefits to 
participate to the study. It is your choice to take part in the study. You may refuse to 
participate, or if at any point you feel uncomfortable you can ask me to leave. Your choice 
will not affect your current or future work in this facility or will not be shared with your 
supervisors. 
 
Persons to Contact: If you have any questions about JiVitA or the study, I can answer them 
now or, you may contact our Field Officer (mention name) in the local field office.  For 




Ali or Dr. Saijuddin Sheikh, senior project officers through the Gaibandha JiVitA office (tel: 
0541-52661). 
 
Would you like to provide consent for participation in the study?  
 
Your signature on this form means:  
• You have been informed about this study’s purpose, procedures, possible 
benefits and risks.  
• You have been given the chance to ask questions before you sign.  
• You have voluntarily agreed to be in this study.  
 
If you agree can you please sign or make your mark below on two copies of this form? 
You will receive one copy of this form and we will keep the other one.   




Name                               Signature or thumbprint of provider                                 Date 
 
 
Name                                Signature or thumbprint of witness                                  Date  
 
 


















Appendix 7. Understanding Service Contents and Costs of Antenatal Care in Rural 
Bangladesh 
 
BACKGROUND: Current efforts to monitor progress of service coverage lack 
information on specific content, quality or cost of care, in fragmented health systems in 
many developing countries. Measuring antenatal care (ANC) service coverage is often 
limited to number of contacts or type of providers, which is a gap in understanding the 
quality as well as estimating costs and health impact. The study was conducted in rural 
Bangladesh, where 18.5% of pregnant women receive any one of ANC service and 82% 
of them receive the care from community-based service by the government and NGO (i.e. 
BRAC) health workers.  
 
OBJECTIVE: 1) To determine antenatal care health service content and practice with 
the equipment or any supplements provided by major service providers in rural 
Bangladesh; 2) To determine the gaps in and scope of service provision as well as related 
costs in respective community and facility care settings. 
 
METHODS: The data collection was conducted from September to October, 2016. 
Adapted from standardized guidelines, we designed and devised data collection methods 
and modules including observation studies of ANC service provision (n=72), and exit 
interviews with clients  
for user costs (n=72) in health clinics of community and facility levels. Based on 
standardized guidelines, the study assessed the service contents and costs of ANC in 
community level (i.e. satellite clinics) and facility level (i.e. primary and secondary health 
centers) services. The study samples were drawn from major service provision agencies 
including government and NGOs (e.g. BRAC and Smiling Sun) in this rural setting. 
Based on the scheduled dates, pregnant women were recruited purposively on the day of 
observation/ interview at the community or facility sites.  
 
Table A 7.1. Study population characteristics 
 




Family Welfare Visitor, 
BRAC SK, Paramedic 
Nurse, Family Welfare 
Visitor, Paramedics 
Age (years) 26, 28, 35, 36 years old 26, 29, 40 years old 
Schooling (years) 11~14 years 10~14 years 
Years of working on ANC 
service 
3~10 years 3~10 years 
Last training received 
(years) 
1~10 years ago 3~10 years ago 
Mother's characteristics 
Community (n=34) Facility (n=36) P-
value n % n % 
Age 
<20 13 38% 9 25% 0.23 
20-34 20 59% 26 72% 0.24 
35-49 1 3% 1 3% 0.98 
Parity 
First pregnancy 18 53% 13 36% 0.16 
Not first pregnancy 16 47% 23 64% 0.16 




13-26 week 6 18% 19 53% <0.05* 
27-32 week 14 41% 13 36% 0.66 
33-38 week 6 18% 2 6% 0.11 
ANC 
1st visit 14 41% 22 61% 0.10 
2nd visit 9 26% 6 17% 0.24 
3rd visit 8 24% 4 11% 0.17 
> 4th visits 3 9% 4 11% 0.75 
Literacy 
Yes 32 94% 30 83% 0.17 
No 2 6% 6 17% 0.17 
Schooling 
No schooling 5 15% 5 14% 0.92 
Class 1~9 completed 25 74% 21 58% 0.18 
SSC/HSC completed 3 9% 7 19% 0.19 




Work on own 
farm/unskilled labor/own 
business 28 82% 27 75% 0.59 
Private 
service/government 6 18% 9 25% 0.59 
• Women in earlier pregnancy stages (gestational age less then 12 weeks) tend to 
seek care at the community level; Women in progressively later pregnancy stages 
(gestational age between 13-26 weeks) tend to seek care at the facility level.  
• Women’s first ANC visits to community/facility clinics are generally sought at a 
gestational age of 8-26 weeks.  
 
Table A 7.2. ANC Service contents in community vs. Facility levels. 
 




    n % n % 
204. Client History 
(first visit and not 
identified 
Fn=28;Cn=20) 
Client’s age 20 100% 23 82% 
Medications the client is taking 7 35% 6 21% 
Date client’s last menstrual period began 20 100% 26 93% 
Number of prior pregnancies client has had 20 100% 26 93% 






Prior stillbirth(s) 4 20% 7 32% 
Infant(s) who died in the first month of life 4 20% 6 27% 
Heavy bleeding, during or after delivery 1 5% 0 0% 
Previous assisted delivery (c-section, ventouse, or 
forceps) 3 15% 9 41% 
Previous spontaneous abortions 3 15% 1 5% 
Previous menstrual regulation and induced abortion 2 10% 1 5% 
Previous multiple pregnancies 2 10% 1 5% 
Previous prolonged labor 1 5% 1 5% 
Previous pregnancy-induced hypertension 0 0% 0 0% 
Previous pregnancy-related convulsions 0 0% 0 0% 
High fever or infection during prior 
pregnancy/pregnancies 0 0% 0 0% 
206. Danger Signs 
of Current 
Pregnancy (n=36) 
Vomitting,/aversion of food 10 28% 21 58% 
Vaginal bleeding 6 17% 2 6% 
Foul smelling discharge 5 14% 5 14% 
Fever 7 19% 4 11% 
Headache or blurred vision 8 22% 3 8% 
Swollen face, hands or legs 8 22% 3 8% 
Severe abdominal pain 4 11% 7 19% 
Tiredness or breathlessness 1 3% 4 11% 




Persistent cough or difficulty breathing for 3 weeks or 
longer 1 3% 0 0% 
Convulsions (pre-eclampsia/eclampsia)  7 19% 2 6% 
Frequent or painful urination 3 8% 2 6% 
207. Physical 
Examination (n=36) 
 Take the client’s blood pressure 34 94% 31 86% 
Weight/height 34 94% 35 97% 
Conjunctiva/palms for anemia 9 25% 15 42% 
Legs/feet/hands for edema 10 28% 4 11% 
Fetal presentation 12 33% 23 64% 
Uterine height 13 36% 21 58% 
Fetal heartbeat (after 28 weeks) 9 25% 0 0% 
Swollen glands 0 0% 1 3% 
Ultrasound/refer client for ultrasound 7 19% 9 25% 
Vaginal examination/exam of perineal area  2 6% 1 3% 
Breasts 0 0% 0 0% 
208. Routine Tests  
(n=36) 
Anemia test (asked/performed/referred) 11 31% 3 8% 
Blood grouping (asked/performed/referred) 10 28% 8 22% 
Any urine test (asked/performed/referred) 11 31% 6 17% 
VDRL (Syphillis etc.) test (asked/performed/referred) 0 0% 3 8% 
209. Maintaining a 
Healthy Pregnancy 
(n=36) 
Discussed nutrition during the pregnancy 22 61% 14 39% 
Informed the client about the progress of the pregnancy  11 31% 22 61% 
Discussed the importance of at least 4 ANC visits 6 17% 2 6% 
Informed or gave a card on next ANC scheduled visits 30 83% 26 72% 
210. Iron 
Prophylaxis (n=36) 
Prescribed or gave iron pills or folic acid (IFA)  34 94% 35 97% 
Explained the purpose of iron or folic acid 6 17% 3 8% 
Explained how to take iron or folic-acid pills 25 69% 20 56% 
Explained side effects of iron pills 3 8% 0 0% 
211. Tetanus Toxoid 
Injection (GA >13 
weeks, 
Fn=34;Cn=26) 
Prescribed or gave a tetanus toxoid (TT) injection 16 62% 17 50% 
Explained the purpose of the TT injection 0 0% 1 3% 
212. Deworming 
Prescribed or gave Mebendazole/ Albendazole 0 0% 0 0% 
Explained the purpose of Mebendazole/ Albendazole 0 0% 0 0% 
214. Preparation for 
Delivery (GA >27 
week, Fn=15; 
Cn=20) 
Asked the client where she will deliver 8 40% 4 27% 
Advised to prepare for delivery (e.g. money, 
emergency transportation) 9 45% 3 20% 
Advised to use a skilled health worker for delivery 0 0% 1 7% 
Discussed what items to have on hand at home for 




(GA > 27 week, 
Fn=15; Cn=20) 
Newborn care (i.e. warmth, hygiene and cord care) 0 0% 0 0% 
Early initiation and prolonged breastfeeding 0 0% 1 7% 
Exclusive breastfeeding (e.g. 6 months) 0 0% 1 7% 
Importance of vaccination for the newborn 0 0% 0 0% 
Family planning options for after delivery 0 0% 0 0% 
 
Note: % of each service item was calculated based on eligible gestational stage of pregnant 

















• Service contents or provision lack in aspects of prior pregnancies, danger signs of current pregnancy, deworming, preparation 
for delivery, and newborn care. 
• Blood pressure, weight check, Iron folic acid, TT vaccine were frequently conducted. 
• Some educational consultation was better provided at the community level, while physical examination is better conducted at 
the Facility level. 
 
Table A.7.3. Provider and User costs for antenatal care 
 


















































Iron & Folic acid 25-30 tk 10 tk 10 tk 25-30 tk 25-30 tk 25-30 tk 10 tk 
Calcium 35-50 tk 10-15 tk 10 tk 35-50 tk 35-50 tk 35-50 tk 10 tk 
Vitamin B 
Complex   
20-36 tk 35 tk 
      
35 tk 
Misoprostal 150 tk     150 tk 150 tk 150 tk   
Total Supp. 
Costs 
220 tk 51 tk 55 tk 220 tk 220 tk 220 tk 55 tk 
Total provider costs (BDT) 233 65 76 230 262 241 113 
Total provider costs (USD) 3.03 0.85 0.99 2.99 3.41 3.13 1.47 






45 (28~55) tk 40 (33~53) tk 68 (32~85) tk 37 (28~71) tk 40 (34~65) tk 48 (37~71) tk 
51 (28~51) 
tk 
















13 (5~56) min 
15 (2~30) 
min 





















































0 tk 50 taka 0 tk 0 tk 0 tk 200 tk 120 tk 
Transportation 




0 tk 0 tk 0 tk 0 tk 0 tk 
55 (10~100) 
tk 
0  tk 





Total user costs (BDT) 54 88 38 34.00 115.00 413.00 117.00 
Total user costs (USD) 0.70 1.14 0.49 0.44 1.50 5.37 1.52 
Average user costs (USD) $0.78 $2.21 
(Note: Medicines and supplements depend on government supply in stock. The medicine costs are based on 1 blister-pack (10 tablets). Wage, 
time, costs are calculated based on median estimates of interquartile ranges 1-3. Hour wages are estimated based on women/husbands’ occupations 
and monthly salaries).  
 
Provider costs:  
• ANC service provision unit costs at the facility level ($2.75) were about double that in the  community ($1.62). These 
estimates are similar or slightly higher to the existing evidence, based on the supplementation condition. (79.2 BDT: 1.1 USD, 
BRAC MNCH Costs report, 2012) 
• Service provision times tend to be longer at NGO clinics (BRAC, Smiling Sun) than government clinics. This is in part due to 
the high volume of clients seeking care at government clinics. 
User costs: 




• Travel and waiting times were considerable (40-120 min) when seeking care at secondary clinics at the facility level, while 
consultation time (10-13 min) was low. 
• User costs in most satellite clinics or community clinics are free or minimal. Service fees and transportation costs are major 
cost drivers at the facility level.  
 
Table A.7.4. Provider and User costs for child delivery   
 
Level of care (Delivery) Community Facility 





Staff level SK FWV 
Staff monthly salary 6000 tk 14000~30000 tk 
Service provision time (Day) 1 (1~2) 1.5 (1~4.5) 
Total provider costs (BDT) 273~545 1000~6136 




Daily wage* 318 (261~386) 364 (227~455) 
Total time (day) 1 (1~2) 1.5 (1~4.5) 
Total wage loss 318 (261~772) 546 (227~2048) 
Direct 
costs 
Total direct costs (Provider consultation, 
transportation, admission, medicine) 
500 (0~1500) 3000 (589~9250) 
Total user costs (BDT) 818 (261~2722) 3546 (816~11298) 
Total user costs (USD) $11 (3~35) $46 (11~147) 
 
Table A.7.5. Provider and User costs for postnatal care   
 
Level of care (Postnatal care for mothers and newborns) Community Facility 




Staff level SK FWV 
Staff monthly salary 6000 tk 14000~30000 tk 
Service provision time (min) 15 18 (8~75) 
Total service costs 9 38 
Supplementation 
costs* 
ORS 3.7 5 




Case management of pneumonia (oral 
antibiotics) 
32 57 
Multiple micronutrients supplementation 2.5 n/a 
Antibiotics for dysentery n/a 1.5 
Cotrimoxazole for ARI(acute respiratory 
illness) 
n/a 20 
Total Supp. Costs 40 104 
Total provider costs (BDT) 48 141 
Total provider costs (USD) $0.6 $1.8 
User costs 
Indirect costs  
Hour wage* 40 (27~57) 45 (38~57) 
Total time (travel time, waiting time, 
consultation time and pharmacy time) 
0 1.42 (0.92~2.5) 
Total wage loss 0 64 (35~143) 
Direct costs Total direct costs (Medicine, transportation) 0 1000 (45~4563) 
Total user costs (BDT) 0 1064 (80~4706) 
Total user costs (USD) $0.0 14 (1.04~61) 
 
CONCLUSION: The study demonstrates that ANC sub-components, contents and care-seeking/provision costs differ by service 
provision setting as well as by stage of pregnancy care-seeking, resulting in different quality and cost implications throughout the 
continuum of care in the health systems.  
 
RECOMMENDATIONS:  
• Community-level workers need to further improve in identifying pregnant women and encouraging to seek their first ANC at 
earlier gestational ages.  
• ANC services at the community level could better focus on educational consultation, preventive measures, screening and 
referral strategies, while the facility level could better focus on physical examinations, laboratory tests, and treatment services. 
• Risk factors from prior and current pregnancy can be more systematically  identified for effective referral and prevention 
strategies at both the community and facility levels.  
• ANC service could be more cost effective through better coordination between public and NGO clinics by reducing waiting 
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